# EDGAR Filing Document

**Accession Number:** 0000822616
**File Stem:** 0001193125-26-181617
**Filing Date:** 2026-4
**Character Count:** 617958
**Document Hash:** e930f680878179ac825df55fe5bcd16d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-181617.hdr.sgml**: 20260427

**ACCESSION NUMBER**: 0001193125-26-181617

**CONFORMED SUBMISSION TYPE**: N-VPFS

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260427

**DATE AS OF CHANGE**: 20260427

**EFFECTIVENESS DATE**: 20260427

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Genworth Life & Annuity VA Separate Account 1
- **CENTRAL INDEX KEY:** 0000822616

**ORGANIZATION NAME:**
- **EIN:** 540283385
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-VPFS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-05343
- **FILM NUMBER:** 26899931

**BUSINESS ADDRESS:**
- **STREET 1:** 6610 WEST BROAD STREET
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23230
- **BUSINESS PHONE:** 804-281-6000

**MAIL ADDRESS:**
- **STREET 1:** 6610 WEST BROAD STREET
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23230

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GE LIFE & ANNUITY ASSURANCE CO IV
- **DATE OF NAME CHANGE:** 19981231

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIFE OF VIRGINIA SEPARATE ACCOUNT 4
- **DATE OF NAME CHANGE:** 19920703

## Series and Classes Contracts Data

### Genworth Life & Annuity VA Separate Account 1 (Series ID: S000009727)

| Class ID   | Class Name                           | Ticker Symbol   |
|:---|:---|:---|
| C000026710 | Commonwealth VA 90                   |  |
| C000026711 | Choice/Pre May 1, 2003               |  |
| C000026712 | RetireReady(SM) Choice VA            |  |
| C000026713 | Foundation/Pre May 1, 2003           |  |
| C000026714 | Foundation VA                        |  |
| C000026715 | RetireReady(SM) Selections VA        |  |
| C000026716 | RetireReady(SM) Retirement Answer VA |  |
| C000026717 | Commonwealth VA Mitchell             |  |
| C000026718 | Commonwealth VA Plus                 |  |
| C000026719 | RetireReady(SM) Extra VA             |  |
| C000026720 | Commonwealth Extra                   |  |
| C000026721 | RetireReady(SM) Extra II VA          |  |
| C000026722 | RetireReady(SM) Freedom VA           |  |
| C000026723 | Commonwealth Freedom                 |  |
| C000026724 | Savvy Investor                       |  |

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

**Financial Statements** 

**Year ended December 31, 2025** 

**(With Report of Independent Registered Public Accounting Firm Thereon)** 

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

**Table of Contents**

Year ended December 31, 2025

---

| | | |
|:---|:---|:---|
|  | **Page** | **Page** |
|  [Report of Independent Registered Public Accounting Firm](#fintoc215142_1) |  | F-1 |
|  [Statements of Assets and Liabilities](#fintoc215142_2) |  | F-6 |
|  [Statements of Operations](#fintoc215142_3) |  | F-18 |
|  [Statements of Changes in Net Assets](#fintoc215142_4) |  | F-30 |
|  [Notes to Financial Statements](#fintoc215142_5) |  | F-62 |

---

------

##### [**Table of Contents**](#toc)
**Report of Independent Registered Public Accounting Firm** 

To the Board of Directors of

Genworth Life and Annuity Insurance Company

and

Contract Owners of

Genworth Life & Annuity VA Separate Account 1:

*Opinion on the Financial Statements* 

We have audited the accompanying statements of assets and liabilities of the subaccounts listed in the Appendix that comprise Genworth Life & Annuity VA Separate Account 1 (the Subaccounts), as of December 31, 2025, the related statements of operations for the year or period listed in the Appendix, the statements of changes in net assets for each of the years or periods listed in the Appendix, and the related notes (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Subaccounts as of December 31, 2025, the results of their operations for the year or period listed in the Appendix, and the changes in their net assets for each of the years or periods listed in the Appendix, in conformity with U.S. generally accepted accounting principles.

*Basis for Opinion* 

These financial statements are the responsibility of the Subaccounts' management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Subaccounts in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Such procedures also included confirmation of securities owned as of December 31, 2025, by correspondence with the transfer agent of the underlying investments. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ KPMG LLP

We have served as the auditor of one or more Genworth Life and Annuity Insurance Company separate account investment companies since 1997.

Richmond, Virginia

April 23, 2026

------

##### [**Table of Contents**](#toc)
**Appendix** 

Statements of assets and liabilities as of December 31, 2025, the related statements of operations for the year then ended, and the statements of changes in net assets for each of the years in the two-year period then ended.

AB Variable Products Series Fund, Inc.

AB VPS Balanced Hedged Allocation Portfolio — Class B

AB VPS International Value Portfolio — Class B

AB VPS Large Cap Growth Portfolio — Class B

AB VPS Relative Value Portfolio — Class B

AB VPS Small Cap Growth Portfolio — Class B

AB VPS Sustainable Global Thematic Portfolio — Class B

Advanced Series Trust

AST International Equity Portfolio — Class I Shares

AIM Variable Insurance Funds (Invesco Variable Insurance Funds)

Invesco V.I. American Franchise Fund — Series I shares

Invesco V.I. American Franchise Fund — Series II shares

Invesco V.I. American Value Fund — Series II shares

Invesco V.I. Comstock Fund — Series II shares

Invesco V.I. Core Equity Fund — Series I shares

Invesco V.I. Core Plus Bond Fund — Series I shares

Invesco V.I. Discovery Large Cap Fund — Series I shares (1)

Invesco V.I. Discovery Large Cap Fund — Series II Shares (1)

Invesco V.I. Discovery Mid Cap Growth Fund — Series I shares

Invesco V.I. Discovery Mid Cap Growth Fund — Series II shares

Invesco V.I. EQV International Equity Fund — Series II shares

Invesco V.I. Equity and Income Fund — Series I shares

Invesco V.I. Equity and Income Fund — Series II shares

Invesco V.I. Global Fund — Series II shares

Invesco V.I. Global Real Estate Fund — Series II shares

Invesco V.I. Global Strategic Income Fund — Series I shares

Invesco V.I. Government Securities Fund — Series I shares

Invesco V.I. Main Street Fund<sup>®</sup> — Series II shares

Invesco V.I. Main Street Small Cap Fund<sup>®</sup> — Series II shares

Invesco V.I. Technology Fund — Series I shares

Allspring Variable Trust

Allspring VT Discovery All Cap Growth Fund — Class 2

BNY Mellon

BNY Mellon Investment Portfolios — MidCap Stock Portfolio — Initial Shares

BNY Mellon Sustainable U.S. Equity Portfolio, Inc. — Initial Shares

BNY Mellon Variable Investment Fund — Government Money Market Portfolio

BlackRock Variable Series Funds, Inc.

BlackRock Advantage SMID Cap V.I. Fund — Class III Shares

BlackRock Basic Value V.I. Fund — Class III Shares

BlackRock Global Allocation V.I. Fund — Class III Shares

BlackRock Large Cap Focus Growth V.I. Fund — Class III Shares

Columbia Funds Variable Series Trust II

CTIVP<sup>®</sup> — Principal Large Cap Growth Fund — Class 1 (1)

Columbia Variable Portfolio — Overseas Core Fund — Class 2

Deutsche DWS Variable Series II

DWS Small Mid Cap Value VIP — Class B Shares

Eaton Vance Variable Trust

VT Floating — Rate Income Fund

------

##### [**Table of Contents**](#toc)
Federated Hermes Insurance Series

Federated Hermes High Income Bond Fund II — Primary Shares

Federated Hermes High Income Bond Fund II — Service Shares

Federated Hermes Kaufmann Fund II — Service Shares

Federated Hermes Managed Volatility Fund II — Primary Shares

Fidelity<sup>®</sup> Variable Insurance Products Fund

VIP Asset Manager 50% Portfolio — Initial Class (1)

VIP Asset Manager 50% Portfolio — Service Class 2 (1)

VIP Balanced Portfolio — Service Class 2

VIP Contrafund<sup>®</sup> Portfolio — Initial Class

VIP Contrafund<sup>®</sup> Portfolio — Service Class 2

VIP Dynamic Capital Appreciation Portfolio — Service Class 2

VIP Equity-Income Portfolio<sup>SM</sup> — Initial Class

VIP Equity-Income Portfolio<sup>SM</sup> — Service Class 2

VIP Growth & Income Portfolio — Initial Class

VIP Growth & Income Portfolio — Service Class 2

VIP Growth Opportunities Portfolio — Initial Class

VIP Growth Opportunities Portfolio — Service Class 2

VIP Growth Portfolio — Initial Class

VIP Growth Portfolio — Service Class 2

VIP Investment Grade Bond Portfolio — Service Class 2

VIP Mid Cap Portfolio — Initial Class

VIP Mid Cap Portfolio — Service Class 2

VIP Overseas Portfolio — Initial Class

VIP Value Strategies Portfolio — Service Class 2

Franklin Templeton Variable Insurance Products Trust

Franklin Allocation VIP Fund — Class 2 Shares

Franklin Income VIP Fund — Class 2 Shares

Franklin Large Cap Growth VIP Fund — Class 2 Shares

Franklin Mutual Shares VIP Fund — Class 2 Shares

Templeton Foreign VIP Fund — Class 1 Shares

Templeton Foreign VIP Fund — Class 2 Shares

Templeton Global Bond VIP Fund — Class 1 Shares

Templeton Growth VIP Fund — Class 2 Shares

Goldman Sachs Variable Insurance Trust

Goldman Sachs Government Money Market Fund — Service Shares

Goldman Sachs Large Cap Value Fund — Institutional Shares

Goldman Sachs Mid Cap Value Fund — Institutional Shares

Janus Aspen Series

Janus Henderson Balanced Portfolio — Institutional Shares

Janus Henderson Balanced Portfolio — Service Shares

Janus Henderson Enterprise Portfolio — Institutional Shares

Janus Henderson Enterprise Portfolio — Service Shares

Janus Henderson Flexible Bond Portfolio — Institutional Shares

Janus Henderson Forty Portfolio — Institutional Shares

Janus Henderson Forty Portfolio — Service Shares

Janus Henderson Global Research Portfolio — Institutional Shares

Janus Henderson Global Research Portfolio — Service Shares

Janus Henderson Global Technology and Innovation Portfolio — Service Shares

Janus Henderson Overseas Portfolio — Institutional Shares

Janus Henderson Overseas Portfolio — Service Shares

Janus Henderson Research Portfolio — Institutional Shares

Janus Henderson Research Portfolio — Service Shares

------

##### [**Table of Contents**](#toc)
Legg Mason Partners Variable Equity Trust

ClearBridge Variable Dividend Strategy Portfolio — Class I

ClearBridge Variable Dividend Strategy Portfolio — Class II

ClearBridge Variable Growth Portfolio — Class II (1)

ClearBridge Variable Large Cap Value Portfolio — Class I

Lincoln Variable Insurance Products Trust

LVIP American Century Disciplined Core Value Fund — Standard Class II (1)

LVIP American Century Inflation Protection Fund — Service Class (1)

LVIP American Century International Fund — Standard Class II (1)

LVIP American Century Ultra<sup>®</sup> Fund — Standard Class II (1)

LVIP American Century Value Fund — Standard Class II (1)

LVIP JPMorgan Core Bond Fund — Standard Class

LVIP JPMorgan Mid Cap Value Fund — Standard Class

LVIP JPMorgan Small Cap Core Fund — Standard Class

LVIP JPMorgan U.S. Equity Fund — Standard Class

MFS<sup>®</sup> Variable Insurance Trust

MFS<sup>®</sup> Investors Trust Series — Service Class Shares

MFS<sup>®</sup> New Discovery Series — Service Class Shares

MFS<sup>®</sup> Total Return Series — Service Class Shares

MFS<sup>®</sup> Utilities Series — Service Class Shares

MFS<sup>®</sup> Variable Insurance Trust II

MFS<sup>®</sup> Income Portfolio — Service Class Shares

MFS<sup>®</sup> Massachusetts Investors Growth Stock Portfolio — Service Class Shares

PIMCO Variable Insurance Trust

All Asset Portfolio — Advisor Class Shares

High Yield Portfolio — Administrative Class Shares

International Bond Portfolio (U.S. Dollar Hedged) — Administrative Class Shares

Long-Term U.S. Government Portfolio — Administrative Class Shares

Low Duration Portfolio — Administrative Class Shares

Total Return Portfolio — Administrative Class Shares

Rydex Variable Trust

NASDAQ — 100<sup>®</sup> Fund

State Street Variable Insurance Series Funds, Inc.

Income V.I.S. Fund — Class 1 Shares

Premier Growth Equity V.I.S. Fund — Class 1 Shares

Real Estate Securities V.I.S. Fund — Class 1 Shares

S&P 500<sup>®</sup> Index V.I.S. Fund — Class 1 Shares

Small-Cap Equity V.I.S. Fund — Class 1 Shares

Total Return V.I.S. Fund — Class 1 Shares

Total Return V.I.S. Fund — Class 3 Shares

U.S. Equity V.I.S. Fund — Class 1 Shares

The Alger Portfolios

Alger Large Cap Growth Portfolio — Class I-2 Shares

Alger Small Cap Growth Portfolio — Class I-2 Shares

The Prudential Series Fund

PSF PGIM Jennison Blend Portfolio — Class II Shares

PSF PGIM Jennison Growth Portfolio — Class II Shares

Statements of assets and liabilities as of December 31, 2025, the related statements of operations for the period from January 1, 2025 to April 11, 2025 (liquidation date) and the statements of changes in net assets for the period from January 1, 2025 to April 11, 2025 (liquidation date) and for the year ended December 31, 2024.

The Prudential Series Fund

PSF Mid-Cap Growth Portfolio — Class II Shares

PSF Natural Resources Portfolio — Class II Shares

(1) See Note 1 to the financial statements for the former name of the subaccount.

------

##### [**Table of Contents**](#toc)
[THIS PAGE INTENTIONALLY LEFT BLANK]

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities

December 31, 2025

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **** <br>**** <br>**AB Variable Products Series Fund, Inc.** | **** <br>**** <br>**AB Variable Products Series Fund, Inc.** | **** <br>**** <br>**AB Variable Products Series Fund, Inc.** | **** <br>**** <br>**AB Variable Products Series Fund, Inc.** | **** <br>**** <br>**AB Variable Products Series Fund, Inc.** |
| | **AB VPS**<br>**Balanced**<br>**Hedged**<br>**Allocation**<br>**Portfolio —**<br>**Class B** | **AB VPS**<br>**International<br>Value<br>Portfolio —**<br>**Class B** | **AB VPS**<br>**Large Cap<br>Growth**<br>**Portfolio —**<br>**Class B** | **AB VPS**<br>**Relative**<br> **Value<br>Portfolio —<br>Class B** | **AB VPS**<br>**Small Cap<br>Growth<br>Portfolio —**<br>**Class B** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $5325555 | $16862081 | $11836975 | $24686698 | $2390031 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  | 4 |  |  |
| **Total assets** | **5325555** | **16862081** | **11836979** | **24686698** | **2390031** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 278 | 694 | 514 | 1050 | 102 |
| Payable for units withdrawn | 17990 | 188 |  | 15673 | 1 |
| **Total liabilities** | **18268** | **882** | **514** | **16723** | **103** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 4772387 | 16851566 | 11456054 | 24296253 | 2388670 |
| Variable annuity contract owners in the annuitization period | 534900 | 9633 | 380411 | 373722 | 1258 |
| **Net assets** | **$5307287** | **$16861199** | **$11836465** | **$24669975** | **$2389928** |
| Investments in securities at cost | $5347190 | $14101962 | $8360256 | $21549158 | $2993228 |
| Shares outstanding | 541765 | 809898 | 145275 | 800217 | 242397 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** |
| | **Invesco<br>V.I.<br>Discovery<br>Large Cap<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Discovery<br>Large Cap<br>Fund —<br>Series II Shares** | **Invesco<br>V.I.<br>Discovery<br>Mid Cap<br>Growth<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Discovery<br>Mid Cap<br>Growth<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>EQV<br>International<br>Equity Fund —<br>Series II shares** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $24273984 | $9569195 | $19329546 | $6141331 | $20662455 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  | 289 |  | 182 |  |
| **Total assets** | **24273984** | **9569484** | **19329546** | **6141513** | **20662455** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 936 | 395 | 719 | 261 | 948 |
| Payable for units withdrawn | 10248 |  | 13087 |  | 9976 |
| **Total liabilities** | **11184** | **395** | **13806** | **261** | **10924** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 24116168 | 9431621 | 19073368 | 6132524 | 20067111 |
| Variable annuity contract owners in the annuitization period | 146632 | 137468 | 242372 | 8728 | 584420 |
| **Net assets** | **$24262800** | **$9569089** | **$19315740** | **$6141252** | **$20651531** |
| Investments in securities at cost | $18302982 | $8136768 | $17403308 | $6358016 | $20001950 |
| Shares outstanding | 383778 | 161505 | 257008 | 96851 | 583850 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **AB Variable<br>Products Series<br>Fund, Inc.<br>(continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** |
| **AB VPS<br>Sustainable<br>Global<br>Thematic<br>Portfolio —<br>Class B** | **Invesco<br>V.I.<br>American<br>Franchise<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>American<br>Franchise<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>American<br>Value<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Comstock<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Core Equity<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Core Plus<br>Bond<br>Fund —<br>Series I shares** |
| $1537310 | $7057151 | $3515745 | $12427821 | $46279304 | $64616725 | $4669871 |
| 6 | 345 | 37 | 82 |  |  |  |
| **1537316** | **7057496** | **3515782** | **12427903** | **46279304** | **64616725** | **4669871** |
| 66 | 309 | 148 | 523 | 2051 | 3049 | 183 |
|  |  |  |  | 12969 | 37445 |  |
| **66** | **309** | **148** | **523** | **15020** | **40494** | **183** |
| 1537122 | 6880128 | 3515376 | 12369763 | 45457386 | 61965807 | 4619610 |
| 128 | 177059 | 258 | 57617 | 806898 | 2610424 | 50078 |
| **$1537250** | **$7057187** | **$3515634** | **$12427380** | **$46264284** | **$64576231** | **$4669688** |
| $1408609 | $5367752 | $2479631 | $11359108 | $42477212 | $61156342 | $4644612 |
| 50803 | 87125 | 48864 | 699765 | 2173758 | 1793415 | 798269 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Invesco<br>V.I.<br>Equity and<br>Income<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Equity and<br>Income<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Global<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Global Real<br>Estate<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Global Strategic<br>Income<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Government<br>Securities<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Main Street<br>Fund<sup>®</sup> —<br>Series II shares** |
| $5818555 | $22095524 | $27362998 | $46129 | $1368706 | $— | $77393605 |
| **5818555** | **22095524** | **27362998** | **46129** | **1368706** | **—** | **77393605** |
| 214 | 1163 | 1158 | 2 | 52 |  | 3622 |
| 5258 | 1212 | 22 | 1 | 873 |  | 37942 |
| **5472** | **2375** | **1180** | **3** | **925** | **—** | **41564** |
| 5760040 | 21326494 | 27188875 | 45798 | 1324549 |  | 74431007 |
| 53043 | 766655 | 172943 | 328 | 43232 |  | 2921034 |
| **$5813083** | **$22093149** | **$27361818** | **$46126** | **$1367781** | **$—** | **$77352041** |
| $5503317 | $20881458 | $27684184 | $45928 | $1488242 | $— | $75152378 |
| 318476 | 1219400 | 753802 | 3343 | 299498 |  | 3608093 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **AIM Variable Insurance Funds**<br>**(Invesco Variable Insurance<br>Funds) (continued)** | **AIM Variable Insurance Funds**<br>**(Invesco Variable Insurance<br>Funds) (continued)** | **Advanced<br>Series Trust** | **Allspring<br>Variable Trust** | **BNY Mellon** |
| | **Invesco<br>V.I.<br>Main Street<br>Small Cap<br>Fund<sup>®</sup> —<br>Series II shares** | **Invesco<br>V.I.<br>Technology<br>Fund —<br>Series I shares** | **AST<br>International<br>Equity<br>Portfolio —<br>Class I Shares** | **Allspring<br>VT Discovery<br>All Cap Growth<br>Fund —<br>Class 2** | **BNY Mellon<br>Investment<br>Portfolios —<br>MidCap<br>Stock<br>Portfolio —<br>Initial Shares** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $22763515 | $— | $— | $2176959 | $123602 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  |  |  |  |
| **Total assets** | **22763515** | **—** | **—** | **2176959** | **123602** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 1041 |  |  | 90 | 5 |
| Payable for units withdrawn | 6784 |  |  | 2 | 1 |
| **Total liabilities** | **7825** | **—** | **—** | **92** | **6** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 22129126 |  |  | 2176867 | 123235 |
| Variable annuity contract owners in the annuitization period | 626564 |  |  |  | 361 |
| **Net assets** | **$22755690** | **$—** | **$—** | **$2176867** | **$123596** |
| Investments in securities at cost | $21705574 | $— | $— | $2540259 | $107441 |
| Shares outstanding | 821491 |  |  | 104360 | 6077 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Columbia<br>Funds Variable<br>Series Trust II<br>(continued)** | **Deutsche DWS<br>Variable<br>Series II** | **Eaton Vance<br>Variable Trust** | **Federated Hermes Insurance<br>Series** | **Federated Hermes Insurance<br>Series** |
| | **Columbia<br>Variable<br>Portfolio —<br>Overseas Core<br>Fund —<br>Class 2** | **DWS Small Mid<br>Cap Value<br>VIP —<br>Class B Shares** | **VT<br>Floating-Rate<br>Income Fund** | **Federated<br>Hermes High<br>Income Bond<br>Fund II —<br>Primary Shares** | **Federated<br>Hermes High<br>Income Bond<br>Fund II —<br>Service Shares** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $8339737 | $143370 | $16229479 | $3814185 | $4865564 |
| Dividend receivable |  |  | 84816 |  |  |
| Receivable for units sold |  |  |  |  | 76 |
| **Total assets** | **8339737** | **143370** | **16314295** | **3814185** | **4865640** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 359 | 8 | 756 | 153 | 206 |
| Payable for units withdrawn | 36366 | 3 | 6489 | 13 |  |
| **Total liabilities** | **36725** | **11** | **7245** | **166** | **206** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 8281921 | 75909 | 15674826 | 3740882 | 4848871 |
| Variable annuity contract owners in the annuitization period | 21091 | 67450 | 632224 | 73137 | 16563 |
| **Net assets** | **$8303012** | **$143359** | **$16307050** | **$3814019** | **$4865434** |
| Investments in securities at cost | $6147947 | $128721 | $16877814 | $4029640 | $5146804 |
| Shares outstanding | 471172 | 10154 | 1939006 | 659894 | 846185 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **BNY Mellon (continued)** | **BNY Mellon (continued)** | **BlackRock Variable Series Funds, Inc.** | **BlackRock Variable Series Funds, Inc.** | **BlackRock Variable Series Funds, Inc.** | **BlackRock Variable Series Funds, Inc.** | **Columbia<br>Funds Variable<br>Series Trust II** |
| **BNY Mellon<br>Sustainable U.S.<br>Equity<br>Portfolio,<br>Inc. —<br>Initial Shares** | **BNY Mellon<br>Variable<br>Investment<br>Fund —<br>Government<br>Money Market<br>Portfolio** | **BlackRock<br>Advantage<br>SMID Cap<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Basic Value<br>V.I.<br>Fund —<br>Class III Shares** | **BlackRock<br>Global<br>Allocation<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Large Cap<br>Focus Growth<br>V.I.<br>Fund —<br>Class III Shares** | **CTIVP<sup>®</sup> —<br>Principal<br>Large Cap<br>Growth<br>Fund —<br>Class 1** |
| $10256077 | $950573 | $2473117 | $14134169 | $107224629 | $9307092 | $25710572 |
|  | 3070 |  |  |  |  |  |
| **10256077** | **953643** | **2473117** | **14134169** | **107224629** | **9307092** | **25710572** |
| 428 | 36 | 108 | 596 | 5474 | 393 | 1069 |
|  |  | 5 | 1030 | 9876 | 1 | 28087 |
| **428** | **36** | **113** | **1626** | **15350** | **394** | **29156** |
| 10255649 | 935414 | 2467804 | 14112717 | 97903181 | 9306698 | 25593155 |
|  | 18193 | 5200 | 19826 | 9306098 |  | 88261 |
| **$10255649** | **$953607** | **$2473004** | **$14132543** | **$107209279** | **$9306698** | **$25681416** |
| $6304442 | $950573 | $2696681 | $14021095 | $112015727 | $8029234 | $14777871 |
| 175318 | 950573 | 239411 | 1033200 | 8037828 | 445529 | 315390 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Federated Hermes Insurance Series<br>(continued)** | **Federated Hermes Insurance Series<br>(continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Federated<br>Hermes<br>Kaufmann<br>Fund II —<br>Service Shares** | **Federated<br>Hermes Managed<br>Volatility<br>Fund II —<br>Primary Shares** | **VIP Asset<br>Manager 50%<br>Portfolio —<br>Initial Class** | **VIP Asset<br>Manager 50%<br>Portfolio —<br>Service Class 2** | **VIP<br>Balanced<br>Portfolio —<br>Service Class 2** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Initial Class** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Service Class 2** |
| $22714024 | $6288993 | $25890637 | $3955169 | $52090915 | $107831270 | $133093817 |
|  |  |  |  | 208 |  |  |
| **22714024** | **6288993** | **25890637** | **3955169** | **52091123** | **107831270** | **133093817** |
| 1031 | 254 | 865 | 191 | 2639 | 4231 | 5990 |
| 6650 | 1425 | 11893 |  |  | 4289 | 51394 |
| **7681** | **1679** | **12758** | **191** | **2639** | **8520** | **57384** |
| 22137430 | 6224842 | 25377908 | 3921757 | 49927394 | 106643279 | 129523443 |
| 568913 | 62472 | 499971 | 33221 | 2161090 | 1179471 | 3512990 |
| **$22706343** | **$6287314** | **$25877879** | **$3954978** | **$52088484** | **$107822750** | **$133036433** |
| $21481790 | $5943313 | $22376429 | $3479182 | $40132926 | $73171237 | $105543717 |
| 1309921 | 604711 | 1469389 | 233068 | 2046794 | 1800489 | 2340728 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** |
| | **VIP<br>Dynamic<br>Capital<br>Appreciation<br>Portfolio —<br>Service Class 2** | **VIP<br>Equity-Income<br>Portfolio<sup>SM</sup> —<br>Initial Class** | **VIP<br>Equity-Income<br>Portfolio<sup>SM</sup> —<br>Service Class 2** | **VIP<br>Growth &<br>Income<br>Portfolio —<br>Initial Class** | **VIP<br>Growth &<br>Income<br>Portfolio —<br>Service Class 2** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $1855741 | $62810286 | $31317951 | $14191879 | $11758093 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  |  |  |  |
| **Total assets** | **1855741** | **62810286** | **31317951** | **14191879** | **11758093** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 79 | 2363 | 1349 | 560 | 505 |
| Payable for units withdrawn | 1 | 3806 | 62257 | 19 | 5502 |
| **Total liabilities** | **80** | **6169** | **63606** | **579** | **6007** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 1855661 | 62078916 | 30669324 | 14170234 | 11665699 |
| Variable annuity contract owners in the annuitization period |  | 725201 | 585021 | 21066 | 86387 |
| **Net assets** | **$1855661** | **$62804117** | **$31254345** | **$14191300** | **$11752086** |
| Investments in securities at cost | $1401207 | $49844641 | $25711842 | $9345392 | $8476420 |
| Shares outstanding | 100473 | 2134227 | 1113329 | 425544 | 367555 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fidelity<sup>®</sup> Variable Insurance<br>Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance<br>Products Fund (continued)** | **Franklin Templeton Variable Insurance Products<br>Trust** | **Franklin Templeton Variable Insurance Products<br>Trust** | **Franklin Templeton Variable Insurance Products<br>Trust** |
| | **VIP<br>Overseas<br>Portfolio —<br>Initial Class** | **VIP<br>Value<br>Strategies<br>Portfolio —<br>Service Class 2** | **Franklin<br>Allocation<br>VIP Fund —<br>Class 2 Shares** | **Franklin<br>Income VIP<br>Fund —<br>Class 2 Shares** | **Franklin<br>Large Cap<br>Growth VIP<br>Fund —<br>Class 2 Shares** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $9895680 | $2311070 | $22984177 | $116171805 | $112515 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  |  |  |  |
| **Total assets** | **9895680** | **2311070** | **22984177** | **116171805** | **112515** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 371 | 99 | 1216 | 6126 | 5 |
| Payable for units withdrawn | 66 | 1 | 973 | 33519 |  |
| **Total liabilities** | **437** | **100** | **2189** | **39645** | **5** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 9819419 | 2304144 | 19060333 | 105466229 | 112510 |
| Variable annuity contract owners in the annuitization period | 75824 | 6826 | 3921655 | 10665931 |  |
| **Net assets** | **$9895243** | **$2310970** | **$22981988** | **$116132160** | **$112510** |
| Investments in securities at cost | $7688665 | $2074903 | $24465590 | $113621511 | $117972 |
| Shares outstanding | 359581 | 142923 | 4148768 | 7663048 | 6275 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **VIP<br>Growth**<br> **Opportunities<br>Portfolio —<br>Initial Class** | **VIP<br>Growth<br>Opportunities<br>Portfolio —<br>Service Class 2** | **VIP<br>Growth<br>Portfolio —<br>Initial Class** | **VIP<br>Growth<br>Portfolio —<br>Service Class 2** | **VIP<br>Investment<br>Grade Bond<br>Portfolio —<br>Service Class 2** | **VIP<br>Mid Cap<br>Portfolio —<br>Initial Class** | **VIP<br>Mid Cap<br>Portfolio —<br>Service Class 2** |
| $16741942 | $8286074 | $73215218 | $17539605 | $44898944 | $— | $45212898 |
|  |  |  | 122 |  |  |  |
| **16741942** | **8286074** | **73215218** | **17539727** | **44898944** | **—** | **45212898** |
| 658 | 352 | 2672 | 747 | 2127 |  | 1902 |
| 2459 | 22 | 3670 |  | 20728 |  | 26013 |
| **3117** | **374** | **6342** | **747** | **22855** | **—** | **27915** |
| 16714198 | 8140281 | 72513779 | 17426800 | 42820724 |  | 44801051 |
| 24627 | 145419 | 695097 | 112180 | 2055365 |  | 383932 |
| **$16738825** | **$8285700** | **$73208876** | **$17538980** | **$44876089** | **$—** | **$45184983** |
| $8251939 | $5010663 | $57104225 | $15085317 | $46151857 | $— | $44377627 |
| 167940 | 85955 | 749235 | 188842 | 4092885 |  | 1285553 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Goldman Sachs Variable Insurance<br>Trust** | **Goldman Sachs Variable Insurance<br>Trust** |
| **Franklin<br>Mutual<br>Shares<br>VIP Fund —<br>Class 2 Shares** | **Templeton<br>Foreign VIP<br>Fund —<br>Class 1 Shares** | **Templeton<br>Foreign VIP<br>Fund —<br>Class 2 Shares** | **Templeton<br>Global Bond<br>VIP Fund —<br>Class 1 Shares** | **Templeton<br>Growth VIP<br>Fund —<br>Class 2 Shares** | **Goldman Sachs<br>Government<br>Money Market<br>Fund —<br>Service Shares** | **Goldman Sachs<br>Large Cap Value<br>Fund —<br>Institutional<br>Shares** |
| $19339360 | $3143742 | $141155 | $1732274 | $4142347 | $111310146 | $4158648 |
|  |  |  |  |  | 335392 |  |
|  |  |  |  |  | 71270 |  |
| **19339360** | **3143742** | **141155** | **1732274** | **4142347** | **111716808** | **4158648** |
| 885 | 128 | 6 | 66 | 176 | 4825 | 167 |
| 11633 | 59 | 1 |  | 552 |  |  |
| **12518** | **187** | **7** | **66** | **728** | **4825** | **167** |
| 18764899 | 3111627 | 141148 | 1666421 | 4070068 | 110797746 | 4111974 |
| 561943 | 31928 |  | 65787 | 71551 | 914237 | 46507 |
| **$19326842** | **$3143555** | **$141148** | **$1732208** | **$4141619** | **$111711983** | **$4158481** |
| $20261833 | $2693198 | $121015 | $2027257 | $3536477 | $111310146 | $4695089 |
| 1201202 | 189040 | 8703 | 123734 | 292745 | 111310146 | 508392 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Goldman Sachs<br>Variable<br>Insurance<br>Trust<br>(continued)** | **Janus Aspen Series** | **Janus Aspen Series** | **Janus Aspen Series** | **Janus Aspen Series** |
| | **Goldman Sachs<br>Mid Cap Value<br>Fund —<br>Institutional**<br> **Shares** | **Janus Henderson<br>Balanced<br>Portfolio —<br>Institutional<br>Shares** | **Janus Henderson<br>Balanced<br>Portfolio —<br>Service Shares** | **Janus Henderson<br>Enterprise<br>Portfolio —<br>Institutional<br>Shares** | **Janus Henderson<br>Enterprise<br>Portfolio —<br>Service Shares** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $24165384 | $48706488 | $69819122 | $35083825 | $4588906 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  |  |  |  |
| **Total assets** | **24165384** | **48706488** | **69819122** | **35083825** | **4588906** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 990 | 1894 | 3426 | 1376 | 193 |
| Payable for units withdrawn | 8013 | 9661 | 23218 | 13752 | 306 |
| **Total liabilities** | **9003** | **11555** | **26644** | **15128** | **499** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 23833135 | 48224450 | 66846679 | 34765866 | 4588407 |
| Variable annuity contract owners in the annuitization period | 323246 | 470483 | 2945799 | 302831 |  |
| **Net assets** | **$24156381** | **$48694933** | **$69792478** | **$35068697** | **$4588407** |
| Investments in securities at cost | $23514666 | $29927473 | $45212309 | $25680310 | $3646488 |
| Shares outstanding | 1483449 | 871939 | 1173825 | 419763 | 62562 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Legg Mason Partners Variable<br>Equity Trust** | **Legg Mason Partners Variable<br>Equity Trust** |
| | **Janus Henderson<br>Overseas<br>Portfolio —<br>Service Shares** | **Janus Henderson<br>Research<br>Portfolio —<br>Institutional<br>Shares** | **Janus Henderson<br>Research<br>Portfolio —<br>Service Shares** | **ClearBridge<br>Variable Dividend<br>Strategy<br>Portfolio —<br>Class I** | **ClearBridge<br>Variable Dividend<br>Strategy<br>Portfolio —<br>Class II** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $1359813 | $41706849 | $3040398 | $3898422 | $4130834 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  |  |  |  |
| **Total assets** | **1359813** | **41706849** | **3040398** | **3898422** | **4130834** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 58 | 1611 | 130 | 154 | 224 |
| Payable for units withdrawn | 7 | 1307 | 91 |  | 2 |
| **Total liabilities** | **65** | **2918** | **221** | **154** | **226** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 1354654 | 41235993 | 3039770 | 3853141 | 3956460 |
| Variable annuity contract owners in the annuitization period | 5094 | 467938 | 407 | 45127 | 174148 |
| **Net assets** | **$1359748** | **$41703931** | **$3040177** | **$3898268** | **$4130608** |
| Investments in securities at cost | $795867 | $21976164 | $1615169 | $3834535 | $4059872 |
| Shares outstanding | 25647 | 642633 | 49647 | 192515 | 202294 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** |
| **Janus Henderson<br>Flexible Bond<br>Portfolio —<br>Institutional<br>Shares** | **Janus Henderson<br>Forty Portfolio —<br>Institutional<br>Shares** | **Janus Henderson<br>Forty Portfolio —<br>Service Shares** | **Janus Henderson<br>Global Research<br>Portfolio —<br>Institutional<br>Shares** | **Janus Henderson<br>Global Research<br>Portfolio —<br>Service Shares** | **Janus Henderson<br>Global Technology<br>and Innovation<br>Portfolio —<br>Service Shares** | **Janus Henderson<br>Overseas<br>Portfolio —<br>Institutional<br>Shares** |
| $5425846 | $38285984 | $16031631 | $34868137 | $2255915 | $13624088 | $16628073 |
|  |  | 228 |  | 63 |  |  |
| **5425846** | **38285984** | **16031859** | **34868137** | **2255978** | **13624088** | **16628073** |
| 211 | 1544 | 680 | 1338 | 95 | 551 | 656 |
| 1 | 2430 |  | 4379 |  | 41386 | 2797 |
| **212** | **3974** | **680** | **5717** | **95** | **41937** | **3453** |
| 5385124 | 37484649 | 16005596 | 33310153 | 2255883 | 13397429 | 16502380 |
| 40510 | 797361 | 25583 | 1552267 |  | 184722 | 122240 |
| **$5425634** | **$38282010** | **$16031179** | **$34862420** | **$2255883** | **$13582151** | **$16624620** |
| $6235508 | $26565537 | $12458181 | $19813616 | $1267942 | $7725077 | $11243618 |
| 546410 | 644328 | 309073 | 437657 | 29520 | 569093 | 297887 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Legg Mason Partners Variable Equity<br>Trust (continued)** | **Legg Mason Partners Variable Equity<br>Trust (continued)** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** |
| **ClearBridge<br>Variable<br>Growth<br>Portfolio —<br>Class II** | **ClearBridge<br>Variable Large<br>Cap Value<br>Portfolio —<br>Class I** | **LVIP American<br>Century<br>Disciplined Core<br>Value Fund —<br>Standard Class II** | **LVIP American<br>Century Inflation<br>Protection<br>Fund —<br>Service Class** | **LVIP American<br>Century<br>International<br>Fund —<br>Standard Class II** | **LVIP American<br>Century Ultra<sup>®</sup><br>Fund —<br>Standard Class II** | **LVIP American<br>Century Value<br>Fund —<br>Standard Class II** |
| $2273533 | $11105388 | $31966 | $13692060 | $195058 | $— | $59195 |
| **2273533** | **11105388** | **31966** | **13692060** | **195058** | **—** | **59195** |
| 100 | 459 | 2 | 650 | 9 |  | 2 |
| 2 | 14240 |  | 6172 | 2 |  |  |
| **102** | **14699** | **2** | **6822** | **11** | **—** | **2** |
| 2262184 | 10971040 | 31964 | 12887097 | 126795 |  | 59193 |
| 11247 | 119649 |  | 798141 | 68252 |  |  |
| **$2273431** | **$11090689** | **$31964** | **$13685238** | **$195047** | **$—** | **$59193** |
| $3309814 | $11414553 | $26498 | $14997382 | $174972 | $— | $48509 |
| 171717 | 579009 | 3302 | 1515279 | 15930 |  | 4582 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Lincoln Variable Insurance Products Trust (continued)** | **Lincoln Variable Insurance Products Trust (continued)** | **Lincoln Variable Insurance Products Trust (continued)** | **Lincoln Variable Insurance Products Trust (continued)** | **MFS<sup>®</sup> Variable<br>Insurance<br>Trust** |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **LVIP JPMorgan<br>Core Bond**<br> **Fund —<br>Standard Class** | **LVIP JPMorgan<br>Mid Cap Value<br>Fund —**<br> **Standard Class** | **LVIP JPMorgan<br>Small Cap Core<br>Fund —<br>Standard Class** | **LVIP JPMorgan<br>U.S. Equity<br>Fund —<br>Standard Class** | **MFS<sup>®</sup> Investors<br>Trust Series —<br>Service<br>Class Shares** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $720588 | $167078 | $12846 | $841474 | $3289570 |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  |  |  | 19 |
| **Total assets** | **720588** | **167078** | **12846** | **841474** | **3289589** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 38 | 8 |  | 42 | 139 |
| Payable for units withdrawn | 1 | 2 |  | 1 |  |
| **Total liabilities** | **39** | **10** | **—** | **43** | **139** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 448754 | 99507 | 12494 | 503579 | 3258803 |
| Variable annuity contract owners in the annuitization period | 271795 | 67561 | 352 | 337852 | 30647 |
| **Net assets** | **$720549** | **$167068** | **$12846** | **$841431** | **$3289450** |
| Investments in securities at cost | $750155 | $181984 | $12032 | $737995 | $3311137 |
| Shares outstanding | 72377 | 18540 | 585 | 17045 | 128650 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **PIMCO Variable Insurance Trust (continued)** | **PIMCO Variable Insurance Trust (continued)** | **PIMCO Variable Insurance Trust (continued)** | **PIMCO Variable Insurance Trust (continued)** | **Rydex Variable<br>Trust** |
| | **International<br>Bond Portfolio<br>(U.S. Dollar<br>Hedged) —<br>Administrative<br>Class Shares** | **Long-Term U.S.<br>Government<br>Portfolio —<br>Administrative<br>Class Shares** | **Low Duration<br>Portfolio —<br>Administrative<br>Class Shares** | **Total Return<br>Portfolio —<br>Administrative<br>Class Shares** | **NASDAQ —<br>100<sup>®</sup> Fund** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $977031 | $23175668 | $22381192 | $85260651 | $9881535 |
| Dividend receivable | 2835 | 69089 | 78150 | 305930 |  |
| Receivable for units sold | 173 |  |  |  |  |
| **Total assets** | **980039** | **23244757** | **22459342** | **85566581** | **9881535** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 41 | 1109 | 1035 | 3849 | 418 |
| Payable for units withdrawn |  | 9569 | 6774 | 76100 | 25 |
| **Total liabilities** | **41** | **10678** | **7809** | **79949** | **443** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 963619 | 22053783 | 21516023 | 82951453 | 9881092 |
| Variable annuity contract owners in the annuitization period | 16379 | 1180296 | 935510 | 2535179 |  |
| **Net assets** | **$979998** | **$23234079** | **$22451533** | **$85486632** | **$9881092** |
| Investments in securities at cost | $1013460 | $27833102 | $22670810 | $89805787 | $5245262 |
| Shares outstanding | 97314 | 3098351 | 2288465 | 9022291 | 102156 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **MFS<sup>®</sup> Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **MFS<sup>®</sup> Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **MFS<sup>®</sup> Variable Insurance Trust (continued)** | **MFS<sup>®</sup> Variable Insurance Trust II** | **MFS<sup>®</sup> Variable Insurance Trust II** | **PIMCO Variable Insurance Trust** | **PIMCO Variable Insurance Trust** |
| **MFS<sup>®</sup><br>New Discovery<br>Series —<br>Service<br>Class Shares** | **MFS<sup>®</sup><br>Total<br>Return<br>Series —<br>Service<br>Class Shares** | **MFS<sup>®</sup><br>Utilities<br>Series —<br>Service<br>Class Shares** | **MFS<sup>®</sup><br>Income<br>Portfolio —<br>Service<br>Class Shares** | **MFS<sup>®</sup><br>Massachusetts<br>Investors Growth<br>Stock Portfolio —<br>Service<br>Class Shares** | **All Asset<br>Portfolio —<br>Advisor<br>Class Shares** | **High Yield<br>Portfolio —<br>Administrative<br>Class Shares** |
| $7592195 | $23061764 | $8860885 | $11924 | $4208326 | $2917569 | $23275436 |
|  |  |  |  |  |  | 121898 |
| 348 |  | 239 |  | 353 |  |  |
| **7592543** | **23061764** | **8861124** | **11924** | **4208679** | **2917569** | **23397334** |
| 322 | 1220 | 384 |  | 178 | 129 | 1058 |
|  | 316 |  |  |  | 266 | 16289 |
| **322** | **1536** | **384** | **—** | **178** | **395** | **17347** |
| 7545222 | 22128673 | 8845452 | 11924 | 4182364 | 2917174 | 22674567 |
| 46999 | 931555 | 15288 |  | 26137 |  | 705420 |
| **$7592221** | **$23060228** | **$8860740** | **$11924** | **$4208501** | **$2917174** | **$23379987** |
| $9018176 | $22935909 | $7353790 | $13124 | $3872396 | $3032747 | $23122624 |
| 627454 | 1018629 | 240654 | 1409 | 192425 | 298931 | 3141084 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc.** |
| **Income<br>V.I.S. Fund —<br>Class 1 Shares** | **Premier<br>Growth Equity<br>V.I.S. Fund —<br>Class 1 Shares** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Real Estate<br>Securities<br>V.I.S. Fund —<br>Class 1 Shares** | **S&P 500<sup>®</sup><br>Index<br>V.I.S. Fund —<br>Class 1 Shares** | **Small-Cap<br>Equity<br>V.I.S. Fund —<br>Class 1 Shares** | **Total Return<br>V.I.S. Fund —<br>Class 1 Shares** | **Total Return<br>V.I.S. Fund —<br>Class 3 Shares** |
| $6673392 | $27074036 | $14597427 | $156625220 | $18158123 | $627990960 | $246723483 |
| 291 | 120 |  |  |  |  |  |
| **6673683** | **27074156** | **14597427** | **156625220** | **18158123** | **627990960** | **246723483** |
| 272 | 1133 | 593 | 6400 | 772 | 28015 | 12881 |
|  |  | 207 | 24034 | 11699 | 223216 | 81783 |
| **272** | **1133** | **800** | **30434** | **12471** | **251231** | **94664** |
| 6492644 | 26713424 | 14559958 | 155502296 | 17971721 | 137755428 | 179389082 |
| 180767 | 359599 | 36669 | 1092490 | 173931 | 489984301 | 67239737 |
| **$6673411** | **$27073023** | **$14596627** | **$156594786** | **$18145652** | **$627739729** | **$246628819** |
| $7562575 | $24255778 | $16313330 | $115128551 | $21342467 | $607840438 | $236256163 |
| 683749 | 235631 | 1387588 | 2643910 | 1637342 | 37027769 | 14547375 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **State Street<br>Variable<br>Insurance<br>Series Funds,<br>Inc.<br>(continued)** | **The Alger Portfolios** | **The Alger Portfolios** | **The Prudential Series Fund** | **The Prudential Series Fund** |
| | **U.S.<br>Equity<br>V.I.S.<br>Fund —<br>Class 1 Shares** | **Alger<br>Large Cap<br>Growth<br>Portfolio —<br>Class I-2 Shares** | **Alger<br>Small Cap<br>Growth<br>Portfolio —<br>Class I-2 Shares** | **PSF<br>Mid-Cap<br>Growth<br>Portfolio —<br>Class II Shares** | **PSF<br>Natural<br>Resources<br>Portfolio —<br>Class II Shares** |
| **Assets:** |  |  |  |  |  |
| Investments at fair value (note 2b) | $15063952 | $30625582 | $9710268 | $— | $— |
| Dividend receivable |  |  |  |  |  |
| Receivable for units sold |  |  |  |  |  |
| **Total assets** | **15063952** | **30625582** | **9710268** | **—** | **—** |
| **Liabilities:** |  |  |  |  |  |
| Accrued expenses payable to affiliate (note 4b) | 639 | 1210 | 386 |  |  |
| Payable for units withdrawn | 3144 | 28262 | 5370 |  |  |
| **Total liabilities** | **3783** | **29472** | **5756** | **—** | **—** |
| **Net assets attributable to:** |  |  |  |  |  |
| Variable annuity contract owners in the accumulation period | 15008135 | 30376271 | 9588791 |  |  |
| Variable annuity contract owners in the annuitization period | 52034 | 219839 | 115721 |  |  |
| **Net assets** | **$15060169** | **$30596110** | **$9704512** | **$—** | **$—** |
| Investments in securities at cost | $14687691 | $20046659 | $12517874 | $— | $— |
| Shares outstanding | 323886 | 296846 | 520937 |  |  |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Assets and Liabilities — Continued

December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund (continued)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PSF PGIM<br>Jennison Blend<br>Portfolio —<br>Class II Shares** | **PSF PGIM<br>Jennison Growth<br>Portfolio —<br>Class II Shares** |
| $9665978 | $8397107 |
| 10 |  |
| **9665988** | **8397107** |
| 414 | 374 |
|  | 1 |
| **414** | **375** |
| 9650113 | 8396732 |
| 15461 |  |
| **$9665574** | **$8396732** |
| $7131209 | $3380360 |
| 69117 | 42515 |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** |
|  | **AB VPS<br>Balanced<br>Hedged<br>Allocation<br>Portfolio —**<br>**Class B** | **AB VPS<br>International<br>Value<br>Portfolio —<br>Class B** | **AB VPS<br>Large Cap<br>Growth<br>Portfolio —<br>Class B** | **AB VPS<br>Relative<br>Value<br>Portfolio —<br>Class B** | **AB VPS<br>Small Cap<br>Growth<br>Portfolio —<br>Class B** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $99365 | $353024 | $— | $214406 | $— |
| Mortality and expense risk and administrative charges (note 4a) | 101381 | 170861 | 184987 | 382101 | 41844 |
| **Net investment income (expense)** | **(2016)** | **182163** | **(184987)** | **(167695)** | **(41844)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | (60357) | 360028 | 783726 | 693525 | (373521) |
| Change in unrealized appreciation (depreciation) | 544347 | 2592818 | (509548) | (526924) | 460476 |
| Capital gain distributions | 275403 |  | 1107027 | 2002121 |  |
| **Net realized and unrealized gain (loss) on investments** | **759393** | **2952846** | **1381205** | **2168722** | **86955** |
| **Increase (decrease) in net assets from operations** | **$757377** | **$3135009** | **$1196218** | **$2001027** | **$45111** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** |
|  | **Invesco**<br>**V.I.**<br>**Discovery**<br>**Large Cap**<br>**Fund —**<br>**Series I shares** | **Invesco**<br>**V.I.**<br>**Discovery**<br>**Large Cap<br>Fund —**<br>**Series II Shares** | **Invesco**<br>**V.I.**<br>**Discovery**<br>**Mid Cap**<br>**Growth**<br>**Fund —**<br>**Series I shares** | **Invesco**<br>**V.I.**<br>**Discovery**<br>**Mid Cap**<br>**Growth**<br>**Fund —**<br>**Series II shares** | **Invesco**<br>**V.I.**<br>**EQV<br>International**<br>**Equity Fund —**<br>**Series II shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $— | $— | $— | $— | $240995 |
| Mortality and expense risk and administrative charges (note 4a) | 340045 | 153204 | 262657 | 100506 | 349314 |
| **Net investment income (expense)** | **(340045)** | **(153204)** | **(262657)** | **(100506)** | **(108319)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 1463495 | 504009 | 251314 | 12143 | 157891 |
| Change in unrealized appreciation (depreciation) | (1421481) | (520425) | (1060052) | (351168) | 1480946 |
| Capital gain distributions | 2868473 | 1210587 | 1646423 | 612168 | 1315072 |
| **Net realized and unrealized gain (loss) on investments** | **2910487** | **1194171** | **837685** | **273143** | **2953909** |
| **Increase (decrease) in net assets from operations** | **$2570442** | **$1040967** | **$575028** | **$172637** | **$2845590** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **AB Variable<br>Products Series<br>Fund,<br>Inc. (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)** |
| **AB VPS<br>Sustainable<br>Global<br>Thematic<br>Portfolio —<br>Class B** | **Invesco<br>V.I.<br>American<br>Franchise<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>American<br>Franchise<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>American<br>Value<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Comstock<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Core<br>Equity<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Core<br>Plus Bond<br>Fund —<br>Series I shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $— | $— | $— | $24783 | $647678 | $409934 | $206100 |
| 24748 | 114538 | 54095 | 170819 | 697789 | 1041191 | 68844 |
| **(24748)** | **(114538)** | **(54095)** | **(146036)** | **(50111)** | **(631257)** | **137256** |
| 36909 | 623149 | 185473 | 122951 | 930261 | 708879 | (1425) |
| (158554) | (447241) | (166372) | 242431 | 579279 | 3373976 | 129237 |
| 206883 | 656219 | 360067 | 1780622 | 4799725 | 4719136 |  |
| **85238** | **832127** | **379168** | **2146004** | **6309265** | **8801991** | **127812** |
| **$60490** | **$717589** | **$325073** | **$1999968** | **$6259154** | **$8170734** | **$265068** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** |
| **Invesco<br>V.I.<br>Equity and<br>Income Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Equity and<br>Income<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Global Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Global<br>Real Estate<br>Fund —<br>Series II shares** | **Invesco<br>V.I.<br>Global<br>Strategic<br>Income<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Government<br>Securities<br>Fund —<br>Series I shares** | **Invesco<br>V.I.<br>Main Street<br>Fund<sup>®</sup> —<br>Series II shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $118935 | $413109 | $— | $819 | $79030 | $— | $240048 |
| 77458 | 434932 | 420556 | 2174 | 19340 |  | 1337989 |
| **41477** | **(21823)** | **(420556)** | **(1355)** | **59690** | **—** | **(1097941)** |
| 49497 | 267607 | 345105 | 8173 | (32098) |  | 45624 |
| 235115 | 819248 | (1684197) | 1931 | 122639 |  | 6648546 |
| 302123 | 1185251 | 5121732 |  |  |  | 4816659 |
| **586735** | **2272106** | **3782640** | **10104** | **90541** | **—** | **11510829** |
| **$628212** | **$2250283** | **$3362084** | **$8749** | **$150231** | **$—** | **$10412888** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **AIM Variable Insurance Funds<br>(Invesco Variable Insurance<br>Funds) (continued)** | **AIM Variable Insurance Funds<br>(Invesco Variable Insurance<br>Funds) (continued)** | **Advanced<br>Series Trust** | **Allspring<br>Variable Trust** | **BNY Mellon** |
|  | **Invesco<br>V.I.<br>Main Street<br>Small Cap<br>Fund<sup>®</sup> —<br>Series II shares** | **Invesco<br>V.I.<br>Technology<br>Fund —<br>Series I shares** | **AST<br>International<br>Equity<br>Portfolio —<br>Class I Shares** | **Allspring<br>VT<br>Discovery<br>All Cap<br>Growth<br>Fund —<br>Class 2** | **BNY Mellon<br>Investment<br>Portfolios—<br>MidCap<br>Stock<br>Portfolio —<br>Initial Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $54944 | $— | $— | $— | $1731 |
| Mortality and expense risk and administrative charges (note 4a) | 395813 |  |  | 33445 | 3255 |
| **Net investment income (expense)** | **(340869)** | **—** | **—** | **(33445)** | **(1524)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 473418 |  |  | (24316) | 7642 |
| Change in unrealized appreciation (depreciation) | (932171) |  |  | (435002) | (11669) |
| Capital gain distributions | 2443036 |  |  | 798197 | 22497 |
| **Net realized and unrealized gain (loss) on investments** | **1984283** | **—** | **—** | **338879** | **18470** |
| **Increase (decrease) in net assets from operations** | **$1643414** | **$—** | **$—** | **$305434** | **$16946** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Columbia<br>Funds Variable<br>Series Trust II<br>(continued)** | **Deutsche DWS<br>Variable<br>Series II** | **Eaton Vance<br>Variable Trust** | **Federated Hermes Insurance<br>Series** | **Federated Hermes Insurance<br>Series** |
|  | **Columbia<br>Variable<br>Portfolio—<br>Overseas<br>Core<br>Fund —<br>Class 2** | **DWS Small<br>Mid Cap<br>Value<br>VIP —<br>Class B Shares** | **VT Floating-<br>Rate<br>Income Fund** | **Federated<br>Hermes<br>High Income<br>Bond<br>Fund II —<br>Primary<br>Shares** | **Federated<br>Hermes<br>High Income<br>Bond<br>Fund II —<br>Service Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income—Ordinary dividends | $142851 | $62 | $1134328 | $248812 | $299765 |
| Mortality and expense risk and administrative charges (note 4a) | 125883 | 1351 | 285429 | 59402 | 77422 |
| **Net investment income (expense)** | **16968** | **(1289)** | **848899** | **189410** | **222343** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 322108 | 1446 | (145407) | (78688) | (88612) |
| Change in unrealized appreciation (depreciation) | 2089427 | 13973 | (347551) | 151509 | 183704 |
| Capital gain distributions |  | 1228 |  |  |  |
| **Net realized and unrealized gain (loss) on investments** | **2411535** | **16647** | **(492958)** | **72821** | **95092** |
| **Increase (decrease) in net assets from operations** | **$2428503** | **$15358** | **$355941** | **$262231** | **$317435** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **BNY Mellon (continued)** | **BNY Mellon (continued)** | **BlackRock Variable Series Funds, Inc.** | **BlackRock Variable Series Funds, Inc.** | **BlackRock Variable Series Funds, Inc.** | **BlackRock Variable Series Funds, Inc.** | **Columbia<br>Funds Variable<br>Series Trust II** |
| **BNY Mellon<br>Sustainable<br>U.S. Equity<br>Portfolio,<br>Inc. —<br>Initial Shares** | **BNY Mellon<br>Variable<br>Investment<br>Fund —<br>Government<br>Money Market<br>Portfolio** | **BlackRock<br>Advantage<br>SMID Cap<br>V.I.<br>Fund —<br>Class III Shares** | **BlackRock<br>Basic Value<br>V.I.<br>Fund —<br>Class III Shares** | **BlackRock<br>Global<br>Allocation<br>V.I.<br>Fund —<br>Class III Shares** | **BlackRock<br>Large Cap<br>Focus<br>Growth<br>V.I.<br>Fund —<br>Class III Shares** | **CTIVP<sup>®</sup> —<br>Principal<br>Large Cap<br>Growth<br>Fund —<br> Class 1** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $26039 | $41640 | $37469 | $243484 | $4248300 | $— | $— |
| 156325 | 16441 | 75451 | 198880 | 2000732 | 141816 | 397726 |
| **(130286)** | **25199** | **(37982)** | **44604** | **2247568** | **(141816)** | **(397726)** |
| 472062 |  | 400019 | 41239 | (289709) | 269645 | 2278807 |
| 228204 |  | (734109) | 865355 | 4841262 | (797377) | 1155297 |
| 832043 |  | 336770 | 1677993 | 10432733 | 1550825 |  |
| **1532309** | **—** | **2680** | **2584587** | **14984286** | **1023093** | **3434104** |
| **$1402023** | **$25199** | **$(35302)** | **$2629191** | **$17231854** | **$881277** | **$3036378** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **<br>Federated Hermes Insurance Series<br>(continued)** | **<br>Federated Hermes Insurance Series<br>(continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund** | **Fidelity<sup>®</sup> Variable Insurance Products Fund** | **Fidelity<sup>®</sup> Variable Insurance Products Fund** | **Fidelity<sup>®</sup> Variable Insurance Products Fund** | **Fidelity<sup>®</sup> Variable Insurance Products Fund** |
| **Federated<br>Hermes<br>Kaufmann<br>Fund II —<br>Service Shares** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Federated<br>Hermes<br>Managed<br>Volatility<br>Fund II —<br>Primary Shares** | **VIP Asset<br>Manager 50%<br>Portfolio —<br>Initial Class** | **VIP Asset<br>Manager 50%<br>Portfolio —<br>Service Class 2** | **VIP Balanced<br>Portfolio —<br>Service Class 2** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Initial Class** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Service Class 2** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $— | $185910 | $625027 | $91298 | $787725 | $142312 | $— |
| 383753 | 92540 | 316536 | 72825 | 946846 | 1486855 | 2157011 |
| **(383753)** | **93370** | **308491** | **18473** | **(159121)** | **(1344543)** | **(2157011)** |
| 83361 | 19830 | 454518 | 60251 | 1913200 | 6940109 | 8429841 |
| (253583) | 109119 | 1329706 | 174085 | 1647578 | (3146155) | (4159119) |
| 2739722 | 113417 | 1223236 | 212913 | 2723595 | 16499282 | 21463369 |
| **2569500** | **242366** | **3007460** | **447249** | **6284373** | **20293236** | **25734091** |
| **$2185747** | **$335736** | **$3315951** | **$465722** | **$6125252** | **$18948693** | **$23577080** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** |
|  | **VIP Dynamic<br>Capital<br>Appreciation<br>Portfolio —<br>Service Class 2** | **VIP Equity-<br>Income<br>Portfolio<sup>SM</sup> —<br>Initial Class** | **VIP Equity-<br>Income<br>Portfolio<sup>SM</sup> —<br>Service Class 2** | **VIP Growth &<br>Income<br>Portfolio —<br>Initial Class** | **VIP Growth &<br>Income<br>Portfolio —<br>Service Class 2** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $7243 | $1071574 | $490520 | $207195 | $165132 |
| Mortality and expense risk and administrative charges (note 4a) | 26471 | 834109 | 480476 | 199046 | 197367 |
| **Net investment income (expense)** | **(19228)** | **237465** | **10044** | **8149** | **(32235)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 24592 | 1881155 | 1062325 | 1200791 | 1177170 |
| Change in unrealized appreciation (depreciation) | (71692) | 4339391 | 1952086 | 4245 | (139293) |
| Capital gain distributions | 327171 | 3340955 | 1749761 | 1267009 | 1202699 |
| **Net realized and unrealized gain (loss) on investments** | **280071** | **9561501** | **4764172** | **2472045** | **2240576** |
| **Increase (decrease) in net assets from operations** | **$260843** | **$9798966** | **$4774216** | **$2480194** | **$2208341** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fidelity<sup>®</sup> Variable Insurance<br>Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance<br>Products Fund (continued)** | **Franklin Templeton Variable Insurance Products<br>Trust** | **Franklin Templeton Variable Insurance Products<br>Trust** | **Franklin Templeton Variable Insurance Products<br>Trust** |
|  | **VIP Overseas<br>Portfolio —<br>Initial Class** | **VIP Value<br>Strategies<br>Portfolio —<br>Service Class 2** | **Franklin<br>Allocation<br>VIP<br>Fund —<br>Class 2 Shares** | **Franklin<br>Income<br>VIP<br>Fund —<br>Class 2 Shares** | **<br>Franklin<br>Large Cap<br>Growth<br>VIP<br>Fund —<br>Class 2 Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $154486 | $19737 | $469840 | $6105382 | $— |
| Mortality and expense risk and administrative charges (note 4a) | 133105 | 37712 | 463622 | 2298611 | 1848 |
| **Net investment income (expense)** | **21381** | **(17975)** | **6218** | **3806771** | **(1848)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 351186 | 49599 | (706975) | (558376) | 5711 |
| Change in unrealized appreciation (depreciation) | 402869 | 25405 | 2092236 | 7246202 | (19452) |
| Capital gain distributions | 859786 | 98949 | 991836 | 1283327 | 21454 |
| **Net realized and unrealized gain (loss) on investments** | **1613841** | **173953** | **2377097** | **7971153** | **7713** |
| **Increase (decrease) in net assets from operations** | **$1635222** | **$155978** | **$2383315** | **$11777924** | **$5865** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** |
| **VIP Growth<br>Opportunities<br>Portfolio —<br>Initial Class** | **VIP Growth<br>Opportunities<br>Portfolio —<br>Service Class 2** | **VIP Growth<br>Portfolio —<br>Initial Class** | **VIP Growth<br>Portfolio —<br>Service Class 2** | **VIP Investment<br>Grade<br>Bond<br>Portfolio —<br>Service Class 2** | **VIP Mid<br>Cap<br>Portfolio —<br>Initial Class** | **VIP Mid<br>Cap<br>Portfolio —<br>Service Class 2** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $— | $— | $203182 | $8371 | $1556045 | $— | $106588 |
| 225177 | 125261 | 940790 | 274822 | 797284 |  | 835942 |
| **(225177)** | **(125261)** | **(737608)** | **(266451)** | **758761** | **—** | **(729354)** |
| 1205568 | 792984 | 2576335 | 724513 | (611124) |  | (1023326) |
| 1725902 | 730730 | (1889169) | (639328) | 2217815 |  | 217234 |
| 250798 | 120083 | 9049702 | 2277241 |  |  | 6153200 |
| **3182268** | **1643797** | **9736868** | **2362426** | **1606691** | **—** | **5347108** |
| **$2957091** | **$1518536** | **$8999260** | **$2095975** | **$2365452** | **$—** | **$4617754** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Franklin Templeton Variable Insurance Products Trust (continued)** | **Goldman Sachs Variable Insurance<br>Trust** | **Goldman Sachs Variable Insurance<br>Trust** |
| **Franklin<br>Mutual<br>Shares<br>VIP Fund —<br>Class 2 Shares** | **Templeton<br>Foreign<br>VIP<br>Fund —<br>Class 1 Shares** | **Templeton<br>Foreign<br>VIP<br>Fund —<br>Class 2 Shares** | **Templeton<br>Global Bond<br>VIP<br>Fund —<br>Class 1 Shares** | **Templeton<br>Growth<br>VIP<br>Fund —<br>Class 2 Shares** | **<br>Goldman Sachs<br>Government<br>Money<br>Market<br>Fund —<br>Service Shares** | **Goldman Sachs<br>Large Cap<br>Value<br>Fund —<br>Institutional Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $398704 | $80533 | $3136 | $— | $35188 | $4487769 | $45201 |
| 329523 | 45934 | 2149 | 24685 | 61688 | 1831772 | 61347 |
| **69181** | **34599** | **987** | **(24685)** | **(26500)** | **2655997** | **(16146)** |
| (137509) | 66215 | 4889 | (68351) | 94839 |  | (61247) |
| 11834 | 453697 | 20881 | 332770 | 431879 |  | (112571) |
| 1964423 | 202588 | 8757 |  | 302095 |  | 562262 |
| **1838748** | **722500** | **34527** | **264419** | **828813** | **—** | **388444** |
| **$1907929** | **$757099** | **$35514** | **$239734** | **$802313** | **$2655997** | **$372298** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Goldman Sachs<br>Variable<br>Insurance<br>Trust (continued)** | **Janus Aspen Series** | **Janus Aspen Series** | **Janus Aspen Series** | **Janus Aspen Series** |
|  | <br>**Goldman<br>Sachs Mid<br>Cap Value<br>Fund —<br>Institutional<br>Shares** | **Janus<br>Henderson<br>Balanced<br>Portfolio —<br>Institutional<br>Shares** | **Janus<br>Henderson<br>Balanced<br>Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Enterprise<br>Portfolio —<br>Institutional<br>Shares** | **Janus<br>Henderson<br>Enterprise<br>Portfolio —<br>Service Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $279477 | $968084 | $1177778 | $113293 | $8156 |
| Mortality and expense risk and administrative charges (note 4a) | 357451 | 682097 | 1251165 | 506668 | 69863 |
| **Net investment income (expense)** | **(77974)** | **285987** | **(73387)** | **(393375)** | **(61707)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 269516 | 2888498 | 4997531 | 1483743 | 86629 |
| Change in unrealized appreciation (depreciation) | (975790) | 1360388 | 1247532 | (1662200) | (155521) |
| Capital gain distributions | 2533848 | 1576006 | 2191462 | 2690260 | 388417 |
| **Net realized and unrealized gain (loss) on investments** | **1827574** | **5824892** | **8436525** | **2511803** | **319525** |
| **Increase (decrease) in net assets from operations** | **$1749600** | **$6110879** | **$8363138** | **$2118428** | **$257818** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Legg Mason Partners Variable<br>Equity Trust** | **Legg Mason Partners Variable<br>Equity Trust** |
|  | **Janus<br>Henderson<br>Overseas<br>Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Research<br>Portfolio —<br>Institutional<br>Shares** | **Janus<br>Henderson<br>Research<br>Portfolio —<br>Service<br>Shares** | <br>**ClearBridge<br>Variable<br>Dividend<br>Strategy<br>Portfolio —<br>Class I** | **ClearBridge<br>Variable<br>Dividend<br>Strategy<br>Portfolio —<br>Class II** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $16841 | $50076 | $3893 | $82396 | $78556 |
| Mortality and expense risk and administrative charges (note 4a) | 20070 | 570699 | 47078 | 54412 | 80894 |
| **Net investment income (expense)** | **(3229)** | **(520623)** | **(43185)** | **27984** | **(2338)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 116429 | 3635620 | 248620 | 34125 | 312992 |
| Change in unrealized appreciation (depreciation) | 200855 | 153403 | (21135) | (183278) | (442086) |
| Capital gain distributions |  | 3079481 | 239405 | 521542 | 559830 |
| **Net realized and unrealized gain (loss) on investments** | **317284** | **6868504** | **466890** | **372389** | **430736** |
| **Increase (decrease) in net assets from operations** | **$314055** | **$6347881** | **$423705** | **$400373** | **$428398** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **<br>Janus Aspen Series (continued)** | **<br>Janus Aspen Series (continued)** | **<br>Janus Aspen Series (continued)** | **<br>Janus Aspen Series (continued)** | **<br>Janus Aspen Series (continued)** | **<br>Janus Aspen Series (continued)** | **<br>Janus Aspen Series (continued)** |
| **Janus<br>Henderson<br>Flexible<br>Bond<br>Portfolio —<br>Institutional<br>Shares** | **Janus<br>Henderson<br>Forty<br>Portfolio —<br>Institutional<br>Shares** | **Janus<br>Henderson<br>Forty<br>Portfolio —<br>Service<br>Shares** | **Janus<br>Henderson<br>Global<br>Research<br>Portfolio —<br>Institutional<br>Shares** | **Janus<br>Henderson<br>Global Research<br>Portfolio —<br>Service<br>Shares** | **Janus<br>Henderson<br>Global<br>Technology<br>and Innovation<br>Portfolio —<br>Service<br>Shares** | **Janus<br>Henderson<br>Overseas<br>Portfolio —<br>Institutional<br>Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $303797 | $110719 | $42083 | $251961 | $14265 | $— | $222648 |
| 85300 | 537009 | 246308 | 478181 | 36698 | 187749 | 221716 |
| **218497** | **(426290)** | **(204225)** | **(226220)** | **(22433)** | **(187749)** | **932** |
| (236943) | 1700524 | 698776 | 2318201 | 262421 | 813823 | 540316 |
| 351896 | (894) | (250456) | 1011702 | (46107) | 892819 | 3151092 |
|  | 4316030 | 2158205 | 2916318 | 220572 | 1185174 |  |
| **114953** | **6015660** | **2606525** | **6246221** | **436886** | **2891816** | **3691408** |
| **$333450** | **$5589370** | **$2402300** | **$6020001** | **$414453** | **$2704067** | **$3692340** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Legg Mason Partners Variable Equity<br>Trust (continued)** | **Legg Mason Partners Variable Equity<br>Trust (continued)** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** | **Lincoln Variable Insurance Products Trust** |
| **ClearBridge<br>Variable<br>Growth<br>Portfolio —<br>Class II** | **ClearBridge<br>Variable<br>Large Cap<br>Value<br>Portfolio —<br>Class I** | **LVIP American<br>Century<br>Disciplined<br>Core<br>Value<br>Fund —<br>Standard<br>Class II** | **LVIP American<br>Century<br>Inflation<br>Protection<br>Fund —<br>Service<br>Class** | **LVIP American<br>Century<br>International<br>Fund —<br>Standard<br>Class II** | **LVIP American<br>Century<br>Ultra<sup>®</sup><br>Fund —<br>Standard<br>Class II** | **LVIP American<br>Century<br>Value<br>Fund —<br>Standard<br>Class II** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $— | $123175 | $511 | $991086 | $2306 | $— | $913 |
| 37039 | 171334 | 665 | 243836 | 3761 | 110 | 848 |
| **(37039)** | **(48159)** | **(154)** | **747250** | **(1455)** | **(110)** | **65** |
| (138526) | 42264 | 1728 | (227853) | 6035 | 7183 | 3086 |
| 54250 | (162918) | 2468 | 124935 | 23791 | (9125) | 469 |
| 369221 | 1110490 |  |  |  |  | 4316 |
| **284945** | **989836** | **4196** | **(102918)** | **29826** | **(1942)** | **7871** |
| **$247906** | **$941677** | **$4042** | **$644332** | **$28371** | **$(2052)** | **$7936** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Lincoln Variable Insurance Products Trust (continued)** | **Lincoln Variable Insurance Products Trust (continued)** | **Lincoln Variable Insurance Products Trust (continued)** | **Lincoln Variable Insurance Products Trust (continued)** | **MFS<sup>®</sup> Variable<br>Insurance Trust** |
|  | **LVIP<br>JPMorgan<br>Core Bond<br>Fund —<br>Standard Class** | **LVIP<br>JPMorgan<br>Mid Cap<br>Value<br>Fund —<br>Standard Class** | **LVIP<br>JPMorgan<br>Small Cap<br>Core<br>Fund —<br>Standard Class** | **LVIP<br>JPMorgan<br>U.S. Equity<br>Fund —<br>Standard Class** | **MFS<sup>®</sup><br>Investors<br>Trust<br>Series —<br>Service<br>Class Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $25330 | $1864 | $78 | $3680 | $19965 |
| Mortality and expense risk and administrative charges (note 4a) | 13810 | 3326 | 1695 | 9898 | 52162 |
| **Net investment income (expense)** | **11520** | **(1462)** | **(1617)** | **(6218)** | **(32197)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | (12704) | (351) | 8079 | 14012 | 128483 |
| Change in unrealized appreciation (depreciation) | 42103 | (11260) | (5820) | 26402 | (1142847) |
| Capital gain distributions |  | 18095 | 991 | 23306 | 1412231 |
| **Net realized and unrealized gain (loss) on investments** | **29399** | **6484** | **3250** | **63720** | **397867** |
| **Increase (decrease) in net assets from operations** | **$40919** | **$5022** | **$1633** | **$57502** | **$365670** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **PIMCO Variable Insurance Trust (continued)** | **PIMCO Variable Insurance Trust (continued)** | **PIMCO Variable Insurance Trust (continued)** | **PIMCO Variable Insurance Trust (continued)** | **Rydex Variable<br>Trust** |
|  | **International<br>Bond Portfolio<br>(U.S. Dollar<br>Hedged) —<br>Administrative<br>Class Shares** | **Long-Term<br>U.S.<br>Government<br>Portfolio —<br>Administrative<br>Class Shares** | **Low Duration<br>Portfolio —<br>Administrative<br>Class Shares** | **Total Return<br>Portfolio —<br>Administrative<br>Class Shares** | **NASDAQ —<br>100<sup>®</sup> Fund** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $34000 | $754489 | $998638 | $3686680 | $2937 |
| Mortality and expense risk and administrative charges (note 4a) | 14943 | 397703 | 425856 | 1476865 | 144745 |
| **Net investment income (expense)** | **19057** | **356786** | **572782** | **2209815** | **(141808)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | (2760) | (2281237) | (273370) | (2199966) | 682563 |
| Change in unrealized appreciation (depreciation) | 6571 | 3108196 | 646485 | 6245403 | 433290 |
| Capital gain distributions |  |  |  |  | 534078 |
| **Net realized and unrealized gain (loss) on investments** | **3811** | **826959** | **373115** | **4045437** | **1649931** |
| **Increase (decrease) in net assets from operations** | **$22868** | **$1183745** | **$945897** | **$6255252** | **$1508123** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **<br>MFS<sup>®</sup> Variable Insurance Trust (continued)** | **<br>MFS<sup>®</sup> Variable Insurance Trust (continued)** | **<br>MFS<sup>®</sup> Variable Insurance Trust (continued)** | **MFS<sup>®</sup> Variable Insurance Trust II** | **MFS<sup>®</sup> Variable Insurance Trust II** | **PIMCO Variable Insurance Trust** | **PIMCO Variable Insurance Trust** |
| **MFS<sup>®</sup> New<br>Discovery<br>Series —<br>Service<br>Class Shares** | **MFS<sup>®</sup> Total<br>Return<br>Series —<br>Service<br>Class Shares** | **MFS<sup>®</sup> Utilities<br>Series —<br>Service<br>Class Shares** | **MFS<sup>®</sup> Income<br>Portfolio —<br>Service<br>Class Shares** | **MFS<sup>®</sup><br>Massachusetts<br>Investors<br>Growth<br>Stock<br>Portfolio —<br>Service<br>Class Shares** | **All Asset<br>Portfolio —<br>Advisor<br>Class Shares** | **High Yield<br>Portfolio —<br>Administrative<br>Class Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $— | $583948 | $238137 | $482 | $769 | $136062 | $1522117 |
| 116714 | 448447 | 139565 | 166 | 72517 | 47493 | 400615 |
| **(116714)** | **135501** | **98572** | **316** | **(71748)** | **88569** | **1121502** |
| (482501) | 113272 | 267823 | (79) | 199350 | (72121) | (24285) |
| 1374203 | 33722 | 570831 | 375 | (445383) | 338535 | 575240 |
|  | 1718007 | 118760 |  | 666573 |  |  |
| **891702** | **1865001** | **957414** | **296** | **420540** | **266414** | **550955** |
| **$774988** | **$2000502** | **$1055986** | **$612** | **$348792** | **$354983** | **$1672457** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **<br>State Street Variable Insurance Series Funds, Inc.** | **<br>State Street Variable Insurance Series Funds, Inc.** | **<br>State Street Variable Insurance Series Funds, Inc.** | **<br>State Street Variable Insurance Series Funds, Inc.** | **<br>State Street Variable Insurance Series Funds, Inc.** | **<br>State Street Variable Insurance Series Funds, Inc.** | **<br>State Street Variable Insurance Series Funds, Inc.** |
| **Income<br>V.I.S.<br>Fund —<br>Class 1 Shares** | **Premier<br>Growth<br>Equity V.I.S.<br>Fund —<br>Class 1 Shares** | **<br>Real Estate<br>Securities<br>V.I.S.<br>Fund —<br>Class 1 Shares** | **S&P 500<sup>®</sup><br>Index<br>V.I.S.<br>Fund —<br>Class 1 Shares** | **Small-Cap<br>Equity<br>V.I.S.<br>Fund —<br>Class 1 Shares** | **Total Return<br>V.I.S.<br>Fund —<br>Class 1 Shares** | **Total Return<br>V.I.S.<br>Fund —<br>Class 3 Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $248221 | $— | $162460 | $1438680 | $— | $15046974 | $5284335 |
| 107862 | 400503 | 228668 | 2260526 | 291323 | 9944520 | 4721979 |
| **140359** | **(400503)** | **(66208)** | **(821846)** | **(291323)** | **5102454** | **562356** |
| (283326) | 1047970 | (294275) | 7987293 | (291547) | 2641192 | 1551625 |
| 454929 | (1054112) | 241706 | 4613537 | (1924080) | 46492291 | 18655999 |
|  | 4795023 | 191749 | 10689019 | 2109845 | 26211642 | 10308070 |
| **171603** | **4788881** | **139180** | **23289849** | **(105782)** | **75345125** | **30515694** |
| **$311962** | **$4388378** | **$72972** | **$22468003** | **$(397105)** | **$80447579** | **$31078050** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **State Street<br>Variable<br>Insurance<br>Series Funds,<br>Inc. (continued)** | **The Alger Portfolios** | **The Alger Portfolios** | **The Prudential Series Fund** | **The Prudential Series Fund** |
|  | <br>**U.S. Equity<br>V.I.S.<br>Fund —<br>Class 1 Shares** | **Alger Large<br>Cap Growth<br>Portfolio —<br>Class I-2 Shares** | **Alger Small<br>Cap Growth<br>Portfolio —<br>Class I-2 Shares** | **PSF Mid-Cap<br>Growth<br>Portfolio —<br>Class II Shares** | **PSF Natural<br>Resources<br>Portfolio —<br>Class II Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** | **Period from<br>January 1 to<br>April 11, 2025** | **Period from<br>January 1 to<br>April 11, 2025** |
| **Investment income and expense:** |  |  |  |  |  |
| Income — Ordinary dividends | $29163 | $— | $— | $— | $— |
| Mortality and expense risk and administrative charges (note 4a) | 236504 | 415254 | 136902 | 76 | 19234 |
| **Net investment income (expense)** | **(207341)** | **(415254)** | **(136902)** | **(76)** | **(19234)** |
| **Net realized and unrealized gain (loss) on investments:** |  |  |  |  |  |
| Net realized gain (loss) | 571402 | 2245889 | (796207) | 11609 | 310892 |
| Change in unrealized appreciation (depreciation) | (947627) | 2282921 | 1127213 | (13928) | (562875) |
| Capital gain distributions | 2620136 | 3308870 | 113556 |  |  |
| **Net realized and unrealized gain (loss) on investments** | **2243911** | **7837680** | **444562** | **(2319)** | **(251983)** |
| **Increase (decrease) in net assets from operations** | **$2036570** | **$7422426** | **$307660** | **$(2395)** | **$(271217)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Operations — Continued

---

| | |
|:---|:---|
| **<br>The Prudential Series Fund (continued)** | **<br>The Prudential Series Fund (continued)** |
| **PSF PGIM<br>Jennison<br>Blend<br>Portfolio —<br>Class II Shares** | **PSF PGIM<br>Jennison<br>Growth<br>Portfolio —<br>Class II Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2025** |
| $— | $— |
| 128129 | 128205 |
| **(128129)** | **(128205)** |
| 515100 | 659024 |
| 1481989 | 425569 |
| **1997089** | **1084593** |
| **$1868960** | **$956388** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** | **<br>AB Variable Products Series Fund, Inc.** |
|  | **AB VPS Balanced<br>Hedged Allocation<br>Portfolio —Class B** | **AB VPS Balanced<br>Hedged Allocation<br>Portfolio —Class B** | **AB VPS<br>International Value<br>Portfolio — Class B** | **AB VPS<br>International Value<br>Portfolio — Class B** | **AB VPS<br>Large Cap Growth<br>Portfolio — Class B** | **AB VPS<br>Large Cap Growth<br>Portfolio — Class B** |
| | **Year ended**<br> **December 31,**<br> **2025** | **Year ended**<br> **December 31,**<br> **2024** | **Year ended**<br> **December 31,**<br> **2025** | **Year ended**<br> **December 31,**<br> **2024** | **Year ended**<br> **December 31,**<br> **2025** | **Year ended**<br> **December 31,**<br> **2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(2016) | $(5654) | $182163 | $(107802) | $(184987) | $(202169) |
| Net realized gain (los<br> s) on investments | (60357) | (292097) | 360028 | 897657 | 783726 | 844925 |
| Change in unrealized appreciation (depreciation) on investments | 544347 | 572733 | 2592818 | 239969 | (509548) | 1442368 |
| Capital gain distributions | 275403 | 120169 |  |  | 1107027 | 570260 |
| **Increase (decrease) in net assets from operations** | **757377** | **395151** | **3135009** | **1029824** | **1196218** | **2655384** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 1152 | 61370 | 127250 | 30282 | 3 | 473 |
| Transfers for contract benefits and terminations | (687785) | (1111300) | (1084896) | (1496989) | (1157530) | (1810565) |
| Administrative expenses | (46775) | (53747) | (69788) | (113878) | (24962) | (29139) |
| Transfers between subaccounts (including fixed account), net | (262488) | (90043) | 10136620 | (14374196) | (787327) | (501532) |
| **Increase (decrease) in net assets from capital transactions** | **(995896)** | **(1193720)** | **9109186** | **(15954781)** | **(1969816)** | **(2340763)** |
| **Increase (decrease) in net assets** | **(238519)** | **(798569)** | **12244195** | **(14924957)** | **(773598)** | **314621** |
| Net assets at beginning of year | 5545806 | 6344375 | 4617004 | 19541961 | 12610063 | 12295442 |
| Net assets at end of year | $5307287 | $5545806 | $16861199 | $4617004 | $11836465 | $12610063 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 9042 | 79041 | 800907 | 162576 | 11865 | 7686 |
| Units redeemed | (68178) | (142996) | (204243) | (2162805) | (59200) | (66351) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(59136)** | **(63955)** | **596664** | **(2000229)** | **(47335)** | **(58665)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **AB Variable Products Series Fund, Inc. (continued)** | **AB Variable Products Series Fund, Inc. (continued)** | **AB Variable Products Series Fund, Inc. (continued)** | **AB Variable Products Series Fund, Inc. (continued)** | **AB Variable Products Series Fund, Inc. (continued)** | **AB Variable Products Series Fund, Inc. (continued)** | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds)** | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds)** |
| **AB VPS Relative Value<br>Portfolio —<br>Class B** | **AB VPS Relative Value<br>Portfolio —<br>Class B** | **AB VPS Small Cap Growth<br>Portfolio — <br>Class B** | **AB VPS Small Cap Growth<br>Portfolio — <br>Class B** | **AB VPS Sustainable Global<br>Thematic Portfolio — <br>Class B** | **AB VPS Sustainable Global<br>Thematic Portfolio — <br>Class B** | **Invesco V.I. American<br>Franchise Fund —<br>Series I shares** | **Invesco V.I. American<br>Franchise Fund —<br>Series I shares** | **Invesco V.I. American<br>Franchise Fund —<br>Series II shares** | **Invesco V.I. American<br>Franchise Fund —<br>Series II shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(167695) | $(81683) | $(41844) | $(53138) | $(24748) | $(27694) | $(114538) | $(121604) | $(54095) | $(54018) |
| 693525 | 707118 | (373521) | (633497) | 36909 | 40836 | 623149 | 241264 | 185473 | 131594 |
| (526924) | 1313116 | 460476 | 1214979 | (158554) | 59896 | (447241) | 2080966 | (166372) | 902054 |
| 2002121 | 976624 |  |  | 206883 | 5273 | 656219 |  | 360067 |  |
| **2001027** | **2915175** | **45111** | **528344** | **60490** | **78311** | **717589** | **2200626** | **325073** | **979630** |
| 121875 | 17821 | 600 | 11972 |  |  | 28736 | 4977 |  |  |
| (3331442) | (3500808) | (756909) | (813790) | (92685) | (148615) | (1344664) | (1075532) | (306237) | (352564) |
| (50133) | (58007) | (12365) | (15934) | (8461) | (9134) | (22887) | (23498) | (13808) | (13771) |
| (236861) | (396619) | (158421) | (106783) | (102412) | (46990) | (412121) | (189328) | (173546) | (137337) |
| **(3496561)** | **(3937613)** | **(927095)** | **(924535)** | **(203558)** | **(204739)** | **(1750936)** | **(1283381)** | **(493591)** | **(503672)** |
| **(1495534)** | **(1022438)** | **(881984)** | **(396191)** | **(143068)** | **(126428)** | **(1033347)** | **917245** | **(168518)** | **475958** |
| 26165509 | 27187947 | 3271912 | 3668103 | 1680318 | 1806746 | 8090534 | 7173289 | 3684152 | 3208194 |
| $24669975 | $26165509 | $2389928 | $3271912 | $1537250 | $1680318 | $7057187 | $8090534 | $3515634 | $3684152 |
| 36470 | 17847 | 6033 | 6856 | 1288 | 875 | 8182 | 1668 | 489 | 187 |
| (125016) | (120117) | (30850) | (32910) | (7163) | (7107) | (45479) | (33491) | (9034) | (10006) |
| **<br>(88546** **)** | **(102270)** | **(24817)** | **(26054)** | **(5875)** | **(6232)** | **(37297)** | **(31823)** | **(8545)** | **(9819)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)**<br>**(continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)**<br>**(continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)**<br>**(continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)**<br>**(continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)**<br>**(continued)** | **AIM Variable Insurance Funds (Invesco Variable Insurance Funds)**<br>**(continued)** |
|  | **Invesco<br>V.I. American<br>Value Fund —<br>Series II shares** | **Invesco<br>V.I. American<br>Value Fund —<br>Series II shares** | **Invesco<br>V.I. Comstock<br>Fund —<br>Series II shares** | **Invesco<br>V.I. Comstock<br>Fund —<br>Series II shares** | **Invesco<br>V.I. Core<br>Equity Fund —<br>Series I shares** | **Invesco<br>V.I. Core<br>Equity Fund —<br>Series I shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(146036) | $(74892) | $(50111) | $(99823) | $(631257) | $(85796) |
| Net realized gain (loss) on investments | 122951 | (50062) | 930261 | 1180363 | 708879 | 190090 |
| Change in unrealized appreciation (depreciation) on investments | 242431 | 2355087 | 579279 | 1738215 | 3373976 | 375746 |
| Capital gain distributions | 1780622 | 244463 | 4799725 | 3041918 | 4719136 | 4915408 |
| **Increase (decrease) in net assets from operations** | **1999968** | **2474596** | **6259154** | **5860673** | **8170734** | **5395448** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 8961 | 48181 | 195518 | 129546 | 177363 | 37346 |
| Transfers for contract benefits and terminations | (744231) | (488327) | (4285993) | (4679260) | (7429173) | (3582608) |
| Administrative expenses | (38699) | (33998) | (316640) | (345644) | (649611) | (287395) |
| Transfers between subaccounts (including fixed account), net | (192596) | 563385 | 1682032 | (5939997) | 5522809 | 52488019 |
| **Increase (decrease) in net assets from capital transactions** | **(966565)** | **89241** | **(2725083)** | **(10835355)** | **(2378612)** | **48655362** |
| **Increase (decrease) in net assets** | **1033403** | **2563837** | **3534071** | **(4974682)** | **5792122** | **54050810** |
| Net assets at beginning of year | 11393977 | 8830140 | 42730213 | 47704895 | 58784109 | 4733299 |
| Net assets at end of year | $12427380 | $11393977 | $46264284 | $42730213 | $64576231 | $58784109 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 43169 | 103092 | 194073 | 95586 | 452264 | 2137779 |
| Units redeemed | (107840) | (97683) | (245512) | (438431) | (525561) | (284995) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(64671)** | **5409** | **(51439)** | **(342845)** | **(73297)** | **1852784** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** |
| **Invesco<br>V.I. Core<br>Plus Bond Fund —<br>Series I shares** | **Invesco<br>V.I. Core<br>Plus Bond Fund —<br>Series I shares** | **Invesco<br>V.I. Discovery<br>Large Cap Fund —<br>Series I shares** | **Invesco<br>V.I. Discovery<br>Large Cap Fund —<br>Series I shares** | **Invesco<br>V.I. Discovery<br>Large Cap Fund —<br>Series II Shares** | **Invesco<br>V.I. Discovery<br>Large Cap Fund —<br>Series II Shares** | **Invesco<br>V.I. Discovery Mid Cap<br>Growth Fund —<br>Series I shares** | **Invesco<br>V.I. Discovery Mid Cap<br>Growth Fund —<br>Series I shares** | **Invesco<br>V.I. Discovery Mid Cap<br>Growth Fund —<br>Series II shares** | **Invesco<br>V.I. Discovery Mid Cap<br>Growth Fund —<br>Series II shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $137256 | $117250 | $(340045) | $(355634) | $(153204) | $(151677) | $(262657) | $(270946) | $(100506) | $(104921) |
| (1425) | (7009) | 1463495 | 861079 | 504009 | 101070 | 251314 | 156984 | 12143 | (150967) |
| 129237 | (25721) | (1421481) | 6448621 | (520425) | 2707179 | (1060052) | 4120083 | (351168) | 1606154 |
|  |  | 2868473 |  | 1210587 |  | 1646423 |  | 612168 |  |
| **265068** | **84520** | **2570442** | **6954066** | **1040967** | **2656572** | **575028** | **4006121** | **172637** | **1350266** |
| 33758 | 10592 | 22859 | 68062 | 16966 | 13930 | 8543 | 91144 | 17833 | 14167 |
| (865821) | (786447) | (4165509) | (3830134) | (1107231) | (859001) | (1749176) | (1740811) | (466242) | (821670) |
| (4802) | (5807) | (12950) | (15605) | (51390) | (54809) | (8960) | (10454) | (30435) | (33991) |
| 233304 | 368422 | (377759) | (246683) | (778759) | (168129) | (146155) | (201963) | (571144) | (217109) |
| **(603561)** | **(413240)** | **(4533359)** | **(4024360)** | **(1920414)** | **(1068009)** | **(1895748)** | **(1862084)** | **(1049988)** | **(1058603)** |
| **(338493)** | **(328720)** | **(1962917)** | **2929706** | **(879447)** | **1588563** | **(1320720)** | **2144037** | **(877351)** | **291663** |
| 5008181 | 5336901 | 26225717 | 23296011 | 10448536 | 8859973 | 20636460 | 18492423 | 7018603 | 6726940 |
| $4669688 | $5008181 | $24262800 | $26225717 | $9569089 | $10448536 | $19315740 | $20636460 | $6141252 | $7018603 |
| 38871 | 47767 | 1179 | 2906 | 9225 | 11301 | 2118 | 4219 | 753 | 3548 |
| (97129) | (89102) | (37540) | (29941) | (40101) | (34980) | (18103) | (25499) | (20618) | (26478) |
| **(58258)** | **(41335)** | **(36361)** | **(27035)** | **(30876)** | **(23679)** | **(15985)** | **(21280)** | **(19865)** | **(22930)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | **<br>AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** |
|  | **Invesco<br>V.I. EQV International<br>Equity Fund —<br>Series II shares** | **Invesco<br>V.I. EQV International<br>Equity Fund —<br>Series II shares** | **Invesco<br>V.I. Equity and<br>Income Fund —<br>Series I shares** | **Invesco<br>V.I. Equity and<br>Income Fund —<br>Series I shares** | **Invesco<br>V.I. Equity and<br>Income Fund —<br>Series II shares** | **Invesco<br>V.I. Equity and<br>Income Fund —<br>Series II shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(108319) | $101146 | $41477 | $53240 | $(21823) | $(25923) |
| Net realized gain (loss) on investments | 157891 | 60763 | 49497 | 11809 | 267607 | 185518 |
| Change in unrealized appreciation (depreciation) on investments | 1480946 | (829050) | 235115 | 80123 | 819248 | 788736 |
| Capital gain distributions | 1315072 | 119122 | 302123 | 236559 | 1185251 | 909451 |
| **Increase (decrease) in net assets from operations** | **2845590** | **(548019)** | **628212** | **381731** | **2250283** | **1857782** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 44770 | 13105 |  | 6093 | 33777 | 9900 |
| Transfers for contract benefits and terminations | (2512936) | (1585086) | (809656) | (328177) | (2778215) | (2860838) |
| Administrative expenses | (195678) | (118663) | (4515) | (3336) | (169847) | (152199) |
| Transfers between subaccounts (including fixed account), net | (1207739) | 14532689 | (172430) | 6115161 | (364454) | 11204170 |
| **Increase (decrease) in net assets from capital transactions** | **(3871583)** | **12842045** | **(986601)** | **5789741** | **(3278739)** | **8201033** |
| **Increase (decrease) in net assets** | **(1025993)** | **12294026** | **(358389)** | **6171472** | **(1028456)** | **10058815** |
| Net assets at beginning of year | 21677524 | 9383498 | 6171472 |  | 23121605 | 13062790 |
| Net assets at end of year | $20651531 | $21677524 | $5813083 | $6171472 | $22093149 | $23121605 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 118489 | 1077549 | 11426 | 641143 | 63281 | 664326 |
| Units redeemed | (350788) | (171295) | (100660) | (61062) | (208657) | (251156) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(232299)** | **906254** | **(89234)** | **580081** | **(145376)** | **413170** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (continued)** |
| **Invesco<br>V.I. Global<br>Fund —<br>Series II shares** | **Invesco<br>V.I. Global<br>Fund —<br>Series II shares** | **Invesco<br>V.I. Global Real<br>Estate Fund —<br>Series II shares** | **Invesco<br>V.I. Global Real<br>Estate Fund —<br>Series II shares** | **Invesco<br>V.I. Global Strategic<br>Income Fund —<br>Series I shares** | **Invesco<br>V.I. Global Strategic<br>Income Fund —<br>Series I shares** | **Invesco<br>V.I. Government<br>Securities Fund —<br>Series I shares** | **Invesco<br>V.I. Government<br>Securities Fund —<br>Series I shares** | **Invesco<br>V.I. Main Street<br>Fund<sup>®</sup> —<br>Series II shares** | **Invesco<br>V.I. Main Street<br>Fund<sup>®</sup> —<br>Series II shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(420556) | $(464544) | $(1355) | $1828 | $59690 | $24025 | $— | $— | $(1097941) | $(745734) |
| 345105 | 318517 | 8173 | 2825 | (32098) | (42938) |  |  | 45624 | (448655) |
| (1684197) | 2355815 | 1931 | 401 | 122639 | 44027 |  |  | 6648546 | (658546) |
| 5121732 | 1711971 |  |  |  |  |  |  | 4816659 | 8270439 |
| **3362084** | **3921759** | **8749** | **5054** | **150231** | **25114** | **—** | **—** | **10412888** | **6417504** |
| 42263 | 49583 |  | 370 | 7537 | 1634 |  |  | 229955 | 71350 |
| (3633378) | (3173469) | (14482) | (18572) | (233792) | (165724) |  |  | (10008777) | (5596322) |
| (119295) | (131701) | (292) | (277) | (1124) | (1288) |  |  | (783961) | (389183) |
| (807179) | (1285239) | (129682) | 158837 | 24505 | 13151 |  |  | (3952861) | 67138680 |
| **(4517589)** | **(4540826)** | **(144456)** | **140358** | **(202874)** | **(152227)** | **—** | **—** | **(14515644)** | **61224525** |
| **(1155505)** | **(619067)** | **(135707)** | **145412** | **(52643)** | **(127113)** | **—** | **—** | **(4102756)** | **67642029** |
| 28517323 | 29136390 | 181833 | 36421 | 1420424 | 1547537 |  |  | 81454797 | 13812768 |
| $27361818 | $28517323 | $46126 | $181833 | $1367781 | $1420424 | $— | $— | $77352041 | $81454797 |
| 33688 | 23004 | 1176 | 17061 | 7791 | 6009 |  |  | 200636 | 2350566 |
| (147027) | (146256) | (12803) | (4867) | (26639) | (20928) |  |  | (608170) | (323143) |
| **(113339)** | **(123252)** | **(11627)** | **12194** | **(18848)** | **(14919)** | **—** | **—** | **(407534)** | **2027423** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds) (continued)** | **AIM Variable Insurance Funds (Invesco Variable<br>Insurance Funds) (continued)** | **Advanced Series Trust** | **Advanced Series Trust** |
|  | <br>**Invesco<br>V.I. Main Street<br>Small Cap Fund<sup>®</sup> —<br>Series II shares** | <br>**Invesco<br>V.I. Main Street<br>Small Cap Fund<sup>®</sup> —<br>Series II shares** | <br>**Invesco<br>V.I. Technology<br>Fund —<br>Series I shares** | <br>**Invesco<br>V.I. Technology<br>Fund —<br>Series I shares** | <br>**AST<br>International<br>Equity Portfolio —<br>Class I Shares** | <br>**AST<br>International<br>Equity Portfolio —<br>Class I Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(340869) | $(284381) | $— | $— | $— | $— |
| Net realized gain (loss) on investments | 473418 | 435371 |  |  |  |  |
| Change in unrealized appreciation (depreciation) on investments | (932171) | 398909 |  |  |  |  |
| Capital gain distributions | 2443036 | 926752 |  |  |  |  |
| **Increase (decrease) in net assets from operations** | **1643414** | **1476651** | **—** | **—** | **—** | **—** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 95452 | 63025 |  |  |  |  |
| Transfers for contract benefits and terminations | (3144899) | (2150718) |  |  |  |  |
| Administrative expenses | (194024) | (117855) |  |  |  |  |
| Transfers between subaccounts (including fixed account), net | (247311) | 13536248 |  |  |  |  |
| **Increase (decrease) in net assets from capital transactions** | **(3490782)** | **11330700** | **—** | **—** | **—** | **—** |
| **Increase (decrease) in net assets** | **(1847368)** | **12807351** | **—** | **—** | **—** | **—** |
| Net assets at beginning of year | 24603058 | 11795707 |  |  |  |  |
| Net assets at end of year | $22755690 | $24603058 | $— | $— | $— | $— |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 90579 | 480440 |  |  |  |  |
| Units redeemed | (170068) | (112899) |  |  |  |  |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(79489)** | **367541** | **—** | **—** | **—** | **—** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Allspring Variable Trust** | **Allspring Variable Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **BNY Mellon** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **BNY Mellon** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **BNY Mellon** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **BNY Mellon** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **BNY Mellon** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **BNY Mellon** | **BlackRock Variable Series<br>Funds, Inc.** | **BlackRock Variable Series<br>Funds, Inc.** |
| **Allspring<br>VT Discovery All Cap<br>Growth Fund —<br>Class 2** | **Allspring<br>VT Discovery All Cap<br>Growth Fund —<br>Class 2** | **BNY Mellon<br>Investment Portfolios —<br>MidCap<br>Stock Portfolio —<br>Initial Shares** | **BNY Mellon<br>Investment Portfolios —<br>MidCap<br>Stock Portfolio —<br>Initial Shares** | **BNY Mellon<br>Sustainable<br>U.S. Equity<br>Portfolio, Inc. —<br>Initial Shares** | **BNY Mellon<br>Sustainable<br>U.S. Equity<br>Portfolio, Inc. —<br>Initial Shares** | **BNY Mellon<br>Variable**<br> **Investment Fund —<br>Government Money<br>Market Portfolio** | **BNY Mellon<br>Variable**<br> **Investment Fund —<br>Government Money<br>Market Portfolio** | **BlackRock<br>Advantage<br>SMID Cap<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Advantage<br>SMID Cap<br>V.I. Fund —<br>Class III Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(33445) | $(36540) | $(1524) | $(2771) | $(130286) | $(96734) | $25199 | $39952 | $(37982) | $(11875) |
| (24316) | (4494) | 7642 | 3751 | 472062 | 332286 |  |  | 400019 | (101061) |
| (435002) | 341445 | (11669) | 20039 | 228204 | 1686144 |  | 3 | (734109) | 1044678 |
| 798197 | 119474 | 22497 | 1578 | 832043 | 64008 |  |  | 336770 |  |
| **305434** | **419885** | **16946** | **22597** | **1402023** | **1985704** | **25199** | **39955** | **(35302)** | **931742** |
| 480 | 480 |  | 370 |  |  |  |  | 1010 | 14142 |
| (283051) | (323631) | (17734) | (22743) | (883359) | (376543) | (1058147) | (1020976) | (671334) | (1387763) |
| (8290) | (8270) | (781) | (799) | (26855) | (23162) | (876) | (1546) | (23394) | (57848) |
| (182292) | (39890) | (131164) | 150609 | (213070) | (965637) | 838169 | 304834 | (6609030) | 422138 |
| **(473153)** | **(371311)** | **(149679)** | **127437** | **(1123284)** | **(1365342)** | **(220854)** | **(717688)** | **(7302748)** | **(1009331)** |
| **(167719)** | **48574** | **(132733)** | **150034** | **278739** | **620362** | **(195655)** | **(677733)** | **(7338050)** | **(77589)** |
| 2344586 | 2296012 | 256329 | 106295 | 9976910 | 9356548 | 1149262 | 1826995 | 9811054 | 9888643 |
| $2176867 | $2344586 | $123596 | $256329 | $10255649 | $9976910 | $953607 | $1149262 | $2473004 | $9811054 |
| 516 | 159 | 535 | 7383 | 37 | 659 | 101001 | 82261 | 3834 | 26652 |
| (8581) | (7561) | (5553) | (2393) | (36340) | (46466) | (123432) | (158150) | (198091) | (55121) |
| **(8065)** | **(7402)** | **(5018)** | **4990** | **(36303)** | **(45807)** | **(22431)** | **(75889)** | **(194257)** | **(28469)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**BlackRock Variable Series Funds, Inc. (continued)** | <br>**BlackRock Variable Series Funds, Inc. (continued)** | <br>**BlackRock Variable Series Funds, Inc. (continued)** | <br>**BlackRock Variable Series Funds, Inc. (continued)** | <br>**BlackRock Variable Series Funds, Inc. (continued)** | <br>**BlackRock Variable Series Funds, Inc. (continued)** |
|  | **BlackRock<br>Basic Value<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Basic Value<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Global Allocation<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Global Allocation<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Large Cap<br>Focus Growth<br>V.I. Fund —<br>Class III Shares** | **BlackRock<br>Large Cap<br>Focus Growth<br>V.I. Fund —<br>Class III Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $44604 | $(119015) | $2247568 | $(583180) | $(141816) | $(135477) |
| Net realized gain (loss) on investments | 41239 | 112563 | (289709) | (677554) | 269645 | 340067 |
| Change in unrealized appreciation (depreciation) on investments | 865355 | 1379941 | 4841262 | 554915 | (797377) | 1264161 |
| Capital gain distributions | 1677993 | 953326 | 10432733 | 8862319 | 1550825 | 725013 |
| **Increase (decrease) in net assets from operations** | **2629191** | **2326815** | **17231854** | **8156500** | **881277** | **2193764** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 156613 | 35869 | 34844 | 114864 | 10228 | 5945 |
| Transfers for contract benefits and terminations | (691601) | (1844052) | (14078901) | (15362599) | (408109) | (2095908) |
| Administrative expenses | (77696) | (171993) | (1240290) | (1343028) | (45804) | (43679) |
| Transfers between subaccounts (including fixed account), net | (432807) | (14796764) | (6460520) | (3636021) | (569496) | (314050) |
| **Increase (decrease) in net assets from capital transactions** | **(1045491)** | **(16776940)** | **(21744867)** | **(20226784)** | **(1013181)** | **(2447692)** |
| **Increase (decrease) in net assets** | **1583700** | **(14450125)** | **(4513013)** | **(12070284)** | **(131904)** | **(253928)** |
| Net assets at beginning of year | 12548843 | 26998968 | 111722292 | 123792576 | 9438602 | 9692530 |
| Net assets at end of year | $14132543 | $12548843 | $107209279 | $111722292 | $9306698 | $9438602 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 16241 | 52577 | 144625 | 186892 | 461 | 1944 |
| Units redeemed | (48347) | (731810) | (1250896) | (1338055) | (15460) | (54394) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(32106)** | **(679233)** | **(1106271)** | **(1151163)** | **(14999)** | **(52450)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Columbia Funds Variable Series Trust II** | **Columbia Funds Variable Series Trust II** | **Columbia Funds Variable Series Trust II** | **Columbia Funds Variable Series Trust II** | **Deutsche DWS Variable<br>Series II** | **Deutsche DWS Variable<br>Series II** | **Eaton Vance Variable<br>Trust** | **Eaton Vance Variable<br>Trust** | **Federated Hermes<br>Insurance Series** | **Federated Hermes<br>Insurance Series** |
| **CTIVP<sup>®</sup> —<br>Principal<br>Large Cap<br>Growth Fund —<br>Class 1** | **CTIVP<sup>®</sup> —<br>Principal<br>Large Cap<br>Growth Fund —<br>Class 1** | **Columbia<br>Variable Portfolio —<br>Overseas<br>Core Fund —<br>Class 2** | **Columbia<br>Variable Portfolio —<br>Overseas<br>Core Fund —<br>Class 2** | **DWS<br>Small Mid Cap<br>Value VIP —<br>Class B Shares** | **DWS<br>Small Mid Cap<br>Value VIP —<br>Class B Shares** | **VT<br>Floating-Rate<br>Income Fund** | **VT<br>Floating-Rate<br>Income Fund** | **Federated<br>Hermes<br>High Income<br>Bond Fund II —<br>Primary Shares** | **Federated<br>Hermes<br>High Income<br>Bond Fund II —<br>Primary Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(397726) | $(1133098) | $16968 | $672531 | $(1289) | $(83) | $848899 | $1320169 | $189410 | $178809 |
| 2278807 | 24591271 | 322108 | 250632 | 1446 | 117 | (145407) | (157530) | (78688) | (114603) |
| 1155297 | (11047024) | 2089427 | (199294) | 13973 | (102) | (347551) | 53860 | 151509 | 134298 |
|  |  |  |  | 1228 | 530 |  |  |  |  |
| **3036378** | **12411149** | **2428503** | **723869** | **15358** | **462** | **355941** | **1216499** | **262231** | **198504** |
| 194004 | 152381 | 8835 | 39826 |  |  | 25974 | 65560 | 360 | 12757 |
| (2707314) | (8153330) | (872200) | (2509110) | (7045) | (474) | (2146116) | (2347336) | (814365) | (768244) |
| (151204) | (635528) | (28243) | (120796) | (53) | (26) | (160392) | (196082) | (2989) | (3582) |
| (1756815) | (76440999) | (636198) | (14142751) | 124301 | (14) | 50822 | (3017637) | 85797 | 84858 |
| **(4421329)** | **(85077476)** | **(1527806)** | **(16732831)** | **117203** | **(514)** | **(2229712)** | **(5495495)** | **(731197)** | **(674211)** |
| **(1384951)** | **(72666327)** | **900697** | **(16008962)** | **132561** | **(52)** | **(1873771)** | **(4278996)** | **(468966)** | **(475707)** |
| 27066367 | 99732694 | 7402315 | 23411277 | 10798 | 10850 | 18180821 | 22459817 | 4282985 | 4758692 |
| $25681416 | $27066367 | $8303012 | $7402315 | $143359 | $10798 | $16307050 | $18180821 | $3814019 | $4282985 |
| 32027 | 118492 | 23196 | 126671 | 6184 | 19 | 158782 | 173223 | 4053 | 7971 |
| (169926) | (3288708) | (117436) | (1342060) | (834) | (38) | (306043) | (525773) | (24618) | (27089) |
| **(137899)** | **(3170216)** | **(94240)** | **(1215389)** | **5350** | **(19)** | **(147261)** | **(352550)** | **(20565)** | **(19118)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Federated Hermes Insurance Series (continued)** | <br>**Federated Hermes Insurance Series (continued)** | <br>**Federated Hermes Insurance Series (continued)** | <br>**Federated Hermes Insurance Series (continued)** | <br>**Federated Hermes Insurance Series (continued)** | <br>**Federated Hermes Insurance Series (continued)** |
|  | **Federated<br>Hermes High Income<br>Bond Fund II —<br>Service Shares** | **Federated<br>Hermes High Income<br>Bond Fund II —<br>Service Shares** | **Federated<br>Hermes Kaufmann<br>Fund II —<br>Service Shares** | **Federated<br>Hermes Kaufmann<br>Fund II —<br>Service Shares** | **Federated<br>Hermes Managed<br>Volatility Fund II —<br>Primary Shares** | **Federated<br>Hermes Managed<br>Volatility Fund II —<br>Primary Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $222343 | $203449 | $(383753) | $(199156) | $93370 | $54193 |
| Net realized gain (loss) on investments | (88612) | (95632) | 83361 | 170214 | 19830 | (19691) |
| Change in unrealized appreciation (depreciation) on investments | 183704 | 114651 | (253583) | 1935137 | 109119 | 837057 |
| Capital gain distributions |  |  | 2739722 | 326574 | 113417 |  |
| **Increase (decrease) in net assets from operations** | **317435** | **222468** | **2185747** | **2232769** | **335736** | **871559** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 4721 | 5526 | 50096 | 34972 | 20806 | 18648 |
| Transfers for contract benefits and terminations | (777650) | (613724) | (2357783) | (1747919) | (830784) | (927888) |
| Administrative expenses | (14649) | (15599) | (197867) | (120281) | (5551) | (6308) |
| Transfers between subaccounts (including fixed account), net | 111253 | 140436 | (663350) | 12917820 | 120712 | 54090 |
| **Increase (decrease) in net assets from capital transactions** | **(676325)** | **(483361)** | **(3168904)** | **11084592** | **(694817)** | **(861458)** |
| **Increase (decrease) in net assets** | **(358890)** | **(260893)** | **(983157)** | **13317361** | **(359081)** | **10101** |
| Net assets at beginning of year | 5224324 | 5485217 | 23689500 | 10372139 | 6646395 | 6636294 |
| Net assets at end of year | $4865434 | $5224324 | $22706343 | $23689500 | $6287314 | $6646395 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 9852 | 15356 | 91072 | 581566 | 7634 | 7335 |
| Units redeemed | (34474) | (34123) | (182701) | (110047) | (33622) | (34177) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(24622)** | **(18767)** | **(91629)** | **471519** | **(25988)** | **(26842)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** |
| **VIP<br>Asset Manager<br>50% Portfolio —<br>Initial Class** | **VIP<br>Asset Manager<br>50% Portfolio —<br>Initial Class** | **VIP<br>Asset Manager<br>50% Portfolio —<br>Service Class 2** | **VIP<br>Asset Manager<br>50% Portfolio —<br>Service Class 2** | **VIP<br>Balanced<br>Portfolio —<br>Service Class 2** | **VIP<br>Balanced<br>Portfolio —<br>Service Class 2** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Initial Class** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Initial Class** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Service Class 2** | **VIP<br>Contrafund<sup>®</sup><br>Portfolio —<br>Service Class 2** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $308491 | $312758 | $18473 | $28413 | $(159121) | $(117149) | $(1344543) | $(1269283) | $(2157011) | $(2235293) |
| 454518 | 280903 | 60251 | 39754 | 1913200 | 2220904 | 6940109 | 8029740 | 8429841 | 12264096 |
| 1329706 | 1130225 | 174085 | 151203 | 1647578 | 2916293 | (3146155) | 9099948 | (4159119) | 11770800 |
| 1223236 | 174588 | 212913 | 27199 | 2723595 | 1786042 | 16499282 | 11694232 | 21463369 | 15992852 |
| **3315951** | **1898474** | **465722** | **246569** | **6125252** | **6806090** | **18948693** | **27554637** | **23577080** | **37792455** |
| 153767 | 195731 |  |  | 50125 | 73837 | 277519 | 221082 | 255108 | 200325 |
| (4129523) | (3028029) | (305550) | (235796) | (5407462) | (6548905) | (14212980) | (15746013) | (14101388) | (17012687) |
| (13690) | (16503) | (7954) | (8972) | (282619) | (301763) | (56497) | (62557) | (993036) | (1082260) |
| (109368) | (72091) | (629633) | 526507 | (1208036) | (349142) | (812992) | (256924) | (9893267) | (18403524) |
| **(4098814)** | **(2920892)** | **(943137)** | **281739** | **(6847992)** | **(7125973)** | **(14804950)** | **(15844412)** | **(24732583)** | **(36298146)** |
| **(782863)** | **(1022418)** | **(477415)** | **528308** | **(722740)** | **(319883)** | **4143743** | **11710225** | **(1155503)** | **1494309** |
| 26660742 | 27683160 | 4432393 | 3904085 | 52811224 | 53131107 | 103679007 | 91968782 | 134191936 | 132697627 |
| $25877879 | $26660742 | $3954978 | $4432393 | $52088484 | $52811224 | $107822750 | $103679007 | $133036433 | $134191936 |
| 3549 | 5762 | 5523 | 31934 | 96429 | 155807 | 12642 | 16298 | 194885 | 209202 |
| (65197) | (51204) | (48204) | (19605) | (333185) | (411935) | (114012) | (142856) | (668760) | (1077174) |
| **(61648)** | **(45442)** | **(42681)** | **12329** | **(236756)** | **(256128)** | **(101370)** | **(126558)** | **(473875)** | **(867972)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** |
|  | **VIP<br>Dynamic Capital<br>Appreciation Portfolio —<br>Service Class 2** | **VIP<br>Dynamic Capital<br>Appreciation Portfolio —<br>Service Class 2** | **VIP<br>Equity-Income<br>Portfolio<sup>SM</sup> —<br>Initial Class** | **VIP<br>Equity-Income<br>Portfolio<sup>SM</sup> —<br>Initial Class** | **VIP<br>Equity-Income<br>Portfolio<sup>SM</sup> —<br>Service Class 2** | **VIP<br>Equity-Income<br>Portfolio<sup>SM</sup> —<br>Service Class 2** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(19228) | $(24764) | $237465 | $210009 | $10044 | $(21665) |
| Net realized gain (loss) on investments | 24592 | 121106 | 1881155 | 2106686 | 1062325 | 1206671 |
| Change in unrealized appreciation (depreciation) on investments | (71692) | 172271 | 4339391 | 2377202 | 1952086 | 1101826 |
| Capital gain distributions | 327171 | 70972 | 3340955 | 3602377 | 1749761 | 1894319 |
| **Increase (decrease) in net assets from operations** | **260843** | **339585** | **9798966** | **8296274** | **4774216** | **4181151** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 980 | 980 | 236176 | 359732 | 149136 | 106678 |
| Transfers for contract benefits and terminations | (86630) | (341739) | (7447342) | (9699560) | (3350436) | (4570232) |
| Administrative expenses | (4937) | (5217) | (33679) | (40313) | (125150) | (139150) |
| Transfers between subaccounts (including fixed account), net | 3666 | 114605 | (707937) | (180765) | (1220307) | (1256910) |
| **Increase (decrease) in net assets from capital transactions** | **(86921)** | **(231371)** | **(7952782)** | **(9560906)** | **(4546757)** | **(5859614)** |
| **Increase (decrease) in net assets** | **173922** | **108214** | **1846184** | **(1264632)** | **227459** | **(1678463)** |
| Net assets at beginning of year | 1681739 | 1573525 | 60957933 | 62222565 | 31026886 | 32705349 |
| Net assets at end of year | $1855661 | $1681739 | $62804117 | $60957933 | $31254345 | $31026886 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 449 | 2626 | 9557 | 15940 | 60006 | 39903 |
| Units redeemed | (1732) | (6305) | (82681) | (144957) | (190042) | (215494) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(1283)** | **(3679)** | **(73124)** | **(129017)** | **(130036)** | **(175591)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund** |
| **VIP<br>Growth & Income<br>Portfolio —<br>Initial Class** | **VIP<br>Growth & Income<br>Portfolio —<br>Initial Class** | **VIP<br>Growth & Income<br>Portfolio —<br>Service Class 2** | **VIP<br>Growth & Income<br>Portfolio —<br>Service Class 2** | **VIP<br>Growth Opportunities<br>Portfolio —<br>Initial Class** | **VIP<br>Growth Opportunities<br>Portfolio —<br>Initial Class** | **VIP<br>Growth Opportunities<br>Portfolio —<br>Service Class 2** | **VIP<br>Growth Opportunities<br>Portfolio —<br>Service Class 2** | **VIP<br>Growth Portfolio —<br>Initial Class** | **VIP<br>Growth Portfolio —<br>Initial Class** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $8149 | $(10942) | $(32235) | $(43283) | $(225177) | $(212794) | $(125261) | $(123234) | $(737608) | $(937737) |
| 1200791 | 1119596 | 1177170 | 672794 | 1205568 | 1169323 | 792984 | 366144 | 2576335 | 4103029 |
| 4245 | 690304 | (139293) | 807221 | 1725902 | 3630724 | 730730 | 2191704 | (1889169) | (1126190) |
| 1267009 | 920715 | 1202699 | 841606 | 250798 |  | 120083 |  | 9049702 | 15221638 |
| **2480194** | **2719673** | **2208341** | **2278338** | **2957091** | **4587253** | **1518536** | **2434614** | **8999260** | **17260740** |
| 19273 | 14897 | 105269 | 61925 | 60334 | (16156) | 52287 | 38733 | 149406 | 137820 |
| (2079872) | (2494612) | (3036835) | (1382401) | (1737126) | (2516512) | (1514776) | (1187059) | (7440000) | (8686907) |
| (11563) | (12959) | (45172) | (44825) | (7320) | (8357) | (34851) | (34056) | (27640) | (32353) |
| (464704) | (128938) | (146028) | (128617) | (40687) | (175488) | (114571) | (38453) | (391494) | 246049 |
| **(2536866)** | **(2621612)** | **(3122766)** | **(1493918)** | **(1724799)** | **(2716513)** | **(1611911)** | **(1220835)** | **(7709728)** | **(8335391)** |
| **(56672)** | **98061** | **(914425)** | **784420** | **1232292** | **1870740** | **(93375)** | **1213779** | **1289532** | **8925349** |
| 14247972 | 14149911 | 12666511 | 11882091 | 15506533 | 13635793 | 8379075 | 7165296 | 71919344 | 62993995 |
| $14191300 | $14247972 | $11752086 | $12666511 | $16738825 | $15506533 | $8285700 | $8379075 | $73208876 | $71919344 |
| 6651 | 4340 | 17020 | 15580 | 8204 | 4033 | 9088 | 8183 | 4479 | 16411 |
| (52250) | (55347) | (90806) | (57828) | (27528) | (44594) | (30129) | (27948) | (46843) | (61655) |
| **(45599)** | **(51007)** | **(73786)** | **(42248)** | **(19324)** | **(40561)** | **(21041)** | **(19765)** | **(42364)** | **(45244)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | <br>**Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** |
|  | **VIP<br>Growth<br>Portfolio —<br>Service Class 2** | **VIP<br>Growth<br>Portfolio —<br>Service Class 2** | **VIP<br>Investment Grade<br>Bond Portfolio —<br>Service Class 2** | **VIP<br>Investment Grade<br>Bond Portfolio —<br>Service Class 2** | **VIP<br>Mid Cap<br>Portfolio —<br>Initial Class** | **VIP<br>Mid Cap<br>Portfolio —<br>Initial Class** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(266451) | $(279981) | $758761 | $942577 | $— | $— |
| Net realized gain (loss) on investments | 724513 | 1002100 | (611124) | (497089) |  |  |
| Change in unrealized appreciation (depreciation) on investments | (639328) | (431591) | 2217815 | (597476) |  |  |
| Capital gain distributions | 2277241 | 4046980 |  |  |  |  |
| **Increase (decrease) in net assets from operations** | **2095975** | **4337508** | **2365452** | **(151988)** | **—** | **—** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 26614 | 35011 | 74273 | 29105 |  |  |
| Transfers for contract benefits and terminations | (2332210) | (1469601) | (6961707) | (4390785) |  |  |
| Administrative expenses | (41734) | (42948) | (525817) | (367824) |  |  |
| Transfers between subaccounts (including fixed account), net | (879465) | (412965) | 822842 | 32666503 |  |  |
| **Increase (decrease) in net assets from capital transactions** | **(3226795)** | **(1890503)** | **(6590409)** | **27936999** | **—** | **—** |
| **Increase (decrease) in net assets** | **(1130820)** | **2447005** | **(4224957)** | **27785011** | **—** | **—** |
| Net assets at beginning of year | 18669800 | 16222795 | 49101046 | 21316035 |  |  |
| Net assets at end of year | $17538980 | $18669800 | $44876089 | $49101046 | $— | $— |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 13489 | 24937 | 647061 | 2875817 |  |  |
| Units redeemed | (78098) | (69937) | (1165110) | (600385) |  |  |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(64609)** | **(45000)** | **(518049)** | **2275432** | **—** | **—** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Fidelity<sup>®</sup> Variable Insurance Products Fund (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust** |
| **VIP<br>Mid Cap<br>Portfolio —<br>Service Class 2** | **VIP<br>Mid Cap<br>Portfolio —<br>Service Class 2** | **VIP<br>Overseas<br>Portfolio —<br>Initial Class** | **VIP<br>Overseas<br>Portfolio —<br>Initial Class** | **VIP<br>Value Strategies<br>Portfolio —<br>Service Class 2** | **VIP<br>Value Strategies<br>Portfolio —<br>Service Class 2** | **Franklin<br>Allocation<br>VIP Fund —<br>Class 2 Shares** | **Franklin<br>Allocation<br>VIP Fund —<br>Class 2 Shares** | **Franklin<br>Income<br>VIP Fund —<br>Class 2 Shares** | **Franklin<br>Income<br>VIP Fund —<br>Class 2 Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(729354) | $(704160) | $21381 | $20785 | $(17975) | $(22126) | $6218 | $28746 | $3806771 | $4472603 |
| (1023326) | 1224508 | 351186 | 430656 | 49599 | 105509 | (706975) | (1015162) | (558376) | (1330531) |
| 217234 | (873552) | 402869 | (493990) | 25405 | (242003) | 2092236 | 2938621 | 7246202 | 3281682 |
| 6153200 | 8393163 | 859786 | 425484 | 98949 | 358462 | 991836 |  | 1283327 | 582870 |
| **4617754** | **8039959** | **1635222** | **382935** | **155978** | **199842** | **2383315** | **1952205** | **11777924** | **7006624** |
| 119736 | 40157 | 44190 | 18946 |  | 7392 | 38159 | 132 | 365631 | 283002 |
| (5316701) | (7411617) | (1055735) | (1094487) | (128256) | (434707) | (4018527) | (4216640) | (15601581) | (19665679) |
| (207105) | (230396) | (7487) | (8068) | (7209) | (7981) | (251822) | (276299) | (796668) | (868305) |
| (19006745) | 12300208 | 316334 | (25061) | (252568) | 4826 | (485104) | (865094) | (6075654) | (4324831) |
| **(24410815)** | **4698352** | **(702698)** | **(1108670)** | **(388033)** | **(430470)** | **(4717294)** | **(5357901)** | **(22108272)** | **(24575813)** |
| **(19793061)** | **12738311** | **932524** | **(725735)** | **(232055)** | **(230628)** | **(2333979)** | **(3405696)** | **(10330348)** | **(17569189)** |
| 64978044 | 52239733 | 8962719 | 9688454 | 2543025 | 2773653 | 25315967 | 28721663 | 126462508 | 144031697 |
| $45184983 | $64978044 | $9895243 | $8962719 | $2310970 | $2543025 | $22981988 | $25315967 | $116132160 | $126462508 |
| 88325 | 535565 | 10128 | 9135 | 1232 | 1289 | 48685 | 43399 | 289473 | 422270 |
| (679720) | (234581) | (28803) | (38889) | (10383) | (12312) | (332997) | (386650) | (1403466) | (1676323) |
| **(591395)** | **300984** | **(18675)** | **(29754)** | **(9151)** | **(11023)** | **(284312)** | **(343251)** | **(1113993)** | **(1254053)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Franklin Templeton Variable Insurance Products Trust (continued)** | <br>**Franklin Templeton Variable Insurance Products Trust (continued)** | <br>**Franklin Templeton Variable Insurance Products Trust (continued)** | <br>**Franklin Templeton Variable Insurance Products Trust (continued)** | <br>**Franklin Templeton Variable Insurance Products Trust (continued)** | <br>**Franklin Templeton Variable Insurance Products Trust (continued)** |
|  | **Franklin<br>Large Cap Growth<br>VIP Fund —<br>Class 2 Shares** | **Franklin<br>Large Cap Growth<br>VIP Fund —<br>Class 2 Shares** | **Franklin<br>Mutual Shares<br>VIP Fund —<br>Class 2 Shares** | **Franklin<br>Mutual Shares<br>VIP Fund —<br>Class 2 Shares** | **Templeton<br>Foreign<br>VIP Fund —<br>Class 1 Shares** | **Templeton<br>Foreign<br>VIP Fund —<br>Class 1 Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(1848) | $(2774) | $69181 | $54218 | $34599 | $34435 |
| Net realized gain (loss) on investments | 5711 | 1695 | (137509) | (278309) | 66215 | 17235 |
| Change in unrealized appreciation (depreciation) on investments | (19452) | 21234 | 11834 | 1822106 | 453697 | (118240) |
| Capital gain distributions | 21454 | 20063 | 1964423 | 434013 | 202588 |  |
| **Increase (decrease) in net assets from operations** | **5865** | **40218** | **1907929** | **2032028** | **757099** | **(66570)** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums |  |  | 45682 | 34946 | 1964 | 23995 |
| Transfers for contract benefits and terminations | (5504) | (20216) | (2434477) | (2184577) | (439603) | (257747) |
| Administrative expenses | (299) | (850) | (192421) | (210448) | (3373) | (4025) |
| Transfers between subaccounts (including fixed account), net | (77672) | (1444) | (923903) | (918932) | (108752) | 21213 |
| **Increase (decrease) in net assets from capital transactions** | **(83475)** | **(22510)** | **(3505119)** | **(3279011)** | **(549764)** | **(216564)** |
| **Increase (decrease) in net assets** | **(77610)** | **17708** | **(1597190)** | **(1246983)** | **207335** | **(283134)** |
| Net assets at beginning of year | 190120 | 172412 | 20924032 | 22171015 | 2936220 | 3219354 |
| Net assets at end of year | $112510 | $190120 | $19326842 | $20924032 | $3143555 | $2936220 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 41 | 24 | 119724 | 124154 | 12034 | 9316 |
| Units redeemed | (1509) | (466) | (280853) | (292531) | (41496) | (22328) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(1468)** | **(442)** | **(161129)** | **(168377)** | **(29462)** | **(13012)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Franklin Templeton Variable Insurance Products Trust (continued)** | **Goldman Sachs Variable Insurance Trust** | **Goldman Sachs Variable Insurance Trust** | **Goldman Sachs Variable Insurance Trust** | **Goldman Sachs Variable Insurance Trust** |
| **Templeton<br>Foreign<br>VIP Fund —<br>Class 2 Shares** | **Templeton<br>Foreign<br>VIP Fund —<br>Class 2 Shares** | **Templeton<br>Global Bond<br>VIP Fund —<br>Class 1 Shares** | **Templeton<br>Global Bond<br>VIP Fund —<br>Class 1 Shares** | **Templeton<br>Growth<br>VIP Fund —<br>Class 2 Shares** | **Templeton<br>Growth<br>VIP Fund —<br>Class 2 Shares** | **Goldman Sachs<br>Government Money<br>Market Fund —<br>Service Shares** | **Goldman Sachs<br>Government Money<br>Market Fund —<br>Service Shares** | **Goldman Sachs<br>Large Cap<br>Value Fund —<br>Institutional Shares** | **Goldman Sachs<br>Large Cap<br>Value Fund —<br>Institutional Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $987 | $1397 | $(24685) | $(28660) | $(26500) | $(24637) | $2655997 | $3926490 | $(16146) | $(4471) |
| 4889 | 1435 | (68351) | (123770) | 94839 | 100785 |  |  | (61247) | (17072) |
| 20881 | (6472) | 332770 | (115775) | 431879 | 84746 |  | 1 | (112571) | 130526 |
| 8757 |  |  |  | 302095 | 14757 |  |  | 562262 | 527467 |
| **35514** | **(3640)** | **239734** | **(268205)** | **802313** | **175651** | **2655997** | **3926491** | **372298** | **636450** |
|  |  | 1147 | 720 | 31088 | 19070 | 1104948 | 793486 | 12378 | 33669 |
| (8750) | (22633) | (166498) | (339817) | (309055) | (470958) | (88969162) | (78705542) | (654467) | (565344) |
| (333) | (636) | (2581) | (3341) | (30264) | (34449) | (382170) | (361710) | (4536) | (5495) |
| (43020) | 3260 | (66176) | 12271 | (489024) | 63071 | 83055590 | 58726100 | 20821 | (21918) |
| **(52103)** | **(20009)** | **(234108)** | **(330167)** | **(797255)** | **(423266)** | **(5190794)** | **(19547666)** | **(625804)** | **(559088)** |
| **(16589)** | **(23649)** | **5626** | **(598372)** | **5058** | **(247615)** | **(2534797)** | **(15621175)** | **(253506)** | **77362** |
| 157737 | 181386 | 1726582 | 2324954 | 4136561 | 4384176 | 114246780 | 129867955 | 4411987 | 4334625 |
| $141148 | $157737 | $1732208 | $1726582 | $4141619 | $4136561 | $111711983 | $114246780 | $4158481 | $4411987 |
| 133 | 377 | 2780 | 5726 | 23428 | 47228 | 12018818 | 9539581 | 4052 | 11985 |
| (2324) | (1222) | (18506) | (28528) | (75149) | (77054) | (12553074) | (11610868) | (24131) | (31208) |
| **(2191)** | **(845)** | **(15726)** | **(22802)** | **(51721)** | **(29826)** | **(534256)** | **(2071287)** | **(20079)** | **(19223)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Goldman Sachs Variable<br>Insurance Trust<br>(continued)** | **Goldman Sachs Variable<br>Insurance Trust<br>(continued)** | **Janus Aspen Series** | **Janus Aspen Series** | **Janus Aspen Series** | **Janus Aspen Series** |
|  | **Goldman Sachs<br>Mid Cap<br>Value Fund —<br>Institutional Shares** | **Goldman Sachs<br>Mid Cap<br>Value Fund —<br>Institutional Shares** | **Janus<br>Henderson<br>Balanced Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Balanced Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Balanced Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Balanced Portfolio —<br>Service Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(77974) | $(136730) | $285987 | $298890 | $(73387) | $(54806) |
| Net realized gain (loss) on investments | 269516 | 393164 | 2888498 | 3636936 | 4997531 | 4776184 |
| Change in unrealized appreciation (depreciation) on investments | (975790) | 981966 | 1360388 | 2451534 | 1247532 | 4339728 |
| Capital gain distributions | 2533848 | 1463686 | 1576006 |  | 2191462 |  |
| **Increase (decrease) in net assets from operations** | **1749600** | **2702086** | **6110879** | **6387360** | **8363138** | **9061106** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 104125 | 114654 | 146332 | 104173 | 255211 | 61713 |
| Transfers for contract benefits and terminations | (2755180) | (3516193) | (5985168) | (7496800) | (7037127) | (8458654) |
| Administrative expenses | (36467) | (40434) | (32032) | (38546) | (353032) | (374521) |
| Transfers between subaccounts (including fixed account), net | (468803) | (704506) | 388554 | (178739) | (3311789) | (723813) |
| **Increase (decrease) in net assets from capital transactions** | **(3156325)** | **(4146479)** | **(5482314)** | **(7609912)** | **(10446737)** | **(9495275)** |
| **Increase (decrease) in net assets** | **(1406725)** | **(1444393)** | **628565** | **(1222552)** | **(2083599)** | **(434169)** |
| Net assets at beginning of year | 25563106 | 27007499 | 48066368 | 49288920 | 71876077 | 72310246 |
| Net assets at end of year | $24156381 | $25563106 | $48694933 | $48066368 | $69792478 | $71876077 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 6864 | 7554 | 24588 | 24133 | 102501 | 158198 |
| Units redeemed | (57591) | (75972) | (96100) | (138086) | (423969) | (464690) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(50727)** | **(68418)** | **(71512)** | **(113953)** | **(321468)** | **(306492)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Janus Aspen Series (continued)** |
| **Janus<br>Henderson<br>Enterprise Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Enterprise Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Enterprise Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Enterprise Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Flexible Bond Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Flexible Bond Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Forty Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Forty Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Forty Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Forty Portfolio —<br>Service Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(393375) | $(261873) | $(61707) | $(42281) | $218497 | $211486 | $(426290) | $(486706) | $(204225) | $(429420) |
| 1483743 | 1638673 | 86629 | 116779 | (236943) | (230736) | 1700524 | 1423453 | 698776 | 5825592 |
| (1662200) | 2051561 | (155521) | 315534 | 351896 | 52139 | (894) | 5322119 | (250456) | (1122640) |
| 2690260 | 1501505 | 388417 | 208937 |  |  | 4316030 | 2016936 | 2158205 | 2187391 |
| **2118428** | **4929866** | **257818** | **598969** | **333450** | **32889** | **5589370** | **8275802** | **2402300** | **6460923** |
| 9636 | 76744 |  |  | 11441 | 9507 | 139360 | 60240 | 30140 | 38973 |
| (4276257) | (5102209) | (359398) | (329690) | (1362942) | (825429) | (4288837) | (4083114) | (1820521) | (3170578) |
| (22691) | (27002) | (6768) | (7173) | (6767) | (7415) | (22117) | (24028) | (56659) | (183249) |
| (99507) | (37712) | (3791) | (62261) | 563986 | (96283) | 117854 | (187903) | (964966) | (20837879) |
| **(4388819)** | **(5090179)** | **(369957)** | **(399124)** | **(794282)** | **(919620)** | **(4053740)** | **(4234805)** | **(2812006)** | **(24152733)** |
| **(2270391)** | **(160313)** | **(112139)** | **199845** | **(460832)** | **(886731)** | **1535630** | **4040997** | **(409706)** | **(17691810)** |
| 37339088 | 37499401 | 4700546 | 4500701 | 5886466 | 6773197 | 36746380 | 32705383 | 16440885 | 34132695 |
| $35068697 | $37339088 | $4588407 | $4700546 | $5425634 | $5886466 | $38282010 | $36746380 | $16031179 | $16440885 |
| 4787 | 4515 | 668 | 1372 | 23742 | 11369 | 10183 | 3082 | 5652 | 23781 |
| (47470) | (57622) | (12088) | (13346) | (60140) | (53942) | (41112) | (44113) | (45237) | (580450) |
| **(42683)** | **(53107)** | **(11420)** | **(11974)** | **(36398)** | **(42573)** | **(30929)** | **(41031)** | **(39585)** | **(556669)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Janus Aspen Series (continued)** | <br>**Janus Aspen Series (continued)** | <br>**Janus Aspen Series (continued)** | <br>**Janus Aspen Series (continued)** | <br>**Janus Aspen Series (continued)** | <br>**Janus Aspen Series (continued)** |
|  | **Janus<br>Henderson**<br>**Global Research<br>Portfolio —<br>Institutional Shares** | **Janus<br>Henderson**<br>**Global Research<br>Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Global Research<br>Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Global Research<br>Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Global Technology and<br>Innovation Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Global Technology and<br>Innovation Portfolio —<br>Service Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(226220) | $(219255) | $(22433) | $(24259) | $(187749) | $(176842) |
| Net realized gain (loss) on investments | 2318201 | 1857914 | 262421 | 244308 | 813823 | 744331 |
| Change in unrealized appreciation (depreciation) on investments | 1011702 | 3751314 | (46107) | 190734 | 892819 | 2479160 |
| Capital gain distributions | 2916318 | 1065003 | 220572 | 80803 | 1185174 |  |
| **Increase (decrease) in net assets from operations** | **6020001** | **6454976** | **414453** | **491586** | **2704067** | **3046649** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 1922 | 53144 |  | 53873 | 3 | 62062 |
| Transfers for contract benefits and terminations | (4321795) | (3493797) | (585488) | (508652) | (943257) | (1419338) |
| Administrative expenses | (17377) | (19967) | (3459) | (3605) | (14685) | (15867) |
| Transfers between subaccounts (including fixed account), net | (316998) | (115380) | (32001) | 28490 | (471905) | 34441 |
| **Increase (decrease) in net assets from capital transactions** | **(4654248)** | **(3576000)** | **(620948)** | **(429894)** | **(1429844)** | **(1338702)** |
| **Increase (decrease) in net assets** | **1365753** | **2878976** | **(206495)** | **61692** | **1274223** | **1707947** |
| Net assets at beginning of year | 33496667 | 30617691 | 2462378 | 2400686 | 12307928 | 10599981 |
| Net assets at end of year | $34862420 | $33496667 | $2255883 | $2462378 | $13582151 | $12307928 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 3153 | 12037 | 393 | 7159 | 8890 | 11804 |
| Units redeemed | (76537) | (72437) | (28754) | (31135) | (42421) | (50619) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(73384)** | **(60400)** | **(28361)** | **(23976)** | **(33531)** | **(38815)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | **Janus Aspen Series (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Legg Mason Partners<br>Variable Equity Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Legg Mason Partners<br>Variable Equity Trust** |
| **Janus<br>Henderson<br>Overseas<br>Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Overseas<br>Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Overseas<br>Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Overseas<br>Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Research<br>Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Research<br>Portfolio —<br>Institutional Shares** | **Janus<br>Henderson<br>Research<br>Portfolio —<br>Service Shares** | **Janus<br>Henderson<br>Research<br>Portfolio —<br>Service Shares** | **ClearBridge<br>Variable Dividend<br>Strategy Portfolio —<br>Class I** | **ClearBridge<br>Variable Dividend<br>Strategy Portfolio —<br>Class I** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $932 | $(16922) | $(3229) | $(4951) | $(520623) | $(556067) | $(43185) | $(47435) | $27984 | $(4785) |
| 540316 | 375692 | 116429 | 141547 | 3635620 | 2983182 | 248620 | 196640 | 34125 | 61623 |
| 3151092 | 341861 | 200855 | (59437) | 153403 | 7844378 | (21135) | 604019 | (183278) | 52618 |
|  |  |  |  | 3079481 | 1158700 | 239405 | 90347 | 521542 | 396378 |
| **3692340** | **700631** | **314055** | **77159** | **6347881** | **11430193** | **423705** | **843571** | **400373** | **505834** |
| 40747 | 13451 | 4780 |  | 184811 | 139978 | 4200 | 396 |  | 42953 |
| (1373767) | (1858731) | (277692) | (407674) | (6016322) | (5876660) | (400583) | (406078) | (236818) | (388215) |
| (8654) | (10355) | (1903) | (3256) | (21634) | (24287) | (4324) | (3992) | (3526) | (3780) |
| (121088) | 70846 | (39557) | (44469) | (706090) | (392423) | (159059) | (22604) | 17255 | 142136 |
| **(1462762)** | **(1784789)** | **(314372)** | **(455399)** | **(6559235)** | **(6153392)** | **(559766)** | **(432278)** | **(223089)** | **(206906)** |
| **2229578** | **(1084158)** | **(317)** | **(378240)** | **(211354)** | **5276801** | **(136061)** | **411293** | **177284** | **298928** |
| 14395042 | 15479200 | 1360065 | 1738305 | 41915285 | 36638484 | 3176238 | 2764945 | 3720984 | 3422056 |
| $16624620 | $14395042 | $1359748 | $1360065 | $41703931 | $41915285 | $3040177 | $3176238 | $3898268 | $3720984 |
| 9626 | 5839 | 698 | 1543 | 6089 | 4968 | 665 | 654 | 2440 | 8909 |
| (40850) | (48786) | (16178) | (23398) | (77899) | (88082) | (17041) | (15151) | (8640) | (15544) |
| <br> **(31224)**<br>  | **(42947)** | **(15480)** | **(21855)** | **(71810)** | **(83114)** | **(16376)** | **(14497)** | **(6200)** | **(6635)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Legg Mason Partners Variable Equity Trust (continued)** | <br>**Legg Mason Partners Variable Equity Trust (continued)** | <br>**Legg Mason Partners Variable Equity Trust (continued)** | <br>**Legg Mason Partners Variable Equity Trust (continued)** | <br>**Legg Mason Partners Variable Equity Trust (continued)** | <br>**Legg Mason Partners Variable Equity Trust (continued)** |
|  | **ClearBridge<br>Variable Dividend<br>Strategy Portfolio —<br>Class II** | **ClearBridge<br>Variable Dividend<br>Strategy Portfolio —<br>Class II** | **ClearBridge<br>Variable Growth<br>Portfolio —<br>Class II** | **ClearBridge<br>Variable Growth<br>Portfolio —<br>Class II** | **ClearBridge<br>Variable Large Cap<br>Value Portfolio —<br>Class I** | **ClearBridge<br>Variable Large Cap<br>Value Portfolio —<br>Class I** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(2338) | $(36972) | $(37039) | $(38853) | $(48159) | $(45255) |
| Net realized gain (loss) on investments | 312992 | 83151 | (138526) | (338924) | 42264 | 300475 |
| Change in unrealized appreciation (depreciation) on investments | (442086) | 96099 | 54250 | (152) | (162918) | (1191126) |
| Capital gain distributions | 559830 | 454270 | 369221 | 643168 | 1110490 | 1779203 |
| **Increase (decrease) in net assets from operations** | **428398** | **596548** | **247906** | **265239** | **941677** | **843297** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums |  |  | 12 | 15794 | 81357 | 12982 |
| Transfers for contract benefits and terminations | (604046) | (701053) | (136068) | (501464) | (1172056) | (3489938) |
| Administrative expenses | (6953) | (8004) | (10225) | (11239) | (26063) | (30341) |
| Transfers between subaccounts (including fixed account), net | (65046) | (80221) | (124349) | (260750) | (455753) | (559511) |
| **Increase (decrease) in net assets from capital transactions** | **(676045)** | **(789278)** | **(270630)** | **(757659)** | **(1572515)** | **(4066808)** |
| **Increase (decrease) in net assets** | **(247647)** | **(192730)** | **(22724)** | **(492420)** | **(630838)** | **(3223511)** |
| Net assets at beginning of year | 4378255 | 4570985 | 2296155 | 2788575 | 11721527 | 14945038 |
| Net assets at end of year | $4130608 | $4378255 | $2273431 | $2296155 | $11090689 | $11721527 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 31056 | 2118 | 1431 | 7688 | 10112 | 11250 |
| Units redeemed | (52256) | (29713) | (7434) | (25794) | (50784) | (187661) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(21200)** | **(27595)** | **(6003)** | **(18106)** | **(40672)** | **(176411)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Lincoln Variable Insurance Products Trust** |
| **LVIP American<br>Century Disciplined<br>Core Value Fund —<br>Standard Class II** | **LVIP American<br>Century Disciplined<br>Core Value Fund —<br>Standard Class II** | **LVIP American<br>Century Inflation<br>Protection Fund —<br>Service Class** | **LVIP American<br>Century Inflation<br>Protection Fund —<br>Service Class** | **LVIP American<br>Century International<br>Fund —<br>Standard Class II** | **LVIP American<br>Century International<br>Fund —<br>Standard Class II** | **LVIP American<br>Century Ultra<sup>®</sup> Fund —<br>Standard Class II** | **LVIP American<br>Century Ultra<sup>®</sup> Fund —<br>Standard Class II** | **LVIP American<br>Century Value Fund —<br>Standard Class II** | **LVIP American<br>Century Value Fund —<br>Standard Class II** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(154) | $(169) | $747250 | $292045 | $(1455) | $(446) | $(110) | $(662) | $65 | $1063 |
| 1728 | 420 | (227853) | (320399) | 6035 | 1716 | 7183 | 4052 | 3086 | 1110 |
| 2468 | 3226 | 124935 | 14234 | 23791 | 2886 | (9125) | 2552 | 469 | (6833) |
|  |  |  |  |  |  |  | 2918 | 4316 | 13705 |
| **4042** | **3477** | **644332** | **(14120)** | **28371** | **4156** | **(2052)** | **8860** | **7936** | **9045** |
|  |  | 26109 | 18763 |  | 370 |  |  |  |  |
| (10418) | (2226) | (1783498) | (2071650) | (24312) | (47824) | (402) | (2388) | (383) | (13601) |
| (11) | (5) | (150662) | (167095) | (257) | (613) |  | (253) | (32) | (171) |
| (558) | 19354 | 132857 | 417502 | (48056) | 13567 | (31621) | (6967) | (15912) | (195622) |
| **(10987)** | **17123** | **(1775194)** | **(1802480)** | **(72625)** | **(34500)** | **(32023)** | **(9608)** | **(16327)** | **(209394)** |
| **(6945)** | **20600** | **(1130862)** | **(1816600)** | **(44254)** | **(30344)** | **(34075)** | **(748)** | **(8391)** | **(200349)** |
| 38909 | 18309 | 14816100 | 16632700 | 239301 | 269645 | 34075 | 34823 | 67584 | 267933 |
| $31964 | $38909 | $13685238 | $14816100 | $195047 | $239301 | $— | $34075 | $59193 | $67584 |
| 77 | 827 | 187920 | 204979 | 1010 | 3010 | 14 | 120 |  | 619 |
| (355) | (176) | (333373) | (350665) | (3863) | (4552) | (535) | (272) | (340) | (8340) |
| <br> **(278)**<br>  | **651** | **(145453)** | **(145686)** | **(2853)** | **(1542)** | **(521)** | **(152)** | **(340)** | **(7721)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Lincoln Variable Insurance Products Trust (continued)** | <br>**Lincoln Variable Insurance Products Trust (continued)** | <br>**Lincoln Variable Insurance Products Trust (continued)** | <br>**Lincoln Variable Insurance Products Trust (continued)** | <br>**Lincoln Variable Insurance Products Trust (continued)** | <br>**Lincoln Variable Insurance Products Trust (continued)** |
|  | **LVIP JPMorgan<br>Core Bond Fund —<br>Standard Class** | **LVIP JPMorgan<br>Core Bond Fund —<br>Standard Class** | **LVIP JPMorgan<br>Mid Cap Value Fund —<br>Standard Class** | **LVIP JPMorgan<br>Mid Cap Value Fund —<br>Standard Class** | **LVIP JPMorgan<br>Small Cap Core Fund —<br>Standard Class** | **LVIP JPMorgan<br>Small Cap Core Fund —<br>Standard Class** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $11520 | $17521 | $(1462) | $(1614) | $(1617) | $(974) |
| Net realized gain (loss) on investments | (12704) | (23651) | (351) | 3942 | 8079 | 3357 |
| Change in unrealized appreciation (depreciation) on investments | 42103 | 10867 | (11260) | (9635) | (5820) | 6437 |
| Capital gain distributions |  |  | 18095 | 32113 | 991 | 2200 |
| **Increase (decrease) in net assets from operations** | **40919** | **4737** | **5022** | **24806** | **1633** | **11020** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums |  | 1482 |  | 370 |  | 370 |
| Transfers for contract benefits and terminations | (78533) | (537039) | (23653) | (27278) | (13515) | (18471) |
| Administrative expenses | (747) | (1536) | (157) | (340) | (83) | (78) |
| Transfers between subaccounts (including fixed account), net | (84035) | 178556 | (17191) | (5816) | (124049) | 150569 |
| **Increase (decrease) in net assets from capital transactions** | **(163315)** | **(358537)** | **(41001)** | **(33064)** | **(137647)** | **132390** |
| **Increase (decrease) in net assets** | **(122396)** | **(353800)** | **(35979)** | **(8258)** | **(136014)** | **143410** |
| Net assets at beginning of year | 842945 | 1196745 | 203047 | 211305 | 148860 | 5450 |
| Net assets at end of year | $720549 | $842945 | $167068 | $203047 | $12846 | $148860 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 6398 | 25386 | 765 | 1494 | 983 | 8571 |
| Units redeemed | (18081) | (49990) | (1789) | (3214) | (6904) | (2519) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(11683)** | **(24604)** | **(1024)** | **(1720)** | **(5921)** | **6052** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Lincoln Variable Insurance<br>Products Trust (continued)** | **Lincoln Variable Insurance<br>Products Trust (continued)** | **MFS<sup>®</sup> Variable Insurance Trust** | **MFS<sup>®</sup> Variable Insurance Trust** | **MFS<sup>®</sup> Variable Insurance Trust** | **MFS<sup>®</sup> Variable Insurance Trust** | **MFS<sup>®</sup> Variable Insurance Trust** | **MFS<sup>®</sup> Variable Insurance Trust** | **MFS<sup>®</sup> Variable Insurance Trust** | **MFS<sup>®</sup> Variable Insurance Trust** |
| **LVIP JPMorgan<br>U.S. Equity Fund —<br>Standard Class** | **LVIP JPMorgan<br>U.S. Equity Fund —<br>Standard Class** | **MFS<sup>®</sup><br>Investors Trust Series —<br>Service Class Shares** | **MFS<sup>®</sup><br>Investors Trust Series —<br>Service Class Shares** | **MFS<sup>®</sup><br>New Discovery Series —<br>Service Class Shares** | **MFS<sup>®</sup><br>New Discovery Series —<br>Service Class Shares** | **MFS<sup>®</sup><br>Total Return Series —<br>Service Class Shares** | **MFS<sup>®</sup><br>Total Return Series —<br>Service Class Shares** | **MFS<sup>®</sup><br>Utilities<br>Series —<br>Service Class Shares** | **MFS<sup>®</sup><br>Utilities<br>Series —<br>Service Class Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(6218) | $(12620) | $(32197) | $(42524) | $(116714) | $(129776) | $135501 | $80104 | $98572 | $56168 |
| 14012 | 267698 | 128483 | 257150 | (482501) | (449359) | 113272 | 240946 | 267823 | 116744 |
| 26402 | (82185) | (1142847) | 128184 | 1374203 | 990772 | 33722 | (196935) | 570831 | 400866 |
| 23306 | 28170 | 1412231 | 288741 |  |  | 1718007 | 1213624 | 118760 | 283554 |
| **57502** | **201063** | **365670** | **631551** | **774988** | **411637** | **2000502** | **1337739** | **1055986** | **857332** |
|  | 370 |  |  | 11949 | 255 | 102844 | 188382 | 136 | 136 |
| (52890) | (568901) | (647398) | (480861) | (839584) | (722753) | (2936278) | (3145065) | (958732) | (993177) |
| (1285) | (1240) | (5711) | (7183) | (13511) | (16253) | (121632) | (130510) | (23967) | (24711) |
| 530408 | (486411) | (15818) | (255540) | (483066) | (156862) | (517971) | 155474 | (937905) | 614176 |
| **476233** | **(1056182)** | **(668927)** | **(743584)** | **(1324212)** | **(895613)** | **(3473037)** | **(2931719)** | **(1920468)** | **(403576)** |
| **533735** | **(855119)** | **(303257)** | **(112033)** | **(549224)** | **(483976)** | **(1472535)** | **(1593980)** | **(864482)** | **453756** |
| 307696 | 1162815 | 3592707 | 3704740 | 8141445 | 8625421 | 24532763 | 26126743 | 9725222 | 9271466 |
| $841431 | $307696 | $3289450 | $3592707 | $7592221 | $8141445 | $23060228 | $24532763 | $8860740 | $9725222 |
| 10425 | 1097 | 149 | 1035 | 3749 | 3780 | 81195 | 107556 | 7862 | 29036 |
| (1406) | (22034) | (17873) | (19599) | (37994) | (29701) | (223494) | (259826) | (55639) | (40449) |
| <br> **9019** | **(20937)** | **(17724)** | **(18564)** | **(34245)** | **(25921)** | **(142299)** | **(152270)** | **(47777)** | **(11413)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **MFS<sup>®</sup> Variable Insurance Trust II** | **MFS<sup>®</sup> Variable Insurance Trust II** | **MFS<sup>®</sup> Variable Insurance Trust II** | **MFS<sup>®</sup> Variable Insurance Trust II** | **PIMCO Variable<br>Insurance Trust** | **PIMCO Variable<br>Insurance Trust** |
|  | **MFS<sup>®</sup><br>Income<br>Portfolio —<br>Service Class Shares** | **MFS<sup>®</sup><br>Income<br>Portfolio —<br>Service Class Shares** | **MFS<sup>®</sup><br>Massachusetts Investors<br>Growth Stock Portfolio —<br>Service Class Shares** | **MFS<sup>®</sup><br>Massachusetts Investors<br>Growth Stock Portfolio —<br>Service Class Shares** | **All Asset<br>Portfolio —<br>Advisor Class Shares** | **All Asset<br>Portfolio —<br>Advisor Class Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $316 | $277 | $(71748) | $(78001) | $88569 | $162879 |
| Net realized gain (loss) on investments | (79) | (745) | 199350 | 132096 | (72121) | (117029) |
| Change in unrealized appreciation (depreciation) on investments | 375 | 599 | (445383) | 176848 | 338535 | 18311 |
| Capital gain distributions |  |  | 666573 | 488853 |  |  |
| **Increase (decrease) in net assets from operations** | **612** | **131** | **348792** | **719796** | **354983** | **64161** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums |  |  | 15534 | 2305 | 12 | 46093 |
| Transfers for contract benefits and terminations |  | (4788) | (847848) | (571155) | (532823) | (404209) |
| Administrative expenses | (36) | (34) | (8531) | (9560) | (13967) | (15046) |
| Transfers between subaccounts (including fixed account), net | 371 | 924 | (608685) | (31309) | (140224) | (172050) |
| **Increase (decrease) in net assets from capital transactions** | **335** | **(3898)** | **(1449530)** | **(609719)** | **(687002)** | **(545212)** |
| **Increase (decrease) in net assets** | **947** | **(3767)** | **(1100738)** | **110077** | **(332019)** | **(481051)** |
| Net assets at beginning of year | 10977 | 14744 | 5309239 | 5199162 | 3249193 | 3730244 |
| Net assets at end of year | $11924 | $10977 | $4208501 | $5309239 | $2917174 | $3249193 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 69 | 83 | 9804 | 11674 | 4761 | 14096 |
| Units redeemed | (40) | (434) | (59732) | (33469) | (41316) | (44922) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **29** | **(351)** | **(49928)** | **(21795)** | **(36555)** | **(30826)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **PIMCO Variable Insurance Trust (continued)** |
| **High Yield<br>Portfolio —<br>Administrative<br>Class Shares** | **High Yield<br>Portfolio —<br>Administrative<br>Class Shares** | **International Bond Portfolio<br>(U.S. Dollar Hedged) —<br>Administrative<br>Class Shares** | **International Bond Portfolio<br>(U.S. Dollar Hedged) —<br>Administrative<br>Class Shares** | **Long-Term U.S.<br>Government Portfolio —<br>Administrative<br>Class Shares** | **Long-Term U.S.<br>Government Portfolio —<br>Administrative<br>Class Shares** | **Low Duration<br>Portfolio —<br>Administrative<br>Class Shares** | **Low Duration<br>Portfolio —<br>Administrative<br>Class Shares** | **Total Return<br>Portfolio —<br>Administrative<br>Class Shares** | **Total Return<br>Portfolio —<br>Administrative<br>Class Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $1121502 | $1106805 | $19057 | $21363 | $356786 | $372622 | $572782 | $819298 | $2209815 | $2255958 |
| (24285) | (131901) | (2760) | (10951) | (2281237) | (9636161) | (273370) | (869153) | (2199966) | (2264451) |
| 575240 | 348357 | 6571 | 28008 | 3108196 | 6487026 | 646485 | 990361 | 6245403 | 771893 |
| **1672457** | **1323261** | **22868** | **38420** | **1183745** | **(2776513)** | **945897** | **940506** | **6255252** | **763400** |
| 54270 | 33256 |  | 537 | 120253 | 82707 | 42900 | 56784 | 226466 | 272632 |
| (3107019) | (3541446) | (40084) | (150043) | (3478340) | (4880752) | (5980522) | (4429948) | (13269661) | (11600475) |
| (177769) | (195560) | (1708) | (1735) | (236579) | (408409) | (240293) | (360876) | (743916) | (774068) |
| (346705) | 155173 | 4955 | 18585 | 2389590 | (19223215) | 159161 | (11827795) | (2554598) | 12536768 |
| **(3577223)** | **(3548577)** | **(36837)** | **(132656)** | **(1205076)** | **(24429669)** | **(6018754)** | **(16561835)** | **(16341709)** | **434857** |
| **(1904766)** | **(2225316)** | **(13969)** | **(94236)** | **(21331)** | **(27206182)** | **(5072857)** | **(15621329)** | **(10086457)** | **1198257** |
| 25284753 | 27510069 | 993967 | 1088203 | 23255410 | 50461592 | 27524390 | 43145719 | 95573089 | 94374832 |
| $23379987 | $25284753 | $979998 | $993967 | $23234079 | $23255410 | $22451533 | $27524390 | $85486632 | $95573089 |
| 107766 | 122433 | 653 | 1926 | 554771 | 658029 | 483535 | 503583 | 807325 | 1426035 |
| (267277) | (288878) | (2418) | (8521) | (592705) | (2444285) | (994807) | (2016958) | (1871916) | (1339902) |
| <br> **(159511)**<br>  | **(166445)** | **(1765)** | **(6595)** | **(37934)** | **(1786256)** | **(511272)** | **(1513375)** | **(1064591)** | **86133** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Rydex Variable Trust** | **Rydex Variable Trust** | <br>**State Street Variable Insurance Series Funds, Inc.** | <br>**State Street Variable Insurance Series Funds, Inc.** | <br>**State Street Variable Insurance Series Funds, Inc.** | <br>**State Street Variable Insurance Series Funds, Inc.** |
|  | **NASDAQ —<br>100<sup>®</sup> Fund** | **NASDAQ —<br>100<sup>®</sup> Fund** | **Income<br>V.I.S. Fund —<br>Class 1 Shares** | **Income<br>V.I.S. Fund —<br>Class 1 Shares** | **Premier<br>Growth Equity<br>V.I.S. Fund —<br>Class 1 Shares** | **Premier<br>Growth Equity<br>V.I.S. Fund —<br>Class 1 Shares** |
| | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(141808) | $(121270) | $140359 | $125889 | $(400503) | $(430969) |
| Net realized gain (loss) on investments | 682563 | 474033 | (283326) | (255429) | 1047970 | 1629844 |
| Change in unrealized appreciation (depreciation) on investments | 433290 | 1275637 | 454929 | (56622) | (1054112) | 323455 |
| Capital gain distributions | 534078 | 171029 |  |  | 4795023 | 5571739 |
| **Increase (decrease) in net assets from operations** | **1508123** | **1799429** | **311962** | **(186162)** | **4388378** | **7094069** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 2488 | 5945 | 326541 | 186107 | 19676 | 10274 |
| Transfers for contract benefits and terminations | (527714) | (771647) | (1053659) | (905865) | (3422314) | (4549056) |
| Administrative expenses | (36440) | (35436) | (25575) | (28028) | (48796) | (60871) |
| Transfers between subaccounts (including fixed account), net | (612370) | (201773) | (390199) | (174597) | (1714626) | (579459) |
| **Increase (decrease) in net assets from capital transactions** | **(1174036)** | **(1002911)** | **(1142892)** | **(922383)** | **(5166060)** | **(5179112)** |
| **Increase (decrease) in net assets** | **334087** | **796518** | **(830930)** | **(1108545)** | **(777682)** | **1914957** |
| Net assets at beginning of year | 9547005 | 8750487 | 7504341 | 8612886 | 27850705 | 25935748 |
| Net assets at end of year | $9881092 | $9547005 | $6673411 | $7504341 | $27073023 | $27850705 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 5063 | 1759 | 66203 | 47424 | 4667 | 3854 |
| Units redeemed | (25657) | (31559) | (148772) | (114209) | (82845) | (100820) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(20594)** | **(29800)** | **(82569)** | **(66785)** | **(78178)** | **(96966)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **State Street Variable Insurance Series Funds, Inc. (continued)** |
| **Real Estate**<br> **Securities<br>V.I.S. Fund —<br>Class 1 Shares** | **Real Estate**<br> **Securities<br>V.I.S. Fund —<br>Class 1 Shares** | **S&P 500<sup>®</sup><br>Index<br>V.I.S. Fund —<br>Class 1 Shares** | **S&P 500<sup>®</sup><br>Index<br>V.I.S. Fund —<br>Class 1 Shares** | **Small-Cap<br>Equity V.I.S.<br>Fund —<br>Class 1 Shares** | **Small-Cap<br>Equity V.I.S.<br>Fund —<br>Class 1 Shares** | **Total<br>Return<br>V.I.S. Fund —<br>Class 1 Shares** | **Total<br>Return<br>V.I.S. Fund —<br>Class 1 Shares** | **Total<br>Return<br>V.I.S. Fund —<br>Class 3 Shares** | **Total<br>Return<br>V.I.S. Fund —<br>Class 3 Shares** |
| **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(66208) | $234140 | $(821846) | $(564131) | $(291323) | $(309098) | $5102454 | $18088014 | $562356 | $5801526 |
| (294275) | (809246) | 7987293 | 7164289 | (291547) | (101160) | 2641192 | (2953897) | 1551625 | (1614831) |
| 241706 | 3543733 | 4613537 | 11117171 | (1924080) | 516170 | 46492291 | 40406402 | 18655999 | 18856724 |
| 191749 |  | 10689019 | 12979445 | 2109845 | 1676224 | 26211642 | 125636 | 10308070 | 53019 |
| **72972** | **2968627** | **22468003** | **30696774** | **(397105)** | **1782136** | **80447579** | **55666155** | **31078050** | **23096438** |
| 11352 | 42736 | 634745 | 186871 | 27769 | 4684 | 910904 | 1915125 | 198360 | 288778 |
| (1863176) | (3960417) | (18720151) | (18153661) | (2614955) | (2422697) | (53141912) | (50220368) | (28705755) | (31997413) |
| (30080) | (247196) | (376635) | (366400) | (51972) | (58125) | (157314) | (180751) | (1918879) | (2054325) |
| (338072) | (32882450) | (3267164) | 472723 | 138041 | (41200) | (6465964) | (3310726) | (8159620) | (8576360) |
| **(2219976)** | **(37047327)** | **(21729205)** | **(17860467)** | **(2501117)** | **(2517338)** | **(58854286)** | **(51796720)** | **(38585894)** | **(42339320)** |
| **(2147004)** | **(34078700)** | **738798** | **12836307** | **(2898222)** | **(735202)** | **21593293** | **3869435** | **(7507844)** | **(19242882)** |
| 16743631 | 50822331 | 155855988 | 143019681 | 21043874 | 21779076 | 606146436 | 602277001 | 254136663 | 273379545 |
| $14596627 | $16743631 | $156594786 | $155855988 | $18145652 | $21043874 | $627739729 | $606146436 | $246628819 | $254136663 |
| 8057 | 190287 | 53341 | 106603 | 15730 | 14080 | 1262000 | 1214009 | 325836 | 489603 |
| (39365) | (1641808) | (402376) | (446760) | (64715) | (65269) | (3673661) | (3537122) | (2673502) | (3279624) |
| <br> **(31308)**<br>  | **(1451521)** | **(349035)** | **(340157)** | **(48985)** | **(51189)** | **(2411661)** | **(2323113)** | **(2347666)** | **(2790021)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **State Street Variable Insurance<br>Series Funds, Inc. (continued)** | **State Street Variable Insurance<br>Series Funds, Inc. (continued)** | **The Alger Portfolios** | **The Alger Portfolios** | **The Alger Portfolios** | **The Alger Portfolios** |
|  | **U.S. Equity<br>V.I.S. Fund —<br>Class 1 Shares** | **U.S. Equity<br>V.I.S. Fund —<br>Class 1 Shares** | **Alger<br>Large Cap<br>Growth Portfolio —<br>Class I-2 Shares** | **Alger<br>Large Cap<br>Growth Portfolio —<br>Class I-2 Shares** | **Alger<br>Small Cap<br>Growth Portfolio —<br>Class I-2 Shares** | **Alger<br>Small Cap<br>Growth Portfolio —<br>Class I-2 Shares** |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| **Increase (decrease) in net assets** |  |  |  |  |  |  |
| **From operations:** |  |  |  |  |  |  |
| Net investment income (expense) | $(207341) | $(224856) | $(415254) | $(381343) | $(136902) | $(122129) |
| Net realized gain (loss) on investments | 571402 | 1283321 | 2245889 | 989615 | (796207) | (649097) |
| Change in unrealized appreciation (depreciation) on investments | (947627) | (518778) | 2282921 | 8405882 | 1127213 | 1483432 |
| Capital gain distributions | 2620136 | 3318841 | 3308870 |  | 113556 |  |
| **Increase (decrease) in net assets from operations** | **2036570** | **3858528** | **7422426** | **9014154** | **307660** | **712206** |
| **From capital transactions (note 4):** |  |  |  |  |  |  |
| Net premiums | 1211629 | 29250 | 25510 | 89505 | 280 | 295 |
| Transfers for contract benefits and terminations | (3136843) | (3727303) | (5034791) | (3477271) | (1446286) | (1151505) |
| Administrative expenses | (40400) | (48893) | (16409) | (18409) | (7192) | (9699) |
| Transfers between subaccounts (including fixed account), net | (1867819) | (726100) | (221623) | (675387) | (55441) | (150931) |
| **Increase (decrease) in net assets from capital transactions** | **(3833433)** | **(4473046)** | **(5247313)** | **(4081562)** | **(1508639)** | **(1311840)** |
| **Increase (decrease) in net assets** | **(1796863)** | **(614518)** | **2175113** | **4932592** | **(1200979)** | **(599634)** |
| Net assets at beginning of year | 16857032 | 17471550 | 28420997 | 23488405 | 10905491 | 11505125 |
| Net assets at end of year | $15060169 | $16857032 | $30596110 | $28420997 | $9704512 | $10905491 |
| **Change in units (note 5):** |  |  |  |  |  |  |
| Units purchased | 55554 | 7555 | 5861 | 11093 | 6511 | 3184 |
| Units redeemed | (131655) | (106262) | (65903) | (86794) | (54853) | (43292) |
| **Net increase (decrease) in units from capital transactions with contract owners** | **(76101)** | **(98707)** | **(60042)** | **(75701)** | **(48342)** | **(40108)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Statements of Changes in Net Assets — Continued

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **The Prudential Series Fund** |
| **PSF<br>Mid-Cap<br>Growth Portfolio —<br>Class II Shares** | **PSF<br>Mid-Cap<br>Growth Portfolio —<br>Class II Shares** | **PSF<br>Natural<br>Resources Portfolio —<br>Class II Shares** | **PSF<br>Natural<br>Resources Portfolio —<br>Class II Shares** | **PSF<br>PGIM Jennison<br>Blend Portfolio —<br>Class II Shares** | **PSF<br>PGIM Jennison<br>Blend Portfolio —<br>Class II Shares** | **PSF<br>PGIM Jennison<br>Growth Portfolio —<br>Class II Shares** | **PSF<br>PGIM Jennison<br>Growth Portfolio —<br>Class II Shares** |
| **Period from<br>January 1 to<br>April 11,**<br> **2025** | **Year ended<br>December 31,<br>2024** | **Period from<br>January 1 to<br>April 11,**<br> **2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** | **Year ended<br>December 31,<br>2025** | **Year ended<br>December 31,<br>2024** |
| $(76) | $(282) | $(19234) | $(214312) | $(128129) | $(71336) | $(128205) | $(122896) |
| 11609 | 1432 | 310892 | 2058755 | 515100 | 132283 | 659024 | 689835 |
| (13928) | 889 | (562875) | (636973) | 1481989 | 912473 | 425569 | 1409528 |
| **(2395)** | **2039** | **(271217)** | **1207470** | **1868960** | **973420** | **956388** | **1976467** |
|  |  |  | 19064 | 17006 |  | 12592 | 10038 |
| (261) | (1549) | (182431) | (1425253) | (1088257) | (703687) | (474020) | (839161) |
|  | (28) | (12153) | (135358) | (46245) | (15240) | (37959) | (38904) |
| (15213) |  | (3963965) | (14334937) | 4030348 | 387667 | (541841) | (218571) |
| **(15474)** | **(1577)** | **(4158549)** | **(15876484)** | **2912852** | **(331260)** | **(1041228)** | **(1086598)** |
| **(17869)** | **462** | **(4429766)** | **(14669014)** | **4781812** | **642160** | **(84840)** | **889869** |
| 17869 | 17407 | 4429766 | 19098780 | 4883762 | 4241602 | 8481572 | 7591703 |
| $— | $17869 | $— | $4429766 | $9665574 | $4883762 | $8396732 | $8481572 |
|  |  | 10429 | 253318 | 395488 | 41846 | 577 | 2554 |
| (366) | (33) | (353708) | (1793786) | (149421) | (76707) | (11248) | (16533) |
| <br> **(366)**<br>  | **(33)** | **(343279)** | **(1540468)** | **246067** | **(34861)** | **(10671)** | **(13979)** |

---

See accompanying notes to financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1** 

Notes to Financial Statements

December 31, 2025

**(1)** **Description of Entity** 

Genworth Life & Annuity VA Separate Account 1 (the "Separate Account") is a separate investment account established on August 19, 1987 by Genworth Life and Annuity Insurance Company ("GLAIC"), pursuant to the laws of the Commonwealth of Virginia. GLAIC is a stock life insurance company operating under a charter granted by the Commonwealth of Virginia on March 21, 1871. GLAIC is licensed as a life insurer to do business in Bermuda, the District of Columbia and all states except for New York. GLAIC is wholly-owned by Genworth Life Insurance Company, which is wholly-owned by Genworth North America Corporation, which is indirectly wholly-owned by Genworth Financial, Inc.

GLAIC has a 34.5% investment in an affiliate, Genworth Life Insurance Company of New York.

GLAIC's principal products are life insurance and fixed deferred and immediate annuities. Life insurance products provide protection against financial hardship after the death of an insured. Deferred annuities are investment vehicles intended for contract owners who want to accumulate tax-deferred assets for retirement, desire a tax-efficient source of income and seek to protect against outliving their assets. Immediate annuities provide a fixed amount of income for either a defined number of years, the annuitant's lifetime or the longer of a defined number of years or the annuitant's lifetime. In March 2016, GLAIC suspended sales of traditional life insurance and fixed annuity products. GLAIC, however, continues to service its existing retained and reinsured blocks of business.

GLAIC also has other products which have not been actively sold since 2011, but it continues to service its existing blocks of business. Those products include variable annuities, including group variable annuities offered through retirement plans, variable life insurance and funding agreements. Most of its variable annuities include guaranteed minimum death benefits. Some of GLAIC's group and individual variable annuity products include guaranteed minimum benefit features such as guaranteed minimum withdrawal benefits and certain types of guaranteed annuitization benefits.

The Separate Account has subaccounts that currently invest in series or portfolios ("Portfolios") of open-end mutual funds ("Funds"). Such Portfolios are not sold directly to the general public. The Portfolios are sold to GLAIC, and they may also be sold to other insurance companies that issue variable annuity contracts and variable life insurance policies, including affiliated insurance companies of GLAIC. In addition, the Portfolios may be sold to retirement plans. GLAIC uses the Separate Account to support flexible premium variable deferred and immediate annuity contracts issued by GLAIC, as well as other purposes permitted by law.

Currently, there are multiple subaccounts of the Separate Account available under each contract. Each subaccount invests exclusively in shares representing an interest in a separate corresponding Portfolio (a division of a Fund, the assets of which are separate from other Portfolios that may be available in the Fund).

The assets of the Separate Account belong to GLAIC. However, GLAIC does not charge the assets in the Separate Account attributable to the contracts with liabilities arising out of any other business that GLAIC may conduct. The assets of the Separate Account will, however, be available to cover the liabilities of GLAIC's General Account to the extent that the assets of the Separate Account exceed its liabilities arising under the contracts supported by it. Income and both realized and unrealized gains or losses from the assets of the Separate Account are credited to or charged against the Separate Account without regard to the income, gains or losses arising out of any other business GLAIC may conduct. Guarantees made under the contracts, including any rider options, are based on the claims paying ability of GLAIC to the extent that the amount of the guarantee exceeds the assets available in the Separate Account.

The Separate Account is registered with the U.S. Securities and Exchange Commission ("SEC") as a unit investment trust under the Investment Company Act of 1940, as amended. The Separate Account meets the definition of a separate account under the Federal securities laws. Registration with the SEC does not involve supervision of the management or investment practices or policies of the Separate Account by the SEC. Contract owners assume the full investment risk for amounts allocated by contract owners to the Separate Account.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

During the years ended December 31, 2025 and 2024, the following Portfolio names were changed:

---

| | | |
|:---|:---|:---|
| **Prior Portfolio Name** | **Current Portfolio Name** | **Effective Date** |
|  Columbia Funds Variable Series Trust II — CTIVP<sup>®</sup> — Principal Blue Chip Growth Fund — Class 1 | Columbia Funds Variable Series Trust II — CTIVP<sup>®</sup> — Principal Large Cap Growth Fund — Class 1 | May 30, 2025 |
|  Fidelity<sup>®</sup> Variable Insurance Products Fund — VIP Asset Manager Portfolio — Initial Class | Fidelity<sup>®</sup> Variable Insurance Products Fund — VIP Asset Manager 50% Portfolio — Initial Class | April 30, 2025 |
|  Fidelity<sup>®</sup> Variable Insurance Products Fund — VIP Asset Manager Portfolio — Service Class 2 | Fidelity<sup>®</sup> Variable Insurance Products Fund — VIP Asset Manager 50% Portfolio — Service Class 2 | April 30, 2025 |
|  AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Capital Appreciation Fund — Series I shares | AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Discovery Large Cap Fund — Series I shares | April 29, 2025 |
|  AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Capital Appreciation Fund — Series II shares | AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Discovery Large Cap Fund — Series II Shares | April 29, 2025 |
|  Legg Mason Partners Variable Equity Trust — ClearBridge Variable Aggressive Growth Portfolio — Class II | Legg Mason Partners Variable Equity Trust — ClearBridge Variable Growth Portfolio — Class II | April 29, 2024 |
|  American Century Variable Portfolios II, Inc. — VP Inflation Protection Fund — Class II | Lincoln Variable Insurance Products Trust — LVIP American Century Inflation Protection Fund — Service Class | April 26, 2024 |
|  American Century Variable Portfolios, Inc. — VP Disciplined Core Value Fund — Class I | Lincoln Variable Insurance Products Trust — LVIP American Century Disciplined Core Value Fund — Standard Class II | April 26, 2024 |
|  American Century Variable Portfolios, Inc. — VP International Fund — Class I | Lincoln Variable Insurance Products Trust — LVIP American Century International Fund — Standard Class II | April 26, 2024 |
|  American Century Variable Portfolios, Inc. — VP Ultra<sup>®</sup> Fund — Class I | Lincoln Variable Insurance Products Trust — LVIP American Century Ultra<sup>®</sup> Fund — Standard Class II | April 26, 2024 |
|  American Century Variable Portfolios, Inc. — VP Value Fund — Class I | Lincoln Variable Insurance Products Trust — LVIP American Century Value Fund — Standard Class II | April 26, 2024 |

---

During the years ended December 31, 2025 and 2024, the following Portfolio(s) were liquidated, and the Portfolio assets were reinvested in new or existing Portfolio(s):

---

| | | |
|:---|:---|:---|
| **Liquidated Portfolio** | **Reinvested Portfolio** | **Inception Date** |
|  The Prudential Series Fund — PSF Mid — Cap Growth Portfolio — Class II Shares | The Prudential Series Fund — PSF PGIM Jennison Growth Portfolio — Class II Shares | April 11, 2025 |
|  The Prudential Series Fund — PSF Natural Resources Portfolio — Class II Shares | The Prudential Series Fund — PSF PGIM Jennison Blend Portfolio — Class II Shares | April 11, 2025 |
|  Deutsche DWS Variable Series I — DWS Capital Growth VIP — Class B Shares | BNY Mellon — BNY Mellon Variable Investment Fund — Government Money Market Portfolio | June 17, 2024 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | |
|:---|:---|:---|
| **Liquidated Portfolio** | **Reinvested Portfolio** | **Inception Date** |
|  Deutsche DWS Variable Series II — DWS CROCI<sup>®</sup> U.S. VIP — Class B Shares | BNY Mellon — BNY Mellon Variable Investment Fund — Government Money Market Portfolio | June 17, 2024 |
|  AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Conservative Balanced Fund — Series I shares | AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Equity and Income Fund — Series I shares | April 26, 2024 |
|  AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Conservative Balanced Fund — Series II shares | AIM Variable Insurance Funds (Invesco Variable Insurance Funds) — Invesco V.I. Equity and Income Fund — Series II shares | April 26, 2024 |

---

All designated Portfolios listed above are series type mutual funds.

**(2)** **Summary of Significant Accounting Policies** 

&nbsp;&nbsp;&nbsp;&nbsp;***(a) Basis of Presentation***

These financial statements have been prepared on the basis of U.S. generally accepted accounting principles ("U.S. GAAP"). Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts and disclosures reported therein. Actual results could differ from those estimates. The Separate Account is an investment company and follows accounting and reporting guidance under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 946, *Financial Services — Investment Companies*.

&nbsp;&nbsp;&nbsp;&nbsp;***(b) Investments***

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Separate Account, generally, uses a market approach as the valuation technique due to the nature of the mutual fund investments offered in the Separate Account. This technique maximizes the use of observable inputs and minimizes the use of unobservable inputs. Investments in mutual funds are valued at the mutual fund's closing net asset value per share on the day of valuation.

**Valuation Inputs:** Various inputs are used to determine the value of the mutual fund's investments. These inputs are summarized in the three broad levels listed below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Level 1** — quoted prices in active markets for identical securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Level 2 —** observable inputs other than Level 1 quoted prices (including, but
not limited to, quoted prices for similar securities, interest rates, prepayment speeds and credit risk); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Level 3** — unobservable inputs.

The investments of the Separate Account are measured at fair value on a recurring basis. All investments are categorized as Level 1 as of December 31, 2025 and there were no transfers between the levels during 2025.

Purchases and redemptions of investments in mutual funds are recorded on that the Valuation Day the request for the purchase or redemption is received. A Valuation Day is any day that the New York Stock Exchange is open for regular trading, except for days on which a Portfolio does not value its shares. Income distributions, and gains from realized gain distributions, are recorded on the ex-dividend date. Realized gains and losses on investments are determined on the average cost basis. Units and unit values are disclosed as of the last Valuation Day of the applicable year or period.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

&nbsp;&nbsp;&nbsp;&nbsp;***(c) Unit Classes***

There are several unit classes of subaccounts based on the variable annuity contract through which the subaccounts are available. An indefinite number of units in each unit class is authorized. Each unit class has its own expense structure as noted in note 4(a) below. In January 2011, Genworth announced that its insurance company subsidiaries, including GLAIC, would discontinue new sales of variable annuity products but would continue to service existing blocks of business. Although the contracts are no longer available for new sales, additional purchase payments may still be accepted under the terms of the contracts.

&nbsp;&nbsp;&nbsp;&nbsp;***(d) Federal Income Taxes***

The operations of the Separate Account are a part of, and taxed with, the operations of GLAIC. Therefore, the Separate Account is not separately taxed as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). Under existing federal income tax laws, investment income and capital gains of the Separate Account are not taxed. Accordingly, the Separate Account paid no federal income taxes and no federal income tax payment was required. GLAIC is taxed as a life insurance company under the Code.

&nbsp;&nbsp;&nbsp;&nbsp;***(e) Payments During Annuitization***

Net assets allocated to the contracts in variable payout stages ("variable annuitization") are computed in accordance with the mortality tables in effect at the time of contract issue. The default assumed interest rate is an effective annual rate of 3% for all variable annuitizations paid on a life contingency basis, with the exception of those contract owners who have annuitized while electing the Payment Optimizer Plus rider option. Under this rider option, the assumed interest rate is 4%. For contract owners who have purchased the RetireReady<sup>SM</sup> Retirement Answer variable annuity, the assumed interest rate is 3.5%. The mortality risk is fully borne by GLAIC and may result in amounts transferred from GLAIC's General Account to the Separate Account should annuitants live longer than assumed. GLAIC may transfer amounts from the Separate Account to its General Account should the contracts experience higher mortality than assumed.

&nbsp;&nbsp;&nbsp;&nbsp;***(f) Segment Reporting***

An operating segment is defined in Topic 280 as a component of a public entity that engages in business activities from which it may recognize revenues and incur expenses, has operating results that are regularly reviewed by a public entity's chief operating decision maker ("CODM") to make decisions about resources to be allocated to the segment and assess its performance, and has discrete financial information available. The subaccounts within the Separate Account apply the guidance in Topic 280, Segment Reporting, which impacts financial statement disclosures only and does not affect the financial position or results of operations of the subaccounts of the Separate Account. The subaccounts have acted as single reportable segments, and the CODM of the subaccounts within the Separate Account is the Variable Product Portfolio Manager. The Separate Account is structured with a limited purpose by design, and its sole purpose is to record and report the invested funds and activities and performance chosen by contract/policy holders. Investment performance of funds may vary based on the underlying fund's investment objectives specified in the fund prospectuses. Significant revenues and expenses are reported on the Statements of Changes in Net Assets and are reviewed by the CODM. The accounting policies of the segment are the same as those described in the summary of significant accounting policies herein.

&nbsp;&nbsp;&nbsp;&nbsp;***(g) Subsequent Events***

No material subsequent events have occurred since December 31, 2025 through April 23, 2026, the date the financial statements were available to be issued, that would require adjustment to the financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

**(3)** **Purchases and Sales of Investments** 

The aggregate cost of investments acquired, and the aggregate proceeds of investments sold, for the year ended December 31, 2025 were:

---

| | | |
|:---|:---|:---|
| **Fund/Portfolio** | **Cost of<br>Shares<br>Acquired** | **Proceeds<br>from<br>Shares Sold** |
|  AB Variable Products Series Fund, Inc. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Balanced Hedged Allocation Portfolio — Class B | $525927 | $1238096 |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS International Value Portfolio — Class B | 12098388 | 2812879 |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Large Cap Growth Portfolio — Class B | 1648763 | 2696570 |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Relative Value Portfolio — Class B | 3461623 | 5174140 |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Small Cap Growth Portfolio — Class B | 219469 | 1188443 |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Sustainable Global Thematic Portfolio — Class B | 236826 | 258254 |
|  AIM Variable Insurance Funds (Invesco Variable Insurance Funds) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. American Franchise Fund — Series I shares | 1024658 | 2234081 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. American Franchise Fund — Series II shares | 387979 | 575767 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. American Value Fund — Series II shares | 2437036 | 1769005 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Comstock Fund — Series II shares | 11886035 | 9848723 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Core Equity Fund — Series I shares | 18829700 | 17098801 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Core Plus Bond Fund — Series I shares | 606042 | 1072462 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Large Cap Fund — Series I shares | 3167349 | 5162112 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Large Cap Fund — Series II Shares | 1610350 | 2473424 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Mid Cap Growth Fund — Series I shares | 1793737 | 2298710 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Mid Cap Growth Fund — Series II shares | 649763 | 1188153 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. EQV International Equity Fund — Series II shares | 3433784 | 6102051 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Equity and Income Fund — Series I shares | 545709 | 1183626 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Equity and Income Fund — Series II shares | 3028176 | 5147190 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Global Fund — Series II shares | 6216891 | 6065941 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Global Real Estate Fund — Series II shares | 15627 | 161444 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Global Strategic Income Fund — Series I shares | 163775 | 306089 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Government Securities Fund — Series I shares |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Main Street Fund<sup>®</sup> — Series II shares | 11619404 | 22388789 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Main Street Small Cap Fund<sup>®</sup> — Series II shares | 5655105 | 7034445 |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Technology Fund — Series I shares |  |  |
|  Advanced Series Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; AST International Equity Portfolio — Class I Shares |  |  |
|  Allspring Variable Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Allspring VT Discovery All Cap Growth Fund — Class 2 | 825278 | 533684 |
|  BNY Mellon |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; BNY Mellon Investment Portfolios — MidCap Stock Portfolio — Initial Shares | 38591 | 167304 |
| &nbsp;&nbsp;&nbsp;&nbsp; BNY Mellon Sustainable U.S. Equity Portfolio, Inc. — Initial Shares | 859050 | 1280565 |
| &nbsp;&nbsp;&nbsp;&nbsp; BNY Mellon Variable Investment Fund — Government Money Market Portfolio | 1004815 | 1199362 |
|  BlackRock Variable Series Funds, Inc. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Advantage SMID Cap V.I. Fund — Class III Shares | 514629 | 7518915 |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Basic Value V.I. Fund — Class III Shares | 2489219 | 1809416 |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Global Allocation V.I. Fund — Class III Shares | 17357319 | 26424106 |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Large Cap Focus Growth V.I. Fund — Class III Shares | 1580231 | 1184407 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | |
|:---|:---|:---|
| **Fund/Portfolio** | **Cost of<br>Shares<br>Acquired** | **Proceeds<br>from<br>Shares Sold** |
|  Columbia Funds Variable Series Trust II |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> — Principal Large Cap Growth Fund — Class 1 | $1023762 | $5812925 |
| &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio — Overseas Core Fund — Class 2 | 523686 | 1997368 |
|  Deutsche DWS Variable Series II |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; DWS Small Mid Cap Value VIP — Class B Shares | 138517 | 21366 |
|  Eaton Vance Variable Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; VT Floating — Rate Income Fund | 3522237 | 4890646 |
|  Federated Hermes Insurance Series |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes High Income Bond Fund II — Primary Shares | 397562 | 939459 |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes High Income Bond Fund II — Service Shares | 561906 | 1015891 |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes Kaufmann Fund II — Service Shares | 5219862 | 6025912 |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes Managed Volatility Fund II — Primary Shares | 555040 | 1041659 |
|  Fidelity<sup>®</sup> Variable Insurance Products Fund |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Asset Manager 50% Portfolio — Initial Class | 2109976 | 4665196 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Asset Manager 50% Portfolio — Service Class 2 | 423722 | 1135496 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Balanced Portfolio — Service Class 2 | 6546094 | 10830161 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Contrafund<sup>®</sup> Portfolio — Initial Class | 18585931 | 18323232 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Contrafund<sup>®</sup> Portfolio — Service Class 2 | 30273963 | 35679416 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Dynamic Capital Appreciation Portfolio — Service Class 2 | 371309 | 150279 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Equity-Income Portfolio<sup>SM</sup> — Initial Class | 5490064 | 9862694 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Equity-Income Portfolio<sup>SM</sup> — Service Class 2 | 3973620 | 6696657 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth & Income Portfolio — Initial Class | 1959006 | 3293094 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth & Income Portfolio — Service Class 2 | 2072964 | 4031831 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Opportunities Portfolio — Initial Class | 828254 | 2524927 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Opportunities Portfolio — Service Class 2 | 780339 | 2397667 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Portfolio — Initial Class | 10133509 | 9554142 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Portfolio — Service Class 2 | 2917006 | 4132747 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Investment Grade Bond Portfolio — Service Class 2 | 9758188 | 15741620 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Mid Cap Portfolio — Initial Class |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Mid Cap Portfolio — Service Class 2 | 9348784 | 28434124 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Overseas Portfolio — Initial Class | 1489369 | 1310721 |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Value Strategies Portfolio — Service Class 2 | 161295 | 468360 |
|  Franklin Templeton Variable Insurance Products Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Allocation VIP Fund — Class 2 Shares | 2237930 | 6323258 |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Income VIP Fund — Class 2 Shares | 12890331 | 30126168 |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Large Cap Growth VIP Fund — Class 2 Shares | 23112 | 86985 |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Mutual Shares VIP Fund — Class 2 Shares | 4808687 | 6270025 |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Foreign VIP Fund — Class 1 Shares | 499858 | 812424 |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Foreign VIP Fund — Class 2 Shares | 13835 | 56194 |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Global Bond VIP Fund — Class 1 Shares | 42069 | 300861 |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Growth VIP Fund — Class 2 Shares | 683080 | 1204709 |
|  Goldman Sachs Variable Insurance Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Goldman Sachs Government Money Market Fund — Service Shares | 119597788 | 121701931 |
| &nbsp;&nbsp;&nbsp;&nbsp; Goldman Sachs Large Cap Value Fund — Institutional Shares | 730936 | 810633 |
| &nbsp;&nbsp;&nbsp;&nbsp; Goldman Sachs Mid Cap Value Fund — Institutional Shares | 3239313 | 3932229 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | |
|:---|:---|:---|
| **Fund/Portfolio** | **Cost of<br>Shares<br>Acquired** | **Proceeds<br>from<br>Shares Sold** |
|  Janus Aspen Series |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Balanced Portfolio — Institutional Shares | $4114104 | $7741102 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Balanced Portfolio — Service Shares | 6758493 | 15226934 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Enterprise Portfolio — Institutional Shares | 3445693 | 5595637 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Enterprise Portfolio — Service Shares | 421098 | 464026 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Flexible Bond Portfolio — Institutional Shares | 961070 | 1536876 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Forty Portfolio — Institutional Shares | 5550006 | 5732273 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Forty Portfolio — Service Shares | 2523069 | 3387932 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Global Research Portfolio — Institutional Shares | 3508552 | 5481490 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Global Research Portfolio — Service Shares | 244371 | 667116 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Global Technology and Innovation Portfolio — Service Shares | 1726234 | 1959291 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Overseas Portfolio — Institutional Shares | 740571 | 2236501 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Overseas Portfolio — Service Shares | 30163 | 347763 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Research Portfolio — Institutional Shares | 3919214 | 7919453 |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Research Portfolio — Service Shares | 267303 | 630549 |
|  Legg Mason Partners Variable Equity Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Dividend Strategy Portfolio — Class I | 687842 | 361396 |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Dividend Strategy Portfolio — Class II | 1622115 | 1740679 |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Growth Portfolio — Class II | 410038 | 348499 |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Large Cap Value Portfolio — Class I | 1644766 | 2141358 |
|  Lincoln Variable Insurance Products Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Disciplined Core Value Fund — Standard Class II | 2685 | 13828 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Inflation Protection Fund — Service Class | 3281904 | 4308093 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century International Fund — Standard Class II | 20295 | 94378 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Ultra<sup>®</sup> Fund — Standard Class II | 907 | 33042 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Value Fund — Standard Class II | 5229 | 17176 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan Core Bond Fund — Standard Class | 107514 | 259313 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan Mid Cap Value Fund — Standard Class | 37561 | 61929 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan Small Cap Core Fund — Standard Class | 21978 | 160260 |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan U.S. Equity Fund — Standard Class | 581306 | 87958 |
|  MFS<sup>®</sup> Variable Insurance Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Investors Trust Series — Service Class Shares | 1437570 | 726475 |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> New Discovery Series — Service Class Shares | 126952 | 1567881 |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Total Return Series — Service Class Shares | 4111202 | 5729440 |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Utilities Series — Service Class Shares | 628598 | 2331766 |
|  MFS<sup>®</sup> Variable Insurance Trust II |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Income Portfolio — Service Class Shares | 1279 | 627 |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Massachusetts Investors Growth Stock Portfolio — Service Class Shares | 938779 | 1854610 |
|  PIMCO Variable Insurance Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; All Asset Portfolio — Advisor Class Shares | 227559 | 825997 |
| &nbsp;&nbsp;&nbsp;&nbsp; High Yield Portfolio — Administrative Class Shares | 3791464 | 6235410 |
| &nbsp;&nbsp;&nbsp;&nbsp; International Bond Portfolio (U.S. Dollar Hedged) — Administrative Class Shares | 48216 | 65426 |
| &nbsp;&nbsp;&nbsp;&nbsp; Long-Term U.S. Government Portfolio — Administrative Class Shares | 8080311 | 8928006 |
| &nbsp;&nbsp;&nbsp;&nbsp; Low Duration Portfolio — Administrative Class Shares | 6648822 | 12085071 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Return Portfolio — Administrative Class Shares | 15790714 | 29854363 |
|  Rydex Variable Trust |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; NASDAQ — 100<sup>®</sup> Fund | 750445 | 1532192 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | |
|:---|:---|:---|
| **Fund/Portfolio** | **Cost of<br>Shares<br>Acquired** | **Proceeds<br>from<br>Shares Sold** |
|  State Street Variable Insurance Series Funds, Inc. |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Income V.I.S. Fund — Class 1 Shares | $1159509 | $2175608 |
| &nbsp;&nbsp;&nbsp;&nbsp; Premier Growth Equity V.I.S. Fund — Class 1 Shares | 5080853 | 5852404 |
| &nbsp;&nbsp;&nbsp;&nbsp; Real Estate Securities V.I.S. Fund — Class 1 Shares | 743600 | 2837816 |
| &nbsp;&nbsp;&nbsp;&nbsp; S&P 500<sup>®</sup> Index V.I.S. Fund — Class 1 Shares | 16054530 | 28447075 |
| &nbsp;&nbsp;&nbsp;&nbsp; Small-Cap Equity V.I.S. Fund — Class 1 Shares | 2802502 | 3471931 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Return V.I.S. Fund — Class 1 Shares | 72176144 | 99516005 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Return V.I.S. Fund — Class 3 Shares | 21048869 | 48696398 |
| &nbsp;&nbsp;&nbsp;&nbsp; U.S. Equity V.I.S. Fund — Class 1 Shares | 5342883 | 6763772 |
|  The Alger Portfolios |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Alger Large Cap Growth Portfolio — Class I — 2 Shares | 3716413 | 6041966 |
| &nbsp;&nbsp;&nbsp;&nbsp; Alger Small Cap Growth Portfolio — Class I — 2 Shares | 316483 | 1847862 |
|  The Prudential Series Fund |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; PSF Mid-Cap Growth Portfolio — Class II Shares |  | 15551 |
| &nbsp;&nbsp;&nbsp;&nbsp; PSF Natural Resources Portfolio — Class II Shares | 98947 | 4275195 |
| &nbsp;&nbsp;&nbsp;&nbsp; PSF PGIM Jennison Blend Portfolio — Class II Shares | 5055717 | 2270877 |
| &nbsp;&nbsp;&nbsp;&nbsp; PSF PGIM Jennison Growth Portfolio — Class II Shares | 37769 | 1207187 |

---

**(4)** **Related Party Transactions** 

&nbsp;&nbsp;&nbsp;&nbsp;***(a) GLAIC***

Net purchase payments (premiums) transferred from GLAIC to the Separate Account represent gross premiums recorded by GLAIC on its flexible premium variable deferred and immediate annuity contracts, less deductions retained as compensation for premium taxes. For contracts issued on or after May 1, 1993, the deduction for premium taxes is deferred until the contracts are surrendered.

Some contracts permit contract owners to elect to allocate assets to a Guarantee Account that is part of the General Account of GLAIC. Amounts allocated to the Guarantee Account earn interest at the interest rate in effect at the time of such allocation or transfer. The interest rate remains in effect for a guaranteed period of time (at least a period of one year), after which a new rate may be declared. Contract owners may transfer amounts from the Guarantee Account to the subaccounts of the Separate Account and in certain instances transfer amounts from the subaccounts of the Separate Account to the Guarantee Account.

Generally, charges are assessed under the contracts to cover surrenders, certain administrative expenses, and the mortality and expense risks that GLAIC assumes, as well as any additional benefits provided under the contract such as optional benefits, as applicable. The surrender charges are assessed to cover certain expenses relating to the sale of a contract. The fees charged to cover administrative expenses and mortality and expense risk charges, as well as through certain electable rider options, are assessed through the daily unit value calculation. Those fees are assessed on the contract owner's daily average net assets in the Separate Account. Other charges assessed to cover certain other administrative expenses, as well as certain optional riders, are assessed by the redemption of units. Note 6 presents the total charge percentage by unit in a range. The unit class may encompass multiple contracts through a combination of one or more electable rider options equal to the total amount assessed on a daily basis.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

The Separate Account assesses charges associated with the contracts issued. These charges are either assessed as a direct reduction in unit values or through a redemption of units for all contracts contained within the Separate Account.

---

| | |
|:---|:---|
| **Mortality and Expense Risk Charge (including benefit rider options)**<br>This charge is assessed through a reduction in unit values. | 0.40% — 2.80% of the daily value of the assets invested in each Portfolio (fund). |
| **Administrative Charge**<br>This charge is assessed through a reduction in unit values. | 0.15% — 0.35% of the daily value of the assets invested in each fund. |
| **Annual Administrative Charge**<br>This charge is assessed through a redemption in units. | $0 — $30 per contract year invested in each fund. |
| **Surrender Charge**<br>This charge is assessed through a redemption in units. | 0.00% — 9.00% on the value of the accumulation units purchased. |

---

&nbsp;&nbsp;&nbsp;&nbsp;***(b) Accrued Expenses Payable to Affiliate***

Charges and deductions made under the contracts for services and benefits unpaid at year-end are accrued and payable to GLAIC.

&nbsp;&nbsp;&nbsp;&nbsp;***(c) Bonus Credit***

For certain contracts, transfers from the General Account for payments by GLAIC were paid in the form of bonus credits. Bonus credits are amounts that are added by GLAIC to the premium payments received from contract owners.

&nbsp;&nbsp;&nbsp;&nbsp;***(d) Capital Brokerage Corporation***

Capital Brokerage Corporation ("CBC"), an affiliate of GLAIC, is a Washington corporation registered with the SEC under the Securities Exchange Act of 1934 as a broker-dealer and is a member of the Financial Industry Regulatory Authority ("FINRA"). CBC serves as the distributor and principal underwriter for variable annuity contracts, variable life insurance policies, and certain guaranteed income annuity contracts issued by GLAIC. GLAIC pays commissions and other marketing related expenses to CBC. Certain officers and directors of GLAIC are also officers and directors of CBC.

**(5)** **Capital Transactions** 

All dividends and capital gain distributions of the Portfolios are automatically reinvested in shares of the distributing Portfolios at their net asset value on the date of distribution. In other words, Portfolio dividends or Portfolio distributions are not paid to contract owners as additional units, but instead are reflected in unit values.

The increase (decrease) in outstanding units and amounts by subaccount from capital transactions for the years ended December 31, 2025 and 2024 is reflected in the Statements of Changes in Net Assets.

**(6)** **Financial Highlights** 

GLAIC's variable annuity products have unique combinations of features and fees that are assessed to the contract owner. Differences in fee structures result in a variety of contract expense rates, unit values, and total returns. A summary by type and by subaccount of the outstanding units, unit values, net assets, expense ratios, investment income ratios, and total return ratios for the years or lesser periods ended December 31, 2025, 2024, 2023, 2022, and 2021 follows. This information is presented as a range based upon product grouping. Expenses as a percent of average net assets are presented as a range of

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

lowest to highest contract expense rate. The unit value and total return ranges are presented to correlate to the respective expense rate. Accordingly, some individual contract amounts may not be within the ranges presented due to the timing of the introduction of new funds.

Financial highlights are only disclosed for Portfolios that were available to contract owners as of December 31, 2025. Portfolios liquidated in the current year (see note 1) are not included.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
|  AB Variable Products Series Fund, Inc. |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Balanced Hedged Allocation Portfolio — Class B |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 302881 | 19.99 to 12.44 | 5307 | 1.85% | 15.66% to 13.90% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 362017 | 17.28 to 10.93 | 5546 | 1.75% | 6.99% to 5.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 425972 | 16.15 to 10.37 | 6344 | 0.89% | 11.03% to 9.34% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 511290 | 14.55 to 9.48 | 6897 | 3.00% | (20.34)% to (21.55)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 585455 | 18.26 to 12.09 | 9952 | 0.25% | 11.72% to 10.02% |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS International Value Portfolio — Class B |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 1019988 | 16.92 to 12.52 | 16861 | 3.11% | 39.23% to 38.03% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 423324 | 12.15 to 10.87 | 4617 | 0.94% | 3.28% to 1.96% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 2423553 | 11.77 to 10.54 | 19542 | 1.10% | 13.17% to 11.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 559485 | 10.40 to 9.54 | 5264 | 1.58% | (15.04)% to (16.12)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 3264527 | 12.24 to 11.30 | 27429 | 1.92% | 9.25% to 7.59% |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Large Cap Growth Portfolio — Class B |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 255174 | 90.00 to 59.51 | 11836 | 0.00% | 11.22% to 10.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 302509 | 80.93 to 19.73 | 12610 | 0.00% | 23.13% to 21.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 361174 | 65.72 to 16.23 | 12295 | 0.00% | 32.84% to 31.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 401192 | 49.48 to 12.38 | 10428 | 0.00% | (29.72)% to (30.61)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 847098 | 70.40 to 17.83 | 38288 | 0.00% | 26.79% to 25.18% |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Relative Value Portfolio — Class B |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.30% | 572536 | 54.27 to 32.17 | 24670 | 0.87% | 8.93% to 7.67% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.70% | 661082 | 49.82 to 14.61 | 26166 | 1.26% | 11.46% to 9.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 2.70% | 763352 | 44.70 to 13.32 | 27188 | 1.28% | 10.44% to 8.71% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.70% | 861737 | 40.48 to 12.25 | 27953 | 1.09% | (5.52)% to (6.99)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.70% | 998243 | 42.84 to 13.17 | 34408 | 0.62% | 26.37% to 24.39% |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Small Cap Growth Portfolio — Class B |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 59657 | 40.59 to 36.73 | 2390 | 0.00% | 2.94% to 2.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 84474 | 39.44 to 12.72 | 3272 | 0.00% | 16.72% to 15.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 110528 | 33.79 to 11.04 | 3668 | 0.00% | 16.02% to 14.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 129295 | 29.12 to 9.64 | 3707 | 0.00% | (40.14)% to (40.90)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 137125 | 48.65 to 16.31 | 6571 | 0.00% | 7.62% to 6.25% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; AB VPS Sustainable Global Thematic Portfolio — Class B |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.70% | 44133 | 37.71 to 20.11 | 1537 | 0.00% | 4.49% to 4.22% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.70% | 50008 | 36.09 to 19.29 | 1680 | 0.00% | 4.41% to 4.15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.70% | 56240 | 34.57 to 18.52 | 1807 | 0.03% | 14.03% to 13.74% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.70% | 61187 | 30.31 to 16.28 | 1735 | 0.00% | (28.22)% to (28.41)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.70% | 68663 | 42.23 to 22.74 | 2731 | 0.00% | 20.80% to 20.49% |
|  AIM Variable Insurance Funds (Invesco Variable Insurance Funds) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. American Franchise Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 0.75% to 1.95% | 140814 | 56.13 to 46.91 | 7057 | 0.00% | 10.83% to 9.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 0.75% to 2.70% | 178111 | 50.65 to 19.82 | 8091 | 0.00% | 33.87% to 31.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 2.70% | 209934 | 37.83 to 15.11 | 7173 | 0.00% | 39.87% to 37.14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 2.70% | 225066 | 27.05 to 11.02 | 5537 | 0.00% | (31.63)% to (32.97)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 2.70% | 266290 | 39.56 to 16.43 | 9679 | 0.00% | 11.09% to 8.90% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. American Franchise Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.85% | 53918 | 78.07 to 58.80 | 3516 | 0.00% | 9.77% to 9.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.85% | 62463 | 71.12 to 53.78 | 3684 | 0.00% | 32.60% to 32.06% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.70% | 72282 | 53.64 to 39.01 | 3208 | 0.00% | 38.57% to 38.22% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.70% | 83441 | 38.71 to 28.22 | 2669 | 0.00% | (32.29)% to (32.46)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.70% | 98756 | 57.17 to 41.78 | 4725 | 0.00% | 10.03% to 9.75% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. American Value Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 715588 | 17.42 to 16.73 | 12427 | 0.22% | 19.01% to 17.98% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.30% | 780259 | 14.63 to 14.18 | 11394 | 0.80% | 28.20% to 27.09% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 774850 | 11.42 to 11.15 | 8830 | 0.40% | 13.62% to 12.65% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.30% | 745062 | 10.05 to 9.90 | 7477 | 0.49% | (4.27)% to (5.09)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 (4) | 1.45% to 2.30% | 651151 | 10.49 to 10.43 | 6830 | 0.25% | 4.95% to 4.34% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Comstock Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1078581 | 58.42 to 17.89 | 46264 | 1.49% | 15.44% to 13.69% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1130020 | 50.61 to 15.74 | 42730 | 1.40% | 13.19% to 11.46% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1472865 | 44.71 to 14.12 | 47705 | 1.90% | 10.47% to 8.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 846530 | 40.47 to 13.09 | 29319 | 1.28% | (0.61)% to (1.87)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 1122231 | 40.72 to 13.34 | 39839 | 1.82% | 31.12% to 29.45% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Core Equity Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1953635 | 39.53 to 18.55 | 64576 | 0.67% | 14.48% to 12.74% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 2026932 | 34.53 to 16.46 | 58784 | 1.19% | 23.78% to 21.88% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.45% | 174148 | 27.89 to 23.29 | 4733 | 0.09% | 21.58% to 20.35% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 3693775 | 22.94 to 11.28 | 71306 | 0.86% | (21.70)% to (22.89)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 4320745 | 29.30 to 14.62 | 107031 | 1.12% | 25.89% to 23.97% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Core Plus Bond Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 441220 | 10.69 to 10.51 | 4670 | 4.25% | 5.86% to 5.38% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 499478 | 10.10 to 9.98 | 5008 | 3.66% | 1.86% to 1.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 540813 | 9.91 to 9.84 | 5337 | 2.58% | 4.92% to 4.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 (5) | 1.15% to 1.60% | 570227 | 9.45 to 9.42 | 5377 | 0.86% | (5.53)% to (5.82)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Large Cap Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 176022 | 314.94 to 55.37 | 24263 | 0.00% | 11.50% to 11.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 212383 | 282.45 to 49.88 | 26226 | 0.00% | 32.61% to 32.01% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 239418 | 213.00 to 37.79 | 23296 | 0.00% | 33.82% to 33.22% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 265129 | 159.16 to 28.36 | 19235 | 0.00% | (31.58)% to (31.89)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 290608 | 232.62 to 41.64 | 30665 | 0.00% | 21.16% to 20.61% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Large Cap Fund — Series II Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% | 151933 | 66.63 to 21.59 | 9569 | 0.00% | 10.90% to 9.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 182809 | 60.08 to 19.72 | 10449 | 0.00% | 31.88% to 30.20% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 206488 | 45.56 to 15.14 | 8860 | 0.00% | 33.08% to 31.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 205836 | 34.24 to 11.52 | 6625 | 0.00% | (31.96)% to (32.83)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 246907 | 50.32 to 17.16 | 11799 | 0.00% | 20.51% to 18.98% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Mid Cap Growth Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 164955 | 202.76 to 39.38 | 19316 | 0.00% | 3.58% to 3.12% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 180940 | 195.75 to 38.19 | 20636 | 0.00% | 22.79% to 22.24% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 202220 | 159.41 to 31.24 | 18492 | 0.00% | 11.85% to 11.35% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 225781 | 142.52 to 28.06 | 18568 | 0.00% | (31.78)% to (32.08)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 255884 | 208.90 to 41.31 | 30780 | 0.00% | 17.73% to 17.20% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Discovery Mid Cap Growth Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.70% | 112976 | 55.30 to 52.02 | 6141 | 0.00% | 3.02% to 2.76% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.70% | 132841 | 53.68 to 50.62 | 7019 | 0.00% | 22.12% to 21.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.70% | 155771 | 43.96 to 41.56 | 6727 | 0.00% | 11.22% to 10.94% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.70% | 156762 | 39.52 to 37.46 | 6091 | 0.00% | (32.13)% to (32.30)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.70% | 201921 | 58.23 to 55.34 | 11546 | 0.00% | 17.07% to 16.77% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. EQV International Equity Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1137532 | 26.92 to 11.86 | 20652 | 1.15% | 14.55% to 12.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1369831 | 23.50 to 10.51 | 21678 | 2.14% | -1.12% to (2.63)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 463577 | 23.77 to 17.68 | 9383 | 0.00% | 16.16% to 15.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 506409 | 20.46 to 9.52 | 8822 | 1.41% | (19.68)% to (20.70)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 573173 | 25.48 to 12.01 | 12521 | 1.08% | 4.07% to 2.75% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Equity and Income Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 490847 | 11.88 to 11.79 | 5813 | 2.04% | 11.51% to 11.01% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 580081 | 10.65 to 10.62 | 6171 | 1.76% | 6.52% to 6.20% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Equity and Income Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 941188 | 26.77 to 14.46 | 22093 | 1.83% | 10.89% to 9.20% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1086564 | 24.14 to 13.25 | 23122 | 1.76% | 10.28% to 8.59% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 673394 | 21.89 to 12.20 | 13063 | 1.05% | 8.64% to 7.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1345395 | 20.15 to 11.40 | 25524 | 1.81% | (9.05)% to (10.43)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 825869 | 22.15 to 12.73 | 16402 | 1.55% | 16.64% to 14.86% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Global Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.35% | 639035 | 68.56 to 28.23 | 27362 | 0.00% | 13.35% to 12.31% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 752374 | 60.49 to 14.40 | 28517 | 0.00% | 14.10% to 12.64% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 875626 | 53.01 to 12.79 | 29136 | 0.00% | 32.50% to 30.83% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 1056272 | 40.01 to 9.77 | 26579 | 0.00% | (32.92)% to (33.77)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 1403987 | 59.65 to 14.76 | 56905 | 0.00% | 13.50% to 12.06% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Global Real Estate Fund — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 2804 | 16.64 to 14.98 | 46 | 1.56% | 6.05% to 5.51% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 14431 | 15.69 to 7.82 | 182 | 2.42% | (3.54)% to (4.77)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.45% | 2237 | 16.27 to 16.27 | 36 | 1.28% | 7.25% to 7.25% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.45% | 2091 | 15.17 to 15.17 | 32 | 2.60% | (26.23)% to (26.23)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.45% | 1929 | 20.56 to 20.56 | 40 | 1.94% | 23.63% to 23.63% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Global Strategic Income Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 119475 | 11.81 to 11.12 | 1368 | 5.69% | 11.68% to 11.18% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 138323 | 10.57 to 10.00 | 1420 | 3.02% | 1.96% to 1.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 153242 | 10.37 to 9.86 | 1548 | 0.00% | 7.63% to 7.15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 172835 | 9.63 to 9.20 | 1626 | 0.00% | (12.48)% to (12.87)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 195809 | 11.01 to 10.56 | 2108 | 4.59% | (4.52)% to (4.96)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Government Securities Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 0.75% to 0.75% |  | 18.33 to 18.33 |  | 0.00% | 6.56% to 6.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 0.75% to 0.75% |  | 17.20 to 17.20 |  | 0.00% | 0.95% to 0.95% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 0.75% |  | 17.04 to 17.04 |  | 0.00% | 3.84% to 3.84% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 0.75% |  | 16.41 to 16.41 |  | 0.00% | (10.96)% to (10.96)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 0.75% |  | 18.43 to 18.43 |  | 0.00% | (3.00)% to (3.00)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Main Street Fund<sup>®</sup> — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 2064873 | 60.79 to 17.86 | 77352 | 0.30% | 13.96% to 12.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 2472407 | 53.34 to 15.92 | 81455 | 0.00% | 21.59% to 19.73% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.45% | 444984 | 43.87 to 25.65 | 13813 | 0.15% | 21.05% to 19.83% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 3362880 | 36.24 to 11.15 | 75688 | 0.97% | (21.46)% to (22.66)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 4459194 | 46.14 to 14.42 | 128165 | 0.84% | 25.39% to 23.48% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Main Street Small Cap Fund<sup>®</sup> — Series II shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 523829 | 69.34 to 15.89 | 22756 | 0.23% | 6.87% to 5.24% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 603318 | 64.88 to 15.10 | 24603 | 0.00% | 10.77% to 9.07% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 235777 | 58.58 to 14.01 | 11796 | 0.92% | 16.12% to 14.65% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 259369 | 50.45 to 12.22 | 11249 | 0.24% | (17.26)% to (18.31)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 305034 | 60.97 to 14.95 | 16198 | 0.12% | 20.49% to 18.96% |
| &nbsp;&nbsp;&nbsp;&nbsp; Invesco V.I. Technology Fund — Series I shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 0.75% to 0.75% |  | 22.28 to 22.28 |  | 0.00% | 19.56% to 19.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 0.75% to 0.75% |  | 18.64 to 18.64 |  | 0.00% | 33.26% to 33.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 0.75% |  | 13.98 to 13.98 |  | 0.00% | 45.85% to 45.85% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 0.75% |  | 9.59 to 9.59 |  | 0.00% | (40.40)% to (40.40)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 0.75% |  | 16.09 to 16.09 |  | 0.00% | 13.55% to 13.55% |
|  Advanced Series Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; AST International Equity Portfolio — Class I Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.55% to 1.55% |  | 15.14 to 15.14 |  | 0.00% | 30.78% to 30.78% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.55% to 1.55% |  | 11.57 to 11.57 |  | 0.00% | 3.82% to 3.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 (6) | 1.55% to 1.55% |  | 11.15 to 11.15 |  | 0.00% | 11.49% to 11.49% |
|  Allspring Variable Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Allspring VT Discovery All Cap Growth Fund — Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 36225 | 60.54 to 55.96 | 2177 | 0.00% | 13.60% to 13.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.95% | 44290 | 53.29 to 49.51 | 2345 | 0.00% | 19.24% to 18.63% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.95% | 51692 | 44.69 to 41.74 | 2296 | 0.00% | 31.24% to 30.58% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.95% | 64087 | 34.05 to 31.96 | 2166 | 0.00% | (38.11)% to (38.42)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.95% | 69207 | 55.02 to 51.91 | 3781 | 0.00% | 13.30% to 12.73% |
|  BNY Mellon |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; BNY Mellon Investment Portfolios — MidCap Stock Portfolio — Initial Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 2390 | 52.92 to 35.71 | 124 | 0.71% | 8.47% to 7.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 7408 | 48.79 to 14.18 | 256 | 0.36% | 10.97% to 9.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.45% | 2418 | 43.96 to 43.96 | 106 | 0.79% | 16.60% to 16.60% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.45% | 2595 | 37.70 to 37.70 | 98 | 0.73% | (15.32)% to (15.32)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.45% | 2730 | 44.52 to 44.52 | 122 | 0.62% | 24.06% to 24.06% |
| &nbsp;&nbsp;&nbsp;&nbsp; BNY Mellon Sustainable U.S. Equity Portfolio, Inc. — Initial Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.50% to 1.70% | 323000 | 31.71 to 30.11 | 10256 | 0.25% | 14.23% to 14.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.50% to 1.70% | 359303 | 27.76 to 26.41 | 9977 | 0.52% | 23.01% to 22.76% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 405110 | 47.85 to 14.69 | 9357 | 0.67% | 22.03% to 20.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.50% to 1.70% | 390488 | 18.50 to 17.68 | 7231 | 0.52% | (24.03)% to (24.18)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.50% to 1.70% | 393232 | 24.36 to 23.32 | 9587 | 0.75% | 25.09% to 24.84% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; BNY Mellon Variable Investment Fund — Government Money Market Portfolio |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.05% | 96383 | 10.00 to 8.91 | 954 | 3.86% | 2.42% to 1.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 118814 | 9.76 to 9.64 | 1149 | 4.49% | 3.24% to 1.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 194703 | 9.46 to 9.46 | 1827 | 4.29% | 3.08% to 1.78% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.20% | 308810 | 9.17 to 8.04 | 2817 | 1.17% | (0.20)% to (0.96)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.05% | 333901 | 9.19 to 8.40 | 2945 | 0.01% | (1.44)% to (2.04)% |
|  BlackRock Variable Series Funds, Inc. |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Advantage SMID Cap V.I. Fund — Class III Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 60250 | 42.62 to 31.12 | 2473 | 0.77% | 9.27% to 8.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.30% | 254507 | 39.00 to 28.73 | 9811 | 1.40% | 10.08% to 9.12% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 282976 | 35.43 to 26.32 | 9889 | 5.00% | 16.92% to 15.91% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.30% | 106880 | 30.31 to 22.71 | 3127 | 1.71% | (17.88)% to (18.59)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.30% | 110260 | 36.91 to 27.90 | 3939 | 1.08% | 11.71% to 10.74% |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Basic Value V.I. Fund — Class III Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 368329 | 40.14 to 32.13 | 14133 | 1.87% | 22.24% to 21.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.45% | 400435 | 32.84 to 22.98 | 12549 | 1.10% | 8.45% to 7.34% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1079668 | 30.28 to 12.95 | 26999 | 1.51% | 14.56% to 12.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1190327 | 26.43 to 11.48 | 25884 | 1.02% | (6.50)% to (7.92)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 1543677 | 28.27 to 12.46 | 33905 | 1.73% | 19.58% to 17.76% |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Global Allocation V.I. Fund — Class III Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 5084798 | 29.70 to 13.82 | 107209 | 3.93% | 17.78% to 15.99% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 6191069 | 25.22 to 11.91 | 111722 | 1.37% | 7.34% to 5.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 7342232 | 23.49 to 11.27 | 123793 | 2.36% | 10.86% to 9.18% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 8575956 | 21.19 to 10.32 | 131161 | 0.00% | (17.29)% to (18.55)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 10019147 | 25.62 to 12.67 | 186114 | 0.81% | 4.87% to 3.28% |
| &nbsp;&nbsp;&nbsp;&nbsp; BlackRock Large Cap Focus Growth V.I. Fund — Class III Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.85% | 133164 | 70.94 to 64.96 | 9307 | 0.00% | 9.87% to 9.42% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.85% | 148163 | 64.57 to 59.36 | 9439 | 0.00% | 29.47% to 28.95% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.95% | 200613 | 49.87 to 44.59 | 9693 | 0.00% | 50.27% to 49.51% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.95% | 213216 | 33.19 to 29.82 | 6870 | 0.00% | (39.15)% to (39.46)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.95% | 268008 | 54.54 to 49.26 | 14206 | 0.00% | 16.07% to 15.48% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
|  Columbia Funds Variable Series Trust II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; CTIVP<sup>®</sup> — Principal Large Cap Growth Fund — Class 1 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 758107 | 34.03 to 31.30 | 25681 | 0.00% | 12.13% to 11.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 896006 | 30.35 to 17.52 | 27066 | 0.00% | 19.65% to 18.12% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 4066222 | 25.37 to 14.67 | 99733 | 0.00% | 37.52% to 35.44% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 3046910 | 18.44 to 10.83 | 54288 | 0.00% | (29.05)% to (30.13)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 923961 | 26.00 to 15.50 | 23666 | 0.00% | 16.85% to 15.08% |
| &nbsp;&nbsp;&nbsp;&nbsp; Columbia Variable Portfolio — Overseas Core Fund — Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 446046 | 18.80 to 17.29 | 8303 | 1.78% | 35.86% to 34.69% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.45% | 540286 | 13.84 to 12.67 | 7402 | 5.83% | 1.73% to 0.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1755675 | 13.61 to 11.18 | 23411 | 1.71% | 13.66% to 11.93% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 2001678 | 11.97 to 9.99 | 23540 | 0.70% | (16.13)% to (17.41)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 1837093 | 14.27 to 12.10 | 25853 | 0.86% | 8.15% to 6.51% |
|  Deutsche DWS Variable Series II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; DWS Small Mid Cap Value VIP — Class B Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% | 5620 | 53.84 to 13.65 | 143 | 0.05% | 16.14% to 14.67% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.05% | 270 | 46.36 to 23.38 | 11 | 0.81% | 4.25% to 3.61% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.05% | 289 | 44.47 to 22.56 | 11 | 0.79% | 12.93% to 12.25% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.05% | 309 | 39.38 to 20.10 | 10 | 0.47% | (17.35)% to (17.86)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.05% | 324 | 47.64 to 24.47 | 12 | 0.87% | 28.16% to 27.38% |
|  Eaton Vance Variable Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; VT Floating-Rate Income Fund |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1065704 | 16.97 to 10.77 | 16307 | 6.71% | 2.45% to 0.89% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1212965 | 16.56 to 10.67 | 18181 | 7.88% | 6.11% to 4.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1565515 | 15.61 to 10.21 | 22460 | 8.17% | 9.60% to 7.94% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1744103 | 14.24 to 9.46 | 22824 | 4.41% | (4.14)% to (5.60)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 1769406 | 14.85 to 10.02 | 25112 | 2.91% | 2.12% to 0.57% |
|  Federated Hermes Insurance Series |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes High Income Bond Fund II — Primary Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 107886 | 49.23 to 27.11 | 3814 | 6.11% | 6.98% to 6.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 128451 | 46.01 to 25.46 | 4283 | 5.56% | 5.04% to 4.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 147569 | 43.81 to 24.35 | 4759 | 5.97% | 11.42% to 10.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 166136 | 39.32 to 21.95 | 4833 | 5.75% | (12.79)% to (13.19)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 208374 | 45.08 to 25.28 | 6975 | 4.97% | 3.64% to 3.17% |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes High Income Bond Fund II — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 174849 | 28.31 to 20.00 | 4865 | 5.97% | 6.62% to 5.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.30% | 199471 | 26.55 to 18.92 | 5224 | 5.35% | 4.31% to 3.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 218238 | 25.46 to 18.30 | 5485 | 5.80% | 10.84% to 9.89% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.30% | 254766 | 22.97 to 16.65 | 5776 | 5.65% | (13.19)% to (13.94)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.30% | 311754 | 26.46 to 19.35 | 8155 | 4.76% | 2.93% to 2.04% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes Kaufmann Fund II — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 617445 | 61.50 to 11.78 | 22706 | 0.00% | 9.65% to 7.98% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 709074 | 56.09 to 10.91 | 23690 | 0.40% | 15.08% to 13.31% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 237555 | 48.74 to 9.74 | 10372 | 0.00% | 13.20% to 11.77% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 976228 | 43.06 to 8.64 | 24832 | 0.00% | (31.27)% to (32.31)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 518125 | 62.64 to 12.76 | 23716 | 0.00% | 0.78% to (0.75)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Federated Hermes Managed Volatility Fund II — Primary Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 211145 | 44.29 to 20.56 | 6287 | 2.95% | 5.80% to 5.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 237133 | 41.86 to 19.52 | 6646 | 2.28% | 14.22% to 13.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 263975 | 36.65 to 17.17 | 6636 | 1.92% | 7.44% to 6.95% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 292743 | 34.11 to 16.05 | 6909 | 1.91% | (14.75)% to (15.13)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 315605 | 40.01 to 18.92 | 8820 | 1.80% | 17.15% to 16.62% |
|  Fidelity<sup>®</sup> Variable Insurance Products Fund |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Asset Manager 50% Portfolio — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 332876 | 86.15 to 26.42 | 25878 | 2.40% | 13.66% to 13.15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 394524 | 75.80 to 23.35 | 26661 | 2.37% | 7.24% to 6.76% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 439966 | 70.68 to 21.87 | 27683 | 2.24% | 11.65% to 11.15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 514019 | 63.31 to 19.68 | 28713 | 1.98% | (15.91)% to (16.29)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 583068 | 75.29 to 23.51 | 38580 | 1.58% | 8.66% to 8.16% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Asset Manager 50% Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 161255 | 26.24 to 21.48 | 3955 | 2.21% | 12.99% to 12.01% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.30% | 203936 | 23.23 to 19.18 | 4432 | 2.46% | 6.66% to 5.73% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 191607 | 21.78 to 18.14 | 3904 | 2.08% | 11.02% to 10.07% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 215325 | 19.62 to 10.27 | 3944 | 1.81% | (16.38)% to (17.44)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 239303 | 23.46 to 12.44 | 5243 | 1.37% | 8.09% to 6.72% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Balanced Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1653970 | 37.51 to 16.85 | 52088 | 1.54% | 13.29% to 11.57% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1890726 | 33.11 to 15.10 | 52811 | 1.65% | 13.94% to 12.20% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 2146854 | 29.06 to 13.46 | 53131 | 1.51% | 19.48% to 17.67% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 2519719 | 24.32 to 11.44 | 52461 | 1.02% | (19.37)% to (20.60)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 2931945 | 30.16 to 14.41 | 76574 | 0.72% | 16.28% to 14.51% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Contrafund<sup>®</sup> Portfolio — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 652640 | 268.86 to 83.54 | 107823 | 0.14% | 20.08% to 19.54% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 754010 | 223.90 to 69.88 | 103679 | 0.18% | 32.24% to 31.64% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 880568 | 169.31 to 53.09 | 91969 | 0.48% | 31.92% to 31.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 995504 | 128.34 to 40.42 | 78297 | 0.49% | (27.16)% to (27.49)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 1129797 | 176.19 to 55.75 | 121184 | 0.06% | 26.37% to 25.79% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Contrafund<sup>®</sup> Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 2223936 | 100.21 to 23.29 | 133036 | 0.00% | 19.44% to 17.62% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 2697811 | 83.90 to 19.80 | 134192 | 0.03% | 31.50% to 29.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 3565783 | 63.80 to 15.29 | 132698 | 0.32% | 31.19% to 29.20% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 2153195 | 48.63 to 11.83 | 70113 | 0.27% | (27.55)% to (28.65)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 2032242 | 67.13 to 16.58 | 100263 | 0.03% | 25.66% to 23.75% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Dynamic Capital Appreciation Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.70% | 22061 | 85.83 to 81.03 | 1856 | 0.42% | 16.77% to 16.48% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.70% | 23344 | 73.51 to 69.57 | 1682 | 0.05% | 23.37% to 23.05% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.70% | 27023 | 59.58 to 56.54 | 1574 | 0.12% | 26.86% to 26.54% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.70% | 31291 | 46.97 to 25.51 | 1418 | 0.10% | (22.19)% to (22.39)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.70% | 35238 | 60.36 to 57.57 | 2076 | 0.11% | 22.47% to 22.16% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Equity-Income Portfolio<sup>SM</sup> — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 491919 | 210.40 to 40.24 | 62804 | 1.75% | 17.65% to 17.12% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 565043 | 178.83 to 34.36 | 60958 | 1.71% | 14.01% to 13.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 694060 | 156.86 to 30.27 | 62223 | 1.86% | 9.38% to 8.89% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 778564 | 143.41 to 27.80 | 63993 | 1.83% | (6.05)% to (6.47)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 858919 | 152.64 to 29.72 | 75265 | 1.86% | 23.46% to 22.90% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Equity-Income Portfolio<sup>SM</sup> — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 780659 | 50.78 to 31.27 | 31254 | 1.60% | 17.03% to 16.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 910695 | 43.39 to 14.93 | 31027 | 1.51% | 13.38% to 11.93% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 1086286 | 38.27 to 13.34 | 32705 | 1.38% | 8.78% to 7.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1950726 | 35.18 to 12.31 | 49057 | 1.83% | (6.62)% to (8.03)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 1737852 | 37.67 to 13.38 | 49553 | 1.04% | 22.80% to 20.93% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth & Income Portfolio — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 201697 | 89.92 to 46.85 | 14191 | 1.49% | 20.11% to 19.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 247296 | 74.87 to 39.19 | 14248 | 1.37% | 20.80% to 20.25% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 298303 | 61.98 to 32.59 | 14150 | 1.61% | 17.36% to 16.83% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 339362 | 52.81 to 27.89 | 13759 | 1.58% | (6.04)% to (6.46)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 395914 | 56.21 to 29.82 | 17190 | 2.31% | 24.50% to 23.94% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth & Income Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 250433 | 61.47 to 48.73 | 11752 | 1.31% | 19.45% to 18.85% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.95% | 324219 | 51.46 to 41.01 | 12667 | 1.23% | 20.18% to 19.57% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.95% | 366467 | 42.81 to 34.29 | 11882 | 1.45% | 16.65% to 16.06% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.95% | 405584 | 36.70 to 29.55 | 11229 | 1.28% | (6.55)% to (7.02)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.95% | 533883 | 39.27 to 31.78 | 16128 | 2.15% | 23.82% to 23.19% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Opportunities Portfolio — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 172309 | 126.16 to 71.02 | 16739 | 0.00% | 20.55% to 20.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 191633 | 104.65 to 59.18 | 15507 | 0.00% | 37.28% to 36.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 232194 | 76.23 to 43.30 | 13636 | 0.00% | 43.98% to 43.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 289360 | 52.95 to 30.21 | 12362 | 0.00% | (38.86)% to (39.14)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 321928 | 86.60 to 49.64 | 22280 | 0.00% | 10.65% to 10.15% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Opportunities Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.20% | 96913 | 86.46 to 77.74 | 8286 | 0.00% | 19.87% to 18.96% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 117954 | 72.13 to 22.13 | 8379 | 0.00% | 36.54% to 34.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 137719 | 52.83 to 16.42 | 7165 | 0.00% | 43.20% to 41.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 161283 | 36.89 to 11.61 | 5862 | 0.00% | (39.21)% to (39.98)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 221009 | 60.68 to 19.35 | 13219 | 0.00% | 10.05% to 8.65% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Portfolio — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 331576 | 433.26 to 64.40 | 73209 | 0.29% | 13.58% to 13.07% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 373940 | 381.46 to 56.95 | 71919 | 0.00% | 28.88% to 28.30% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 419184 | 295.99 to 44.39 | 62994 | 0.13% | 34.68% to 34.07% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 491163 | 219.78 to 33.11 | 54130 | 0.62% | (25.32)% to (25.66)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 581242 | 294.31 to 44.54 | 82131 | 0.00% | 21.80% to 21.25% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Growth Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.20% | 317364 | 99.57 to 69.73 | 17539 | 0.05% | 12.95% to 12.09% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.20% | 381973 | 88.16 to 62.21 | 18670 | 0.00% | 28.18% to 27.20% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.20% | 426973 | 68.78 to 48.91 | 16223 | 0.00% | 33.93% to 32.91% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.30% | 471888 | 51.36 to 35.43 | 13442 | 0.37% | (25.74)% to (26.38)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.30% | 531475 | 69.15 to 48.12 | 20672 | 0.00% | 21.12% to 20.08% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Investment Grade Bond Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 3464255 | 13.76 to 9.14 | 44876 | 3.37% | 5.38% to 3.78% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 3982304 | 13.06 to 8.81 | 49101 | 4.50% | 0.02% to (1.51)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1706872 | 13.06 to 8.94 | 21316 | 1.67% | 4.47% to 2.88% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 3365612 | 12.50 to 8.69 | 39972 | 1.74% | (14.47)% to (15.77)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 4924558 | 14.61 to 10.32 | 68538 | 1.80% | (2.33)% to (3.82)% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Mid Cap Portfolio — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 0.75% to 0.75% |  | 93.33 to 93.33 |  | 0.00% | 10.92% to 10.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 0.75% to 0.75% |  | 84.14 to 84.14 |  | 0.00% | 16.61% to 16.61% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 0.75% |  | 72.16 to 72.16 |  | 0.00% | 14.22% to 14.22% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 0.75% |  | 63.18 to 63.18 |  | 0.00% | (15.38)% to (15.38)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 0.75% |  | 74.66 to 74.66 |  | 0.00% | 24.66% to 24.66% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Mid Cap Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.70% | 654272 | 86.46 to 16.55 | 45185 | 0.20% | 10.21% to 8.48% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.95% | 1245667 | 78.45 to 15.04 | 64978 | 0.36% | 15.82% to 13.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 2.30% | 944683 | 67.74 to 29.15 | 52240 | 0.33% | 13.49% to 12.17% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.70% | 1235335 | 59.69 to 11.98 | 61536 | 0.28% | (15.94)% to (17.26)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.70% | 1094199 | 71.01 to 14.48 | 63111 | 0.32% | 23.87% to 21.92% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Overseas Portfolio — Initial Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 204637 | 72.03 to 25.19 | 9895 | 1.59% | 19.01% to 18.47% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 223312 | 60.53 to 21.26 | 8963 | 1.59% | 3.83% to 3.37% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 253066 | 58.29 to 20.57 | 9688 | 1.02% | 19.12% to 18.59% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 281147 | 48.93 to 17.34 | 9106 | 1.04% | (25.35)% to (25.69)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 303483 | 65.55 to 23.34 | 13167 | 0.51% | 18.32% to 17.79% |
| &nbsp;&nbsp;&nbsp;&nbsp; VIP Value Strategies Portfolio — Service Class 2 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.70% | 55599 | 42.49 to 28.86 | 2311 | 0.80% | 6.14% to 5.87% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.70% | 64750 | 40.03 to 27.26 | 2543 | 0.73% | 7.57% to 7.30% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.70% | 75773 | 37.22 to 25.41 | 2774 | 0.89% | 18.86% to 18.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.70% | 92425 | 31.31 to 21.43 | 2852 | 0.87% | (8.69)% to (8.92)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.70% | 108235 | 34.29 to 32.78 | 3670 | 1.27% | 31.41% to 31.08% |
|  Franklin Templeton Variable Insurance Products Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Allocation VIP Fund — Class 2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1329891 | 19.29 to 12.86 | 22982 | 1.95% | 10.97% to 9.28% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1614203 | 17.39 to 11.77 | 25316 | 2.04% | 7.56% to 5.91% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1957454 | 16.16 to 11.11 | 28722 | 1.46% | 12.96% to 11.24% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 2349148 | 14.31 to 9.99 | 30672 | 1.63% | (17.22)% to (18.47)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 2777133 | 17.29 to 12.25 | 44074 | 1.76% | 10.06% to 8.39% |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Income VIP Fund — Class 2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 5493336 | 26.48 to 12.52 | 116132 | 5.12% | 10.93% to 9.24% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 6607329 | 23.88 to 11.46 | 126463 | 5.22% | 5.64% to 4.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 7861382 | 22.60 to 11.01 | 144032 | 5.19% | 7.05% to 5.43% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 9237386 | 21.11 to 10.45 | 159365 | 4.97% | (6.84)% to (8.26)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 10383063 | 22.66 to 11.39 | 188586 | 4.68% | 15.06% to 13.31% |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Large Cap Growth VIP Fund — Class 2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.05% | 1916 | 60.29 to 43.34 | 113 | 0.00% | 5.66% to 5.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.05% | 3384 | 57.06 to 41.27 | 190 | 0.00% | 24.46% to 23.69% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.05% | 3826 | 45.85 to 33.36 | 172 | 0.00% | 38.41% to 37.57% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 8961 | 33.12 to 10.08 | 240 | 0.00% | (37.46)% to (38.25)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 6294 | 52.96 to 16.32 | 294 | 0.00% | 13.60% to 12.16% |
| &nbsp;&nbsp;&nbsp;&nbsp; Franklin Mutual Shares VIP Fund — Class 2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 855443 | 35.67 to 13.01 | 19327 | 2.01% | 9.90% to 8.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1016572 | 32.45 to 12.02 | 20924 | 1.92% | 9.65% to 7.97% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1184949 | 29.60 to 11.13 | 22171 | 1.84% | 11.82% to 10.13% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1352681 | 26.47 to 10.11 | 22858 | 0.68% | (8.77)% to (10.16)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 6853421 | 29.01 to 11.25 | 118673 | 5.08% | 17.44% to 15.65% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Foreign VIP Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 154207 | 21.83 to 19.85 | 3144 | 2.59% | 28.02% to 27.44% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 183669 | 17.05 to 15.57 | 2936 | 2.58% | (1.94)% to (2.39)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 196681 | 17.39 to 15.96 | 3219 | 3.42% | 19.70% to 19.17% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 232474 | 14.53 to 13.39 | 3188 | 3.44% | (8.45)% to (8.86)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 246527 | 15.87 to 14.69 | 3706 | 2.03% | 3.23% to 2.77% |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Foreign VIP Fund — Class 2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.05% | 5397 | 29.13 to 16.08 | 141 | 2.23% | 27.32% to 26.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.05% | 7588 | 22.88 to 12.70 | 158 | 2.36% | (2.44)% to (3.04)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.05% | 8433 | 23.45 to 13.10 | 181 | 3.18% | 19.01% to 18.29% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.05% | 9152 | 19.71 to 11.08 | 164 | 3.21% | (8.94)% to (9.50)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 15860 | 21.64 to 10.26 | 264 | 1.43% | 2.65% to 1.35% |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Global Bond VIP Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.40% | 111579 | 16.31 to 15.47 | 1732 | 0.00% | 14.75% to 14.46% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.40% | 127305 | 14.21 to 13.51 | 1727 | 0.00% | (12.16)% to (12.38)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.40% | 150107 | 16.18 to 15.42 | 2325 | 0.00% | 2.01% to 1.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.40% | 163060 | 15.86 to 15.16 | 2482 | 0.00% | (5.94)% to (6.18)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.40% | 191673 | 16.86 to 16.15 | 3121 | 0.00% | (5.72)% to (5.96)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Templeton Growth VIP Fund — Class 2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% | 243190 | 18.41 to 13.99 | 4142 | 0.88% | 22.03% to 20.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 294911 | 15.09 to 11.61 | 4137 | 0.97% | 3.87% to 2.54% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.95% | 324737 | 14.52 to 13.28 | 4384 | 3.26% | 19.26% to 18.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.20% | 411691 | 12.18 to 10.72 | 4673 | 0.16% | (12.78)% to (13.45)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 464747 | 13.96 to 11.17 | 6021 | 1.07% | 3.35% to 2.04% |
|  Goldman Sachs Variable Insurance Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Goldman Sachs Government Money Market Fund — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.95% | 11424646 | 10.34 to 9.64 | 111712 | 3.87% | 2.75% to 0.88% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.95% | 11958902 | 10.06 to 9.56 | 114247 | 4.80% | 3.69% to 1.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 2.95% | 14030189 | 10.16 to 9.39 | 129868 | 4.67% | 4.00% to 1.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 2.95% | 15653008 | 9.77 to 9.23 | 140395 | 1.39% | 0.61% to (1.61)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 2.95% | 13708774 | 9.71 to 9.38 | 123322 | 0.01% | (0.74)% to (2.94)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Goldman Sachs Large Cap Value Fund — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 125068 | 34.40 to 31.55 | 4158 | 1.07% | 9.61% to 9.11% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 145147 | 31.38 to 28.92 | 4412 | 1.37% | 15.74% to 15.22% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 164370 | 27.12 to 25.10 | 4335 | 1.69% | 11.72% to 11.21% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 195188 | 24.27 to 22.57 | 4627 | 1.21% | (7.44)% to (7.86)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 251827 | 26.23 to 24.49 | 6490 | 1.11% | 22.71% to 22.15% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Goldman Sachs Mid Cap Value Fund — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.30% | 362635 | 78.63 to 32.33 | 24156 | 1.16% | 8.14% to 6.88% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.30% | 413362 | 72.71 to 30.25 | 25563 | 0.97% | 11.10% to 9.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 2.30% | 481780 | 65.45 to 27.55 | 27007 | 1.02% | 10.14% to 8.86% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.30% | 507282 | 59.43 to 25.31 | 26585 | 0.66% | (11.02)% to (12.06)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.30% | 569305 | 66.79 to 28.78 | 34036 | 0.45% | 29.45% to 27.94% |
|  Janus Aspen Series |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Balanced Portfolio — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 605641 | 118.07 to 48.48 | 48695 | 2.00% | 13.78% to 13.27% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 677153 | 103.77 to 42.80 | 48066 | 2.03% | 14.09% to 13.57% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 791106 | 90.96 to 37.68 | 49289 | 2.07% | 14.09% to 13.58% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 915650 | 79.72 to 33.18 | 49790 | 1.36% | (17.36)% to (17.73)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 1053486 | 96.47 to 40.33 | 68972 | 1.11% | 15.85% to 15.32% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Balanced Portfolio — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 2035237 | 49.11 to 15.00 | 69792 | 1.68% | 13.16% to 11.44% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 2356705 | 43.40 to 13.46 | 71876 | 1.73% | 13.47% to 11.73% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 2663197 | 38.25 to 12.05 | 72310 | 1.74% | 13.47% to 11.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 3040782 | 33.71 to 10.78 | 73166 | 1.09% | (17.82)% to (19.07)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 3497016 | 41.02 to 13.32 | 103288 | 0.87% | 15.21% to 13.46% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Enterprise Portfolio — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 294649 | 205.12 to 55.01 | 35069 | 0.32% | 6.43% to 5.95% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 337332 | 192.72 to 51.92 | 37339 | 0.74% | 14.27% to 13.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 390439 | 168.66 to 45.64 | 37499 | 0.15% | 16.72% to 16.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 449010 | 144.50 to 39.28 | 36431 | 0.38% | (16.91)% to (17.28)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 501217 | 173.90 to 47.49 | 49547 | 0.32% | 15.49% to 14.97% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Enterprise Portfolio — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.50% to 1.70% | 147816 | 29.07 to 27.60 | 4588 | 0.18% | 5.80% to 5.59% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.50% to 1.70% | 159236 | 27.47 to 26.14 | 4701 | 0.63% | 13.58% to 13.35% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.50% to 1.70% | 171210 | 24.19 to 23.06 | 4501 | 0.09% | 16.01% to 15.78% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.50% to 1.70% | 184293 | 20.85 to 19.92 | 4158 | 0.27% | (17.41)% to (17.57)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.50% to 1.70% | 192932 | 25.24 to 24.16 | 5287 | 0.24% | 14.79% to 14.56% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Flexible Bond Portfolio — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 0.75% to 1.60% | 205438 | 25.57 to 20.54 | 5426 | 5.13% | 6.60% to 5.69% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 0.75% to 1.60% | 241836 | 23.99 to 19.44 | 5886 | 4.72% | 1.19% to 0.32% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 1.60% | 284409 | 23.71 to 19.38 | 6773 | 4.19% | 4.71% to 3.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 1.60% | 315820 | 22.64 to 18.66 | 7185 | 2.61% | (14.31)% to (15.04)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 1.60% | 358273 | 26.42 to 21.96 | 9622 | 2.77% | (1.64)% to (2.48)% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Forty Portfolio — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 280124 | 227.21 to 82.53 | 38282 | 0.30% | 16.78% to 16.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 311053 | 194.56 to 70.99 | 36746 | 0.11% | 26.98% to 26.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 352084 | 153.22 to 56.16 | 32705 | 0.19% | 38.36% to 37.74% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 404767 | 110.74 to 40.77 | 26747 | 0.18% | (34.32)% to (34.61)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 468125 | 168.60 to 62.36 | 46901 | 0.49% | 21.48% to 20.94% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Forty Portfolio — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.05% | 207305 | 116.65 to 72.24 | 16031 | 0.26% | 16.15% to 15.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.45% | 246890 | 100.43 to 53.77 | 16441 | 0.01% | 26.27% to 24.98% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 803559 | 79.53 to 15.10 | 34133 | 0.13% | 37.64% to 35.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 860555 | 57.79 to 11.14 | 26711 | 0.07% | (34.69)% to (35.68)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 388821 | 88.48 to 17.43 | 22540 | 0.54% | 20.82% to 19.29% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Global Research Portfolio — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 410689 | 127.89 to 35.56 | 34862 | 0.73% | 19.53% to 18.99% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 484073 | 106.99 to 29.89 | 33497 | 0.75% | 22.15% to 21.60% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 544473 | 87.59 to 24.58 | 30618 | 0.92% | 25.32% to 24.76% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 626407 | 69.89 to 19.70 | 27831 | 1.62% | (20.34)% to (20.70)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 699744 | 87.73 to 24.84 | 38786 | 0.51% | 16.73% to 16.20% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Global Research Portfolio — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.50% to 1.70% | 95140 | 22.54 to 21.41 | 2256 | 0.60% | 18.79% to 18.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.50% to 1.70% | 123501 | 18.98 to 18.06 | 2462 | 0.58% | 21.41% to 21.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.50% to 1.70% | 147477 | 15.63 to 14.90 | 2401 | 0.76% | 24.58% to 24.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.50% to 1.70% | 169516 | 12.55 to 11.99 | 2214 | 1.47% | (20.81)% to (20.98)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.50% to 1.70% | 187057 | 15.85 to 15.17 | 3079 | 0.36% | 16.03% to 15.79% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Global Technology and Innovation Portfolio — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.70% | 288942 | 51.30 to 43.55 | 13582 | 0.00% | 23.41% to 22.72% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.70% | 322473 | 41.57 to 35.48 | 12308 | 0.00% | 30.23% to 29.51% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.70% | 361288 | 31.92 to 27.40 | 10600 | 0.00% | 52.51% to 51.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.70% | 391525 | 20.93 to 18.07 | 7549 | 0.00% | (37.85)% to (38.19)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.70% | 442480 | 33.67 to 29.23 | 13783 | 0.66% | 16.39% to 15.74% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Overseas Portfolio — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 285080 | 75.33 to 39.73 | 16625 | 1.44% | 27.39% to 26.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 316304 | 59.13 to 31.33 | 14395 | 1.34% | 4.61% to 4.14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 359251 | 56.53 to 30.09 | 15479 | 1.49% | 9.60% to 9.11% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 453822 | 51.57 to 27.58 | 17125 | 1.74% | (9.65)% to (10.06)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 503564 | 57.09 to 30.66 | 21111 | 1.13% | 12.28% to 11.77% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Overseas Portfolio — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.70% | 57907 | 51.18 to 20.98 | 1360 | 1.29% | 26.72% to 26.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.70% | 73387 | 40.39 to 16.60 | 1360 | 1.26% | 4.04% to 3.77% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.10% | 95242 | 38.83 to 23.64 | 1738 | 1.40% | 8.99% to 8.27% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.10% | 106468 | 35.62 to 21.83 | 1785 | 1.65% | (10.16)% to (10.75)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.10% | 118255 | 39.65 to 24.46 | 2269 | 1.01% | 11.65% to 10.91% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Research Portfolio — Institutional Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 401587 | 168.49 to 52.35 | 41704 | 0.12% | 17.03% to 16.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 473397 | 143.97 to 44.93 | 41915 | 0.03% | 33.74% to 33.14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 556511 | 107.65 to 33.75 | 36638 | 0.15% | 41.53% to 40.89% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 647195 | 76.06 to 23.95 | 30080 | 0.70% | (30.70)% to (31.01)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 721553 | 109.75 to 34.72 | 48298 | 0.10% | 18.95% to 18.41% |
| &nbsp;&nbsp;&nbsp;&nbsp; Janus Henderson Research Portfolio — Service Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.50% to 1.70% | 75022 | 39.08 to 37.11 | 3040 | 0.13% | 16.33% to 16.09% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.50% to 1.70% | 91398 | 33.60 to 31.97 | 3176 | 0.00% | 32.92% to 32.65% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.50% to 1.70% | 105895 | 25.28 to 24.10 | 2765 | 0.06% | 40.68% to 40.39% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.50% to 1.70% | 116746 | 17.97 to 17.16 | 2173 | 0.57% | (31.11)% to (31.25)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.50% to 1.70% | 127775 | 26.08 to 24.97 | 3457 | 0.02% | 18.25% to 18.01% |
|  Legg Mason Partners Variable Equity Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Dividend Strategy Portfolio — Class I |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 102967 | 39.87 to 36.64 | 3898 | 2.17% | 11.32% to 10.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 109167 | 35.81 to 33.06 | 3721 | 1.32% | 15.49% to 14.97% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 115802 | 31.01 to 28.76 | 3422 | 2.07% | 12.89% to 12.38% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 136003 | 27.47 to 25.59 | 3571 | 1.37% | (9.16)% to (9.57)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 149457 | 30.24 to 28.30 | 4330 | 1.49% | 25.34% to 24.77% |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Dividend Strategy Portfolio — Class II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 125612 | 36.70 to 16.66 | 4131 | 1.88% | 10.83% to 9.14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 146812 | 33.11 to 15.27 | 4378 | 1.11% | 14.99% to 13.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 174407 | 28.80 to 13.48 | 4571 | 1.96% | 12.36% to 10.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 190214 | 25.63 to 12.19 | 4466 | 1.22% | (9.56)% to (10.93)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 200036 | 28.34 to 13.68 | 5208 | 1.34% | 24.78% to 22.88% |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Growth Portfolio — Class II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 48974 | 50.60 to 30.41 | 2273 | 0.00% | 11.46% to 10.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.30% | 54977 | 45.40 to 27.52 | 2296 | 0.11% | 10.78% to 9.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 73083 | 40.98 to 25.06 | 2789 | 0.06% | 22.34% to 21.29% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.30% | 79595 | 33.50 to 20.66 | 2477 | 0.00% | (27.65)% to (28.27)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.30% | 117214 | 46.30 to 28.81 | 5118 | 0.17% | 8.45% to 7.51% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; ClearBridge Variable Large Cap Value Portfolio — Class I |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.30% | 345270 | 64.49 to 19.36 | 11091 | 1.08% | 8.93% to 7.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.30% | 385942 | 59.21 to 17.98 | 11722 | 1.17% | 6.83% to 5.58% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 2.30% | 562353 | 55.42 to 17.03 | 14945 | 1.27% | 13.77% to 12.46% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.30% | 601144 | 48.71 to 15.15 | 14261 | 1.30% | (7.50)% to (8.58)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.30% | 650591 | 52.66 to 16.57 | 16744 | 1.05% | 24.76% to 23.31% |
|  Lincoln Variable Insurance Products Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Disciplined Core Value Fund — Standard Class II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.05% | 907 | 50.18 to 32.15 | 32 | 1.62% | 13.19% to 12.51% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.05% | 1185 | 44.33 to 28.57 | 39 | 1.31% | 11.45% to 10.76% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.05% | 534 | 39.78 to 25.80 | 18 | 1.50% | 7.08% to 6.43% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 10140 | 37.15 to 11.81 | 235 | 1.87% | (14.00)% to (15.09)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 7937 | 43.19 to 13.90 | 246 | 1.00% | 21.86% to 20.31% |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Inflation Protection Fund — Service Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1104011 | 13.50 to 9.50 | 13685 | 7.04% | 4.79% to 3.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1249464 | 12.89 to 9.21 | 14816 | 3.59% | 0.06% to (1.47)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1395150 | 12.88 to 9.34 | 16633 | 3.30% | 1.90% to 0.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1491405 | 12.64 to 9.31 | 17508 | 5.08% | (14.34)% to (15.64)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 1162727 | 14.75 to 11.04 | 15954 | 3.10% | 4.73% to 3.13% |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century International Fund — Standard Class II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% | 9387 | 33.92 to 12.62 | 195 | 1.15% | 14.30% to 12.85% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 12240 | 29.67 to 11.18 | 239 | 1.64% | 1.11% to (0.18)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 13782 | 29.35 to 11.20 | 270 | 1.27% | 10.94% to 9.54% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 11777 | 26.45 to 10.23 | 216 | 1.48% | (25.84)% to (26.78)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 11901 | 35.67 to 13.97 | 297 | 0.21% | 7.17% to 5.81% |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Ultra<sup>®</sup> Fund — Standard Class II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% |  | 93.10 to 24.01 |  | 0.00% | 11.21% to 9.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.85% to 1.85% | 521 | 65.38 to 65.38 | 34 | 0.00% | 26.40% to 26.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.85% to 1.85% | 673 | 51.73 to 51.73 | 35 | 0.00% | 40.87% to 40.87% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.85% to 1.85% | 903 | 36.72 to 36.72 | 33 | 0.00% | (33.63)% to (33.63)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 2338 | 69.98 to 19.00 | 116 | 0.00% | 21.38% to 19.84% |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP American Century Value Fund — Standard Class II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.45% | 1112 | 53.21 to 53.21 | 59 | 1.58% | 14.34% to 14.34% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.45% | 1452 | 46.53 to 46.53 | 68 | 2.87% | 7.89% to 7.89% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 9173 | 43.13 to 13.40 | 268 | 2.38% | 7.52% to 6.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 8246 | 40.11 to 12.62 | 223 | 2.07% | (0.91)% to (2.17)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 4637 | 40.48 to 12.90 | 141 | 1.30% | 22.71% to 21.15% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan Core Bond Fund — Standard Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% | 53309 | 14.87 to 9.22 | 721 | 3.45% | 5.85% to 4.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 64992 | 14.05 to 8.82 | 843 | 3.23% | 0.24% to (1.04)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 89596 | 14.02 to 8.91 | 1197 | 3.59% | 4.38% to 3.05% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 77516 | 13.43 to 8.65 | 960 | 1.96% | (13.84)% to (14.93)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 86497 | 15.59 to 10.17 | 1248 | 2.33% | (2.79)% to (4.02)% |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan Mid Cap Value Fund — Standard Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% | 6633 | 53.22 to 14.10 | 167 | 1.09% | 3.20% to 1.89% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 7657 | 51.57 to 13.83 | 203 | 1.15% | 12.62% to 11.18% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 9377 | 45.79 to 12.44 | 211 | 2.34% | 9.30% to 7.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.95% | 1332 | 41.90 to 39.08 | 54 | 1.01% | (9.49)% to (9.95)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 5273 | 46.29 to 12.90 | 138 | 1.01% | 28.00% to 26.38% |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan Small Cap Core Fund — Standard Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 256 | 51.62 to 47.42 | 13 | 0.39% | 8.67% to 8.12% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 6177 | 47.50 to 12.96 | 149 | 0.77% | 10.08% to 8.68% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.45% | 125 | 43.15 to 43.15 | 5 | 1.37% | 11.46% to 11.46% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.45% | 125 | 38.72 to 38.72 | 5 | 0.45% | (20.52)% to (20.52)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.45% | 125 | 48.71 to 48.71 | 6 | 0.76% | 19.63% to 19.63% |
| &nbsp;&nbsp;&nbsp;&nbsp; LVIP JPMorgan U.S. Equity Fund — Standard Class |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.70% | 14725 | 65.77 to 21.97 | 841 | 0.68% | 12.88% to 11.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 5706 | 58.27 to 19.71 | 308 | 0.18% | 22.18% to 20.62% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 26643 | 47.69 to 16.34 | 1163 | 1.55% | 25.32% to 23.74% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 27733 | 38.05 to 13.21 | 876 | 0.54% | (19.87)% to (20.89)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.70% | 31410 | 47.49 to 16.70 | 1248 | 0.70% | 27.47% to 25.85% |
|  MFS<sup>®</sup> Variable Insurance Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Investors Trust Series — Service Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.70% | 78647 | 62.59 to 38.16 | 3289 | 0.59% | 11.68% to 11.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.70% | 96371 | 56.04 to 34.26 | 3593 | 0.47% | 17.48% to 17.18% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.70% | 114935 | 47.70 to 29.23 | 3705 | 0.45% | 16.95% to 16.65% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.70% | 141118 | 40.79 to 25.06 | 3916 | 0.38% | (17.89)% to (18.10)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.70% | 156913 | 49.68 to 30.60 | 5300 | 0.41% | 24.67% to 24.36% |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> New Discovery Series — Service Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.30% | 194982 | 63.84 to 38.53 | 7592 | 0.00% | 11.26% to 9.97% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.30% | 229227 | 57.38 to 35.03 | 8141 | 0.00% | 5.20% to 3.97% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 2.30% | 255148 | 54.54 to 33.69 | 8625 | 0.00% | 12.94% to 11.63% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.30% | 285655 | 48.29 to 30.18 | 8585 | 0.00% | (30.80)% to (31.60)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.30% | 312846 | 69.79 to 44.13 | 13745 | 0.00% | 0.40% to (0.76)% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Total Return Series — Service Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1026024 | 31.66 to 12.89 | 23060 | 2.49% | 9.31% to 7.64% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1168323 | 28.97 to 11.98 | 24533 | 2.24% | 5.89% to 4.27% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1320593 | 27.35 to 11.49 | 26127 | 1.82% | 8.62% to 6.98% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1402440 | 25.18 to 10.74 | 25776 | 1.45% | (11.14)% to (12.49)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 1820883 | 28.34 to 12.27 | 37727 | 1.59% | 12.19% to 10.48% |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Utilities Series — Service Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 193078 | 70.94 to 40.61 | 8861 | 2.63% | 13.09% to 12.52% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.95% | 240855 | 62.73 to 36.09 | 9725 | 2.14% | 9.72% to 9.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.95% | 252268 | 57.17 to 33.06 | 9271 | 3.28% | (3.74)% to (4.23)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.20% | 275570 | 59.39 to 33.00 | 10616 | 2.19% | (0.97)% to (1.73)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.20% | 302306 | 59.98 to 33.58 | 11610 | 1.52% | 12.17% to 11.32% |
|  MFS<sup>®</sup> Variable Insurance Trust II |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Income Portfolio — Service Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.45% | 995 | 11.97 to 11.97 | 12 | 4.23% | 5.54% to 5.54% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.45% | 966 | 11.34 to 11.34 | 11 | 3.64% | 1.41% to 1.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.45% | 1317 | 11.18 to 11.18 | 15 | 3.53% | 5.81% to 5.81% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.45% | 1339 | 10.57 to 10.57 | 14 | 3.02% | (15.09)% to (15.09)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.45% | 1350 | 12.45 to 12.45 | 17 | 2.70% | (1.35)% to (1.35)% |
| &nbsp;&nbsp;&nbsp;&nbsp; MFS<sup>®</sup> Massachusetts Investors Growth Stock Portfolio — Service Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.30% | 136259 | 31.12 to 28.35 | 4209 | 0.02% | 8.02% to 7.09% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.70% | 186187 | 28.81 to 16.95 | 5309 | 0.13% | 14.29% to 12.83% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.70% | 207982 | 25.21 to 15.02 | 5199 | 0.05% | 21.92% to 20.38% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.70% | 244498 | 20.68 to 12.48 | 5013 | 0.00% | (20.61)% to (21.62)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.30% | 273142 | 26.05 to 24.57 | 7079 | 0.03% | 23.84% to 22.77% |
|  PIMCO Variable Insurance Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; All Asset Portfolio — Advisor Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 146530 | 20.68 to 18.62 | 2917 | 4.50% | 12.54% to 11.97% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.95% | 183085 | 18.38 to 16.63 | 3249 | 6.29% | 2.06% to 1.54% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.95% | 213911 | 18.01 to 16.38 | 3730 | 2.79% | 6.46% to 5.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.95% | 230086 | 16.91 to 15.46 | 3765 | 7.52% | (13.14)% to (13.58)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.95% | 251131 | 19.47 to 17.89 | 4731 | 10.85% | 14.36% to 13.78% |
| &nbsp;&nbsp;&nbsp;&nbsp; High Yield Portfolio — Administrative Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 991485 | 27.21 to 10.98 | 23380 | 6.27% | 7.37% to 5.74% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1150996 | 25.34 to 10.39 | 25285 | 5.83% | 5.33% to 3.72% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 1317441 | 24.06 to 10.01 | 27510 | 5.66% | 10.60% to 8.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 1459658 | 21.75 to 9.19 | 27559 | 5.08% | (11.58)% to (12.92)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 1113122 | 24.60 to 10.56 | 25510 | 4.44% | 2.13% to 0.57% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; International Bond Portfolio (U.S. Dollar Hedged) — Administrative Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.50% to 1.70% | 46035 | 21.49 to 20.40 | 980 | 3.49% | 2.40% to 2.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.50% to 1.70% | 47800 | 20.99 to 19.97 | 994 | 3.60% | 3.87% to 3.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.50% to 1.70% | 54395 | 20.20 to 19.26 | 1088 | 2.58% | 7.38% to 7.17% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.50% to 1.70% | 57462 | 18.81 to 17.97 | 1071 | 1.47% | (11.50)% to (11.68)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.50% to 1.70% | 71668 | 21.26 to 20.35 | 1503 | 1.59% | (3.43)% to (3.62)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Long-Term U.S. Government Portfolio — Administrative Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1636293 | 16.26 to 7.00 | 23234 | 3.26% | 4.75% to 3.15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 1674227 | 15.52 to 6.78 | 23255 | 2.73% | (7.38)% to (8.80)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 3460483 | 16.76 to 7.44 | 50462 | 2.38% | 2.48% to 0.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 3778536 | 16.35 to 7.37 | 53874 | 2.05% | (29.91)% to (30.97)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 2622435 | 23.33 to 10.68 | 54640 | 1.55% | (6.16)% to (7.59)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Low Duration Portfolio — Administrative Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 1904117 | 12.78 to 9.30 | 22452 | 3.94% | 3.99% to 2.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 2415389 | 12.29 to 9.08 | 27524 | 4.00% | 2.97% to 1.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 3928764 | 11.93 to 8.95 | 43146 | 3.59% | 3.45% to 1.88% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 4050621 | 11.53 to 8.79 | 43248 | 1.56% | (7.10)% to (8.51)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 5989897 | 12.41 to 9.60 | 68669 | 0.52% | (2.36)% to (3.85)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Return Portfolio — Administrative Class Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.95% | 5290272 | 18.10 to 9.16 | 85487 | 4.10% | 7.64% to 5.68% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.95% | 6354863 | 16.81 to 8.67 | 95573 | 4.03% | 1.35% to (0.51)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 2.95% | 6268730 | 16.59 to 8.71 | 94375 | 3.56% | 4.72% to 2.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.95% | 5386289 | 15.84 to 8.47 | 80255 | 2.56% | (15.28)% to (16.82)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.95% | 8123779 | 18.70 to 10.19 | 139271 | 1.82% | (2.40)% to (4.18)% |
|  Rydex Variable Trust |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; NASDAQ — 100<sup>®</sup> Fund |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.70% | 186691 | 138.21 to 34.00 | 9881 | 0.03% | 17.31% to 17.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 1.70% | 207285 | 117.81 to 29.06 | 9547 | 0.20% | 22.10% to 21.79% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 1.70% | 237085 | 96.49 to 23.86 | 8750 | 0.00% | 51.01% to 50.63% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 1.85% | 194977 | 63.90 to 45.27 | 4355 | 0.00% | (35.10)% to (35.36)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 1.85% | 227854 | 98.45 to 70.03 | 7892 | 0.00% | 23.72% to 23.22% |
|  State Street Variable Insurance Series Funds, Inc. |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Income V.I.S. Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 0.75% to 2.30% | 489997 | 17.93 to 9.98 | 6673 | 3.44% | 5.12% to 3.48% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 0.75% to 2.30% | 572566 | 17.06 to 9.64 | 7504 | 3.06% | (1.56)% to (3.11)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 2.30% | 639351 | 17.33 to 9.95 | 8613 | 2.01% | 3.90% to 2.28% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 2.30% | 685203 | 16.68 to 9.73 | 9008 | 2.53% | (15.02)% to (16.35)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 2.30% | 802680 | 19.63 to 11.63 | 12578 | 2.12% | (2.55)% to (4.07)% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; Premier Growth Equity V.I.S. Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.95% | 362793 | 84.56 to 73.69 | 27073 | 0.00% | 18.62% to 17.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.95% | 440971 | 71.29 to 62.63 | 27851 | 0.00% | 29.54% to 28.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.95% | 537937 | 55.03 to 48.74 | 25936 | 0.00% | 44.60% to 43.44% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.10% | 610779 | 38.06 to 31.53 | 20493 | 0.00% | (31.23)% to (31.89)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.10% | 696883 | 55.34 to 46.29 | 34295 | 0.00% | 23.53% to 22.35% |
| &nbsp;&nbsp;&nbsp;&nbsp; Real Estate Securities V.I.S. Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 0.75% to 2.05% | 190959 | 79.69 to 28.60 | 14597 | 1.05% | 1.19% to (0.13)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 0.75% to 2.70% | 222267 | 78.75 to 11.30 | 16744 | 2.27% | 9.63% to 7.47% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 2.95% | 1673788 | 71.83 to 10.39 | 50822 | 2.81% | 12.65% to 10.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 2.95% | 963995 | 63.76 to 9.43 | 31805 | 1.73% | (25.49)% to (27.14)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 2.70% | 516159 | 85.58 to 13.03 | 38566 | 2.23% | 40.74% to 37.98% |
| &nbsp;&nbsp;&nbsp;&nbsp; S&P 500<sup>®</sup> Index V.I.S. Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.95% | 2096924 | 306.05 to 54.83 | 156595 | 0.94% | 16.17% to 15.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.30% | 2445959 | 263.46 to 43.06 | 155856 | 1.12% | 23.18% to 21.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 2.30% | 2786116 | 40.21 to 35.37 | 143020 | 1.42% | 25.02% to 23.07% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 2.70% | 2688055 | 32.16 to 12.29 | 112022 | 1.25% | (18.93)% to (20.52)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 2.70% | 3167505 | 39.67 to 15.47 | 163536 | 1.07% | 27.31% to 24.81% |
| &nbsp;&nbsp;&nbsp;&nbsp; Small-Cap Equity V.I.S. Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.30% | 359948 | 56.62 to 29.31 | 18146 | 0.00% | (1.40)% to (2.54)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.30% | 408933 | 57.42 to 30.08 | 21044 | 0.11% | 9.04% to 7.77% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 2.30% | 460122 | 52.66 to 27.91 | 21779 | 0.00% | 12.25% to 10.95% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 2.30% | 516378 | 46.91 to 25.15 | 21877 | 0.00% | (16.37)% to (17.34)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 2.30% | 614611 | 56.09 to 30.43 | 31221 | 0.00% | 19.15% to 17.76% |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Return V.I.S. Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 2.95% | 23976850 | 107.95 to 12.85 | 627740 | 2.45% | 14.52% to 12.44% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 2.95% | 26388511 | 94.26 to 11.43 | 606146 | 4.58% | 10.02% to 8.01% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 2.95% | 28711624 | 24.68 to 10.58 | 602277 | 2.27% | 14.62% to 12.09% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 2.95% | 31236127 | 21.53 to 9.44 | 576738 | 0.90% | (17.13)% to (18.97)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 2.95% | 33565522 | 25.98 to 11.65 | 754081 | 2.08% | 12.60% to 10.10% |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Return V.I.S. Fund — Class 3 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.95% | 13808620 | 21.09 to 12.64 | 246629 | 2.13% | 13.81% to 12.08% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.95% | 16156286 | 18.53 to 11.28 | 254137 | 4.10% | 9.44% to 7.76% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.95% | 18946307 | 16.93 to 10.46 | 273380 | 1.93% | 13.54% to 11.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.95% | 22276836 | 14.91 to 9.36 | 284279 | 0.38% | (17.92)% to (19.17)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.95% | 25159448 | 18.17 to 11.58 | 393270 | 1.75% | 11.56% to 9.86% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Expense as a**<br>**% of Average<br>Net Assets (1)** | **Units** | **Unit Value** | **Net<br>Assets<br>000s** | **Investment<br>Income<br>Ratio (2)** | **Total Return (3)** |
| &nbsp;&nbsp;&nbsp;&nbsp; U.S. Equity V.I.S. Fund — Class 1 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.95% | 266759 | 69.97 to 52.92 | 15060 | 0.19% | 15.12% to 14.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.95% | 342860 | 60.78 to 46.35 | 16857 | 0.35% | 23.10% to 22.10% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 0.75% to 1.95% | 441567 | 43.47 to 37.96 | 17472 | 0.47% | 26.95% to 25.42% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 0.75% to 1.95% | 545773 | 34.24 to 30.26 | 17119 | 0.46% | (19.52)% to (20.49)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 0.75% to 1.95% | 632397 | 42.54 to 38.06 | 24875 | 0.33% | 24.55% to 23.05% |
|  The Alger Portfolios |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Alger Large Cap Growth Portfolio — Class I-2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 327767 | 137.73 to 55.99 | 30596 | 0.00% | 28.77% to 28.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 387809 | 106.96 to 43.67 | 28421 | 0.00% | 41.23% to 40.59% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 463510 | 75.73 to 31.06 | 23488 | 0.00% | 31.15% to 30.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 522231 | 57.74 to 23.79 | 20174 | 0.00% | (39.36)% to (39.63)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 571353 | 95.22 to 39.42 | 36365 | 0.00% | 10.56% to 10.06% |
| &nbsp;&nbsp;&nbsp;&nbsp; Alger Small Cap Growth Portfolio — Class I-2 Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.15% to 1.60% | 267613 | 42.41 to 30.01 | 9705 | 0.00% | 4.69% to 4.22% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.15% to 1.60% | 315955 | 40.51 to 28.79 | 10905 | 0.37% | 6.88% to 6.39% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.15% to 1.60% | 356063 | 37.90 to 27.06 | 11505 | 0.00% | 15.16% to 14.64% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.15% to 1.60% | 400023 | 32.91 to 23.61 | 11230 | 0.00% | (38.73)% to (39.00)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.15% to 1.60% | 434896 | 53.72 to 38.70 | 20053 | 0.00% | (7.14)% to (7.56)% |
|  The Prudential Series Fund |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; PSF PGIM Jennison Blend Portfolio — Class II Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 1.95% | 593474 | 14.97 to 14.81 | 9666 | 0.00% | 16.34% to 15.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.30% | 347407 | 12.86 to 12.75 | 4884 | 0.00% | 23.97% to 22.90% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 382268 | 10.38 to 10.37 | 4242 | 0.00% | 3.77% to 3.72% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.55% to 1.55% |  | 26.21 to 26.21 |  | 0.00% | (26.55)% to (26.55)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.55% to 1.55% |  | 35.68 to 35.68 |  | 0.00% | 18.03% to 18.03% |
| &nbsp;&nbsp;&nbsp;&nbsp; PSF PGIM Jennison Growth Portfolio — Class II Shares |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2025 | 1.45% to 2.20% | 82549 | 105.97 to 75.27 | 8397 | 0.00% | 12.16% to 11.30% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2024 | 1.45% to 2.30% | 93220 | 94.48 to 58.79 | 8482 | 0.00% | 28.45% to 27.34% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | 1.45% to 2.30% | 107199 | 73.55 to 46.17 | 7592 | 0.00% | 50.69% to 49.39% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 | 1.45% to 2.30% | 118813 | 48.81 to 30.90 | 5548 | 0.00% | (38.75)% to (39.28)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021 | 1.45% to 2.30% | 138763 | 79.69 to 50.89 | 10610 | 0.00% | 13.88% to 12.90% |

---

(1) Expenses as a percentage of average net assets represent the annualized asset-based contract expenses of the
Separate Account, consisting of mortality and expense risk charges, administrative expenses, and other rider charges for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made
directly to the contract owner through the redemption of units and expenses of the underlying Portfolios are excluded.

(2) The investment income ratio represents the ordinary dividends received by the subaccount from the Portfolio
divided by average net assets.

(3) The total return represents a range of maximum and minimum annual total returns for the year or lesser period
indicated and includes deductions for expenses assessed through the daily unit value calculation. The total return does not include any expenses assessed through the redemption of units; inclusion of these expenses in the calculation would result in
a

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE & ANNUITY VA SEPARATE ACCOUNT 1**

Notes to Financial Statements — Continued

December 31, 2025

reduction in the total return presented. Standardized total returns shown separately in a prospectus or marketing material for a product supported by the Separate Account include the maximum contract charges that may be assessed to any contract through both the daily unit value calculation and the redemption of units. Accordingly, these standardized total returns will generally reflect a lower return than the total return.

(4) The ratios of expenses and net investment income to average net assets are annualized for the period from
April 30, 2021, to December 31, 2021.

(5) The ratios of expenses and net investment income to average net assets are annualized for the period from
April 29, 2022, to December 31, 2022.

(6) The ratios of expenses and net investment income to average net assets are annualized for the period from
March 10, 2023, to December 31, 2023.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

**Statutory Financial Statements** 

**Years Ended December 31, 2025, 2024 and 2023** 

**(With Independent Auditors' Report Thereon)** 

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Index to Statutory Financial Statements

---

| | |
|:---|:---|
|  | **Page** |
|  [Independent Auditors' Report](#fintoc40390_1) | F-1 |
|  [Statutory Statements of Admitted Assets, Liabilities and Capital and Surplus](#fintoc40390_2) | F-3 |
|  [Statutory Statements of Summary of Operations](#fintoc40390_3) | F-5 |
|  [Statutory Statements of Changes in Capital and Surplus](#fintoc40390_4) | F-6 |
|  [Statutory Statements of Cash Flow](#fintoc40390_5) | F-7 |
|  [Notes to Statutory Financial Statements](#fintoc40390_6) | F-9 |

---

------

##### [**Table of Contents**](#toc)
**Independent Auditors' Report** 

Audit, Compensation, and Nominating Committee

Genworth Life and Annuity Insurance Company:

**Report on the Audit of the Financial Statements** 

*Opinions* 

We have audited the financial statements of Genworth Life and Annuity Insurance Company (the Company), which comprise the statutory statements of admitted assets, liabilities, and capital and surplus as of December 31, 2025 and 2024, and the related statutory statements of summary of operations, statutory statements of changes in capital and surplus, and statutory statements of cash flow for each of the years in the three-year period ended December 31, 2025, and the related notes to the financial statements.

*Unmodified Opinion on Statutory Basis of Accounting* 

In our opinion, the accompanying financial statements present fairly, in all material respects, the admitted assets, liabilities, and capital and surplus of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flow for each of the years in the three-year period ended December 31, 2025 in accordance with accounting practices prescribed or permitted by the Virginia State Corporation Commission, Bureau of Insurance described in Note 1.

*Adverse Opinion on U.S. Generally Accepted Accounting Principles* 

In our opinion, because of the significance of the matter discussed in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the financial statements do not present fairly, in accordance with U.S. generally accepted accounting principles, the financial position of the Company as of December 31, 2025 and 2024, or the results of its operations or its cash flows for each of the years in the three-year period ended December 31, 2025.

*Basis for Opinions* 

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

*Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles* 

As described in Note 1 to the financial statements, the financial statements are prepared by the Company using accounting practices prescribed or permitted by the Virginia State Corporation Commission, Bureau of Insurance, which is a basis of accounting other than U.S. generally accepted accounting principles. Accordingly, the financial statements are not intended to be presented in accordance with U.S. generally accepted accounting principles. The effects on the financial statements of the variances between the statutory accounting practices described in Note 1 and U.S. generally accepted accounting principles, although not reasonably determinable, are presumed to be material and pervasive.

*Responsibilities of Management for the Financial Statements* 

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting practices prescribed or permitted by the Virginia State Corporation Commission, Bureau of Insurance. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date that the financial statements are issued.

------

##### [**Table of Contents**](#toc)
*Auditors' Responsibilities for the Audit of the Financial Statements* 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Exercise professional judgment and maintain professional skepticism throughout the audit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or
error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting
estimates made by management, as well as evaluate the overall presentation of the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise
substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.

/s/ KPMG LLP

Richmond, Virginia

April 21, 2026

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Statutory Statements of Admitted Assets, Liabilities and Capital and Surplus

December 31, 2025 and 2024

(Dollar amounts in millions, except per share amounts)

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| **Admitted Assets** |  |  |
|  Cash and invested assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds | $8386.0 | $8808.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stocks — nonaffiliates | 31.5 | 33.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stocks — affiliates | 103.3 | 119.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stocks — nonaffiliates | 45.4 | 46.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans | 1498.2 | 1599.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate | 10.9 | 11.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contract loans | 420.8 | 422.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash, cash equivalents and short-term investments | 366.5 | 234.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other invested assets | 193.8 | 180.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivable for securities | 2.7 | 5.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative assets | 19.0 | 20.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total cash and invested assets | 11078.1 | 11482.5 |
|  Amounts recoverable from reinsurers and funds held | 282.5 | 324.2 |
|  Deferred tax asset | 19.2 | 51.4 |
|  Guaranty funds receivable | 6.5 | 7.2 |
|  Premiums and accounts receivable | 275.3 | 287.3 |
|  Investment income due and accrued | 104.0 | 110.6 |
|  Receivable from parent, subsidiaries and affiliates | 0.2 |  |
|  Current Federal income tax recoverable |  | 1.1 |
|  Other assets | 7.4 | 8.9 |
|  Separate account assets | 4117.1 | 4175.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total admitted assets | $15890.3 | $16448.4 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Statutory Statements of Admitted Assets, Liabilities and Capital and Surplus — Continued

December 31, 2025 and 2024

(Dollar amounts in millions, except per share amounts)

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| **Liabilities and Capital and Surplus** |  |  |
|  Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aggregate reserves — life | $6772.5 | $6905.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aggregate reserves — annuity contracts | 1863.5 | 2112.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aggregate reserves — accident and health policies | 0.2 | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liability for deposit-type contracts | 259.6 | 337.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liability for policy and contract claims | 106.5 | 95.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholders dividends | 0.3 | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Premiums and annuity considerations received in advance | 3.1 | 4.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other amounts payable on reinsurance | 144.4 | 147.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest maintenance reserve | 13.9 | 20.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commissions payable | 0.2 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General expenses due or accrued | 3.4 | 3.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers to separate accounts due or accrued | (14.7) | (12.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taxes, licenses, and fees due or accrued | 6.3 | 6.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Federal income tax payable | 8.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unearned investment income | 5.4 | 5.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amounts withheld or retained by company as agent or trustee | 26.3 | 28.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remittances and items not allocated | 28.5 | 31.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset valuation reserve | 109.7 | 116.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payable to parent, subsidiaries and affiliates | 12.3 | 12.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Funds held under coinsurance and treaties with unauthorized reinsurers | 1597.0 | 1621.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payable for securities | 0.2 | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative liabilities | 3.2 | 0.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account liabilities | 4117.1 | 4175.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 15066.9 | 15614.0 |
|  Capital and surplus: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stock, Class A ($1,000 par value. 50,000 shares authorized; 25,651 shares issued and outstanding) | 25.6 | 25.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paid in surplus | 1456.7 | 1456.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unassigned deficit | (658.9) | (647.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total capital and surplus | 823.4 | 834.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities and capital and surplus | $15890.3 | $16448.4 |

---

See accompanying notes to statutory financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Statutory Statements of Summary of Operations

Years ended December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
|  Revenues: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Premiums and annuity considerations | $126.3 | $137.6 | $220.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Considerations for supplementary contracts with life contingencies | 24.7 | 25.7 | 23.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net investment income | 538.5 | 533.5 | 552.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of interest maintenance reserve | (0.2) | 1 | 2.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commissions and expense allowances on reinsurance ceded | 88.1 | 99.5 | 97.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reserve adjustments on reinsurance ceded | (100.6) | (95.7) | (95.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income from fees associated with investment management, administration, and contract guarantees from separate accounts | 72.6 | 76.7 | 78 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other income | 20.3 | 22.4 | 24.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total revenues | 769.7 | 800.7 | 903.2 |
|  Benefits: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Death benefits | 378.9 | 380.7 | 419.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Matured endowments | 2.8 | 1.1 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annuity benefits | 279.9 | 276.6 | 308.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disability benefits and benefits under accident and health policies | 4.2 | 4.3 | 4.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surrender benefits and other fund withdrawals | 402.1 | 477.1 | 511.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payments on supplementary contracts with life contingencies | 23.8 | 22.5 | 20.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest and adjustments on contracts or deposit-type contract funds | 11.5 | 11.6 | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in aggregate reserves — life, annuity and accident and health | (382.5) | (458.2) | (592.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total benefits | 720.7 | 715.7 | 689.4 |
|  Expenses: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commissions | 73.2 | 78.9 | 83.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General insurance expenses | 141.8 | 147.9 | 134.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insurance taxes, licenses, and fees, excluding Federal income taxes | 19.3 | 20.6 | 20.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfer from separate accounts | (357.6) | (362.2) | (329.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other expenses | 47.1 | 63.8 | 71.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total expenses | (76.2) | (51.0) | (19.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total benefits and expenses | 644.5 | 664.7 | 670.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income before Federal income taxes and realized capital losses, net | 125.2 | 136 | 232.9 |
|  Federal income taxes | (11.8) | (6.9) | 14.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income before realized capital losses | 137 | 142.9 | 218 |
|  Realized capital losses, net | (38.0) | (79.4) | (119.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income | $99 | $63.5 | $98.4 |

---

See accompanying notes to statutory financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Statutory Statements of Changes in Capital and Surplus

Years ended December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** | | | |
|  | **Amount** | **Shares** |<br>**Paid in<br>surplus** |<br>**Unassigned<br>deficit** |<br>**Total** |
|  Balances as of December 31, 2022 | $25.6 | 25651 | $1456.7 | $(677.8) | $804.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income |  |  |  | 98.4 | 98.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized capital gains and losses |  |  |  | (5.0) | (5.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized foreign exchange capital gains and losses |  |  |  | 1.3 | 1.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net deferred income taxes |  |  |  | (6.6) | (6.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in nonadmitted assets |  |  |  | 31.3 | 31.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in liability for reinsurance in unauthorized companies |  |  |  | 12.4 | 12.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in asset valuation reserve |  |  |  | (9.5) | (9.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in surplus as a result of reinsurance |  |  |  | (31.8) | (31.8) |
|  Balances as of December 31, 2023 | 25.6 | 25651 | 1456.7 | (587.3) | 895.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income |  |  |  | 63.5 | 63.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized capital gains and losses |  |  |  | (47.4) | (47.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized foreign exchange capital gains and losses |  |  |  | (1.4) | (1.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net deferred income taxes |  |  |  | (11.1) | (11.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in nonadmitted assets |  |  |  | (34.5) | (34.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in asset valuation reserve |  |  |  | 3.0 | 3.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in surplus as a result of reinsurance |  |  |  | (32.7) | (32.7) |
|  Balances as of December 31, 2024 | 25.6 | 25651 | 1456.7 | (647.9) | 834.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income |  |  |  | 99.0 | 99.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized capital gains and losses |  |  |  | (59.6) | (59.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized foreign exchange capital gains and losses |  |  |  | 4.4 | 4.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net deferred income taxes |  |  |  | (17.5) | (17.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in nonadmitted assets |  |  |  | (15.7) | (15.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in asset valuation reserve |  |  |  | 6.4 | 6.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in surplus as a result of reinsurance |  |  |  | (28.0) | (28.0) |
|  Balances as of December 31, 2025 | $25.6 | 25651 | $1456.7 | $(658.9) | $823.4 |

---

See accompanying notes to statutory financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Statutory Statements of Cash Flow

Years ended December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
|  Cash flow from operations: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Premiums collected net of reinsurance | $156.0 | $172.2 | $231.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net investment income | 514.6 | 510.2 | 538.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Miscellaneous income | 89.3 | 109.2 | 140.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total cash provided from revenues | 759.9 | 791.6 | 910.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit and loss related payments | 1020.2 | 1096.8 | 1143.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfers from separate, segregated accounts, and protected cell accounts | (355.6) | (360.8) | (327.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commissions, expenses paid, and aggregate write-ins for deductions | 230.8 | 243.2 | 236.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal income taxes paid (recovered), net of capital gains (losses) | 15.9 | 30.3 | 66.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total cash applied to benefits and general and other expenses | 911.3 | 1009.5 | 1119.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash applied to operations | (151.4) | (217.9) | (208.6) |
|  Cash flow from investments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from investments sold, matured, or repaid: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds | 759.9 | 1151.9 | 827.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stocks | 7.0 | 7.8 | 8.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans | 211.5 | 171.3 | 91.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other invested assets | 9.4 | 6.5 | 2.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Miscellaneous proceeds | 2.8 | 0.3 | 6.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total investment proceeds | 990.6 | 1337.8 | 935.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cost of investments acquired: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds | 314.6 | 769.1 | 238.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stocks | 0.6 | 0.7 | 4.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans | 110.3 | 89.2 | 27.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate | 0.1 | 1.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives, net | 40.7 | 105.0 | 99.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other invested assets | 21.0 | 19.7 | 26.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Miscellaneous applications | 0.1 | 1.2 | (2.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total investments acquired | 487.4 | 986.0 | 394.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net decrease in contract loans and premium notes | 0.9 | (11.6) | (8.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash provided by investments | 502.3 | 363.4 | 549.7 |
|  Cash flow from financing and miscellaneous sources: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash applied: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net deposits on deposit-type contracts and other insurance liabilities | (146.2) | (167.6) | (209.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other cash applied | (73.1) | (57.3) | (32.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash applied to financing and miscellaneous sources | (219.3) | (224.9) | (242.1) |
|  Net change in cash, cash equivalents and short-term investments | 131.6 | (79.4) | 99.0 |
|  Cash, cash equivalents and short-term investments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beginning of year | 234.9 | 314.3 | 215.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; End of year | $366.5 | $234.9 | $314.3 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Statutory Statements of Cash Flow — Continued

Years ended December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
|  Supplemental information: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest capitalization — net investment income | $(7.8) | $(8.4) | $(8.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest capitalization — bond purchases | (7.8) | (8.4) | (8.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities exchanged — bond proceeds | (85.1) | (50.1) | (62.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities exchanged — bond purchases | (85.1) | (50.1) | (62.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tax sharing agreement transfer of taxes payable — taxes paid | (38.6) | (37.6) | (28.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tax sharing agreement transfer of taxes payable — stock proceeds | (55.6) | (49.5) | (38.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tax sharing agreement transfer of taxes payable — stock purchases | (94.2) | (87.1) | (67.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer to stocks — bond proceeds |  | (24.0) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer from bonds — stock purchases |  | (24.0) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance treaty non-cash transaction Scottish Re recapture — premiums collected net of reinsurance |  |  | (36.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance treaty non-cash transaction Scottish Re recapture — miscellaneous income |  |  | (6.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance treaty non-cash transaction Scottish Re recapture — benefit and loss related payments |  |  | (30.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance treaty non-cash transaction Scottish Re recapture — other cash applied |  |  | (1.0) |

---

See accompanying notes to statutory financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

**(1)** **Corporate Structure, Basis of Presentation, and Summary of Significant Accounting Policies** 

&nbsp;&nbsp;&nbsp;&nbsp;***(a) Corporate Structure***

Genworth Life and Annuity Insurance Company (the "Company" or "GLAIC") is a stock life insurance company operating under a charter granted by the Commonwealth of Virginia on March 21, 1871. The Company is licensed as a life insurer to do business in Bermuda, the District of Columbia and all states except for New York. The Company is wholly-owned by Genworth Life Insurance Company ("GLIC"), which is wholly-owned by Genworth North America Corporation ("GNA"), which is indirectly wholly-owned by Genworth Financial, Inc. ("Genworth").

The following are the Company's direct subsidiaries with percentage of ownership listed as of December 31, 2025:

---

| | |
|:---|:---|
|  Genworth Life Insurance Company of New York ("GLICNY") | 34.5 |
|  River Lake Insurance Company VI ("RLIC VI") | 100.0 |
|  River Lake Insurance Company X ("RLIC X") | 100.0 |
|  GNWLAAC Real Estate Holding, LLC ("GNWLAAC RE") | 100.0 |
|  Newco Properties, Inc. ("Newco") | 100.0 |
|  Jamestown Assignment Company, Inc. ("JAC") | 100.0 |
|  Assigned Settlement Inc. ("ASI") | 100.0 |

---

As of December 31, 2025, GNWLAAC RE, JAC and ASI were unaudited and fully nonadmitted.

&nbsp;&nbsp;&nbsp;&nbsp;***(b) Nature of Business***

The Company's principal products are life insurance and fixed deferred and immediate annuities. Life insurance products provide protection against financial hardship after the death of an insured. Deferred annuities are investment vehicles intended for contractholders who want to accumulate tax-deferred assets for retirement, desire a tax-efficient source of income and seek to protect against outliving their assets. Immediate annuities provide a fixed amount of income for either a defined number of years, the annuitant's lifetime or the longer of a defined number of years or the annuitant's lifetime. In March 2016, Genworth suspended sales of traditional life insurance and fixed annuity products; however, the Company continues to service its existing retained and reinsured blocks of business.

The Company also has other products which have not been actively sold since 2011, but it continues to service its existing blocks of business. Those products include variable annuities, including group variable annuities offered through retirement plans; variable life insurance and funding agreements. Most of its variable annuities include guaranteed minimum death benefits ("GMDBs"). Some of the Company's group and individual variable annuity products include guaranteed minimum benefit features such as guaranteed minimum withdrawal benefits ("GMWBs") and certain types of guaranteed annuitization benefits.

&nbsp;&nbsp;&nbsp;&nbsp;***(c) Basis of Presentation***

The accompanying statutory financial statements of the Company have been prepared in conformity with accounting practices prescribed or permitted by the Virginia State Corporation Commission, Bureau of Insurance (the "Virginia Bureau"). These prescribed statutory accounting practices ("SAP") include a variety of publications of the National Association of Insurance Commissioners ("NAIC"), including Statements of Statutory Accounting Principles ("SSAP"), as well as state laws, regulations, and general administrative rules. Permitted statutory accounting practices encompass all accounting practices not so prescribed.

Certain of the Company's subsidiaries have permitted practices granted by their respective state of domicile as described in Note 2(b).

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The preparation of financial statements requires management to make informed judgments and estimates that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and liabilities, as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company considers its significant estimates to be those made for future policy benefits and claims. The Company also makes estimates for legal and regulatory reserves, certain investment and derivative valuations and valuation of deferred tax assets, if applicable. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation.

&nbsp;&nbsp;&nbsp;&nbsp;***(d) Differences Between SAP and U.S. GAAP***

The effects on the financial statements of the variances between SAP and U.S. generally accepted accounting principles ("U.S. GAAP"), although not reasonably determinable, are presumed to be material. The principal differences between SAP and U.S. GAAP include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Investments in bonds are generally carried at amortized cost under SAP. The amortized cost is written down when
an impairment is deemed other-than-temporary. Under U.S. GAAP, investments in bonds are carried at fair value with changes recorded in accumulated other comprehensive income (loss). A temporary allowance is recorded for declines in fair value
related to credit losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The carrying value of commercial mortgage loans is stated at principal amounts outstanding under SAP. Under U.S.
GAAP, the carrying value of commercial mortgage loans is stated at principal amounts outstanding, net of unamortized premium or discount, deferred expenses and allowance for credit losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The change in the unrealized gains or losses on certain investments is recorded as an increase or decrease in
statutory surplus under SAP. Under U.S. GAAP, such unrealized gains and losses are recorded as a component of comprehensive income (loss).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Investments in subsidiaries are generally carried on a statutory equity basis with equity in the earnings of
subsidiaries reflected in unassigned surplus. Under U.S. GAAP, controlled subsidiaries are consolidated and results of operations are included in net income (loss).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, derivative instruments are valued consistently with hedged items. Derivatives are recorded at
amortized cost if the hedged item is recorded at amortized cost. Derivatives are recorded at fair value and surplus is adjusted for fair value changes, if the hedged item is also recorded at fair value. Derivative instruments that do not meet or no
longer meet the criteria of a highly effective hedge ("non-qualifying derivatives") are recorded at fair value and the changes in fair value are recorded as unrealized gains and losses in statutory
surplus. Under U.S. GAAP, derivatives are recorded at fair value and changes in fair value are recorded in accumulated other comprehensive income (loss) for qualified cash flow hedges or net income (loss) (with an offsetting change in value for
changes in the hedged item) for qualified fair value hedges and non-qualifying derivatives. To the extent that hedging relationships are highly effective, the derivatives' impact on operations is limited
to payments and receipts of periodic coupons.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, embedded derivatives are carried consistently with the host instruments. Under U.S. GAAP, the embedded
derivatives that are not clearly and closely related to the host are bifurcated and accounted for like any other free-standing derivative.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest maintenance reserve ("IMR") represents the deferral of interest related realized gains and
losses, net of tax, on primarily fixed maturity investments and interest rate derivatives which are amortized into operations over the remaining life of the investment sold under SAP. No such reserve is required under U.S. GAAP.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Asset valuation reserve ("AVR") represents a contingency reserve for credit related risk on most
invested assets of the Company, and is charged to statutory surplus under SAP. No such reserve is required under U.S. GAAP, but mortgage loans are recorded net of allowances for estimated uncollectible amounts.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Certain assets, principally furniture, equipment, prepaid expenses, agents' balances, and certain deferred
tax assets have been designated as nonadmitted assets and excluded from assets by a charge to statutory surplus under SAP. Under U.S. GAAP, such amounts are carried with an appropriate valuation allowance, when necessary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Intangible assets such as present value of future profits and other adjustments, resulting from the
Company's acquisitions, are not recorded under SAP. Intangible assets such as goodwill are recorded under SAP and amortized. Under U.S. GAAP, the present value of future profits is recorded and amortized and goodwill is recorded at cost and
tested for impairment using a fair value methodology at least annually.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, a provision is established for unsecured reinsurance recoverable balances from unauthorized reinsurers
with the change credited or charged to unassigned statutory surplus. In addition, any amounts over due by 90 days are nonadmitted. Under U.S. GAAP, an allowance is established for expected credit losses for reinsurance balances with any changes to
this allowance reflected in operations for the period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, aggregate reserves for a majority of life insurance and fixed annuity products are based on statutory
mortality and interest requirements without consideration for anticipated withdrawals. Variable annuity contracts are reserved for using a prescribed principles-based approach. Reserves for long-term care insurance ("LTC") are based on
morbidity assumptions derived from the Company's experience. Asset adequacy analysis (for which the Company uses cash flow testing) is performed annually using best estimate assumptions with provisions for adverse deviation to determine if
there is adequate margin when comparing assets to all future liabilities under moderately adverse conditions. If the margin is negative, the Company would be required to record additional statutory reserves in the statutory statements of admitted
assets, liabilities and capital and surplus through the statutory statements of summary of operations. Under U.S. GAAP, reserves for term life insurance, life-contingent annuity, and LTC products are based on the present value of future benefits
less the present value of future net premiums based on mortality, morbidity and other assumptions. Reserves for universal life insurance, term universal life insurance and non life-contingent annuity products are recognized by establishing a
liability equal to the current account value of the policyholders' contracts, with an additional reserve for certain guaranteed benefits. The U.S. GAAP liability uses best estimate cash flow assumptions, which are reviewed at least annually or
more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits resulting from cash flow assumption updates is recorded in the income statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reserves are reported net of ceded reinsurance under SAP. Under U.S. GAAP, reserves relating to business in which
the ceding company is not legally relieved of its liability are reported gross with an offsetting reinsurance receivable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, certain annuity contracts which do not pass through all investment gains to the contractholders are
maintained in the separate accounts, whereas U.S. GAAP reports these contracts in the general account of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Policy acquisition costs are expensed as incurred under SAP. Under U.S. GAAP, costs that are related to the
successful acquisition of new and renewal insurance policies and investment contracts are deferred and recognized on a constant-level basis.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, the cumulative effect of changes in accounting principles are recorded as increases or decreases in
statutory surplus. Under U.S. GAAP, cumulative effects of changes in accounting principles generally affect equity and net income (loss).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, premiums of universal life insurance and deferred annuity contracts, including policy charges, are
recorded as revenue when received. Under U.S. GAAP, policy charges are recorded as revenue when due, and the premiums are recorded as policyholder account balances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under SAP, Federal income taxes are provided for in the Company's estimated current and deferred tax
liability. Income taxes incurred include current year estimates of Federal income taxes due or refundable, based on tax returns for the current year and all prior years to the extent not previously provided. Deferred taxes are provided for
differences between the financial statement basis and the tax basis of assets and liabilities. Changes in deferred tax

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

assets ("DTA") and deferred tax liabilities ("DTL") are recognized as a separate component of gains and losses in statutory unassigned surplus, while under U.S. GAAP, these changes are included in income tax expense or benefit. Under U.S. GAAP and SAP, gross DTAs are reduced by a valuation allowance if it is more likely than not that some portion or all of the assets will not be realized. The remaining adjusted gross DTA not meeting certain criteria outlined in SSAP No. 101, *Income Taxes,* are not admitted for SAP. **** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Statutory Statements of Cash Flow differs in certain respects from the presentation required by U.S. GAAP,
including the presentation of the changes in cash, cash equivalents and short-term investments instead of cash and cash equivalents. Short-term investments include securities with maturities of one year or less at the time of acquisition. For
statutory purposes, there is no reconciliation between net income (loss) and cash from operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• SAP does not require the presentation of a Statement of Comprehensive Income; however, U.S. GAAP does require a
Statement of Comprehensive Income.

&nbsp;&nbsp;&nbsp;&nbsp;***(e) Recognition of Revenue and Related Expenses***

Scheduled life and accident and health insurance premiums and annuity considerations are recognized as revenue when due from policyholders with an unearned premium reserve provided for amounts unearned at the valuation date. Premiums and fund deposits for universal life insurance and single premium contracts are recognized as revenue when collected. Benefits, surrenders and withdrawals are expensed as incurred. All acquisition costs and maintenance expenses are charged to operations as incurred.

&nbsp;&nbsp;&nbsp;&nbsp;***(f) Investments***

Investments in bonds are generally stated at amortized cost except for bonds where the NAIC designation has fallen to six and the fair value has fallen below amortized cost, in which case they are carried at fair value. Debt securities that do not qualify as bonds are stated at amortized cost using the scientific method except where the fair value has fallen below amortized cost, in which case they are carried at fair value. Amortization of asset-backed securities and debt securities that do not qualify as bonds is based on prepayment assumptions that are updated at least quarterly. Significant changes of estimated cash flows from original purchase assumptions are accounted for using the retrospective adjustment method for all such securities that are reported with NAIC designations that are of high credit quality at the time of acquisition. Significant changes of estimated cash flows from original purchase assumptions are accounted for using the prospective adjustment method for all such securities that are not reported with NAIC designations that are of high credit quality at the time of acquisition and for securities that have been other than temporarily impaired. For securities which the Company recorded other-than-temporary impairment ("OTTI") charges, the Company stops amortization until the security begins performing as anticipated, at which time the Company applies that prospective methodology for amortization. Amortization is accounted for using a method that approximates the scientific interest method. Prepayment assumptions for asset-backed securities and debt securities that do not qualify as bonds are based on internal estimates.

Investments in common stocks of unaffiliated companies are carried at fair value. Investments in common stocks of subsidiary controlled and affiliated ("SCA") insurance companies are carried at the Company's proportionate share of the audited statutory capital and surplus of the entity. Noninsurance SCAs are carried at the audited U.S. GAAP equity of the investee, adjusted for unamortized goodwill. Changes in the proportionate share of equity of such subsidiaries are recorded as unrealized gains and losses. Dividends from subsidiaries are recorded as net investment income when paid.

Investments in preferred stocks are carried at fair value.

Investments in short-term investments (maturity dates of one year or less from the acquisition date) are stated at amortized cost, which approximates fair value due to their short-term maturity. Money market funds are stated at fair value and classified as cash equivalents.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The Company regularly evaluates securities, excluding asset backed securities and debt securities that do not qualify as bonds, in an unrealized loss position for other-than-temporary impairments ("OTTI"). For these securities, the Company considers all available information relevant to the collectability of the securities, including information about past events, current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. When it is determined that an impairment is other than temporary because the Company has made a decision to sell the security at an amount below its carrying value, or it is probable that the Company will not collect all amounts due based on the contractual terms of the security, the Company will recognize that an OTTI has occurred and record a realized loss equal to the difference between the security's carrying value and its fair value.

For asset backed securities and debt securities that do not qualify as bonds, the Company also utilizes performance indicators of the underlying assets including defaults or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, collateral vintage and other relevant characteristics of the underlying assets or the security to develop its estimate of cash flows. Estimating the expected cash flows is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data is benchmarked against third-party sources. When it is determined that an impairment is other than temporary because it is probable that the Company will not collect all amounts due based on the contractual terms of the security, even if the Company has no intent to sell and has the intent and ability to hold to recovery, the Company will recognize a realized loss equal to the difference between the carrying value of the security and the present value of the expected cash flows. Under circumstances whereby the Company has the intent to sell or does not have the ability and intent to hold to recovery, the security is impaired to its fair value.

In addition, for certain asset-backed securities in an unrealized loss position, management also evaluates whether it has the intent and ability to retain the investment for a period of time sufficient to recover the amortized cost basis.

Investments in real estate are stated at depreciated cost. As of December 31, 2025 and 2024, the Company's investment in real estate consisted of properties occupied by the Company of $10.9 and $11.5, respectively.

Newco, a noninsurance subsidiary, owns and leases certain properties occupied by the Company and its affiliates.

Mortgage loans are stated at principal amounts outstanding, net of discounts, premiums, and valuation allowances. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Premiums and discounts are amortized as level yield adjustments over the respective loan terms.

GNWLAAC RE, a noninsurance subsidiary, at times owns certain mortgage loans contributed by the Company. GNWLAAC RE will take possession of real estate through, or in lieu of, foreclosure on its loans. The transfers are recorded at the lower of book value or fair value at the date of transfer. GNWLAAC RE was nonadmitted as of December 31, 2025 and 2024.

Impaired loans are defined by SSAP No. 37, *Mortgage Loans,* as loans for which it is probable that the Company will be unable to collect all amounts due according to original contractual terms of the loan agreement. In determining whether it is probable that the Company will be unable to collect all amounts due, the Company considers current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. For individually impaired loans, the Company records an impairment charge when it is probable that a loss has occurred. Impaired loans are carried on a non-accrual status. Loans are placed on non-accrual status when, in management's opinion, the collection of principal or interest is unlikely, or when the collection of principal or interest is 90 days or more past due. Income on impaired loans is not recognized until the loan is sold or the cash received exceeds the carrying amount recorded.

Investments in joint ventures, partnerships or limited liability companies are stated based on the underlying audited U.S. GAAP equity adjusted for any unamortized goodwill. Changes in the proportionate share of these investments are recorded

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

as unrealized gains and losses. The cost basis and carrying value of joint ventures and limited partnership investments are adjusted for impairments in value deemed to be other than temporary, with associated realized loss reported in net income (loss).

Realized investment gains and losses, determined on a specific identification basis and recorded on the trade date, are reduced by amounts transferred to IMR and are reflected as an element of net income (loss), net of related tax. For bonds carried at fair value, the difference between amortized cost and fair value is reflected as unrealized gains and losses on investments in unassigned surplus. Changes in fair values of common stocks, preferred stocks and changes in statutory equity of subsidiaries are reflected as unrealized gains and losses on investments in unassigned surplus.

The Company may from time to time participate in a program managed by an unaffiliated financial institution in which it lends securities to brokers or other parties. The Company receives collateral for the loaned securities which can consist of cash or government securities, on a daily basis, in amounts equal to or exceeding 102% of the fair value of the applicable securities loaned. Currently, the Company only accepts cash collateral from borrowers under the program. As of December 31, 2025 and 2024, there were no loaned securities or collateral held.

Sales of securities to affiliates are considered economic transactions and are accounted for at fair value, with interest related gains and losses transferred to IMR.

&nbsp;&nbsp;&nbsp;&nbsp;***(g) Fair Value Measurements***

The Company may from time to time hold certain long-term bonds, common and preferred stocks, derivatives, securities held as collateral, and separate account assets which are carried at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect a view of market assumptions in the absence of observable market information. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets carried or disclosed at fair value are classified and disclosed in one of the following three categories:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 — Quoted prices for identical instruments in active markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar
instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 — Instruments whose significant value drivers are unobservable.

Level 1 primarily consists of separate account assets and financial instruments whose value is based on quoted market prices such as actively traded equity securities and actively traded mutual fund investments.

Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable information, in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate bonds; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate swaps.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

Level 3 is comprised of financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In limited instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid bonds and preferred stocks, and certain derivative instruments where the Company cannot corroborate the significant valuation inputs with market observable data.

As of each reporting period, all assets and liabilities recorded or disclosed at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value from including a particular input. The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur.

The valuation of financial futures is based on the closing exchange prices. Accordingly, these financial futures are classified as Level 1.

The valuation of equity index options is determined using an income approach. The primary inputs into the valuation are forward interest rate volatility and a time value component associated with the optionality in the derivative, which are considered significant unobservable inputs in most instances. The equity index volatility surface is determined based on market information that is not readily observable and is developed based upon inputs received from several third-party sources. Accordingly, these options are classified as Level 3.

The valuation of cross currency swaps is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve and foreign currency exchange rates, both of which are considered an observable input, and results in the derivative being classified as Level 2.

The valuation of bond purchase commitments is determined using an income approach. The primary inputs into the valuation represent current bond prices and interest rates, as well as an estimate of the cost of counterparty financing to acquire and carry the bond during the forward period. The estimated cost of counterparty financing is not readily observable and is developed based upon an assumed spread; accordingly, these derivatives are classified as Level 3.

The fair value of the majority of separate account assets is based on the quoted price of the underlying fund investments and, therefore, represents Level 1 pricing. The remaining separate account assets represent Level 2 pricing, as defined above.

&nbsp;&nbsp;&nbsp;&nbsp;***(h) Investment Income Due and Accrued***

Accrued investment income consists primarily of interest and dividends. Interest is recognized on an accrual basis and dividends are recorded as earned on the ex-dividend date. Due and accrued income is not recorded on: (a) bonds in default and (b) bonds delinquent more than 90 days or where collection of interest is improbable. As of December 31, 2025 and 2024, the Company's nonadmitted investment income due and accrued was zero.

&nbsp;&nbsp;&nbsp;&nbsp;***(i) Nonadmitted Assets***

Certain assets, principally furniture, equipment, agents' debit balances, certain amounts related to investments in or near default, prepaid expenses, and certain deferred income tax assets have been designated as nonadmitted assets and are excluded from assets by a charge to statutory surplus. Changes in these nonadmitted assets are presented as changes in unassigned surplus.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;***(j) Aggregate Reserves and Liability for Deposit-Type Contracts***

Policy reserves on non-variable annuity and supplementary contracts are calculated using the Commissioners' Annuity Reserve Valuation Method. The valuation interest assumptions follow the Standard Valuation Law and vary by the contracts' characteristics and their issue year.

Variable annuity reserves follow the reserve requirements prescribed in the NAIC Valuation Manual-21: Requirements for Principle-Based Reserves for Variable Annuities.

Policy reserves on life insurance contracts are based on statutory mortality and valuation interest rates using the Commissioner's Reserve Valuation Method without consideration of withdrawals. The valuation interest and mortality assumptions follow the Standard Valuation Law and vary by the contracts' characteristics and their issue year.

Valuation methods provide, in the aggregate, reserves that are greater than or equal to the minimum guaranteed policy cash values or the amount required by law.

Accident and health benefit reserves are developed by actuarial methods and are determined based on published tables using specified statutory interest rates and mortality. Morbidity assumptions are based on Company experience.

Liability for deposit-type contracts represents contracts without significant mortality or morbidity risk. Payments received from sales of deposit-type contracts are recognized by providing a liability equal to the current value of the policyholders' contracts. Interest rates credited to these contracts are based on the applicable terms of the respective contract.

&nbsp;&nbsp;&nbsp;&nbsp;***(k) Liability for Policy and Contract Claims***

The liability for policy and contract claims represents the amount needed to provide for the estimated cost of settling due and unpaid claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for payments of claims that have been reported to the insurer, and claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated.

Management considers the liability for policy and contract claims provided to be satisfactory to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. The methods of determining such estimates and establishing the liability are reviewed continuously and any adjustments are reflected in operations in the period in which they become known. Future developments may result in losses greater or less than the liability for policy and contract claims provided.

&nbsp;&nbsp;&nbsp;&nbsp;***(l) Interest Maintenance Reserve***

IMR represents the deferral of interest-related realized capital gains and losses, net of tax, on primarily fixed maturity investments and interest rate derivatives. These gains and losses are amortized into income (loss) on a level yield method, based on statutory factor tables over the estimated remaining life of the investment sold or called.

&nbsp;&nbsp;&nbsp;&nbsp;***(m) Asset Valuation Reserve***

AVR is a contingency reserve for credit-related losses on most investments and is recorded as a liability through a charge to statutory surplus. The reserve is calculated based on credit quality using factors provided by the NAIC.

&nbsp;&nbsp;&nbsp;&nbsp;***(n) Federal Income Taxes***

The Company determines DTAs and/or DTLs by multiplying the differences between the statutory financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

recovered or settled if there is no change in law. The effect on deferred taxes of a change in tax rates is recognized in unassigned deficit in the period that includes the enactment date. Valuation allowances on DTAs are estimated based on the Company's assessment of the realizability of such amounts.

&nbsp;&nbsp;&nbsp;&nbsp;***(o) Reinsurance***

Premiums, commissions, expense reimbursement, claim, and claim adjustment expenses related to reinsured business are accounted for on a basis consistent with that used in accounting for the original policies issued and with the terms of the reinsurance contracts and are reported net of amounts ceded to other companies.

A liability has been provided for unsecured policy reserves on reinsurance ceded to companies not authorized to assume business in the state of domicile and is included in reinsurance in unauthorized companies. Changes in this liability are reported directly in unassigned surplus.

Policy and contract liabilities ceded have been reported as reductions to the related reserves.

&nbsp;&nbsp;&nbsp;&nbsp;***(p) Guaranty Association Assessments***

The Company is required by law to participate in the guaranty associations of the various states in which it is licensed to do business. The state guaranty associations ensure payment of guaranteed benefits, with certain restrictions, to policyholders of impaired or insolvent insurance companies by assessing all other companies involved in similar lines of business. See Note 7(b).

&nbsp;&nbsp;&nbsp;&nbsp;***(q) Derivative Instruments***

Derivative instruments used in hedging transactions that meet the criteria of a highly effective hedge are valued and reported consistently with the hedged items. Derivative instruments used in hedging transactions that do not meet or no longer meet the criteria of an effective hedge shall be valued at fair value with the changes in fair value recorded as unrealized gains and losses in statutory surplus.

The Company uses cross currency swaps, equity index options, bond purchase commitments, and financial futures for hedging. Interest rate futures are used to reduce market risks from changes in interest rates and to alter interest rate exposures arising from mismatches between assets and liabilities. Equity index options and equity futures are used to hedge the equity market risks that are part of some of the Company's annuity liabilities. Bond purchase commitments are used to lock in prices of future bond purchases.

The Company uses cross currency swaps to reduce market risks from changes in foreign currency rates and to alter interest rate exposure arising from mismatches between assets and liabilities. In a cross currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a forward exchange rate calculated by reference to an agreed upon principal amount. The principal amount of each currency is exchanged at the inception and termination of the currency swap by each party.

Cross currency swaps and bond purchase commitments that qualify for hedge accounting are carried at amortized cost while non-qualifying equity options and financial futures are carried at fair value with changes in fair value recorded in statutory surplus. Realized investment gains and losses from derivatives that qualify for hedge accounting are reduced by amounts transferred to IMR and are reflected as an element of investment income, net of investment and interest expenses. Any fees associated with swaps are held in surplus and the full fee amount will be recognized in income at the time of termination.

The Company reports net cash flows from the purchase or termination of derivative instruments as cash flows from investing activities in the Statutory Statements of Cash Flow.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;***(r) Experience Refunds***

Experience refunds are calculated in accordance with the applicable reinsurance agreements. Experience refunds are primarily determined by claims experience on the ceded blocks, in addition to numerous factors that include profitability of the Company during the period covered by the refund and capitalization levels of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;***(s) Going Concern***

The Company's management does not have any doubts about the Company's ability to continue as a going concern within one year from the date the statutory financial statements were issued.

&nbsp;&nbsp;&nbsp;&nbsp;***(t) Accounting Changes***

In March and May 2025, the NAIC adopted revisions to SSAP No. 1, *Accounting Policies, Risks & Uncertainties, and Other Disclosures*, effective December 31, 2025. The revisions clarify and expand restricted asset disclosures to include assets under modified coinsurance ("Modco") and funds withheld ("FWH") agreements and identify differences between the restricted asset annual statement disclosure and the amount reported in the annual statement general interrogatories. Additionally, these revisions expand restricted asset disclosures to capture the book/adjusted carrying value of Modco and FWH assets by investment schedule and to include breakdowns by related party codes for assets affiliated with the reinsurer. These revisions expanded disclosures but did not have an impact on the Company's financial statements. See Note 2.

In August 2023, the NAIC adopted revisions to SSAP No. 26, *Bonds,* and SSAP No. 43, *Asset-Backed Securities*, effective January 1, 2025. The revisions adopt a principles-based bond definition for determining the investments eligible for bond accounting and reporting as issuer credit obligations ("ICO") and asset-backed securities ("ABS"). The Company adopted the revisions prospectively effective January 1, 2025. Upon adoption, the Company did not have any bonds that failed to qualify as bonds under the revised guidance. Accordingly, Note 2 reflects the adopted revisions for 2025 disclosures, while the 2024 disclosures reflects the prior guidance.

In March 2023, the NAIC adopted modifications to SSAP No. 34, *Investment Income Due and Accrued*, effective December 31, 2023. The modifications require additional disclosures related to gross, non-admitted and admitted amounts for interest income due and accrued, deferred interest, and paid-in-kind ("PIK") interest. See Note 2.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

**(2)** **Investments** 

&nbsp;&nbsp;&nbsp;&nbsp;***(a) Bonds and Preferred and Common Stocks***

As of December 31, 2025 and 2024, the carrying value, gross unrealized gains and losses, and fair value of the Company's bonds and preferred and common stocks, excluding stocks of affiliates, were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** |
|  | | **Gross<br>unrealized gains** | **Gross<br>unrealized gains** | **Gross<br>unrealized losses** | **Gross<br>unrealized losses** | |
|  |<br>**Carrying<br>value** | **Not<br>OTTI** | **OTTI** | **Not<br>OTTI** | **OTTI** |<br>**Fair value** |
|  ICO: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government obligations (exempt from RBC): | $569.2 | $0.6 | $— | $(89.3) | $— | $480.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other U.S. government obligations (not exempt from RBC): | 19.8 | 1.2 |  |  |  | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-U.S. sovereign jurisdiction securities: | 268.6 | 5.6 |  | (37.0) |  | 237.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Municipal bonds — general obligation (direct and guaranteed): | 93.4 | 1.1 |  | (3.1) |  | 91.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Municipal bonds — special revenue: | 227.9 | 1.4 |  | (20.2) |  | 209.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Project finance bonds issued by operating entities: | 191.4 | 2 |  | (19.5) |  | 173.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate bonds: | 5683 | 95.2 |  | (530.3) |  | 5247.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Single entity backed obligations: | 79.9 | 1 |  | (4.3) |  | 76.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds issued by funds representing operating entities | 329.1 | 0.6 |  | (25.8) |  | 303.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bank loans — issued: | 28.8 | 0.1 |  | (0.1) |  | 28.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other ICO: | 10.9 | 0.4 |  | (0.4) |  | 10.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total ICO: | 7502 | 109.2 |  | (730.0) |  | 6881.2 |
|  ABS: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agency residential mortgage-backed securities — fully guaranteed (exempt from RBC): | 9 | 0.4 |  |  |  | 9.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agency commercial mortgage-backed securities — fully guaranteed (exempt from RBC): | 274.4 |  |  | (60.7) |  | 213.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agency residential mortgage-backed securities — not/ partially guaranteed (not exempt from RBC): | 201.3 | 3.5 |  | (5.0) |  | 199.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Agency residential mortgage-backed securities: | 78.7 |  |  | (8.0) |  | 70.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Agency commercial mortgage-backed securities: | 83.4 |  |  | (5.8) |  | 77.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Agency — CLOs/CBOs/CDOs: | 25.1 |  |  |  |  | 25.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other financial ABS — self-liquidating: | 15.1 | 0.1 |  |  |  | 15.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity-backed securities: | 12.3 | 0.1 |  |  |  | 12.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lease-backed transactions (practical expedient): | 15.9 | 0.1 |  |  |  | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other non-financial ABS (practical expedient): | 26.1 |  |  | (2.1) |  | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lease-backed transactions (full analysis): | 35 | 0.6 |  | (0.1) |  | 35.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other non-financial ABS (full analysis): | 107.7 | 0.6 |  | (3.2) |  | 105.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total ABS: | 884 | 5.4 |  | (84.9) |  | 804.5 |
|  Preferred and common stocks (nonaffiliates): | 76.9 |  |  |  |  | 76.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total bonds and preferred and common stocks | $8462.9 | $114.6 | $— | $(814.9) | $— | $7762.6 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** |
|  | | **Gross<br>unrealized gains** | **Gross<br>unrealized gains** | **Gross<br>unrealized losses** | **Gross<br>unrealized losses** | |
|  |<br>**Carrying<br>value** | **Not<br>OTTI** | **OTTI** | **Not<br>OTTI** | **OTTI** |<br>**Fair value** |
|  Bonds: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government and U.S. government agencies | $536 | $0.7 | $— | $(90.2) | $— | $446.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All other governments | 149.3 | 0.9 |  | (21.8) |  | 128.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; States, territories, and possessions | 100.7 | 0.3 |  | (2.3) |  | 98.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Special revenue and special assessment obligations | 322.1 | 5.7 |  | (27.9) |  | 299.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and miscellaneous | 6767.6 | 50.3 |  | (733.2) |  | 6084.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bank loans — industrial and miscellaneous | 8.8 | 0 |  |  |  | 8.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Residential mortgage-backed | 317.6 | 1.4 |  | (21.8) |  | 297.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commercial mortgage-backed | 398.7 |  |  | (83.2) |  | 315.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other asset-backed and structured securities | 187.8 | 0.7 |  | (4.3) |  | 184.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hybrids | 20.3 | 0.5 |  | (0.1) |  | 20.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total bonds | 8808.9 | 60.5 |  | (984.8) |  | 7884.6 |
|  Preferred and common stocks — nonaffiliates | 80.5 | 1 |  |  |  | 81.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total bonds and preferred and common stocks | $8889.4 | $61.5 | $— | $(984.8) | $— | $7966.1 |

---

Gross unrealized losses in the tables above include declines in the fair value of certain bonds below carrying value, where an OTTI has not occurred as the Company does not intend to sell, has the intent and ability to retain the investment for a period of time sufficient to recover the entire amortized cost basis of the investment and otherwise expects to recover the entire amortized cost basis of the investment. In addition, gross unrealized losses include declines in the fair value below the carrying value for certain bonds that have been other-than-temporarily impaired and were written down to their discounted estimated future cash flows, which were greater than their fair value, as the Company does not expect to recover the entire amortized cost basis of these bonds based on its estimate of future cash flows to be collected, despite not having the intent to sell and having the intent and ability to retain the investment for a period of time sufficient to recover the amortized cost basis.

As of December 31, 2025, the scheduled contractual maturity distribution of the ICO bond portfolio was as follows:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2025** |
|  | **Carrying value** | **Fair value** |
|  Due in one year or less | $180.6 | $180.7 |
|  Due after one year through five years | 902.9 | 901.6 |
|  Due after five years through ten years | 1060.0 | 1050.9 |
|  Due after ten years through twenty years | 2345.2 | 2190.3 |
|  Due after twenty years | 3013.3 | 2557.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Totals | $7502.0 | $6881.2 |

---

Actual and expected maturities may differ from scheduled contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.

As required by law, the Company has investments on deposit with governmental authorities and banks for the protection of policyholders with a statement value of $7.6 and $7.5 as of December 31, 2025 and 2024, respectively.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The vast majority of the Company's portfolio is rated investment grade and are senior secured bonds. The Company's portfolio is widely diversified among various geographic regions in the United States, and is not dependent on the economic stability of one particular region.

As of December 31, 2025 and 2024, the Company did not hold any investments in any single issuer, other than securities issued or guaranteed by the U.S. government or money market securities, which exceeded 10% of capital and surplus.

The credit quality mix of the bond portfolio as of December 31, 2025 and 2024 was as follows. The quality ratings represent NAIC designations.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** |
|  | **Carrying value** | **Percent** | **Carrying value** | **Percent** |
|  Class 1 — highest quality | $4596.0 | 54.8% | $4584.6 | 52.0% |
|  Class 2 — high quality | 3503.4 | 41.8 | 3921.1 | 44.5 |
|  Class 3 — medium quality | 264.1 | 3.1 | 281.8 | 3.2 |
|  Class 4 — low quality | 21.4 | 0.3 | 16.2 | 0.2 |
|  Class 5 — lower quality | 1.1 |  | 5.2 | 0.1 |
|  Class 6 — in or near default |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Totals | $8386.0 | 100.0% | $8808.9 | 100.0% |

---

Bonds with ratings categories ranging from AAA/Aaa to BBB/Baa, as assigned by a rating service such as Standard & Poor's Financial Services LLC or Moody's Investors Service, Inc., are generally regarded as investment grade securities. Some agencies and treasuries (that is, those securities issued by the U.S. government or an agency thereof) are not rated, but all are considered to be investment grade securities. The NAIC regards agencies and treasuries and all A ratings as Class 1 (highest quality), BBB/Baa ratings as Class 2 (high quality), BB/Ba ratings as Class 3 (medium quality), B ratings as Class 4 (low quality), CCC/Caa ratings as Class 5 (lower quality), and CC/Ca or below ratings as Class 6 (in or near default).

There were no bonds in default as of December 31, 2025 and 2024.

&nbsp;&nbsp;&nbsp;&nbsp;***(b) Common Stocks of Affiliates***

The Company's investment in common stocks of affiliates as of December 31, 2025 and 2024 included its proportionate ownership percentage as disclosed in Note 1(a), except as disclosed below. The following tables summarize data from the statutory financial statements of the Company's insurance company subsidiaries as of and for the years ended December 31, 2025, 2024 and 2023:

---

| | | | |
|:---|:---|:---|:---|
|  | **GLICNY** | **RLIC VI<sup>1</sup>** | **RLIC X<sup>1</sup>** |
| **2025** |  |  |  |
|  Total admitted assets | $6747.4 | $1669.5 | $851.0 |
|  Total liabilities | 6525.4 | 1595.7 | 819.2 |
|  Total capital and surplus | 222.0 | 73.8 | 31.8 |
|  Net income | 1.4 | 117.6 | 21.9 |
| **2024** |  |  |  |
|  Total admitted assets | $6849.0 | $1877.2 | $879.9 |
|  Total liabilities | 6630.8 | 1803.1 | 852.8 |
|  Total capital and surplus | 218.2 | 74.1 | 27.1 |
|  Net income (loss) | 4.7 | 100.4 | 28.4 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | |
|:---|:---|:---|:---|
|  | **GLICNY** | **RLIC VI<sup>1</sup>** | **RLIC X<sup>1</sup>** |
| **2023** |  |  |  |
|  Total admitted assets | $7050.7 | $2038.2 | $926.6 |
|  Total liabilities | 6838.8 | 1966.5 | 901.5 |
|  Total capital and surplus | 211.9 | 71.7 | 25.1 |
|  Net income | (1.1) | 80.3 | 13.5 |

---

<sup>1</sup> As of December 31, 2025 and 2024, the Company carried its investment in the subsidiary at zero.

As of December 31, 2025 and 2024, the Company's investment in GLICNY was $76.6 and $75.3, respectively.

Effective December 1, 2021, RLIC X was granted a permitted practice from the Vermont Department of Financial Regulation to record an excess of loss ("XOL") reinsurance agreement with Hannover Life Reassurance Company of America ("Hannover") as a gross admitted asset and as paid in surplus.

Effective December 1, 2019, RLIC VI entered into an XOL reinsurance agreement (the "RLIC VI XOL Treaty") with Canada Life Assurance Company ("Canada Life"), operating through its Barbados branch and the Company. The Company requested and was subsequently granted effective December 1, 2019, a permitted practice from the Delaware Department of Insurance ("Delaware Department") pursuant to Title 18, Sections 6907 and 6962 of the Delaware Insurance Code. RLIC VI is permitted to record the portion of the XOL coverage amount pursuant to the RLIC VI XOL Treaty allocable to the universal life insurance contracts as a gross admitted asset and as paid in surplus. Effective December 1, 2021, RLIC VI was granted a permitted practice from the Delaware Department whereby RLIC VI is permitted to record the portion of the XOL coverage amount pursuant to the RLIC VI XOL Treaty allocable to the term life insurance policies as a gross admitted asset and as paid in surplus.

The Company has an investment in Newco which is audited and fully admitted at audited U.S. GAAP equity in common stock of affiliates. As of December 31, 2025 and 2024, the Company's investment in Newco was $26.7 and $43.8, respectively, with the decrease primarily due to a dividend paid by Newco to the Company in 2025. See Note 5.

As of December 31, 2025 and 2024, GNWLAAC RE, JAC and ASI were unaudited and nonadmitted.

&nbsp;&nbsp;&nbsp;&nbsp;***(c) Mortgage Loans***

As of December 31, 2025 and 2024, the Company's mortgage loan portfolio consisted of 319 and 351, respectively, of first lien commercial mortgage loans. The loans, which were originated by the Company through a network of mortgage bankers, were made only on developed and leased properties and had a maximum loan-to-value ratio of 75% as of the date of origination. The Company does not engage in construction lending or land loans. The maximum and minimum lending rates for new mortgage loans during 2025 were 7.3% and 4.6%, respectively.

The Company's mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of mortgage loans is stated at original cost net of prepayments and amortization.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The Company diversifies its mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for mortgage loans as of December 31, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** |
| **Property type** | **Carrying<br>value** | **Percent of<br>total** | **Carrying<br>value** | **Percent of<br>total** |
|  Retail | $577.0 | 38.5% | $622.8 | 38.9% |
|  Industrial | 377.8 | 25.2 | 380.3 | 23.8 |
|  Office | 368.4 | 24.6 | 397.2 | 24.8 |
|  Mixed use | 88.6 | 5.9 | 99.4 | 6.2 |
|  Apartments | 61.6 | 4.1 | 73.2 | 4.6 |
|  Other | 24.8 | 1.7 | 26.5 | 1.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total principal balance | $1498.2 | 100.0% | $1599.4 | 100.0% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** |
| **Geographic region** | **Carrying<br>value** | **Percent of<br>total** | **Carrying<br>value** | **Percent of<br>total** |
|  South Atlantic | $430.6 | 28.7% | $465.1 | 29.1% |
|  Pacific | 258.5 | 17.2 | 270.8 | 16.9 |
|  Mountain | 180.6 | 12.1 | 182.3 | 11.4 |
|  Middle Atlantic | 165.8 | 11.1 | 166.3 | 10.4 |
|  West South Central | 126.1 | 8.4 | 123.7 | 7.7 |
|  West North Central | 122.6 | 8.2 | 142.1 | 8.9 |
|  East North Central | 119.5 | 8.0 | 129.6 | 8.1 |
|  East South Central | 49.6 | 3.3 | 72.8 | 4.6 |
|  New England | 44.9 | 3.0 | 46.7 | 2.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total principal balance | $1498.2 | 100.0% | $1599.4 | 100.0% |

---

Mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. The Company had two loans and zero loans greater than 30 days past due as of December 31, 2025 and 2024, respectively. The Company had no impaired loans as of December 31, 2025 and 2024.

The following table sets forth the age analysis of mortgage loans and identification of mortgage loans in which the insurer is a participant or co-lender in a mortgage loan agreement as of December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
|  | **Commercial** | **Commercial** | | **Commercial** | **Commercial** | |
|  | **Insured** | **All Other** |<br>**Total** | **Insured** | **All Other** |<br>**Total** |
|  Recorded investment (All) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current (less than 30 days past due) | $— | $1494.9 | $1494.9 | $— | $1599.4 | $1599.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30-59 days past due |  | 3.3 | 3.3 |  |  |  |
|  Interest reduced |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recorded investment | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number of loans |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Percent reduced | —% | —% | —% | —% | —% | —% |
|  Participant or co-lender in a mortgage loan agreement |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recorded investment | $— | $26.0 | $26.0 | $— | $— | $— |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

As of December 31, 2025 and 2024, the Company held no farm, mezzanine or residential mortgage loans.

During the years ended December 31, 2025 and 2024, the Company did not have any modifications or extensions that were considered troubled debt restructurings.

In evaluating the credit quality of mortgage loans, the Company assesses the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with mortgage loans can be evaluated by reviewing both the loan-to-value and debt service coverage ratios to understand both the probability of the borrower not being able to make the necessary loan payments as well as the ability to sell the underlying property for an amount that would enable the Company to recover its unpaid principal balance in the event of default by the borrower. A higher debt service coverage ratio indicates the borrower is less likely to default on the loan. The debt service coverage ratio should not be used without considering other factors associated with the borrower, such as the borrower's liquidity or access to other resources that may result in the Company's expectation that the borrower will continue to make the future scheduled payments. A lower loan-to-value indicates that its loan value is more likely to be recovered in the event of default by the borrower if the property was sold.

The Company monitors mortgage loan concentration by state. California is the only state exceeding 10% of the total mortgage loan portfolio. During the years ended December 31, 2025, 2024 and 2023, the Company originated $25.2, $6.8, and $3.8, respectively, in mortgage loans secured by real estate in California. As of December 31, 2025 and 2024, the Company held $157.6 and $160.0, respectively, of mortgages secured by real estate in California, which was 10.5% and 10.0%, respectively, of its total mortgage portfolio.

The following tables set forth the average loan-to-value of mortgage loans by property type as of December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025 Average loan-to-value<sup>(1)</sup>** | **2025 Average loan-to-value<sup>(1)</sup>** | **2025 Average loan-to-value<sup>(1)</sup>** | **2025 Average loan-to-value<sup>(1)</sup>** | **2025 Average loan-to-value<sup>(1)</sup>** | **2025 Average loan-to-value<sup>(1)</sup>** |
| **Property type** | **0%-50%** | **51%-60%** | **61%-75%** | **76%-100%** | **Greater than**<br>**100%** | **Total** |
|  Retail | $279.5 | $116.9 | $176.8 | $3.8 | $— | $577 |
|  Industrial | 166.9 | 50.7 | 160.2 |  |  | 377.8 |
|  Office | 52.6 | 67 | 170 | 78.8 |  | 368.4 |
|  Mixed use | 1.9 | 15.2 | 56.5 |  | 15 | 88.6 |
|  Apartments | 27.1 | 19.5 | 15 |  |  | 61.6 |
|  Other | 8.3 | 13.7 | 2.8 |  |  | 24.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $536.3 | $283 | $581.3 | $82.6 | $15 | $1498.2 |
|  Percent of total | 35.8% | 18.9% | 38.8% | 5.5% | 1.0% | 100.0% |
|  Weighted-average debt service coverage ratio<sup>(2)</sup> | 2.5 | 2 | 1.5 | 1.3 | 0.8 | 1.9 |

---

<sup>(1)</sup> Average loan-to-value is based on the Company's most recent estimate of the fair value for the underlying property as of the date indicated above. Values are evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan.

<sup>(2)</sup> Debt service coverage ratio is based on "normalized" annual net operating income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. 

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2024 Average loan-to-value<sup>(1)</sup>** | **2024 Average loan-to-value<sup>(1)</sup>** | **2024 Average loan-to-value<sup>(1)</sup>** | **2024 Average loan-to-value<sup>(1)</sup>** | **2024 Average loan-to-value<sup>(1)</sup>** | **2024 Average loan-to-value<sup>(1)</sup>** |
| **Property type** | **0%-50%** | **51%-60%** | **61%-75%** | **76%-100%** | **Greater than<br>100%** | **Total** |
|  Retail | $265.0 | $146.2 | $211.6 | $— | $— | $622.8 |
|  Office | 51.9 | 40.1 | 199.6 | 105.6 |  | 397.2 |
|  Industrial | 156.9 | 82.1 | 137.5 | 3.8 |  | 380.3 |
|  Mixed use | 9.0 | 6.8 | 68.6 |  | 15.0 | 99.4 |
|  Apartments | 39.5 | 3.7 | 30.0 |  |  | 73.2 |
|  Other | 9.5 | 14.2 | 2.8 |  |  | 26.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $531.8 | $293.1 | $650.1 | $109.4 | $15.0 | $1599.4 |
|  Percent of total | 33.3% | 18.3% | 40.7% | 6.8% | 0.9% | 100.0% |
|  Weighted-average debt service coverage ratio<sup>(2)</sup>  | 2.4 | 1.8 | 1.6 | 1.5 | 0.8 | 1.9 |

---

<sup>(1)</sup> Average loan-to-value is based on the Company's most recent estimate of the fair value for the underlying property as of the date indicated above. Values are evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan.

<sup>(2)</sup> Debt service coverage ratio is based on "normalized" annual net operating income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. 

The following tables set forth the debt service coverage ratio for fixed rate mortgage loans by property type as of December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2025 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2025 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2025 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2025 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2025 Debt service coverage ratio — fixed rate<sup>(1)</sup>** |
| **Property type** | **Less than<br>1.00** | **1.00 – 1.25** | **1.26 – 1.50** | **1.51 – 2.00** | **Greater than<br>2.00** | **Total** |
|  Retail | $9.7 | $10.8 | $75.6 | $265.0 | $215.9 | $577.0 |
|  Industrial | 5.1 | 13.7 | 57.8 | 124.2 | 177.0 | 377.8 |
|  Office | 58.6 | 56.7 | 45.7 | 97.5 | 109.9 | 368.4 |
|  Mixed use | 15.0 | 7.4 | 15.3 | 41.7 | 9.2 | 88.6 |
|  Apartments | 4.9 |  | 7.2 | 29.6 | 19.9 | 61.6 |
|  Other |  |  | 13.7 | 2.8 | 8.3 | 24.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $93.3 | $88.6 | $215.3 | $560.8 | $540.2 | $1498.2 |
|  Percent of total | 6.2% | 5.9% | 14.4% | 37.4% | 36.1% | 100.0% |
|  Weighted-average loan-to-value<sup>(2)</sup>  | 81.4% | 70.4% | 61.6% | 59.4% | 43.5% | 56.0% |

---

<sup>(1)</sup> Debt service coverage ratio is based on "normalized" annual net operating income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. 

<sup>(2)</sup> Average loan-to-value is based on the Company's most recent estimate of the fair value for the underlying property as of the date indicated above. Values are evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2024 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2024 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2024 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2024 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2024 Debt service coverage ratio — fixed rate<sup>(1)</sup>** | **2024 Debt service coverage ratio — fixed rate<sup>(1)</sup>** |
| **Property type** | **Less than<br>1.00** | **1.00 – 1.25** | **1.26 – 1.50** | **1.51 – 2.00** | **Greater than<br>2.00** | **Total** |
|  Retail | $18.4 | $15.7 | $145.1 | $250.2 | $193.4 | $622.8 |
|  Office | 52.4 | 15.4 | 74.3 | 141.9 | 113.2 | 397.2 |
|  Industrial |  | 10.3 | 75.6 | 160.0 | 134.4 | 380.3 |
|  Mixed use | 27.2 | 23.8 | 17.2 | 28.0 | 3.2 | 99.4 |
|  Apartments |  | 1.9 | 6.7 | 39.4 | 25.2 | 73.2 |
|  Other |  | 14.2 | 2.5 | 2.8 | 7.0 | 26.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $98.0 | $81.3 | $321.4 | $622.3 | $476.4 | $1599.4 |
|  Percent of total | 6.1% | 5.1% | 20.1% | 38.9% | 29.8% | 100.0% |
|  Weighted-average loan-to-value<sup>(2)</sup>  | 78.6% | 58.1% | 65.5% | 60.2% | 43.5% | 57.3% |

---

<sup>(1)</sup> Debt service coverage ratio is based on "normalized" annual net operating income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. 

<sup>(2)</sup> Average loan-to-value is based on the Company's most recent estimate of the fair value for the underlying property as of the date indicated above. Values are evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan.

As of December 31, 2025 and 2024, the Company did not have any floating rate mortgage loans.

&nbsp;&nbsp;&nbsp;&nbsp;***(d) Derivative Instruments***

The Company uses exchange-traded futures to reduce the market risks from changes in interest rates and equity indexes. Under exchange traded financial futures, the Company purchases or sells a futures contract on an exchange and posts variation margin to the exchange on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company accesses the exchange through regulated futures commission merchants who are members of a trading exchange.

The Company uses cross currency swaps to reduce market risks from changes in foreign currency rates and to alter interest rate exposure arising from mismatches between assets and liabilities. In a cross currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a forward exchange rate calculated by reference to an agreed upon principal amount. The principal amount of each currency is exchanged at the inception and termination of the currency swap by each party.

The Company also purchases over-the-counter equity index call and put options to hedge the risk embedded in the Company's annuity liabilities. These transactions are entered into pursuant to an International Swaps and Derivatives Association, Inc ("ISDA") Master Agreement. The Company may make a single option premium payment to the counterparty at the inception of the transaction or a series of premium payment installations over the life of the option.

The Company uses bond purchase commitments to lock in prices of future bond purchases.

<u>Counterparty Risk</u> 

The Company is exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments, but it does not expect any counterparties to fail to meet their obligations given their high credit ratings. The

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

Company manages counterparty risk by transacting with multiple high-rated counterparties and uses collateral support where possible. The Company's maximum credit exposure to derivative counterparties is limited to the sum of the net fair value of contracts with counterparties that exhibit a positive fair value net of collateral.

The current credit exposure of the Company's derivative contracts is limited to net positive fair value owed by the counterparties, less collateral posted by the counterparties to the Company. Credit risk is managed by entering into transactions with creditworthy counterparties and requiring the posting of collateral. In many instances, new over-the-counter derivatives contracts will require both parties to post initial margin, thereby resulting in over collateralizations. The Company also attempts to minimize its exposure to credit risk through the use of various credit monitoring techniques and monitoring overall collateral held. All of the net credit exposure for the Company from derivative contracts is with investment-grade counterparties. As of December 31, 2025, the counterparties to all of the Company's derivatives had a minimum credit rating of BBB+. As of December 31, 2025 and 2024, the Company held derivative counterparty collateral with fair value of $8.1 and zero, respectively.

The table below provides a summary of the net carrying value, fair value and notional value by the type of derivative instruments held by the Company as of December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| **Derivative type** | **Carrying<br>value** | **Fair<br>value** | **Notional<br>value** | **Carrying<br>value** | **Fair<br>value** | **Notional<br>value** |
|  Financial futures | $— | $— | $889.0 | $— | $— | $988.4 |
|  Cross currency swaps | (3.2) | (0.8) | 42.8 | 1.3 | 2.4 | 42.8 |
|  Equity index options | 17.4 | 17.4 | 502.9 | 18.9 | 18.9 | 603.1 |
|  Bond purchase commitments |  | (10.9) | 860.0 |  | (9.7) | 960.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Totals | $14.2 | $5.7 | $2294.7 | $20.2 | $11.6 | $2594.3 |

---

The financial futures, cross currency swaps, equity index options, and bond purchase commitments in the table above are presented net of their respective liabilities. The Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus present derivative assets and liabilities separately.

The Company has no amounts excluded from the assessment of hedge effectiveness for the years ended December 31, 2025, 2024 and 2023.

The Company recorded no unrealized gains or losses as of December 31, 2025 and 2024 resulting from derivatives that no longer qualify for hedge accounting.

For derivatives accounted for as cash flow hedges of a forecasted transaction:

1) As of December 31, 2025, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for forecasted transactions is 8 years; and

2) For the years ended December 31, 2025, 2024, and 2023, there were no cash flow hedges discontinued in the statement year as a result of it no longer being probable that the original forecasted transactions would occur by the end of the originally specified time period or within two months of that date.

The futures margin account recorded as part of derivative assets was $1.6 and zero as of December 31, 2025 and 2024, respectively, and the futures margin account recorded as part of derivative liabilities was zero and $0.6 as of December 31, 2025 and 2024, respectively.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The Company has no derivative contracts with financing premiums in which premium cost is paid at the end of the derivative contract or throughout the derivative contract.

Certain of the Company's master swap agreements contain a provision that allows the counterparty to terminate derivative transactions if the risk-based capital ("RBC") ratio of the Company goes below a certain threshold. As of December 31, 2025, the RBC ratio of the Company was above the thresholds negotiated in the applicable master swap agreements; therefore, no counterparty had rights to take action against the Company under the RBC threshold provisions.

&nbsp;&nbsp;&nbsp;&nbsp;***(e) Net Investment Income***

For the years ended December 31, 2025, 2024 and 2023, the sources of net investment income of the Company were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
|  Bonds | $407.3 | $419.5 | $439.6 |
|  Preferred and common stocks | 27.1 | 2.8 | 2.8 |
|  Mortgage loans | 69.9 | 73.0 | 74.1 |
|  Contract loans | 25.6 | 26.7 | 27.3 |
|  Cash, cash equivalents and short-term investments | 11.7 | 14.7 | 12.6 |
|  Real estate | 3.4 | 3.6 | 3.6 |
|  Other invested assets | 9.1 | 9.0 | 7.9 |
|  Derivative instruments | 0.5 | 0.4 | 0.4 |
|  Other |  | 0.1 | 0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gross investment income | 554.6 | 549.8 | 568.4 |
|  Investment and interest expenses | (16.1) | (16.3) | (15.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net investment income | $538.5 | $533.5 | $552.8 |

---

The gross, nonadmitted and admitted amounts for interest income due and accrued as of December 31, 2025 and 2024 were as follows:

---

| | | |
|:---|:---|:---|
| **Interest Income Due and Accrued** | **2025** | **2024** |
| 1. Gross | $104.0 | $110.6 |
| 2. Nonadmitted | $— | $— |
| 3. Admitted | $104.0 | $110.6 |

---

There was no aggregate deferred interest as of December 31, 2025 and 2024.

The cumulative amounts of PIK interest included in the current principal balance as of December 31, 2025 and 2024 were $60.5 and $65.9, respectively.

The number of CUSIPs sold, redeemed or otherwise disposed as a result of a callable feature and the aggregate amount of investment income (loss) generated as a result of a prepayment penalty and/or accelerations fees for the years ended December 31, 2025, 2024 and 2023 were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** | **2023** | **2023** |
|  | **General<br>account** | **Separate<br>account** | **General<br>account** | **Separate<br>account** | **General<br>account** | **Separate<br>account** |
| (1) Number of CUSIPS | 18 |  | 17 |  | 9 |  |
| (2) Aggregate amount of investment income (loss) | $— | $— | $(1.4) | $— | $(0.4) | $— |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

For the years ended December 31, 2025, 2024 and 2023, proceeds and gross realized capital gains and losses resulting from sales, maturities, impairments, or other redemptions of investment securities were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
|  Proceeds from sales, maturities or other redemptions of bonds | $759.9 | $1151.9 | $827.1 |
|  Gross realized capital: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gains on sales | $65.2 | $72.5 | $40.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Losses on sales | (111.9) | (163.7) | (173.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gains (losses) on sales | (46.7) | (91.2) | (133.3) |
|  Impairment losses | (0.3) | (0.8) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Subtotal | (47.0) | (92.0) | (133.3) |
|  Federal income tax provision | 1.8 | 3.7 | 3.8 |
|  Transfers to IMR, net of tax | 7.2 | 8.9 | 9.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Realized capital losses, net | $(38.0) | $(79.4) | $(119.6) |

---

&nbsp;&nbsp;&nbsp;&nbsp;***(f) Impairment of Investment Securities***

The evaluation of OTTI is subject to risks and uncertainties and is intended to determine the appropriate amount and timing for recognizing an impairment charge. The assessment of whether such impairment has occurred is based on management's best estimate of the cash flows to be collected at the individual security level. The Company regularly monitors its investment portfolio to ensure that securities that may be other-than-temporarily impaired are identified in a timely manner and that any impairment charges are recognized in the proper period.

The Company recognizes OTTI on asset backed securities in an unrealized loss position when one of the following circumstances exists:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company does not expect full recovery of the amortized cost based on its estimate of cash flows expected to
be collected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company intends to sell a security; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company does not have the intent and ability to retain the investment for a period of time sufficient to
recover the amortized cost basis of the investment.

As of December 31, 2025, the Company had no asset backed securities which recognized OTTI.

As of December 31, 2025, the Company had no asset-backed securities with recognized OTTI where it had the intent to sell or did not have the intent and ability to retain the investment for a period of time sufficient to recover the amortized cost basis.

For equity securities, the Company recognizes an impairment charge in the period in which the Company determines that the security will not recover to book value within a reasonable period. The Company determines what constitutes a reasonable period on a security-by-security basis based upon consideration of all the evidence available to it, including the magnitude of an unrealized loss and its duration. The Company measures OTTI based upon the difference between the amortized cost of a security and its fair value.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The following table presents the gross unrealized losses and fair value of the Company's investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position as of December 31, 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** |
|  | **Less Than 12 Months** | **Less Than 12 Months** | **Less Than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** |
| **Description of securities** | **Fair value** | **Gross<br>unrealized<br>losses** | **Number of<br>securities** | **Fair value** | **Gross<br>unrealized<br>losses** | **Number of<br>securities** |
|  ICO: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government obligations (exempt from RBC) | $41.7 | $(1.7) | 5 | $376.9 | $(87.6) | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other U.S. government obligations (not exempt from RBC) |  |  |  | 1.1 |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-U.S. sovereign jurisdiction securities | 15 | (0.2) | 7 | 128.7 | (36.8) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Municipal bonds — general obligation (direct and guaranteed) | 5.6 |  | 1 | 31.6 | (3.1) | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Municipal bonds — special revenue | 16.1 | (0.4) | 5 | 143 | (19.8) | 37 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Project finance bonds issued by operating entities | 1 |  | 2 | 116.8 | (19.5) | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate bonds | 289.2 | (15.2) | 75 | 3012.4 | (515.1) | 661 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mandatory convertible bonds |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Single entity backed obligations |  |  |  | 31.3 | (4.3) | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SVO-identified bond exchange traded funds — fair value |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SVO-identified bond exchange traded funds — systematic value |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds issued by funds representing operating entities |  |  |  | 270 | (25.8) | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bank loans — issued | 13.3 | (0.1) | 25 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bank loans — acquired |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other ICO |  |  |  | 8.4 | (0.4) | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired ICO securities | 381.9 | (17.6) | 120 | 4120.2 | (712.4) | 846 |
|  ABS: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agency residential mortgage-backed securities — fully guaranteed (exempt from RBC): (exempt from RBC) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agency commercial mortgage-backed securities — fully guaranteed (exempt from RBC) |  |  |  | 212.2 | (60.7) | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agency residential mortgage-backed securities — not/ partially guaranteed (not exempt from RBC) | 0.7 |  | 4 | 85 | (5.0) | 36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agency commercial mortgage-backed securities — not/ partially guaranteed (not exempt from RBC) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-agency residential mortgage-backed securities |  |  |  | 70.7 | (8.0) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-agency commercial mortgage-backed securities | 0.8 | (0.2) | 1 | 76.8 | (5.6) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-agency — CLOs/CBOs/CDOs |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other financial ABS — self-liquidating |  |  |  | 4.7 |  | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity-backed securities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other financial ABS — not self-liquidating |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lease-backed transactions (practical expedient) | 4.5 |  | 1 | 0.2 |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other non-financial ABS (practical expedient) | 18.8 | (2.1) | 2 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lease-backed transactions (full analysis) |  |  |  | 9.1 | (0.1) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other non-financial ABS (full analysis) | 11.3 | (0.9) | 4 | 53.8 | (2.3) | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired ABS securities | 36.1 | (3.2) | 12 | 512.5 | (81.7) | 139 |
|  Total equity securities | 0.6 |  | 1 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired securities | $418.6 | $(20.8) | 133 | $4632.7 | $(794.1) | 985 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** |
|  | **Less Than 12 Months** | **Less Than 12 Months** | **Less Than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** |
| **Description of securities** | **Fair value** | **Gross<br>unrealized<br>losses** | **Number of<br>securities** | **Fair value** | **Gross<br>unrealized<br>losses** | **Number of<br>securities** |
|  % below cost — fixed maturity securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <20% below cost | $397.8 | $(12.5) | 124 | $3543.3 | $(368.8) | 754 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20-50% below cost | 20.2 | (8.3) | 8 | 1089 | (424.9) | 230 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; >50% below cost |  |  |  | 0.4 | (0.4) | 1 |
|  Total fixed maturity securities | 418 | (20.8) | 132 | 4632.7 | (794.1) | 985 |
|  % below cost — equity securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <20% below cost | 0.6 |  | 1 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20-50% below cost |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; >50% below cost |  |  |  |  |  |  |
|  Total equity securities | 0.6 |  | 1 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired securities | 418.6 | (20.8) | 133 | 4632.7 | (794.1) | 985 |
|  Investment grade — fixed maturity securities | 381 | (13.7) | 100 | 4471.3 | (775.5) | 949 |
|  Below investment grade — fixed maturity securities | 37 | (7.1) | 32 | 161.4 | (18.6) | 36 |
|  Investment grade — equity securities |  |  |  |  |  |  |
|  Below investment grade — equity securities | 0.6 |  | 1 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired securities | $418.6 | $(20.8) | 133 | $4632.7 | $(794.1) | 985 |

---

Based on a qualitative and quantitative review of the issuers of the securities in the table above, the Company believes the decline in fair value was largely due to increased interest rates since purchase and was not indicative of credit losses. The issuers continue to make timely principal and interest payments. For all securities in an unrealized loss position, the Company expects to recover the amortized cost based on its estimate of the amount and timing of cash flows to be collected. The Company does not intend to sell nor does it expect that it will be required to sell these securities prior to recovering its amortized cost.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The following table presents the gross unrealized losses and fair value of the Company's investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position as of December 31, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** |
|  | **Less Than 12 Months** | **Less Than 12 Months** | **Less Than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** |
| **Description of securities** | **Fair value** | **Gross<br>unrealized<br>losses** | **Number of<br>securities** | **Fair value** | **Gross<br>unrealized<br>losses** | **Number of<br>securities** |
|  Fixed maturity securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. governments and U.S. government agencies | $259.8 | $(19.2) | 12 | $167.0 | $(71.0) | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All other governments | 53.3 | (2.9) | 28 | 62.8 | (18.9) | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; States, territories and possessions | 57.4 | (1.3) | 14 | 5.3 | (1.0) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Special revenue and special assessment obligations | 80.1 | (2.6) | 17 | 146.9 | (25.3) | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and miscellaneous | 999.4 | (34.0) | 256 | 3666.1 | (699.2) | 811 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bank loans — industrial and miscellaneous | 1.2 |  | 3 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Residential mortgage-backed | 55.7 | (1.1) | 31 | 160.1 | (20.7) | 64 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commercial mortgage-backed | 1.5 |  | 3 | 314.0 | (83.2) | 66 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other asset-backed and structured securities | 15.4 | (0.1) | 5 | 106.6 | (4.2) | 34 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hybrids | 9.2 | (0.1) | 2 | 5.0 |  | 1 |
|  Total fixed maturity securities | 1533.0 | (61.3) | 371 | 4633.8 | (923.5) | 1050 |
|  Total equity securities | 2.0 |  | 1 | 8.4 | (0.4) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired securities | $1535.0 | $(61.3) | 372 | $4642.2 | $(923.9) | 1051 |
|  % below cost — fixed maturity securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <20% below cost | $1516.6 | $(56.6) | 368 | $3267.8 | $(383.6) | 753 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20-50% below cost | 16.4 | (4.7) | 3 | 1364.8 | (538.6) | 295 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; >50% below cost |  |  |  | 1.2 | (1.3) | 2 |
|  Total fixed maturity securities | 1533.0 | (61.3) | 371 | 4633.8 | (923.5) | 1050 |
|  % below cost — equity securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <20% below cost | 2.0 |  | 1 | 8.4 | (0.4) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20-50% below cost |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; >50% below cost |  |  |  |  |  |  |
|  Total equity securities | 2.0 |  | 1 | 8.4 | (0.4) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired securities | $1535.0 | $(61.3) | 372 | $4642.2 | $(923.9) | 1051 |
|  Investment grade — fixed maturity securities | $1486.2 | $(58.9) | 347 | $4443.7 | $(895.1) | 1002 |
|  Below investment grade — fixed maturity securities | 46.8 | (2.4) | 24 | 190.1 | (28.4) | 48 |
|  Investment grade — equity securities | 2.0 |  | 1 |  |  |  |
|  Below investment grade — equity securities |  |  |  | 8.4 | (0.4) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total temporarily impaired securities | $1535.0 | $(61.3) | 372 | $4642.2 | $(923.9) | 1051 |

---

&nbsp;&nbsp;&nbsp;&nbsp;***(g) Sub-prime Mortgage Related Risk***

Fair Isaac Company ("FICO") developed the FICO credit-scoring model to calculate a score based upon a borrower's credit history. FICO credit scores are used as one indicator of a borrower's credit quality. The higher the credit score, the lower the likelihood that a borrower will default on a loan. FICO credit scores range up to 850, with a score of 620 or more generally viewed as a "prime" loan and a score below 620 generally viewed as a "sub-prime" loan. "A minus" loans

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

generally are loans where the borrowers have FICO credit scores between 575 and 660, and where the borrower has a blemished credit history.

As of December 31, 2025, the Company did not hold any direct investments in sub-prime or Alt-A mortgage loans. Alt-A mortgage loans are loans considered alternative or low documentation loans.

The Company did not have any direct exposure in other investments with underlying sub-prime or Alt-A related risk as of December 31, 2025.

The Company did not have any underwriting exposure to sub-prime or Alt-A mortgages as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;***(h) Restricted Assets***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The following table sets forth restricted assets including pledged assets held by the Company as of
December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross (admitted and nonadmitted) restricted** | **Gross (admitted and nonadmitted) restricted** | **Gross (admitted and nonadmitted) restricted** | **Gross (admitted and nonadmitted) restricted** | **Gross (admitted and nonadmitted) restricted** | **Gross (admitted and nonadmitted) restricted** |
|  | **2025** | **2025** | **2025** | **2025** | | |
|  | **1** | **2** | **3** | **4** | **5** | **6** |
| **Restricted asset category** | **Total<br>general<br>account<br>(G/A)** | **G/A<br>supporting<br>S/A activity** | **Total separate<br>accounts<br>(S/A) restricted<br>assets** | **Total<br>(1 plus 3)** | **Total<br>from<br>2024** | **Increase/<br>(decrease)<br>(4 minus 5)** |
|  Federal Home Loan Bank ("FHLB") capital stock | $11.5 | $— | $— | $11.5 | $14.4 | $(2.9) |
|  On deposit with states | 7.6 |  |  | 7.6 | 7.5 | 0.1 |
|  Pledged as collateral: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; FHLB agreements | 160.8 |  |  | 160.8 | 186.7 | (25.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives | 134.8 |  |  | 134.8 | 143.9 | (9.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance trusts | 42.7 |  |  | 42.7 | 42.6 | 0.1 |
|  Assets held under Modco reinsurance agreements | 677.8 |  | 1371.0 | 2048.8 | 2089.1 | (40.3) |
|  Assets held under FWH reinsurance agreements | 1599.1 |  |  | 1599.1 | 1588.9 | 10.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total restricted assets | $2634.3 | $— | $1371.0 | $4005.3 | $4073.1 | $(67.8) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | | **Percentage** | **Percentage** |
|  | **7** | **8** | **9** |
| **Restricted asset category** | **Total 2025<br>admitted restricted** | **Gross (admitted and<br>nonadmitted) restricted<br>to total assets** | **Admitted restricted<br>to total admitted<br>assets** |
|  FHLB capital stock | $11.5 | 0.1% | 0.1% |
|  On deposit with states | 7.6 |  |  |
|  Pledged as collateral: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; FHLB agreements | 160.8 | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives | 134.8 | 0.8 | 0.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance trusts | 42.7 | 0.3 | 0.3 |
|  Assets held under Modco reinsurance agreements | 2048.8 | 12.5 | 12.9 |
|  Assets held under FWH reinsurance agreements | 1599.1 | 9.8 | 10.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total restricted assets | $4005.3 | 24.5% | 25.2% |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

There were no general account restricted assets, including pledged assets, supporting separate account activity as of December 31, 2025 and 2024.

As of December 31, 2025 and 2024, the Company held no other restricted assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The following tables set forth collateral received and assets held under Modco/FWH reinsurance agreements
reflected as assets by the Company as of December 31, 2025:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **1** | **2** | **3** | **4** | **5** | **6** | **7** | **8** |
| **Assets** | **BACV<br>collateral** | **BACV<br>Modco** | **BACV<br>FWH** | **Fair value<br>collateral** | **Fair value<br>Modco** | **Fair value<br>FWH** | **% of BACV<br>to total assets<br>(admitted and<br>nonadmitted)** | **% of BACV<br>to total<br>admitted<br>assets** |
|  General account: |  |  |  |  |  |  |  |  |
| a. Cash, cash equivalents and short-term investments | $— | $6.1 | $40.7 | $— | $6.1 | $40.7 | 0.4% | 0.4% |
| b. Schedule D, Part 1, Section 1 |  | 546.6 | 1289.2 |  | 500.8 | 1157.8 | 15 | 15.6 |
| c. Schedule D, Part 1, Section 2 |  | 42.6 | 85 |  | 32.4 | 77.4 | 1 | 1.1 |
| d. Section D, Part 2, Section 1 |  |  |  |  |  |  |  |  |
| e. Schedule D. Part 2, Section 2 |  |  |  |  |  |  |  |  |
| f. Schedule B |  | 63.7 | 155.8 |  | 62.9 | 150.1 | 1.8 | 1.9 |
| g. Schedule A |  |  |  |  |  |  |  |  |
| h. Schedule BA, Part 1 |  | 18.8 | 28.4 |  | 16.6 | 26.9 | 0.4 | 0.4 |
| i. Schedule DL, Part 1 |  |  |  |  |  |  |  |  |
| j. Other |  |  |  |  |  |  |  |  |
| **k. Total Assets (a+b+c+d+e+f+g+h+i+j)** | $**—** | $**677.8** | $**1599.1** | $**—** | $**618.8** | $**1452.9** | **18.6%** | **19.4%** |
| l. Percentage to total FWH assets (including modco) | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
|  Separate account: |  |  |  |  |  |  |  |  |
| m. Cash, cash equivalents and short-term investments | $— | $— | $— | $— | $— | $— | —% | —% |
| n. Schedule D, Part 1, Section 1 |  |  |  |  |  |  |  |  |
| o. Schedule D, Part 1, Section 2 |  |  |  |  |  |  |  |  |
| p. Section D, Part 2, Section 1 |  |  |  |  |  |  |  |  |
| q. Schedule D. Part 2, Section 2 |  | 1371 |  |  | 1371 |  | 33.3 | 33.3 |
| r. Schedule B |  |  |  |  |  |  |  |  |
| s. Schedule A |  |  |  |  |  |  |  |  |
| t. Schedule BA, Part 1 |  |  |  |  |  |  |  |  |
| u. Schedule DL, Part 1 |  |  |  |  |  |  |  |  |
| v. Other |  |  |  |  |  |  |  |  |
| **w. Total Assets (m+n+o+p+q+r+s+t+u+v)** | $— | $**1371.0** | $**—** | $— | $**1371.0** | $**—** | **33.3%** | **33.3%** |
| x. Percentage to total FWH assets (including modco) | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **9** | **10** | **11** | **12** | **13** | **14** | **15** |
| **Assets** | **BACV** | **Related party code** | **Related party code** | **Related party code** | **Related party code** | **Related party code** | **Related party code** |
|  | **FWH<br>including<br>Modco** | **1** | **2** | **3** | **4** | **5** | **6** |
|  General account: |  |  |  |  |  |  |  |
| a. Cash, cash equivalents and short-term investments | $46.8 | $— | $— | $— | $— | $— | $46.8 |
| b. Schedule D, Part 1, Section 1 | 1835.8 |  |  |  |  |  | 1835.8 |
| c. Schedule D, Part 1, Section 2 | 127.6 |  |  |  |  |  | 127.6 |
| d. Section D, Part 2, Section 1 |  |  |  |  |  |  |  |
| e. Schedule D. Part 2, Section 2 |  |  |  |  |  |  |  |
| f. Schedule B | 219.5 |  |  |  |  |  | 219.5 |
| g. Schedule A |  |  |  |  |  |  |  |
| h. Schedule BA, Part 1 | 47.2 |  |  |  |  |  | 47.2 |
| i. Schedule DL, Part 1 |  |  |  |  |  |  |  |
| j. Other |  |  |  |  |  |  |  |
| **k. Total Assets (a+b+c+d+e+f+g+h+i+j)** | $**2276.9** | $**—** | **$—** | **$—** | **$—** | **$—** | **$2276.9** |
| l. Percentage to total FWH assets (including modco) | —% | —% | —% | —% | —% | —% | 100.0% |
|  Separate account: |  |  |  |  |  |  |  |
| m. Cash, cash equivalents and short-term investments | $— | $— | $— | $— | $— | $— | $— |
| n. Schedule D, Part 1, Section 1 |  |  |  |  |  |  |  |
| o. Schedule D, Part 1, Section 2 |  |  |  |  |  |  |  |
| p. Section D, Part 2, Section 1 |  |  |  |  |  |  |  |
| q. Schedule D. Part 2, Section 2 | 1371.0 |  |  |  |  |  | 1371.0 |
| r. Schedule B |  |  |  |  |  |  |  |
| s. Schedule A |  |  |  |  |  |  |  |
| t. Schedule BA, Part 1 |  |  |  |  |  |  |  |
| u. Schedule DL, Part 1 |  |  |  |  |  |  |  |
| v. Other |  |  |  |  |  |  |  |
| **w. Total Assets (m+n+o+p+q+r+s+t+u+v)** | **$1371.0** | $**—** | $**—** | $**—** | $**—** | $**—** | **$1371.0** |
| x. Percentage to total FWH assets (including modco) | —% | —% | —% | —% | —% | —% | 100.0% |

---

---

| | | |
|:---|:---|:---|
|  | **1**<br>**Amount** | **2**<br>**% of liability<br>to total liabilities\*** |
| y. Recognized obligation to return collateral asset (general account) | $— | —% |
| z. Recognized obligation to return collateral asset (separate account) | $— | —% |
|  aa. Recognized obligation for Modco assets (general account) | $674.8 | 6.2% |
|  bb. Recognized obligation for Modco assets (separate account) | $1371.0 | 33.3% |
| cc. Recognized obligation FWH (excluding modco) assets (general account) | $1597.0 | 14.6% |
| dd. Recognized obligation FWH (excluding modco) assets (separate account) | $— | —% |

---

\* y + aa + cc = Column 1 divided by total liabilities excluding separate accounts 

z + bb + dd = Column 1 divided by separate account liabilities

As of December 31, 2025 and 2024, the Company had no assets held as collateral, under Modco or FWH reinsurance agreements pledged for another purpose.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;***(i) 5GI Securities***

The table below presents 5GI securities held as of December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Number of 5GI<br>Securities** | **Number of 5GI<br>Securities** | **Aggregate<br>BACV** | **Aggregate<br>BACV** | **Aggregate fair<br>value** | **Aggregate fair<br>value** |
| **Investments** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| (1) Bonds — AC |  | 1 | $— | $0.7 | $— | $0.7 |
| (2) Loan-backed & Structured Securities — AC |  |  |  |  |  |  |
| (3) Preferred Stock — AC |  |  |  |  |  |  |
| (4) Preferred Stock — FV | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 |
| (5) Total (1+2+3+4) | 1 | 2 | $0.5 | $1.2 | $0.5 | $1.2 |

---

AC — Amortized cost FV — Fair value BACV — Book adjusted carry value

**(3) Aggregate Reserves** 

As of December 31, 2025 and 2024, the following table summarizes the aggregate reserves and weighted-average interest rate assumptions for the Company:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** |
| **Line of business** | **Amount** | **Interest<br>rates** | **Amount** | **Interest<br>rates** |
|  Individual life: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Traditional | $413.9 | 3.9% | $467.6 | 3.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Universal | 5291.3 | 4.3% | 5296.2 | 4.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supplementary contracts with life contingencies | 122.7 | 4.0% | 121.2 | 3.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total individual life | 5827.9 |  | 5885.0 |  |
|  Group life | 12.8 | 4.0% | 13.3 | 4.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total life | 5840.7 |  | 5898.3 |  |
|  Annuities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Individual annuities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Immediate | 769.2 | 5.8% | 819.5 | 5.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred | 686.9 | 4.4% | 815.3 | 4.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Variable | 48.1 | 3.9% | 51.7 | 3.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total individual annuities | 1504.2 |  | 1686.5 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Group annuities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other group annuities | 19.5 | 6.3% | 22.0 | 6.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total annuities | 1523.7 |  | 1708.5 |  |
|  Accidental death benefits | 0.4 | 3.0% | 0.4 | 3.0% |
|  Disability: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Active lives | 5.6 | 4.3% | 6.6 | 4.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disabled lives | 66.4 | 3.7% | 66.9 | 3.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total disability | 72.0 |  | 73.5 |  |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** |
| **Line of business** | **Amount** | **Interest<br>rates** | **Amount** | **Interest<br>rates** |
|  Other reserves | $1199.2 | 3.9% | $1337.7 | 3.9% |
|  Accident and health: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Individual | 0.2 | 3.4% | 0.3 | 3.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total accident and health | 0.2 |  | 0.3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total life, annuities, and accident and health aggregate reserves | 8636.2 |  | 9018.7 |  |
|  Deposit-type funds: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supplementary contracts without life contingencies | 214.8 | 2.8% | 236.9 | 2.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other deposit-type funds | 44.8 | 5.3% | 100.8 | 3.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total deposit-type funds | 259.6 |  | 337.7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total aggregate reserves and deposit-type funds | $8895.8 |  | $9356.4 |  |

---

Liabilities for life insurance products are based on the AE, AM (5), 41 CSO, 41 STD IND, 58 CSO, 58 CET, 61 CIET, 61 CSI, 80 CSO, 80 CET, 2001 CSO, or 2017 CSO mortality tables. Liabilities for most annuities used the a-1949, 51 GAM, 71 IAM, 71 GAM, 83 GAM, 83a, 94 GAR, 37SA, 2012 IAR, 2012 IAM Basic, or a-2000 mortality tables.

As of December 31, 2025 and 2024, the Company had $748.4 and $805.8, respectively, of additional statutory reserves resulting from updates to its asset adequacy testing assumptions for universal life insurance products with secondary guarantees related to Actuarial Guideline XXXVIII ("AG38") section 8.D.

The Company waives deduction of deferred fractional premiums upon death of the insured and returns any portion of the final premium beyond the end of the month of death. There were $0.4 in reserves for surrender values in excess of reserves otherwise required as of December 31, 2025 and 2024.

Additional premiums or charges apply for policies issued on substandard lives according to underwriting classifications. The substandard extra reserve held on such policies was either one-half of the annual gross extra premiums or one-twenty-fourth of the annual valuation cost of insurance, adjusted for the substandard ratings on the policy.

The reserve for substandard structured settlements policies is based on a flat extra mortality rate calculated at issue to produce the life expectancy determined during the underwriting process.

The reserve for substandard immediate annuities issued in 2005 and later, other than structured settlement policies, is based on a standard mortality plus a flat extra mortality rate calculated at issue to produce the present value of future benefits using the rated age determined during the underwriting process.

As of December 31, 2025 and 2024, the Company had $18,884.8 and $20,428.6, respectively, of insurance in-force for which the future guaranteed maximum gross premiums were less than the future net premiums according to the standard of valuation set by the Virginia Bureau. Reserves to cover the above insurance totaled $243.6 and $259.0, respectively, as of December 31, 2025 and 2024 and are reported in aggregate reserves — life and annuity contracts.

For certain interest sensitive life and immediate annuity reserves, tabular interest has been determined from basic data. The tabular interest for all other lines of business has been determined by formula as described in the NAIC instructions. For certain interest sensitive life reserves, tabular cost has been determined from basic data. Tabular cost for all other lines of business and tabular less actual reserve released have been determined by formula as described in the NAIC instructions.

For funds held on deposit, interest on funds was the actual interest credited to funds. For other funds not involving life contingencies, interest has been determined by formula or from basic data.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

As of December 31, 2025, withdrawal characteristics of annuity actuarial reserves and deposit-type contract funds and other liabilities without life or disability contingencies were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** |
|  | **General<br>account** | **Separate<br>accounts<br>with<br>guarantees** | **Separate<br>accounts<br>nonguaranteed** | **Total** | **Percent<br>of total** |
| A. Individual annuities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. With market value adjustment | $491.3 | $4.0 | $— | $495.3 | 5.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. At book value less current surrender charge of 5% or more | 7.6 |  |  | 7.6 | 0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. At fair value |  |  | 3725.9 | 3725.9 | 37.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Total with market value adjustment or at fair value (total of a-c) | 498.9 | 4.0 | 3725.9 | 4228.8 | 42.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. At book value without adjustment (minimal or no charge or adjustment) | 513.0 |  |  | 513.0 | 5.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal | 5102.7 |  | 20.8 | 5123.5 | 51.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | 6114.6 | 4.0 | 3746.7 | 9865.3 | 100.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance ceded | 4487.7 |  |  | 4487.7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(5) Total net (3) – (4) | $1626.9 | $4.0 | $3746.7 | $5377.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(6) Amount included in A(1)b above that will move to A(1)e for the first time within the year after the statement date: | $2.2 | $— | $— | $2.2 |  |
|  | **General<br>account** | **Separate<br>accounts<br>with<br>guarantees** | **Separate<br>accounts<br>nonguaranteed** | **Total** | **Percent<br>of total** |
| B. Group annuities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. With market value adjustment | $— | $— | $— | $— | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. At book value less current surrender charge of 5% or more |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. At fair value |  |  | 38.9 | 38.9 | 66.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Total with market value adjustment or at fair value (total of a-c) |  |  | 38.9 | 38.9 | 66.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. At book value without adjustment (minimal or no charge or adjustment) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal | 19.5 |  |  | 19.5 | 33.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | 19.5 |  | 38.9 | 58.4 | 100.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance ceded |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(5) Total net (3) – (4) | $19.5 | $— | $38.9 | $58.4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(6) Amount included in B(1)b above that will move to B(1)e for the first time within the year after the statement date: | $— | $— | $— | $— |  |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **General<br>account** | **Separate<br>accounts<br>with<br>guarantees** | **Separate<br>accounts<br>nonguaranteed** | **Total** | **Percent<br>of total** |
| C. Deposit-type contracts (no life contingencies): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. With market value adjustment | $— | $— | $— | $— | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. At book value less current surrender charge of 5% or more |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. At fair value |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Total with market value adjustment or at fair value (total of a-c) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. At book value without adjustment (minimal or no charge or adjustment) | 177.2 |  |  | 177.2 | 29.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal | 419.6 |  |  | 419.6 | 70.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | 596.8 |  |  | 596.8 | 100.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance ceded | 337.2 |  |  | 337.2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(5) Total net (3) – (4) | $259.6 | $— | $— | $259.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(6) Amount included in C(1)b above that will move to C(1)e for the first time within the year after the statement date: | $— | $— | $— | $— |  |

---

As of December 31, 2025, withdrawal characteristics of life actuarial reserves were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Account value** | **Cash value** | **Reserve** |
| A. General account |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans; |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term policies with cash value | $— | $132.7 | $201.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Universal life | 1651.2 | 1446.9 | 1618.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Universal life with secondary guarantees | 2143.3 | 2110.9 | 6493.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Indexed universal life | 44.2 | 40.0 | 44.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Indexed universal life with secondary guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. Indexed life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. Other permanent cash value life insurance |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable universal life | 7.3 | 7.3 | 7.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. Miscellaneous reserves |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term policies without cash value | XXX | XXX | 4788.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental death benefits | XXX | XXX | 0.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability — active lives | XXX | XXX | 6.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability — disabled lives | XXX | XXX | 67.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous reserves | XXX | XXX | 1007.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | 3846.0 | 3737.8 | 14235.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance ceded | 1065.3 | 1063.0 | 7463.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) – (4) | $2780.7 | $2674.8 | $6772.5 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | |
|:---|:---|:---|:---|
|  | **Account value** | **Cash value** | **Reserve** |
| B. Separate account with guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans; |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term policies with cash value | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Universal life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Universal life with secondary guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Indexed universal life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Indexed universal life with secondary guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. Indexed life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. Other permanent cash value life insurance |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable universal life | 307.4 | 307.4 | 307.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. Miscellaneous reserves |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term policies without cash value | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental death benefits | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability — active lives | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability — disabled lives | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous reserves | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | 307.4 | 307.4 | 307.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance ceded |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) – (4) | $307.4 | $307.4 | $307.7 |
|  | **Account value** | **Cash value** | **Reserve** |
| C. Separate account nonguaranteed |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans; |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term policies with cash value | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Universal life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Universal life with secondary guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Indexed universal life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Indexed universal life with secondary guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. Indexed life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. Other permanent cash value life insurance |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable universal life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. Miscellaneous reserves |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term policies without cash value | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental death benefits | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability — active lives | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability — disabled lives | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous reserves | XXX | XXX |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance ceded |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) – (4) | $— | $— | $— |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

Deferred and uncollected life insurance premiums and annuity considerations as of December 31, 2025 and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** |
|  | **Gross** | **Net of<br>loading** | **Gross** | **Net of<br>loading** |
|  Industrial | $0.2 | $0.2 | $0.2 | $0.1 |
|  Ordinary renewal | 130.5 | 274.0 | 136.8 | 286.0 |
|  Group life | 0.3 | 1.2 | 0.2 | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $131.0 | $275.4 | $137.2 | $287.3 |

---

The Company did not have any direct written premiums generated through managing general agents or third-party administrators during the years ended December 31, 2025 and 2024.

**Guaranteed Minimum Death Benefit, Guaranteed Minimum Withdrawal Benefit and Guaranteed Annuitization Benefit** 

The Company's variable annuity products provide a basic GMDB which provides a minimum account value to be paid upon the annuitant's death. Some variable annuity contracts permit contractholders to have the option to purchase through riders, at an additional charge, enhanced death benefits. The Company's separate account guarantees are primarily death benefits but also include some GMWBs and guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit each year, either for a specified period of time or for life. The guaranteed annuitization benefit generally provides for a guaranteed minimum level of income upon annuitization accompanied by the potential for upside market participation. As of December 31, 2025 and 2024, the Company had reserves related to these guaranteed benefits of $217.0 and $283.0, respectively.

The following table sets forth total account values, net of reinsurance, with death benefit and living benefit guarantees as of December 31, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| **Account values with death benefit guarantees (net of reinsurance):** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Standard death benefits (return of net deposits) account value | $1614.1 | $1638.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net amount at risk | $0.6 | $0.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Average attained age of contractholders | 78 | 78 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enhanced death benefits (step-up, roll-up, payment protection) account value | $853.4 | $888.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net amount at risk | $78.7 | $95.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Average attained age of contractholders | 78 | 78 |
| **Account values with living benefit guarantees:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Guaranteed minimum withdrawal benefits | $957.5 | $1021.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Guaranteed annuitization benefits | $848.3 | $775.9 |

---

The contracts underlying the GMWB and guaranteed annuitization benefits are considered "in the money" if the contractholder's benefit base, defined as the greater of the contract value or the protected value, is greater than the account value. As of December 31, 2025 and 2024, the Company's exposure related to GMWB and guaranteed annuitization benefits contracts that were considered "in the money" was $504.0 and $587.0, respectively. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefit base over the account value of the contract is upon annuitization and the amount to be paid by the Company will either be in the form of a lump sum, or over the annuity period for certain GMWBs and guaranteed annuitization benefits.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

**(4)** **Liability for Policy and Contract Claims** 

Activity in the accident and health policy claim reserves, including the present value of amounts not yet due (which were included as a component of aggregate reserves) of $0.2, $0.3, and $0.4 as of December 31, 2025, 2024 and 2023, respectively, is summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
|  Balance as of January 1 | $24.7 | $26.5 | $30.4 |
|  Less reinsurance reserve credit and recoverable | 24.4 | 26.1 | 30.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net balance as of January 1 | 0.3 | 0.4 | 0.4 |
|  Incurred related to: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current year |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prior years | (0.1) |  | 0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total incurred | (0.1) |  | 0.1 |
|  Paid related to: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current year |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prior years |  | 0.1 | 0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total paid |  | 0.1 | 0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net balance as of December 31 | 0.2 | 0.3 | 0.4 |
|  Plus reinsurance reserve credit and recoverable | 19.7 | 24.4 | 26.1 |
|  Balance as of December 31 | $19.9 | $24.7 | $26.5 |

---

Incurred claims related to prior years did not change by a significant amount in any year as a result of changes in estimates of insured events in prior years.

For the years ended December 31, 2025, 2024 and 2023, the Company did not have any significant changes in methodologies or assumptions used to calculate the liability for unpaid claims and claim adjustment expenses.

The liability for policy and contract claims presented in the Statutory Statements of Admitted Assets, Liabilities and Capital and Surplus included $106.5 and $95.2 of life contract claims as of December 31, 2025 and 2024, respectively.

**(5)** **Transactions with Affiliates** 

The Company and various affiliates, all direct and/or indirect subsidiaries of Genworth, are parties to an amended and restated services and shared expenses agreement under which each company agrees to provide and each company agrees to receive certain general services. These services include, but are not limited to, data processing, communications, marketing, public relations, advertising, investment management, human resources, accounting, actuarial, legal, administration of agent and agency matters, purchasing, underwriting and claims. Under the terms of the agreement, settlements are to be made quarterly. This agreement represents the principal administrative service agreement between the Company and the following affiliates:

GLIC

GNA

Enact Mortgage Insurance Corporation ("EMIC")

JAC

RLIC VI

RLIC X

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

On December 26, 2025, the Company received $23.3 in cash from Newco as a dividend payment.

On January 6, 2023, RLIC VI returned contributed surplus to the Company of $5.0 in cash.

For years ended December 31, 2025, 2024 and 2023, the Company made net payments for intercompany settlements of $42.6, $45.6, and $41.4, respectively.

On August 31, 2021, after receiving approval from the Virginia Bureau and the State of Delaware Department of Insurance, the Company and GLIC executed a Master Promissory Note. Under terms of this note the borrower may borrow up to a maximum of $300.0 from the lender for up to 90 business days. Any loan shall be repaid by the borrower to the lender immediately upon written demand. The note pays interest at the daily overnight U.S. Federal Funds Rate less 0.10%, with a floor of 0.25%. There were no outstanding balances payable to or due from GLIC as of December 31, 2025 or 2024.

The Company has a Master Promissory Note agreement, approved by the Virginia Bureau, which involves borrowing from and making loans to GNA, the Company's indirect parent. The principal is payable upon written demand by GNA or at the discretion of the Company. The note pays interest at the cost of funds of GNA, which was 3.54%, 4.23%, and 5.23% during the years ended December 31, 2025, 2024 and 2023, respectively. There were no outstanding balances payable to or due from GNA as of December 31, 2025 or 2024.

The Company and GLICNY are parties to an Administrative Services Agreement whereby the Company provides services to GLICNY with respect to GLICNY's variable annuity products.

The Company and GLIC are parties to a Master Services and Shared Expenses Agreement with two affiliates, Genworth Financial India Private Limited and EMIC, whereby the parties agree to benefit from centralized functions and processes by pooling their purchasing power by entering separate Statements of Work which will provide the specifics of each service to be provided.

The Company participates in reinsurance agreements whereby the Company assumes business from or cedes business to its affiliates. See Note 8 for further details on affiliate reinsurance agreements.

Total amounts due from or owed to affiliates as of December 31, 2025 and 2024 are included in the following balance sheet captions:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
|  Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amounts recoverable from reinsurers and funds held | $243.8 | $281.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivable from parent, subsidiaries and affiliates | 0.2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Federal income tax recoverable |  | 1.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $244.0 | $283.0 |
|  Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Federal income tax payable | $8.0 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payable to parent, subsidiaries and affiliates | 12.3 | 12.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other amounts payable on reinsurance | 24.9 | 24.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | $45.2 | $36.7 |

---

**(6)** **Income Taxes** 

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA"), which includes certain tax provisions, was signed into law. The OBBBA did not have a material impact on the Company's financial statements.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

In August 2022, the Inflation Reduction Act of 2022 ("Act") was passed by the U.S. Congress and signed into law by President Biden. The Act includes a new Federal corporate alternative minimum tax ("CAMT"), effective in 2023, that is based on the adjusted financial statement income ("AFSI") set forth on the applicable financial statement ("AFS") of an applicable corporation. A corporation is an applicable corporation if its rolling average pre-tax AFSI over three prior years (starting with 2020-2022) is greater than $1.0 billion. For a group of related entities, the $1.0 billion threshold is determined on a group basis, and the group's AFS is generally treated as the AFS for all separate taxpayers in the group. Except under limited circumstances, once a corporation is an applicable corporation, it is an applicable corporation in all future years.

An applicable corporation is not automatically subject to a CAMT liability. The corporation's tentative CAMT liability is equal to 15% of its adjusted AFSI, and CAMT is payable to the extent the tentative CAMT liability exceeds regular corporate income tax. However, any CAMT paid would be indefinitely available as a credit carryover that could reduce future regular tax in excess of CAMT. The controlled group of corporations of which the Company is a member was not an applicable corporation in 2025 or 2024. The Company intends to amend its tax sharing agreement in 2026 to reflect CAMT.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(a) Components of deferred tax assets and deferred tax liabilities***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The components of the net DTA recognized in the Company's Statutory Statements of Admitted Assets,
Liabilities and Capital and Surplus as of December 31, 2025 and 2024 were as follows:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** | **Change** | **Change** | **Change** |
|  | **Ordinary** | **Capital** | **Total** | **Ordinary** | **Capital** | **Total** | **Ordinary** | **Capital** | **Total** |
| a. Gross DTA | $497.5 | $4.5 | $502.0 | $523.9 | $7.5 | $531.4 | $(26.4) | $(3.0) | $(29.4) |
| b. Statutory valuation allowance adjustment |  |  |  |  |  |  |  |  |  |
| c. Adjusted gross DTA (1a – 1b) | 497.5 | 4.5 | 502.0 | 523.9 | 7.5 | 531.4 | (26.4) | (3.0) | (29.4) |
| d. DTA nonadmitted | 417.9 | 2.8 | 420.7 | 398.5 | 7.3 | 405.8 | 19.4 | (4.5) | 14.9 |
| e. Subtotal: net admitted DTA (1c – 1d) | 79.6 | 1.7 | 81.3 | 125.4 | 0.2 | 125.6 | (45.8) | 1.5 | (44.3) |
| f. DTL | 60.4 | 1.7 | 62.1 | 74.0 | 0.2 | 74.2 | (13.6) | 1.5 | (12.1) |
| g. Net admitted DTA/(DTL) (1e – 1f) | $19.2 | $— | $19.2 | $51.4 | $— | $51.4 | $(32.2) | $— | $(32.2) |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Admission calculation components for SSAP No. 101 as of December 31, 2025 and 2024:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** | **Change** | **Change** | **Change** |
|  | **Ordinary** | **Capital** | **Total** | **Ordinary** | **Capital** | **Total** | **Ordinary** | **Capital** | **Total** |
| a. Federal income taxes paid in prior years recoverable through loss carrybacks | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| b. Adjusted gross DTA expected to be realized (excluding the amount of DTA from 2(a) above) after application of the threshold limitation. (The lessor of 2(b)1 and 2(b)2 below) | 19.2 |  | 19.2 | 51.4 |  | 51.4 | (32.2) |  | (32.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted gross DTA expected to be realized following the balance sheet date | 19.2 |  | 19.2 | 51.4 |  | 51.4 | (32.2) |  | (32.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Adjusted gross DTA allowed per limitation threshold | XXX | XXX | 120.6 | XXX | XXX | 117.4 | XXX | XXX | 3.2 |
| c. Adjusted gross DTA (excluding the amount of DTA from 2(a) and 2(b) above) offset by gross DTL | 60.4 | 1.7 | 62.1 | 74.0 | 0.2 | 74.2 | (13.6) | 1.5 | (12.1) |
| d. DTA admitted as a result of the application of SSAP No. 101 (Total 2(a) + 2(b) + 2(c)) | $79.6 | $1.7 | $81.3 | $125.4 | $0.2 | $125.6 | $(45.8) | $1.5 | $(44.3) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Ratio used to determine applicable period used in 6(a)2:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| a. Ratio percentage used to determine recovery period and threshold limitation amount | 842% | 789% |
| b. Amount of adjusted capital and surplus used to determine recovery period and threshold limitation in 2(b)2 above | $930.1 | $915.9 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The Company did not use tax planning strategies in the computation of either the adjusted gross DTA or net
admitted DTA for the years ended December 31, 2025 and 2024.

&nbsp;&nbsp;&nbsp;&nbsp;***(b) Unrecognized deferred tax liabilities***

The Company did not have any unrecognized DTLs for the years ended December 31, 2025 and 2024.

&nbsp;&nbsp;&nbsp;&nbsp;***(c) Current income tax and change in deferred tax***

The provision for income taxes incurred on operations for the years ended December 31, 2025, 2024 and 2023 were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **Change** |
| **1. Current Income Taxes** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Federal income taxes | $(11.8) | $(6.9) | $(4.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Foreign income taxes |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Federal and foreign income taxes | (11.8) | (6.9) | (4.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Federal income tax on net capital gains (losses) | (1.8) | (3.7) | 1.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Utilization of capital loss carry forwards |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. Other |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. Federal income taxes incurred | $(13.6) | $(10.6) | $(3.0) |
|  | **2024** | **2023** | **Change** |
| **1. Current Income Taxes** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Federal income taxes | $(6.9) | $14.9 | $(21.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Foreign income taxes |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Federal and foreign income taxes | (6.9) | 14.9 | (21.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Federal income tax on net capital gains (losses) | (3.7) | (3.8) | 0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Utilization of capital loss carry forwards |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. Other |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. Federal income taxes incurred | $(10.6) | $11.1 | $(21.7) |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The tax effects of temporary differences that give rise to significant portions of the DTAs and DTLs were as follows as of December 31, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **Change** |
| **2. DTA** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Ordinary |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Discounting of unpaid losses | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Unearned premium reserve |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3a. Transition reserves |  | 1.5 | (1.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3b. Policyholder reserves | 321.5 | 340.9 | (19.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Investments | 44.4 | 50.4 | (6.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Deferred acquisition costs | 128.4 | 127.6 | 0.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Policyholder dividends accrual |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Fixed assets | 0.5 | 0.6 | (0.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. Compensation and benefits accrual |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. Pension accrual |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. Receivable–nonadmitted | 2.3 | 2.0 | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. Net operating loss carry forward |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. Tax credit carry forward |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. Other (including items less than 5% of total ordinary tax assets) | 0.4 | 0.9 | (0.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99. Subtotal ordinary | 497.5 | 523.9 | (26.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. Statutory valuation allowance adjustment |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. Nonadmitted DTA | 417.9 | 398.5 | 19.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D. Admitted ordinary DTA (2A99 – 2B – 2C) | 79.6 | 125.4 | (45.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E. Capital |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Investments | 4.5 | 7.5 | (3.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Net capital loss carry forward |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Real estate |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Other (including items less than 5% of total ordinary tax assets) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99. Subtotal capital | 4.5 | 7.5 | (3.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F. Statutory valuation allowance adjustment |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;G. Nonadmitted DTA | 2.8 | 7.3 | (4.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;H. Admitted capital DTA (2E99 – 2F – 2G) | 1.7 | 0.2 | 1.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I. Admitted DTA (2D + 2H) | $81.3 | $125.6 | $(44.3) |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **Change** |
| **3. DTL** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Ordinary |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Investments | $1.8 | $3.0 | $(1.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Fixed assets |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Deferred and uncollected premiums | 57.8 | 60.4 | (2.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4(a). Transition reserves |  | 9.1 | (9.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4(b). Policyholder reserves | 0.8 | 1.5 | (0.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Other |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99. Subtotal ordinary | 60.4 | 74.0 | (13.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. Capital |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Investments | 1.7 | 0.2 | 1.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Real estate |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Other |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99. Subtotal capital | 1.7 | 0.2 | 1.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. DTL (3A99 + 3B99) | 62.1 | 74.2 | (12.1) |
| **4. Net DTA (DTL) (2I – 3C)** | $19.2 | $51.4 | $(32.2) |

---

Based on an analysis of the Company's tax position for the year ended December 31, 2025, management concluded it is more likely than not that the results of future operations will generate sufficient taxable income to enable the Company to realize all of its DTAs. Accordingly, no valuation allowance for DTA has been established.

The change in net deferred taxes is comprised of the following (this analysis is exclusive of nonadmitted assets, as the change in nonadmitted assets is reported separately from the change in net deferred income taxes in the Statutory Statements of Admitted Assets, Liabilities and Capital and Surplus):

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31,** | **December 31,** | |
|  | **2025** | **2024** |<br>**Change** |
|  Total gross DTA | $502.0 | $531.4 | $(29.4) |
|  Statutory valuation allowance adjustment |  |  |  |
|  Adjusted gross DTAs | 502.0 | 531.4 | (29.4) |
|  Total gross DTL | 62.1 | 74.2 | (12.1) |
|  Net DTA | $439.9 | $457.2 | (17.3) |
|  Deferred tax on change in net unrealized capital gains (losses) |  |  | (0.2) |
|  Change in net deferred income taxes |  |  | $(17.5) |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;***(d) Reconciliation of Federal income tax rate to actual effective tax rate***

The provision for Federal income taxes incurred is different from that which would be obtained by applying the statutory Federal income tax rate to income before income taxes. The significant items causing this difference were as follows for the years ended December 31, 2025, 2024 and 2023:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
|  Provision computed at statutory tax rate | $16.4 | $9.3 | $20.9 |
|  Tax exempt interest |  |  | (0.1) |
|  Benefit of dividends | (6.5) | (1.6) | (1.7) |
|  Statutory amortization of IMR |  | (0.2) | (0.4) |
|  Foreign taxes | (0.2) | (0.2) | (0.2) |
|  Change in nonadmitted assets | (0.2) | 0.3 | 5.9 |
|  Deferred reinsurance gains | (5.9) | (6.9) | (6.7) |
|  Other adjustments | 0.3 | (0.2) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $3.9 | $0.5 | $17.7 |
|  Federal income taxes incurred | $(13.6) | $(10.6) | $11.1 |
|  Change in net deferred income taxes | 17.5 | 11.1 | 6.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $3.9 | $0.5 | $17.7 |

---

&nbsp;&nbsp;&nbsp;&nbsp;***(e) Operating loss and tax credit carry forwards and protective tax deposits***

As of December 31, 2025, the Company had no operating losses to carry forward.

As of December 31, 2025, the Company had no tax credits to carry forward.

There were no income taxes incurred in the current or prior years that will be available for recoupment in the event of future net losses.

The Company had no protective tax deposits which are on deposit with the IRS under Section 6603 of the Internal Revenue Code.

&nbsp;&nbsp;&nbsp;&nbsp;***(f) Consolidated Federal income tax return***

The Company is an affiliated member of a consolidated Life/Non-Life U.S. Federal income tax return with its ultimate parent company, Genworth, and will be included with the following companies in the consolidated Federal income tax return for 2025:

ASI

Capital Brokerage Corporation

CareScout Holdings, Inc.

CareScout, LLC

Enact Financial Assurance Corporation

Enact Financial Services, Inc.

Enact Global Holdings Corporation

Enact Holdings, Inc.

Enact Mortgage Holdings, LLC

EMIC

Enact Mortgage Insurance Corporation of North Carolina

Enact Mortgage Services, LLC

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

Enact Re Ltd.

Enact Residential Insurance Corporation

Genworth

Genworth Annuity Service Corporation

Genworth Financial Agency, Inc. ("GFA")

Genworth Financial International Holdings, LLC

Genworth Holdings, Inc. ("Genworth Holdings")

GLIC

GLICNY

GNA

HGI Annuity Service Corporation

JAC

Mayflower

Monument Lane IC 1, Inc.

Monument Lane IC 2, Inc.

Monument Lane PCC, Inc.

Newco

RLIC VI

RLIC X

Seniorly, Inc.

Sponsored Captive Re, Inc.

United Pacific Structured Settlement Company

The Company is a party to the Amended and Restated Tax Allocation Agreement dated May 14, 2021, between Genworth and certain of its subsidiaries (the "New TAA"). The New TAA includes updates to the Tax Allocation Agreement dated May 24, 2004 (the "Old TAA") for company names and other administrative matters but did not fundamentally change the methodology used to allocate taxes amongst Genworth and its subsidiaries. The New TAA was approved by state insurance regulators and the Company's Board of Directors. The tax allocation methodology is based on the separate return liabilities with offsets for losses and credits utilized to reduce the current consolidated tax liability as allowed by applicable law and regulation. The Company's policy is to settle intercompany tax balances quarterly, with a final settlement after filing of Genworth's Federal consolidated U.S. corporation income tax return.

The Company also has special tax sharing agreements with RLIC VI and RLIC X and its indirect parent, Genworth, effective June 1, 2018 for RLIC VI and January 1, 2018 for RLIC X. Under these special tax sharing agreements, the Company is obligated to receive or make payments on behalf of RLIC VI and RLIC X for Federal income tax amounts receivable or payable by those companies pursuant to the Tax Allocation Agreement. The tax payments made by the Company on behalf of RLIC VI and RLIC X are accounted for as deemed capital contributions to RLIC VI and RLIC X. The tax payments received by the Company on behalf of RLIC VI and RLIC X are accounted for as deemed dividends from RLIC VI and RLIC X. As of December 31, 2025, the Company recorded tax payables and increases in common stock of affiliates of $32.0 and $6.6 for RLIC VI and RLIC X, respectively. The Company carries RLIC VI and RLIC X at zero; therefore, the change in common stock of affiliates ultimately impacts unassigned surplus.

The cumulative benefit recognized by the Company relating to the special tax sharing agreements with RLIC VI and RLIC X and the Special Tax Allocation Agreement with Genworth was $267.4 and $306.0 as of December 31, 2025 and 2024, respectively.

For tax years beginning in 2011, the Company was included in the Life/Non-Life consolidated return filed by Genworth and filed various state and local tax returns. The Company is not currently subject to any significant examinations by federal or state income tax authorities. Generally, the Company is no longer subject to federal or state income tax examinations for years prior to 2022.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;***(g) Federal or foreign income tax loss contingencies***

As of December 31, 2025 and 2024, the total amount of unrecognized tax benefits was $7.1 for each year, which, if recognized, would affect the effective tax rate on operations.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. During the years ended December 31, 2025, 2024 and 2023, the Company accrued interest of $0.6, 0.4, and zero, respectively. The Company had an interest liability balance of $1.0 and $0.4 as of December 31, 2025 and 2024, respectively, and no interest liability balance as of December 31, 2023. There was no penalty accrual balance as of December 31, 2025, 2024 and 2023.

As a result of Genworth's open audits and appeals, the Company believes no unrecognized tax benefits will be recognized in 2026.

&nbsp;&nbsp;&nbsp;&nbsp;***(h) State transferable and non-transferable tax credits***

The Company did not have any state transferable and non-transferable tax credits as of December 31, 2025 and 2024.

The Company estimated the utilization of the remaining transferable and non-transferable state tax credits by projecting future premium taking into account policy growth and rate changes, projected future tax liability based on projected premiums, tax rates and tax credits, and comparing projected future tax liability to the availability of remaining transferable and non-transferable tax credits.

The Company had no impairment loss related to the write-down as a result of impairment analysis of the carrying amount for state transferable and non-transferable tax credits during 2025 and 2024.

**(7)** **Commitments and Contingencies** 

&nbsp;&nbsp;&nbsp;&nbsp;***(a) Litigation***

The Company is a defendant in various cases of litigation considered to be in the normal course of business. The Company does not consider existing contingent liabilities arising from litigation, income taxes and other matters to be material in relation to the financial statements of the Company.

In March 2024, the Company was served with a putative class action lawsuit venued in the Superior Court of the State of California, Sacramento County, captioned *James Fox, individually and on behalf of the class v. Genworth Life and Annuity Insurance Co*. Plaintiff, the holder of a lapsed California ****life insurance policy of the Company, seeks to represent a class of current and former California policyholders of the Company and beneficiaries whose policies were allegedly wrongfully terminated. The complaint alleges that the Company wrongfully terminated hundreds of California life insurance policies by failing to provide the policyholders with the notices and grace periods mandated by the contract and by the California Insurance Code as interpreted by the California Supreme Court in *McHugh v. Protective Life Ins. Co.* The complaint asserts causes of action for breach of contract, violation of the California Insurance Code, unfair competition and bad faith, and it seeks, inter alia, declaratory and injunctive relief, compensatory damages, restitution, attorneys' fees and costs. The action was removed to the United States District Court for the Eastern District of California on April 3, 2024. On May 8, 2024, the Company answered the complaint. On October 15, 2024, the court granted the Company's motion to stay the action pending final determination of an appeal in a related case. On March 4, 2025, the court lifted the stay, and plaintiff filed an amended complaint on April 21, 2025. On June 2, 2025, the Company answered the complaint and moved to strike its class action allegations. Plaintiff filed opposition papers to the Company's motion to strike on June 16, 2025. Plaintiff moved to remand the matter to state court on June 30, 2025, and the Company opposed that motion on July 22, 2025. On August 19, 2025, the court denied both the Company's motion to strike the class allegations and plaintiff's motion to remand

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

the case to state court. Plaintiff filed a notice of appeal from that order on September 18, 2025, but the appeal was dismissed by the United States Court of Appeals for the Ninth Circuit on October 1, 2025. The Company intends to continue to vigorously defend this action.

Starting in June 2023, various Genworth entities (including Genworth Financial, GLIC and the Company) have been named as defendants in certain putative class action lawsuits in the United States District Courts for the Eastern District of Virginia and the District of Massachusetts. These cases are captioned as follows: *Anastasio v. Genworth Financial, Inc. et al; Hauser v. Genworth Life Insurance Company; Smith v. Genworth Financial, Inc.; Behrens v. Genworth Life Insurance Company; Hale et al v. Genworth Financial, Inc.; Burkett, Jr. v. Genworth Life and Annuity Insurance Company; Manar v. Genworth Financial, Inc.; Romine et al. v. Progress Software Corporation et al.; Schwarz et al. v. Progress Software Corporation et al.; Casey et al. v. Genworth Life & Annuity Insurance Company; and Bailey v. Genworth Financial, Inc.* The actions relate to the ****data security events involving the MOVEit file transfer system, which PBI Research Services ("PBI"), a third-party vendor, uses in the performance of its services ("MOVEit Cybersecurity Incident"). Genworth's legacy insurance subsidiaries previously used PBI to, among other things, satisfy applicable regulatory obligations to search various databases to identify the deaths of insured persons under life insurance policies, and to identify deaths under long-term care insurance and annuity policies which can impact premium payment obligations and benefit eligibility. Plaintiffs seek to represent various classes and subclasses of Genworth long-term care insurance policyholders and agents whose data was accessed or potentially accessed by the MOVEit Cybersecurity Incident, alleging that Genworth breached its purported duty to safeguard their sensitive data from cybercriminals. The complaints assert claims for, inter alia, negligence, negligence per se, breach of contract, unjust enrichment, and violations of various consumer protection and privacy statutes, and they seek, inter alia, declaratory and injunctive relief, compensatory and punitive damages, restitution, attorneys' fees and costs. On October 4, 2023, the Joint Panel on Multidistrict Litigation issued an order consolidating all actions relating to the MOVEit Cybersecurity Incident before a single federal judge in the United States District Court for the District of Massachusetts. All defendants, including the Genworth entities, filed a joint motion to dismiss the complaints on July 23, 2024. Oral argument on this motion occurred on October 9, 2024. On December 12, 2024, as relevant to Genworth, the court denied the motion. On February 4, 2025, several defendants, including the Genworth entities, filed a second motion to dismiss the complaints, and plaintiffs filed opposition papers on April 7, 2025. Oral argument was conducted on the second motion to dismiss on May 12, 2025. On July 31, 2025, the court granted the second motion to dismiss in part and dismissed most of the causes of action against Genworth, retaining only the claims for common law negligence, breach of implied contract, and a Massachusetts statutory violation. On September 9, 2025, Genworth moved for partial reconsideration of certain aspects of the July 31, 2025 decision, and plaintiffs opposed that motion on September 23, 2025. On January 9, 2026, the court granted in part Genworth's motion for partial reconsideration by dismissing a certain negligence claim under California law and by confirming the dismissal of an Illinois statutory claim. Genworth intends to continue to vigorously defend these actions.

In September 2018, the Company was named as a defendant in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned *TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. on behalf of itself and all others similarly situated v. Genworth Life and Annuity Insurance Company*. Plaintiff alleges unlawful and ****excessive cost of insurance charges were imposed on policyholders. The complaint asserts claims for breach of contract, alleging that the Company improperly considered non-mortality factors when calculating cost of insurance rates and failed to decrease cost of insurance charges in light of improved expectations of future mortality, and seeks unspecified compensatory damages, costs, and equitable relief. On October 29, 2018, the Company filed a motion to enjoin the case in the Middle District of Georgia, and a motion to dismiss and motion to stay in the Eastern District of Virginia. The Company moved to enjoin the prosecution of the Eastern District of Virginia action on the basis that it involves claims released in a prior nationwide class action settlement (the "McBride settlement") that was approved by the Middle District of Georgia. Plaintiff filed an amended complaint on November 13, 2018. On December 6, 2018, the Company moved the Middle District of Georgia for leave to file its counterclaim, which alleges that plaintiff breached the covenant not to sue contained in the prior settlement agreement by filing its current action. On March 15, 2019, the Middle District of Georgia granted the Company's motion to enjoin and denied its motion for leave to file its counterclaim. As such, plaintiff is enjoined from pursuing its class action in the Eastern District of Virginia. On March 29, 2019, plaintiff filed a

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

notice of appeal in the Middle District of Georgia, notifying the Court of its appeal to the United States Court of Appeals for the Eleventh Circuit from the order granting the Company's motion to enjoin. On March 29, 2019, the Company filed its notice of cross-appeal in the Middle District of Georgia, notifying the Court of its cross-appeal to the Eleventh Circuit from the portion of the order denying its motion for leave to file the Company's counterclaim. On April 8, 2019, the Eastern District of Virginia dismissed the case without prejudice, with leave for plaintiff to refile an amended complaint only if a final appellate Court decision vacates the injunction and reverses the Middle District of Georgia's opinion. On May 21, 2019, plaintiff filed its appeal and memorandum in support in the Eleventh Circuit. The Company filed its response to plaintiff's appeal memorandum on July 3, 2019. The Eleventh Circuit Court of Appeals heard oral argument on plaintiff's appeal and the Company's cross-appeal on April 21, 2020. On May 26, 2020, the Eleventh Circuit Court of Appeals vacated the Middle District of Georgia's order enjoining Plaintiff's class action and remanded the case back to the Middle District of Georgia for further factual development as to whether the Company has altered how it calculates or charges cost of insurance since the McBride settlement. The Eleventh Circuit Court of Appeals did not reach a decision on the Company's counterclaim. On June 30, 2021, the Company filed in the Middle District of Georgia its renewed motion to enforce the class action settlement and release, and renewed its motion for leave to file a counterclaim. The briefing on both motions concluded in October 2021. On March 24, 2022, the Court denied the Company's motions. On April 11, 2022, the Company filed an appeal of the Court's denial to the United States Court of Appeals for the Eleventh Circuit. On June 22, 2022, the Company filed its opening brief in support of the appeal. Plaintiff filed its respondent's brief on September 20, 2022, and the Company filed its reply brief on November 10, 2022. The appeal was orally argued on August 17, 2023, and on January 8, 2025, the Eleventh Circuit entered an order affirming the district court's order. On January 29, 2025, the Company moved for rehearing by the panel and by the full court. On March 4, 2025, the Eleventh Circuit denied the Company's motion for rehearing. On March 7, 2025, plaintiff refiled its complaint in the United States District Court for the Eastern District of Virginia. On May 9, 2025, the Company moved to dismiss the refiled complaint for failure to state a cause of action. Plaintiff filed an amended complaint on June 24, 2025 and a second amended complaint on July 14, 2025. On July 28, 2025, the Company moved to dismiss the second amended complaint for failure to state a cause of action. The plaintiff opposed the Company's motion to dismiss the second amended complaint on August 25, 2025, and the court denied the Company's motion to dismiss on November 18, 2025. On February 13, 2026, the Company moved for summary judgment dismissing the complaint, and the plaintiff moved for class certification. The Company intends to continue to vigorously defend this action.

As of December 31, 2025, the Company could not determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above. In light of the inherent uncertainties involved in these matters, no amounts have been accrued. The Company is not able to provide an estimate or range of possible losses related to these matters.

&nbsp;&nbsp;&nbsp;&nbsp;***(b) Guaranty Association Assessments***

The Company is required by law to participate in the guaranty fund associations of the various states in which it is licensed to do business. The state guaranty associations ensure payment of guaranteed benefits, with certain restrictions, to policyholders of impaired or insolvent insurance companies by assessing all other companies operating in similar lines of business.

As of December 31, 2025 and 2024, the Company has accrued and recognized through net operations a liability for retrospective premium-based guaranty fund assessments of $7.0 and $7.5, respectively, and a related premium tax benefit asset of $6.5 and $7.2, respectively. These amounts represent management's best estimate based on information received from the states in which the Company writes business and may change due to many factors including the Company's share of the ultimate cost of current insolvencies. The premium tax benefit is generally realized over a five year period, but can vary depending on the state law.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The following table provides information about the Company's guaranty funds receivable as of December 31, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
|  Assets recognized from paid and accrued premium tax offsets and policy surcharges prior year end | $7.2 | $6.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decreases current year: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Premium tax offset applied | 0.2 | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrual true-up | 0.3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prior period adjustment | 0.2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increases current year: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prior period adjustment |  | 0.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current year adjustment |  | 0.3 |
|  Assets recognized from paid and accrued premium tax offsets and policy surcharges current year end | $6.5 | $7.2 |

---

As of December 31, 2025 and 2024, the Company's guaranty fund liabilities and assets related to assessments from insolvencies of entities that wrote LTC contracts were de minimis.

&nbsp;&nbsp;&nbsp;&nbsp;***(c) Related Party Guarantees***

The Company has guaranteed the structured settlement payment obligations of ASI, provided that such obligations are funded with the Company's annuity contracts. ASI is a direct, wholly-owned subsidiary of the Company and the assignment company for the Company's structured settlement business.

There are no current obligations by the Company under the guarantee nor does the Company expect to make any future payments. However, if any payments were to be made they would be treated as a capital contribution. The maximum amount of payments that could be made under the guarantee is equal to the structured settlement payment obligations of ASI. The structured settlement reserves related to this guarantee as of December 31, 2025 and 2024 were $240.7 and $245.7, respectively. The guarantee will remain intact until modified or rescinded by the Company's board of directors.

&nbsp;&nbsp;&nbsp;&nbsp;***(d) Commitments***

As of December 31, 2025, the Company had future commitments related to its investments in limited partnerships of $105.4, bank loans of $7.0, and private placement securities of $52.5. The limited partnerships are part of the Company's private equity and real estate programs. The funding commitments relate to future equity stakes in a portfolio of private companies, commercial mortgage loans and investments in fixed maturity securities.

**(8)** **Reinsurance** 

The Company follows the standard industry practices of reinsuring portions of its risk with other companies. Use of reinsurance does not discharge the Company from liability on the insurance ceded. The Company is required to pay in full the amount of its insurance obligations regardless of whether it is entitled or able to receive payment from its reinsurer. The Company monitors both the financial condition of the reinsurers as well as risk concentrations arising from activities and economic characteristics of the reinsurers to lessen the risk of default by such reinsurers.

The maximum amounts of life insurance retained by the Company on any one life may not exceed the following limits: individual life, $5.0; accidental death benefit, $0.1; group life, $0.2; group mortgage accidental benefits, $0.1; and payroll deduction and 401(k) automatic issue coverage, $0.2. Amounts in excess of these maximums are reinsured with other insurance companies.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The effects of reinsurance on premiums earned and benefits incurred for the years ended December 31, 2025, 2024 and 2023 were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Premiums earned** | **Premiums earned** | **Premiums earned** | **Benefits incurred** | **Benefits incurred** | **Benefits incurred** |
|  | **2025** | **2024** | **2023** | **2025** | **2024** | **2023** |
|  Direct | $830.6 | $890.4 | $948.4 | $1951.1 | $1996.5 | $2060.9 |
|  Assumed | 219.9 | 232.1 | 236.5 | 296.1 | 289.8 | 279.7 |
|  Ceded | (924.2) | (984.9) | (964.8) | (1557.6) | (1601.1) | (1585.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net | $126.3 | $137.6 | $220.1 | $689.6 | $685.2 | $755.0 |

---

The Company did not have any retrospectively rated contracts or contracts subject to redetermination.

**<u>Affiliated Special Purpose Captives Reinsurance Transactions</u>**

The Company has over the past years entered into significant reinsurance treaties with its subsidiaries to cede universal and term life insurance policies. Reserves ceded by the Company as of December 31, 2025 and 2024 related to these treaties were as follows:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
|  **<u>Universal Life Insurance Business</u>** |  |  |
|  RLIC VI | $866.8 | $862.5 |
|  **<u>Term Life Insurance Business</u>** |  |  |
|  RLIC VI | $649.2 | $873.2 |
|  RLIC X | 794.0 | 830.2 |

---

*RLIC VI* 

The Company is a party to a coinsurance with funds withheld agreement with RLIC VI whereby it cedes certain term life insurance and universal life insurance business to RLIC VI.

Effective December 1, 2017, RLIC VI entered into a monthly renewable term ("MRT") reinsurance agreement with New Reinsurance Company Ltd ("NewRe") whereby it retrocedes the mortality risk on certain term life insurance business assumed from the Company.

Effective December 1, 2019, RLIC VI entered into a MRT reinsurance agreement with Hannover Re (Ireland) DAC ("Hannover Re Ireland") whereby it retrocedes the mortality risk on additional term life insurance business assumed from the Company.

RLIC VI is also a party to an XOL reinsurance agreement with Canada Life and the Company. Under this XOL reinsurance agreement Canada Life will pay claims up to the difference between (i) full statutory reserves and (ii) the combination of the qualified reserves and economic reserves, subject to a cap, as supported as settlements under the NewRe MRT Treaty and the Hannover Re Ireland MRT Treaty, if the term life and universal life funds withheld accounts and the Company's capital and surplus are exhausted to zero.

During 2025, 2024 and 2023, under the terms of the coinsurance treaty with RLIC VI, the Company recaptured term life insurance policies from RLIC VI where the level term period of the policies had expired. Reserves held on recaptured policies were $2.6, $1.4, and $2.2 at the beginning of the period of recapture for the years ended December 31, 2025, 2024 and 2023, respectively.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

*RLIC X* 

The Company is a party to a coinsurance with funds withheld agreement with RLIC X whereby it cedes certain term life insurance business to RLIC X. The Company also entered into an XOL reinsurance agreement with RLIC X and Hannover, which was approved by the Virginia Bureau as a form of security otherwise acceptable to the Commissioner in order for the Company to take reinsurance credit on its balance sheet for the amount of its reinsurance credits for reserves ceded to RLIC X in an amount subject to a cap, equal to the difference between the statutory reserves and the qualified reserves with respect to such business. Effective July 31, 2016, the Company terminated this XOL reinsurance agreement with Hannover and RLIC X for new business. The XOL reinsurance agreement remains in effect for policies issued on or prior to July 31, 2016.

Effective December 1, 2017, RLIC X entered into a MRT reinsurance agreement with NewRe whereby it retrocedes the mortality risk on the term life insurance business assumed from the Company.

During 2025, 2024, and 2023, under the terms of its coinsurance treaty with RLIC X, the Company recaptured term life insurance policies from RLIC X where the level term period of the policies had expired. Reserves held on recaptured policies were $0.8, $1.9, and $0.9 at the beginning of the period of recapture for the years ended December 31, 2025, 2024, and 2023 respectively.

**<u>Other Affiliate Reinsurance Transactions</u>**

Effective January 1, 2000, the Company ceded new term and universal life insurance business to GLIC. These agreements were terminated with respect to new business in 2001. Effective September 1, 2016, the Company recaptured most liabilities on the universal life insurance policies ceded to GLIC. Ceded reinsurance reserves to GLIC as of December 31, 2025 and 2024 were $502.2 and $576.4, respectively.

Effective April 1, 2011, the Company amended and restated its existing universal life insurance treaty with GLIC to assume certain additional universal life insurance policies, including total living coverage ("TLC") insurance policies, from GLIC. Effective September 1, 2016, GLIC recaptured all of the liabilities of the TLC insurance policies ceded to the Company. Reserves assumed as of December 31, 2025 and 2024 were $1,701.8 and $1,694.0, respectively.

**<u>Significant External Reinsurers</u>**

Effective December 1, 2021, the Company entered into a coinsurance agreement with SCOR (the "2021 SCOR Coinsurance Treaty") to reinsure the term life insurance business recaptured from RLIC VII and RLIC VIII and an additional block of term life insurance business that was previously retained by the Company. As of December 31, 2025 and 2024, the ceded reserves under the 2021 SCOR Coinsurance Treaty were $986.6 and $1,083.0, respectively.

On April 15, 2004, the Company entered into two reinsurance agreements with Union Fidelity Life Insurance Company ("UFLIC") pursuant to which it ceded, effective as of January 1, 2004, substantially all its variable annuity block of business and its structured settlement block of business to UFLIC. Ceded general account reinsurance reserves to UFLIC for the variable annuity block of business as of December 31, 2025 and 2024 were $346.9 and $381.8, respectively, and modified coinsurance ("Modco") reserves established by the Company as of December 31, 2025 and 2024 for the separate accounts were $1,245.1 and $1,262.3, respectively. Ceded reinsurance reserves for the structured settlement block of business as of December 31, 2025 and 2024 were $4,524.6 and $4,617.2, respectively.

Under a separate reinsurance agreement, the Company assumed a Medicare supplement block of business from UFLIC. The assumed reserves for this block of business as of December 31, 2025 and 2024 were de minimis. To secure the payment of its obligations to the Company under the reinsurance agreements governing the reinsurance transactions, UFLIC has established trust accounts to maintain an aggregate amount of assets with a statutory book value at least equal to the statutory general account reserves attributable to the reinsured business less an amount to be held in certain claims paying accounts. A

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

trustee administers the trust accounts and the Company is permitted to withdraw from the trust accounts amounts due to the Company pursuant to terms of the reinsurance agreements that are not otherwise paid by UFLIC. As of December 31, 2025, the amount of assets in the trust was $5,885.5.

Effective December 1, 2013, immediately after recapturing a substantially similar block of business from Hannover, the Company entered into a new reinsurance agreement with Hannover to cede certain universal life and term life insurance business on coinsurance, Modco with funds withheld and yearly renewable term ("YRT") basis. As of December 31, 2025 and 2024, ceded Modco reserves were $674.8 and $692.1, respectively. As of December 31, 2025 and 2024, ceded yearly renewable term reserves were $134.0 and $137.4, respectively, and ceded coinsurance reserves were $1,593.2 and $1,583.6, respectively.

Effective January 1, 2016, the Company entered into a coinsurance agreement with Protective Life Insurance Company to cede certain term life insurance business. As of December 31, 2025 and 2024, ceded reserves were $697.3 and $788.7, respectively.

On March 6, 2019, Scottish Re US Inc. ("Scottish Re"), a reinsurance company domiciled in Delaware, was ordered into receivership for the purposes of rehabilitation by the Court of Chancery of the State of Delaware. On May 3, 2023, the Receiver concluded that Scottish Re should be liquidated and expected to file a petition to liquidate within 45 days. On July 13, 2023, the Receiver filed a Motion for Entry of a Liquidation and Injunction Order. On July 18, 2023, the Court entered a Liquidation and Injunction Order. On August 9, 2023, the Company received notice that reinsurance agreements with Scottish Re would terminate effective September 30, 2023. Accordingly, the Company recaptured the policies previously ceded to Scottish Re in accordance with SSAP No. 61R, *Life, Deposit-Type and Accident and Health Reinsurance*, by writing off balances through the accounts, exhibits and schedules in which they were ****originally recorded. The Company wrote off assets and liabilities of $24.9 associated with the reinsurance and recorded an increase in reserves of $12.6, resulting in a $37.5 pre-tax loss. However, this did not significantly impact the Company's capital position because nonadmitted and unauthorized reinsurance balances totaling $42.7 were released through unassigned surplus.

Effective September 1, 2023, the Company recaptured certain policies that were previously reinsured to Employers Reassurance Corporation ("ERAC"). The total reserves recaptured were $5.9 and the Company received a refund of unearned premiums of $1.9.

Effective November 1, 2023, the Company recaptured certain policies that were previously reinsured to American United Life Insurance Company ("AUL"). The total reserves recaptured were $2.0 and the Company received a refund of unearned premiums of $0.5.

Effective December 31, 2023, the Company entered into a binding letter of intent with RGA Reinsurance Company to reinsure certain term and universal life insurance policies, primarily composed of the risk recaptured from Scottish Re, ERAC and AUL during 2023, on a yearly renewable term ("YRT") basis. The total reserves ceded were $5.7 and premiums were $7.0. The final treaty was executed and signed on January 30, 2024, with no changes to the terms outlined in the binding letter of intent.

As of December 31, 2025, no reinsurance contracts had been identified which would require the Company to include the supplemental reinsurance risk interrogatories.

*<u>Ceding Entities that Utilize Captive Reinsurers to Assume Reserves Subject to the XXX/AXXX Captive Framework</u>* 

As of December 31, 2025, the Company had one reinsurance agreement carried under the Term and Universal Life Insurance Reserve Financing Model Regulation, for which risks under covered policies have been ceded by the Company to RLIC X. There were no RBC implications as there was no shortfall as of December 31, 2025.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

**(9)** **Statutory Capital and Surplus and Dividend Restriction** 

The NAIC utilizes RBC to evaluate the adequacy of statutory capital and surplus in relation to risks associated with: (1) asset risk, (2) insurance risk, (3) interest rate and equity market risk, and (4) business risk. The RBC formula is designed as an early warning tool for the states to identify potential undercapitalized companies for the purpose of initiating regulatory action. In the course of operations, the Company periodically monitors the level of its RBC and it exceeded the minimum required levels as of and for the years ended December 31, 2025, 2024 and 2023.

State insurance departments, which regulate insurance companies, recognize only statutory accounting practices for determining and reporting the financial condition and results of operations of an insurance company, for determining its solvency under law, and for determining whether its financial condition warrants payment of a dividend to its shareholder.

The maximum amount of dividends that can be paid by the Company without prior approval of the Virginia Bureau is subject to restrictions. The maximum unrestricted dividend payout that may be made in 2026 is the greater of 10% of the Company's statutory capital and surplus as of December 31, 2025 or its net gain from operations for 2025, with such dividend payout not to exceed the Company's earned surplus. The Company has no capacity to make a dividend payment without prior approval in 2026.

**(10)** **Separate Accounts** 

The Company has separate account assets and liabilities related to closed blocks of variable universal life insurance, individual and group variable deferred annuities and modified guaranteed annuities. Separate account assets are carried at fair value and are offset by liabilities that represent the policyholders' equity in those assets. The Company earns mortality and expense risk fees from the separate accounts and may assess withdrawal charges in the event of early withdrawals. Separate account variable universal life insurance contracts include a GMDB and a secondary no-lapse guarantee, which keeps the policy in-force as long as minimum scheduled premiums are paid. Variable annuity contracts may include a GMDB, a guaranteed payout annuity floor (similar to a guaranteed minimum income benefit), a guaranteed minimum income benefit or guaranteed minimum withdrawal benefit or a combination thereof. These guarantees are backed by investments held in the general account. The separate account assets without guarantees represent variable life and annuity products with assets and liabilities valued at fair value. The Company bears no market or default risk for these assets.

The total amounts paid from the general account to the separate account related to separate account guarantees for the preceding five years ended December 31, 2025, 2024, 2023, 2022 and 2021 were $26.2, $24.7, $34.3, $30.9, and $23.0, respectively. To compensate the general account for the risks taken, the separate accounts has paid risk charges of $21.6, $21.9, $23.4, $25.5, and $27.9, for the past five years ended December 31, 2025, 2024, 2023, 2022 and 2021, respectively.

Assets supporting the Company's separate account product contracts of $4,117.1 and $4,175.2 as of December 31, 2025 and 2024, respectively, were considered legally insulated and not subject to claims of the general account.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

Information regarding the separate accounts of the Company as of and for the year ended December 31, 2025 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Non-indexed<br>guarantee<br>less than or<br>equal to 4%** | **Non-indexed<br>guarantee<br>more than 4%** | **Non-guaranteed<br>separate<br>accounts** | **Total** |
|  Premiums, considerations or deposits for the year ended December 31, 2025 | $— | $— | $15.3 | $15.3 |
|  Reserves as of December 31, 2025: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For accounts with assets at: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair value | $2.5 | $1.5 | $4093.3 | $4097.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total reserves | $2.5 | $1.5 | $4093.3 | $4097.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; By withdrawal characteristics: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With fair value adjustment | $2.5 | $1.5 | $— | $4.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At fair value |  |  | 4093.3 | 4093.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Subtotal | 2.5 | 1.5 | 4093.3 | 4097.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not subject to discretionary withdrawal |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $2.5 | $1.5 | $4093.3 | $4097.3 |

---

Reconciliation of net transfers to (from) separate accounts for the year ended December 31, 2025 was as follows:

---

| | |
|:---|:---|
|  | **2025** |
|  Transfers as reported in the Summary of Operations of the separate accounts statement: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers to separate accounts | $15.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers from separate accounts | 550.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfers from separate accounts, per the separate accounts annual statement | (535.4) |
|  Reconciling adjustments: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer to separate accounts – reinsured | 177.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfers from separate accounts, per the Statutory Statement of Summary of Operations | $(357.6) |

---

All assets, liabilities and surplus related to the separate accounts have been recorded in the financial statements.

**(11)** **FHLB Funding Agreement** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Company is a member of the Federal Home Loan Bank of Atlanta ("FHLB Atlanta"). Through its
membership, the Company has outstanding funding agreements with FHLB Atlanta, as of December 31, 2025, the Company did not have any funding agreements outstanding with FHLB Atlanta. As of December 31, 2024, the Company had outstanding
funding agreements with FHLB Atlanta in the amount of $50.0, which related to total liabilities of $50.1, of which $0.1 was accrued interest. The Company uses these funds for liquidity management and asset liability management in an investment
spread strategy, consistent with its other investment spread programs. The Company records the funds under SSAP No. 52, *Deposit-Type Contracts*, consistent with its accounting for other deposit type contracts. It is not part of the
Company's strategy to utilize these funds for operations, and any funds obtained from the FHLB Atlanta for use in general operations would be accounted for under SSAP No. 15, *Debt and Holding Company Obligations*, as borrowed money.
The tables below indicate the amount of FHLB Atlanta stock purchased, collateral pledged, assets and liabilities related to the agreement with

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

FHLB Atlanta as of December 31, 2025 and 2024. The Company has determined the actual or estimated maximum borrowing capacity in accordance with FHLB Atlanta regulatory and or specific borrowing limits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The tables below indicate the amount of FHLB Atlanta stock purchased, collateral pledged, assets and
liabilities related to the agreement with FHLB Atlanta as of December 31, 2025 and 2024:

FHLB Capital Stock

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Aggregate Totals as of December 31, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** |
| **Description** | **Total** | **General<br>account** | **Separate<br>accounts** |
|  Membership stock — Class A | $— | $— | $— |
|  Membership stock — Class B | 11.5 | 11.5 |  |
|  Activity stock |  |  |  |
|  Excess stock |  |  |  |
|  Aggregate total | $11.5 | $11.5 | $— |
|  Actual or estimated borrowing capacity as determined by the insurer | $750.0 | XXX | XXX |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **2024** | **2024** | **2024** |
| **Description** | **Total** | **General<br>account** | **Separate<br>accounts** |
|  Membership stock — Class A | $— | $— | $— |
|  Membership stock — Class B | 12.0 | 12.0 |  |
|  Activity stock | 2.4 | 2.4 |  |
|  Excess stock |  |  |  |
|  Aggregate total | $14.4 | $14.4 | $— |
|  Actual or estimated borrowing capacity as determined by the insurer | $750.0 | XXX | XXX |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Membership stock (Class A and B) eligible for redemption

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Membership stock** | **2025 total** | **Not eligible<br>for<br>redemption** | **Less<br>than<br>6 months** | **6 months<br>to less<br>than<br>1 year** | **1 to less<br>than<br>3 years** | **3 to 5<br>years** |
|  Class A | $— | $— | $– $|  | $– $|  |
|  Class B | 11.5 | 11.5 | – |  | – |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Collateral Pledged to FHLB

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Amount pledged as of December 31, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
|  | **Fair<br>value** | **Carrying<br>value** | **Aggregate total<br>borrowing** |
| 1. Current year total general and separate accounts total collateral pledged (Lines 2+3) | $— | $— | $— |
| 2. Current year general account total collateral pledged |  |  |  |
| 3. Current year separate accounts total collateral pledged |  |  |  |
| 4. Prior year-end total general and separate accounts total collateral pledged | 169.9 | 186.7 | 50.0 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Maximum amount pledged during reporting period ending December 31, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
|  | **Fair<br>value** | **Carrying<br>value** | **Amount borrowed at<br>time of maximum<br>collateral** |
| 1. Current year total general and separate accounts maximum collateral pledged (Lines 2+3) | $174.0 | $186.1 | $50.1 |
| 2. Current year general account maximum collateral pledged | 174.0 | 186.1 | 50.1 |
| 3. Current year separate accounts maximum collateral pledged |  |  |  |
| 4. Prior year-end total general and separate accounts maximum collateral pledged | 190.2 | 200.7 | 100.0 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Borrowing from FHLB

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. As of December 31, 2025, the Company did not have any funding agreements outstanding with FHLB Atlanta.

---

| | |
|:---|:---|
| Amount | as of December 31, 2024:  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2024** | **2024** | **2024** | **2024** |
| **Description** | **Total** | **General<br>account** | **Separate<br>accounts** | **Funding<br>agreements<br>reserves<br>established** |
| 1. Debt | $— | $— | $— | XXX |
| 2. Funding agreements | 50.1 | 50.1 |  | $50.1 |
| 3. Other |  |  |  | XXX |
| 4. Aggregate total (1+2+3) | $50.1 | $50.1 | $— | $50.1 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Maximum amount during reporting period ending December 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Description** | **Total** | **General<br>account** | **Separate<br>accounts** |
| 1. Debt | $— | $— | $— |
| 2. Funding agreements | 50.1 | 50.1 |  |
| 3. Other |  |  |  |
| 4. Aggregate total (Lines 1+2+3) | $50.1 | $50.1 | $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. FHLB – prepayment obligations

---

| | | |
|:---|:---|:---|
| **Description** | **Does the company have**<br>**prepayment obligations under the**<br>**following arrangements (Yes/No)?** | **Does the company have**<br>**prepayment obligations under the**<br>**following arrangements (Yes/No)?** |
|  Debt |  | No |
|  Funding agreements |  | No |
|  Other |  | No |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

**(12)** **Fair Value of Financial Instruments** 

The following tables set forth the Company's assets and liabilities that were reported at fair value as of December 31, 2025 and 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** |
|  | **Level 1** | **Level 2** | **Level 3** | **Net asset<br>value<br>(NAV)** | **Total** |
|  Assets |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Perpetual Preferred Stock: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and miscellaneous | $21.1 | $9.2 | $1.2 | $— | $31.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total preferred stock | 21.1 | 9.2 | 1.2 |  | 31.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stock: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and miscellaneous | 33.9 |  | 11.5 |  | 45.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total common stock | 33.9 |  | 11.5 |  | 45.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash equivalents: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Money market mutual funds | 395.4 |  |  |  | 395.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total cash equivalents | 395.4 |  |  |  | 395.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options |  |  | 17.4 |  | 17.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total derivative assets |  |  | 17.4 |  | 17.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account assets | 4099.0 | 12.9 |  |  | 4111.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $4549.4 | $22.1 | $30.1 | $— | $4601.6 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2024** | **2024** | **2024** | **2024** | **2024** |
|  | **Level 1** | **Level 2** | **Level 3** | **Net asset<br>value<br>(NAV)** | **Total** |
|  Assets |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Perpetual Preferred Stock: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and miscellaneous | $— | $10.4 | $1.1 | $— | $11.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total preferred stock |  | 10.4 | 1.1 |  | 11.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stock: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and miscellaneous | 32.5 |  | 14.4 |  | 46.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total common stock | 32.5 |  | 14.4 |  | 46.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash equivalents: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Money market mutual funds | 272.7 |  |  |  | 272.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total cash equivalents | 272.7 |  |  |  | 272.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivative assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options |  |  | 18.9 |  | 18.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total derivative assets |  |  | 18.9 |  | 18.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account assets | 4156.5 | 12.6 |  |  | 4169.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $4461.7 | $23.0 | $34.4 | $— | $4519.1 |

---

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The following tables present additional information about assets and liabilities measured at fair value for which the Company has utilized significant unobservable (Level 3) inputs to determine fair value as of December 31, 2025, 2024 and 2023:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** |
| **Investments** | **Beginning<br>balance<br>as of<br>January 1,<br>2025** | **Transfers<br>in to<br>Level 3** | **Transfers<br>out of<br>Level 3** | **Total<br>gains and<br>(losses)<br>included<br>in net<br>income<br>(loss)** | **Total<br>gains and<br>(losses)<br>included<br>in surplus** | **Purchases** | **Issuances** | **Sales** | **Settlements** | **Ending<br>balance as of<br>December 31,<br>2025** |
|  Preferred and Common stock | $15.5 | $— | $— | $— | $— | $— | $— | $(2.8) | $— | $12.7 |
|  Derivative assets | 18.9 |  |  | 5.4 | 1.4 | 12.6 |  | (20.9) |  | 17.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $34.4 | $— | $— | $5.4 | $1.4 | $12.6 | $— | $(23.7) | $— | $30.1 |
|  | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** |
| **Investments** | **Beginning<br>balance<br>as of<br>January 1,<br>2024** | **Transfers<br>in to<br>Level 3** | **Transfers<br>out of<br>Level 3** | **Total<br>gains and<br>(losses)<br>included<br>in net<br>income<br>(loss)** | **Total<br>gains and<br>(losses)<br>included<br>in surplus** | **Purchases** | **Issuances** | **Sales** | **Settlements** | **Ending<br>balance as of<br>December 31,<br>2024** |
|  Preferred and Common stock | $18.3 | $— | $— | $— | $(0.1) | $— | $— | $(2.7) | $— | $15.5 |
|  Derivative assets | 14.9 |  |  | 8.0 | 1.1 | 16.1 |  | (21.2) |  | 18.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $33.2 | $— | $— | $8.0 | $1.0 | $16.1 | $— | $(23.9) | $— | $34.4 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2023** | **2023** | **2023** | **2023** | **2023** | **2023** | **2023** | **2023** | **2023** | **2023** |
| **Investments** | **Beginning<br>balance as<br>of<br>January 1,<br>2023** | **Transfers<br>in to<br>Level 3** | **Transfers<br>out of<br>Level 3** | **Total<br>gains and<br>(losses)<br>included<br>in net<br>income<br>(loss)** | **Total<br>gains and<br>(losses)<br>included<br>in surplus** | **Purchases** | **Issuances** | **Sales** | **Settlements** | **Ending<br>balance as of<br>December 31,<br>2023** |
|  Preferred and Common stock | $17.6 | $— | $— | $— | $— | $4.1 | $— | $(3.4) | $— | $18.3 |
|  Derivative assets | 5.7 |  |  | (3.6) | 9.6 | 12.4 |  | (9.2) |  | 14.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $23.3 | $— | $— | $(3.6) | $9.6 | $16.5 | $— | $(12.6) | $— | $33.2 |

---

Realized and unrealized gains (losses) on Level 3 assets and liabilities are primarily reported in either net income (loss) or change in net unrealized capital gains (losses) based on the appropriate accounting treatment for the instrument.

Purchases, sales, issuances and settlements represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and settlements of investments.

There were no gains or losses for the period included in net income (loss) attributable to unrealized gains (losses) related to assets still held as of the reporting date.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

The following tables set forth the Company's financial instruments' fair value, admitted amounts and level of fair value amounts as of December 31, 2025 and 2024:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** |
| **Financial instruments** | **Aggregate<br>fair value** | **Admitted<br>assets** | **Level 1** | **Level 2** | **Level 3** | **Net asset<br>value<br>(NAV)** | **Not<br>practicable<br>(carrying<br>value)** |
|  Bonds: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ICO | $6881.2 | $7502.0 | $— | $6262.9 | $618.3 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ABS | 804.5 | 884.0 |  | 737.0 | 67.5 |  |  |
|  Preferred and common stocks-nonaffiliates | 76.9 | 76.9 | 55.0 | 9.2 | 12.7 |  |  |
|  Separate account assets | 4111.9 | 4111.9 | 4099.0 | 12.9 |  |  |  |
|  Mortgage loans | 1428.1 | 1498.2 |  |  | 1428.1 |  |  |
|  Short-term investments | 3.5 | 3.5 |  |  | 3.5 |  |  |
|  Cash equivalents | 395.4 | 395.4 | 395.4 |  |  |  |  |
|  Other invested assets | 128.0 | 141.9 |  | 128.0 |  |  |  |
|  Derivative assets | 23.4 | 19.0 |  | 1.6 | 21.8 |  |  |
|  Derivative liabilities | 17.7 |  |  | 2.4 | 15.3 |  |  |
|  | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** | **2024** |
| **Financial instruments** | **Aggregate<br>fair value** | **Admitted<br>assets** | **Level 1** | **Level 2** | **Level 3** | **Net asset<br>value<br>(NAV)** | **Not<br>practicable<br>(carrying<br>value)** |
|  Bonds | $7884.6 | $8808.9 | $— | $7248.4 | $636.2 | $— | $— |
|  Preferred and common stocks-nonaffiliates | 81.5 | 80.5 | 32.5 | 33.5 | 15.5 |  |  |
|  Separate account assets | 4169.1 | 4169.1 | 4156.5 | 12.6 |  |  |  |
|  Mortgage loans | 1476.3 | 1599.4 |  |  | 1476.3 |  |  |
|  Short-term investments | 0.7 | 0.7 |  | 0.7 |  |  |  |
|  Cash equivalents | 272.7 | 272.7 | 272.7 |  |  |  |  |
|  Other invested assets | 131.2 | 147.3 |  | 131.2 |  |  |  |
|  Derivative assets | 24.4 | 20.4 |  | 3.0 | 21.4 |  |  |
|  Derivative liabilities | 12.8 |  |  | 0.6 | 12.2 |  |  |

---

The carrying value of contract loans, payables and receivables that are financial instruments approximate fair value as of December 31, 2025 and 2024, and therefore are not presented in the tables above. There were no financial instruments for which it was not practicable to estimate fair value.

**(13)** **Retained Assets** 

The Company provides a claim form to the beneficiary to choose among various disbursement options which include a payment by check, annuity stream or retained asset account, which the Company refers to as a Secure Access Account. Since April 2011, the Company has required the beneficiary to make a positive election of a retained asset account in order to credit death benefit proceeds from a life insurance policy or an annuity contract to a retained asset account (except in Vermont, whose residents are not eligible for retained asset accounts). Prior to April 2011, in nine states, the Company credited death benefit proceeds from a life insurance policy or an annuity contract to a retained asset account only if the beneficiary affirmatively selected a retained asset account. In all other states (except Vermont, whose residents are not eligible for retained asset accounts) prior to April 2011, the Company credited death benefit proceeds to a retained asset account if the beneficiary affirmatively selected a retained asset account or if the beneficiary failed to select any disbursement options on the claim form.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

Credited interest rates ranged from 1.0% to 6.0% and the weighted average crediting rate was 2.6% for the years ended December 31, 2025, 2024, and 2023. The Company discloses the relevant details about its retained asset program, including disclosure of the fact that accounts are not Federal Deposit Insurance Corporation insured, in the information provided to the beneficiary with the claim form and in the supplemental contract issued when a retained asset account is established. The account balance and credited interest are fully backed by the claims-paying ability of the issuing insurance company. The Company's Secure Access program is fully compliant with guidance on retained asset account programs issued in 1995 by the NAIC, and the NAIC's sample bulletin on retained asset accounts issued in December 2010.

The following table sets forth the number and balance of retained asset accounts in force as of December 31, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **In force** | **In force** | **In force** | **In force** |
|  | **2025** | **2025** | **2024** | **2024** |
|  | **Number of<br>policies** | **Amount** | **Number of<br>policies** | **Amount** |
|  Up to and including 12 months | 3 | $0.1 | 3 | $0.2 |
|  13 to 24 months | 3 | 0.2 | 14 | 0.6 |
|  25 to 36 months | 14 | 0.6 | 16 | 1.2 |
|  37 to 48 months | 14 | 1 | 30 | 3.4 |
|  49 to 60 months | 27 | 2.8 | 43 | 5 |
|  Over 60 months | 1769 | 168 | 1947 | 181.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | 1830 | $172.7 | 2053 | $192.3 |

---

Retained assets are a component of Liability for deposit-type contracts on the Statutory Statements of Admitted Assets, Liabilities and Capital and Surplus.

The following table presents additional information regarding the changes in the number and balance of the retained asset accounts related to individual contracts for the years ended December 31, 2025, 2024 and 2023. There were no group contracts in 2025, 2024 and 2023.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2024** | **2024** | **2023** | **2023** |
|  | **Number of<br>policies** | **Amount** | **Number of<br>policies** | **Amount** | **Number of<br>policies** | **Amount** |
|  Retained assets accounts as of the beginning of the year | 2053 | $192.3 | 2385 | $229.8 | 3663 | $293.5 |
|  Retained asset accounts issued/ added during the year | 5 | 0.4 | 3 | 0.9 | 14 | 1.4 |
|  Investment earnings credited to retained asset accounts during the year |  | 4.7 |  | 5.4 |  | 7.3 |
|  Fees and other charges assessed to retained asset accounts during the year |  |  |  |  |  |  |
|  Retained asset accounts transferred to state unclaimed property funds during the year |  |  | (1) |  |  |  |
|  Retained asset accounts closed/ withdrawn during the year | (228) | (24.7) | (334) | (43.8) | (1292) | (72.4) |
|  Retained asset accounts at the end of the year | 1830 | $172.7 | 2053 | $192.3 | 2385 | $229.8 |

---

**(14)** **Risk Sharing Provisions of the Affordable Care Act** 

The Company does not write accident and health insurance policies subject to the affordable care act risk sharing provisions. Although the Company holds several accident and health policies in-force, these policies are not subject to the affordable care act sharing provisions.

------

##### [**Table of Contents**](#toc)
**GENWORTH LIFE AND ANNUITY INSURANCE COMPANY** 

Notes to Statutory Financial Statements — Continued

December 31, 2025, 2024 and 2023

(Dollar amounts in millions)

**(15)** **Investments in SCA Entities** 

The Company has two controlling investments in the common stock and one controlling investment in the preferred stock of noninsurance subsidiaries as of December 31, 2025 and 2024:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Description of SCA<br>investment<br>(excluding 8.b.i entities)** | **Gross<br>amount** | **Nonadmitted<br>amount** | **Admitted<br>amount** | **Date of filing<br>to NAIC** | **Type<br>of<br>NAIC<br>filing** | **NAIC<br>response<br>received<br>(yes/no)** | **2025<br>NAIC<br>valuation<br>amount** | **2024<br>NAIC<br>valuation<br>amount** | **NAIC reject<br>entity's<br>valuation<br>method,<br>resubmission<br>required<br>(yes/no)** |
|  JAC (VA) | $3.6 | $3.6 | $— | 8/3/2022 | Sub-1 | yes | $— | $— | no |
|  ASI (VA)\* |  |  |  | 9/6/2017 | Sub-1 | yes |  |  | no |
|  Newco (VA) | 26.7 |  | 26.7 | 7/14/2025 | Sub-2 | yes | 43.7 | 45.0 | no |
|  GFA | 0.5 | 0.5 |  | 12/5/2017 | Sub-1 | yes |  |  | no |
|  Aggregate Total | $30.8 | $4.1 | $26.7 |  |  |  | $43.7 | $45.0 |  |

---

\* ASI (VA) rounds to zero.

**(16)** **Reconciliation to the Annual Statement** 

The accompanying statutory financial statements do not agree to the 2023 Annual Statement of the Company. The following tables summarize the differences:

---

| | | | |
|:---|:---|:---|:---|
|  | **2023** | **2023** | **2023** |
|  | **As reported in the<br>Annual Statement** | **Difference** | **As reported in the<br>accompanying<br>statutory financial<br>statements** |
| **Statutory Statements of Summary of Operations** |  |  |  |
|  Federal income taxes | $23.6 | $(8.7) | $14.9 |
| **Statutory Statements of Changes in Capital and Surplus** |  |  |  |
|  Net income | 89.7 | 8.7 | 98.4 |
|  Change in net deferred income taxes | 2.1 | (8.7) | (6.6) |
|  Change in nonadmitted assets | 34.6 | (3.3) | 31.3 |
|  Prior period correction — cross-entity term conversions | 32.3 | (32.3) |  |
|  Prior period correction — term conversion coding | (3.2) | 3.2 |  |

---

The 2023 Annual Statement reflected prior period corrections that were recorded through surplus but were corrected in the 2022 audited statutory financial statements. Therefore, there was no change in the ending 2023 capital and surplus.

**(17)** **Subsequent Events** 

There were no material events that occurred subsequent to December 31, 2025. Subsequent events have been considered through April 21, 2026, the date the statutory financial statements were available to be issued.